{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/tanoManzo/mimic_trajectories/blob/dev/MIMIC_TRAJECTORY_embeddings_01.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "! pip install transformers -q"
      ],
      "metadata": {
        "id": "mcvHX_-AewgN",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "19162bf3-4f66-4717-9837-e2c00e1cc29a"
      },
      "execution_count": 1,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.8/6.8 MB\u001b[0m \u001b[31m49.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m199.8/199.8 KB\u001b[0m \u001b[31m14.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m7.6/7.6 MB\u001b[0m \u001b[31m22.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "id": "35BpcyS4eWHw"
      },
      "outputs": [],
      "source": [
        "import torch \n",
        "import torch.nn.functional as F\n",
        "from transformers import AutoTokenizer, AutoModel"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GKFaijaIsKBU",
        "outputId": "bb0ec680-c1ed-45ee-8a37-d3d1f69a71ff"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at /content/drive\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "load nursing notes subject-caregiver-chartdate"
      ],
      "metadata": {
        "id": "2YFjrsu1tkB2"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "notes_path = \"/content/drive/MyDrive/NIH/Data/\"\n",
        "notes_name = \"NOTES_NURSING_TRAJECTORIES_01.csv\"\n",
        "df_notes = pd.read_csv(notes_path+notes_name)\n",
        "df_notes.info()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "sSNmSwI5Ix2P",
        "outputId": "9e0b6be9-5ea0-4191-92b9-497011aa47ee"
      },
      "execution_count": 12,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<class 'pandas.core.frame.DataFrame'>\n",
            "RangeIndex: 65708 entries, 0 to 65707\n",
            "Data columns (total 5 columns):\n",
            " #   Column      Non-Null Count  Dtype \n",
            "---  ------      --------------  ----- \n",
            " 0   ROW_ID      65708 non-null  int64 \n",
            " 1   SUBJECT_ID  65708 non-null  int64 \n",
            " 2   CGID        65708 non-null  int64 \n",
            " 3   CHARTDATE   65708 non-null  object\n",
            " 4   TEXT        65708 non-null  object\n",
            "dtypes: int64(3), object(2)\n",
            "memory usage: 2.5+ MB\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Data exploration "
      ],
      "metadata": {
        "id": "TGpZTurgtr04"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import seaborn as sns\n",
        "sns.set()\n",
        "\n",
        "gb_notes = df_notes.groupby(['CGID','SUBJECT_ID'])\n",
        "num_notes = gb_notes['TEXT'].count()\n",
        "print(f'number of notes: min={num_notes.min()}, max={num_notes.max()}, mean={num_notes.mean()}')\n",
        "sns.boxplot(x=num_notes)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 493
        },
        "id": "S8E5fCVWtzkz",
        "outputId": "fba4b44b-a2ea-4a67-e508-3c082c10f498"
      },
      "execution_count": 28,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "number of notes: min=1, max=31, mean=1.5725636607313804\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<Axes: xlabel='TEXT'>"
            ]
          },
          "metadata": {},
          "execution_count": 28
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "sns.displot(num_notes[((num_notes>5) & (num_notes<15))])\n",
        " "
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 518
        },
        "id": "2DRzgXE9zyNg",
        "outputId": "053662e4-ddeb-4776-9098-815dc6ff0129"
      },
      "execution_count": 44,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<seaborn.axisgrid.FacetGrid at 0x7f9dff7cb730>"
            ]
          },
          "metadata": {},
          "execution_count": 44
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 500x500 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Embeddings "
      ],
      "metadata": {
        "id": "fQeSSVtctxMI"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "model_ckpt = \"sentence-transformers/all-MiniLM-L6-v2\"\n",
        "tokenizer = AutoTokenizer.from_pretrained(model_ckpt)\n",
        "model = AutoModel.from_pretrained(model_ckpt)"
      ],
      "metadata": {
        "id": "NmTObg-8fWZb"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "encoded_input = tokenizer(sentences, padding=True, truncation=True, return_tensors=\"pt\")\n",
        "with torch.no_grad():\n",
        "  model_output = model(**encoded_input)\n",
        "\n",
        "for k,v in encoded_input.items():\n",
        "  print(k)\n",
        "  print(v.numpy())"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "C0lR0E7BgUoV",
        "outputId": "ebfa8573-ac84-43e3-a101-44bc528fefde"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "input_ids\n",
            "[[  101  4700  1061 ...     0     0     0]\n",
            " [  101  2023  2003 ...  3718  1059   102]\n",
            " [  101  2861 10930 ...  2000  8430   102]\n",
            " ...\n",
            " [  101  5187  1061 ...  1011  5018   102]\n",
            " [  101  2720  1012 ...     0     0     0]\n",
            " [  101  5388  2546 ...  1008  1008   102]]\n",
            "token_type_ids\n",
            "[[0 0 0 ... 0 0 0]\n",
            " [0 0 0 ... 0 0 0]\n",
            " [0 0 0 ... 0 0 0]\n",
            " ...\n",
            " [0 0 0 ... 0 0 0]\n",
            " [0 0 0 ... 0 0 0]\n",
            " [0 0 0 ... 0 0 0]]\n",
            "attention_mask\n",
            "[[1 1 1 ... 0 0 0]\n",
            " [1 1 1 ... 1 1 1]\n",
            " [1 1 1 ... 1 1 1]\n",
            " ...\n",
            " [1 1 1 ... 1 1 1]\n",
            " [1 1 1 ... 0 0 0]\n",
            " [1 1 1 ... 1 1 1]]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "token_embeddings = model_output.last_hidden_state\n",
        "print(token_embeddings.size())\n",
        "print('num of sentences, num of tokens, embed dim')\n",
        "print('ONE EMBEDDING VECTOR PER TOKEN')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SpwQQNjZiAYR",
        "outputId": "6c16cd89-cc4c-487b-a54c-97aad37827e3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "torch.Size([202, 512, 384])\n",
            "num of sentences, num of tokens, embed dim\n",
            "ONE EMBEDDING VECTOR PER TOKEN\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def mean_pooling(model_output, attention_mask):\n",
        "  token_embeddings = model_output.last_hidden_state\n",
        "  input_mask_expanded = attention_mask.unsqueeze(-1).expand(token_embeddings.size()).float()\n",
        "  return torch.sum(token_embeddings * input_mask_expanded, 1) / torch.clamp(input_mask_expanded.sum(1), min=1e-9)\n",
        "\n",
        "# Perform pooling\n",
        "sentence_embeddings = mean_pooling(model_output, encoded_input['attention_mask'])\n",
        "\n",
        "# Normalize embeddings\n",
        "sentence_embeddings = F.normalize(sentence_embeddings, p=2, dim=1)\n",
        "\n",
        "print(\"Sentence embeddings:\")\n",
        "print(sentence_embeddings)\n",
        "print('ONE EMBEDDING VECTOR PER SENTENCE')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "pRX2x9TJi__Y",
        "outputId": "0bff94ec-ae6a-4421-d01d-6a0abe817c6e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Sentence embeddings:\n",
            "tensor([[-0.0450, -0.0408,  0.0401,  ..., -0.0268,  0.0031, -0.0270],\n",
            "        [-0.0188,  0.0095, -0.0139,  ..., -0.0397,  0.0347,  0.0718],\n",
            "        [-0.0230, -0.0206, -0.0222,  ..., -0.0719,  0.0716, -0.0368],\n",
            "        ...,\n",
            "        [-0.0328,  0.0021, -0.0175,  ..., -0.0331, -0.0105, -0.0132],\n",
            "        [-0.0227, -0.0065,  0.0247,  ..., -0.0686,  0.0142, -0.0196],\n",
            "        [-0.0021, -0.0212, -0.0115,  ..., -0.0255,  0.0196, -0.0147]])\n",
            "ONE EMBEDDING VECTOR PER SENTENCE\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import numpy as np\n",
        "from sklearn.metrics.pairwise import cosine_similarity\n",
        "\n",
        "sentence_embeddings_np = sentence_embeddings.detach().numpy()\n",
        "\n",
        "scores = np.zeros((sentence_embeddings_np.shape[0],sentence_embeddings_np.shape[0]))\n",
        "dist = []\n",
        "for idx in range(sentence_embeddings_np.shape[0]):\n",
        "  scores[idx,:] = cosine_similarity([sentence_embeddings_np[idx]],sentence_embeddings_np)[0]            \n",
        "  if idx < len(sentence_embeddings_np)-1:\n",
        "    dist.append(scores[idx,idx+1])\n",
        "\n",
        "scores     "
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "dqOwfus2oaRl",
        "outputId": "d333de68-87b4-46d8-e5cd-6076687741f7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "array([[1.        , 0.39844483, 0.6181047 , ..., 0.64212191, 0.61692476,\n",
              "        0.63839036],\n",
              "       [0.39844483, 1.00000024, 0.46432194, ..., 0.43172589, 0.48976815,\n",
              "        0.43978009],\n",
              "       [0.6181047 , 0.46432194, 1.        , ..., 0.7098881 , 0.47162813,\n",
              "        0.57140279],\n",
              "       ...,\n",
              "       [0.64212191, 0.43172589, 0.7098881 , ..., 1.00000012, 0.56964445,\n",
              "        0.65199769],\n",
              "       [0.61692476, 0.48976815, 0.47162813, ..., 0.56964445, 1.        ,\n",
              "        0.5653671 ],\n",
              "       [0.63839036, 0.43978009, 0.57140279, ..., 0.65199769, 0.5653671 ,\n",
              "        1.00000012]])"
            ]
          },
          "metadata": {},
          "execution_count": 55
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import seaborn as sns\n",
        "sns.set()\n",
        "\n",
        "sns.heatmap(scores)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 472
        },
        "id": "JLxiHc4ewr0l",
        "outputId": "7a1debaf-dca9-43a2-f9e3-7243e0b861d6"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<Axes: >"
            ]
          },
          "metadata": {},
          "execution_count": 56
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 2 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "sns.lineplot(dist)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 451
        },
        "id": "eRMCcjHvxd9I",
        "outputId": "74deae3b-fc76-4397-a8b5-0522ec5fa3fd"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<Axes: >"
            ]
          },
          "metadata": {},
          "execution_count": 57
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Clustering "
      ],
      "metadata": {
        "id": "_Sp2Zjlsrpb8"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "from sklearn.cluster import KMeans"
      ],
      "metadata": {
        "id": "BLITj_bchkU8"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "clustering_model = KMeans(n_clusters=6)\n",
        "clustering_model.fit(sentence_embeddings_np)\n",
        "cluster_assignment = clustering_model.labels_\n",
        "print(cluster_assignment)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "lYJw_xlwplLP",
        "outputId": "c05db0b7-cd69-41db-ecdf-21092b67bbd1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[0 0 4 3 2 4 3 5 1 0 3 1 3 3 3 1 1 1 2 2 0 3 0 3 5 3 2 2 4 4 4 4 4 0 3 3 1\n",
            " 4 2 4 1 0 1 3 1 4 0 3 0 2 3 2 2 1 2 1 4 2 2 2 1 3 3 3 2 4 3 2 2 5 4 3 2 0\n",
            " 1 2 0 0 3 0 1 1 2 5 0 2 3 1 3 2 3 4 3 2 2 1 2 0 0 3 0 0 5 2 3 2 4 3 1 1 1\n",
            " 3 2 2 5 0 0 5 5 4 5 3 2 0 3 1 2 3 2 0 2 2 5 2 2 4 4 0 0 2 3 3 2 3 3 3 1 3\n",
            " 2 2 2 1 2 1 2 4 0 4 0 2 1 2 0 3 3 0 2 2 4 4 5 3 1 0 0 2 3 4 3 0 1 0 0 1 4\n",
            " 2 5 1 5 3 2 2 5 3 3 1 2 2 2 2 0 0]\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "clustered_sentences = {}\n",
        "for sentence_id, cluster_id in enumerate(cluster_assignment):\n",
        "    if cluster_id not in clustered_sentences:\n",
        "        clustered_sentences[cluster_id] = []\n",
        "\n",
        "    clustered_sentences[cluster_id].append(sentences[sentence_id])\n",
        "clustered_sentences"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MK4a3n8hp0ix",
        "outputId": "f7454e3f-2aaa-47e2-ba39-b6c1f1aa839a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{0: ['47 yr old woman admitted through EW w/vaginal bleeding & abdominal pain\\n   from fibroids.  On 12R received transfusion X10min, developed crushing\\n   chest pain & BP up to 260/110.  Received 10mg IV lopressor & BP down to\\n   157/86 w/HR 88 SR no ectopy upon arrival to MICU @ 0500. BP L\\n   arm:157/86,  BP R arm: 157/68.  Patient teary eyed & anxious.   C/o\\n   nausea, received 4mg IV zofran w/relief.   Sent for head CT w/out\\n   contrast which was negative.\\n   When patient arrived back from head CT@ 0600, MD discovered that she\\n   had new L sided weakness. Unable to lift L arm above head.  Unable to\\n   dorsiflex w/ L foot (can do so w/R foot).  Barely able to lift L leg\\n   off bed. Could lift R leg high off bed.  Unable to wiggle toes L foot.\\n   Can wiggle toes on R.  Patient scheduled for MRI of body.  Patient\\n   received 4mg IV morphine @ 0600 for abdominal pain, w/some relief (had\\n   [**9-19**] pain which dropped to 5/10).  Said abdominal pain has slowly\\n   increased in intensity from being @ home to arrival in ICU.   Able to\\n   speak normally & no change in mentation. No change in facial\\n   expressions-no facial droop.   Scheduled for full body MRI.\\n   Patient c/o chest pain @ 0700.  EKG done & examined by resident.  Given\\n   2mg IV morphine & 1mg IV dilaudid w/relief.  Patient seen by vascular\\n   surgery & neurology.  In addition, GYN following patient.  No vaginal\\n   bleeding @ this time.\\n',\n",
              "  'This is a 64 year old female with a history of pustular psoriasis and\\n   hypertension who presents with hypotension.  She was in her usual state\\n   of health until 2-3 weeks ago when she began to note a rash consistent\\n   with her psoriasis throughout her body sparing her face.  She was seen\\n   by her PCP who gave her what appears to be a 2 week course of\\n   prednisone, completed 1 week ago.  Her rash was accompanied by nausea\\n   and vomitting.  She also felt chills and subjective fevers and began to\\n   have worsening lightheadedness and SOB on exertion.  She notes that\\n   this is consistent with her prior flare of pustular psoriasis that led\\n   to a hospitalization in [**2101-12-12**].\\n   Pt came to her local hospital in [**Location (un) 945**] c/o fevers, weakness and\\n   SOB. Found to have BP 60. Also c/o not voiding for two days. Creatinine\\n   was 3.0. Pt treated with Vanco and zosyn. 4L IVF given and pt started\\n   on Levophed. Tranferred to [**Hospital1 19**] for further care.\\n   Seen by derm in consult who ordered topical Clobetasol Propionate 0.05%\\n   cream (steroid) to be applied to her affected areas (which is almost\\n   her entire body) twice daily. After cream is applied she needs to be\\n   wrapped in saran wrap for 30  minutes. Bactroban is applied to areas\\n   that are macerated. In between steroid cream applications we need to\\n   keep skin as moist as possible with Aloe Vesta cream.\\n   Overnight pt was weaned off Levophed [**8-11**].   Her pustular psoriasis is\\n   improving over the past few days with the steroid cream applications.\\n   Pt\\ns WBC down to 15 from a high of 30. Continues on Vanco.  Urine\\n   culture positive and blood cultures positive in [**2-15**] bottles.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Patient had some dried crusted skin on various parts of her body, her\\n   torso mostly.\\n   Action:\\n   Applied clobetasol propionate cream to all affected areas &covered\\n   w/plastic wrap X30min.  Keep patient warm as she looses heat & fluid\\n   w/insensible losses via skin.\\n   Response:\\n   Crusted skin is being removed w/procedure, leaving pink new skin.\\n   Plan:\\n   Continue to apply clobetasol cream [**Hospital1 **]; apply aloe vesta cream to keep\\n   skin moist between applications.\\n   .H/O pain control (acute pain, chronic pain)\\n   Assessment:\\n   No c/o pain overnight.\\n   Action:\\n   Received 2mg IV morphine before clobetasol proionate cream applied.\\n   Response:\\n   Morphine relieved pain w/procedure.\\n   Plan:\\n   Continue to medicate for pain before giving clobetasol cream.\\n   Shock, septic\\n   Assessment:\\n   U/o 15-25cc overnight.  Amber urine w/ a little sediment.  CVP 13-17.\\n   BP 113-157/ 62-98       HR: 53 SB-71  SR.   BUN 24 (23)     Cr 1.1\\n   (1.0)      WBC 12.2 (15.7)    Afebrile.\\n   Action:\\n   IV NS increased from 100cc/hr to 125cc/hr.  Then it was increased to\\n   200cc/hr.  Patient given 500cc NS boluses X4.  Urine electrolytes sent.\\n   Response:\\n   U/o still low.  Patient may be having insensible fluid losses via skin.\\n   Plan:\\n   Continue to follow u/o.  Bolus as necessary.\\n   Patient had slurred speech from soriatane po, as she has in the past\\n   she said.  Neuro vs stable.  Smile symmetric, tongue not deviating,\\n   grasps equal, pupils equal & reactive to light.  Slurred speech noted @\\n   [**2093**]  (received med @ 1600) & cleared w/normal speech by 0400.\\n   Scheduled for cardiac echo today.\\n',\n",
              "  'This 59 yr old woman w/extensive PMH including bipolar dz,\\n   polysubstance abuse, fibromyalgia.  Admitted to [**Hospital **] Hosp [**10-18**] w/abd\\n   pain & intermitant diarrhea.  Had abd/pelvic CT  showing ileum\\n   w/infectious vs inflammatory wall thickening & pneumotosis of mid small\\n   bowel & small areas of microperforation.  Patient had transient\\n   hypotension w/BP in 80\\ns/sys, no tachycardia, Tmax 100.9 po.  Patient\\n   c/o chills & rigors.  Concern for sepsis.  Transferred to [**Hospital1 19**] for w/u\\n   of RLQ abd pain.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   No c/o pain overnight.  No pain medication given.  Tox screens were\\n   negative.  Unable to draw them until after narcan given (after PICC\\n   placed , placement confirmed & introducer wire removed).  Belongings\\n   examined w/security officer & all medications (many unlabelled pills\\n   put in safe w/patient\\ns name on bag).  Unable to arouse patient @ the\\n   time although spoke patient\\ns name & shook R arm.  After narcan given,\\n   patient was informed of the same. Preliminary result of head CT ([**10-28**])\\n   is negative.\\n   Action:\\n   Medicated w/0.4mg IV narcan @ 2200.  Turned patient immediately\\n   afterwards.\\n   Response:\\n   Patient woke up @ 2210, opened eyes & answered questions as to where\\n   she was, & who she was,  correctly.  When asked the date she answered\\n19  [**Hospital 1030**] Hospital.\\n   When asked again she repeated the same answer\\n   .  When asked even again,  she repeated the same answer. Afterwards,\\n   patient spoke clearly some of the time, alternating w/not making\\n   sense.  Patient slept for the rest of the night, arousing easily.\\n   Plan:\\n   Continue to assess mental status.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP: 119-142/ 63-83      HR: 83-94 SR   no ectopy      Tmax 97.8 ax\\n   Lactate 0.8     Sed rate 25 (up to 20 WNL)       CXR from [**10-28**] showed\\n   atelectasis @ bases.\\n   Action:\\n   Was hydrated w/IV LR @ 200-125cc/hr, now @ KVO.\\n   Response:\\n   U/o: 125+ cc/hr clear yellow urine\\n   Plan:\\n   Continue to monitor I&O, labs, vs.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   U/o: 125cc+/hr clear yellow urine.   BUN 26 (25)   &  Cr 3.2 (3.5)  @\\n   0100  ([**10-29**])    K 4.5 (unchanged)\\n   Action:\\n   IV LR running @ 200cc/hr.  Patient remains NPO.\\n   Response:\\n   Am labs pending, sent @ 0630.\\n   Plan:\\n   Continue to monitor u/o, BUN & Cr.\\n   Events:\\n   New L double lumen PICC placed.\\n',\n",
              "  'This 80 yr old woman is a resident @ the [**Hospital3 1152**] Nursing Home,\\n   where she was found unconscious. In EW she dropped her BP to 68/ & was\\n   treated w/dopamine for a short time & received 1L IVF. Her CXR showed\\n   CHF & LLL pneumonia.  She received cefepime & levofloxacin IV. Code\\n   sepsis was initiated. Her pCO2 was 61 & she was intubated.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   Patient\\ns BP dropped several times, as low as upper 70\\ns/sys requiring\\n   3000cc NS boluses in total.  U/o also dropped to 3-14cc/hr.  Lactate\\n   was 0.7 in EW. Highest [**Location (un) 308**] was 1.1 @ [**2036**].  BUN 38(down from 39\\n   earlier) & Cr 1.2 (down from 1.5 earlier).  Troponin was 0.26 (CK 47) @\\n   1330. Troponin was 0.20 @ [**2036**] (CK58 & MB 4).  T 95.5po on arrival to\\n   MICU, down from 102 in EW [**Name6 (MD) **] EW RN. Temp slowly increased overnight,\\n   now T 97 po.\\n   Action:\\n   Code sepsis protocol observed. Placed on droplet precautions & nasal\\n   aspirate sent for Cx. Started NS @ 100cc/hr X 1000cc after boluses.\\n   Increased heat in room. Used blankets.\\n   Response:\\n   Lactate remained <1.0.  sVO2 remained 71-86%. U/o improved to 20cc/hr.\\n   BP improved to > 90/systolic. Temp 97 po now.\\n   Plan:\\n   Continue sepsis protocol.  Keep patient warm. Start dopamine @ 0700 for\\n   BP 86/sys\\n   .H/O arthritis, rheumatoid (RA)\\n   Assessment:\\n   She c/o low level of generalized body aches, although changing position\\n   frequently seemed to help[. She was receiving 20mg oxycontin [**Hospital1 **] @\\n   [**Hospital3 1152**] for her rheumatoid arthritis.   As that may have\\n   contributed to her LOC, that was not continued here. She aroused easily\\n   but slept most of the night, most likey due to ativan & residual effect\\n   of oxycontin. Her last dose of any sedative was ativan @ 1840 in EW.\\n   Action:\\n   Repositioned patient for comfort.\\n   Response:\\n   Patient has become much more alert as night has progressed..\\n   Plan:\\n   Continue to assess for pain. Medicate as needed. Note: patient is\\n   allergic to tylenol.  Prepare for weaning.  Failed RSBI due to apnea\\n   this am.\\n   Patient has thick green secretions difficult to Sx  because so thick.\\n   Will have humidified circuit  on vent. CXR done this ([**4-1**]) am.\\n   Fully A&O.  Because of rheumatoid arthritis, was complete care @\\n   nursing home.  Fragile skin (due to age).\\n',\n",
              "  '39 yr old man w/hx DM, HTN, ETOH abuse, gout & stable ankle fx.\\n   Patient was admitted to OSH on [**8-11**] w/abdominal pain.  Lipase 1687 &\\n   WBC 11.  Patient became progressively more confused & was treated\\n   w/ativan per CIWA.  Intubated [**8-14**] after increasing SOB.  On [**8-16**]\\n   patient self extubated & was reintubated later that day.  At OSH,\\n   unable to wean vent due to complications w/hypercapnea & hypoxia.\\n   Despite antibiotics patient has had persistent temp.  Transferred to\\n   [**Hospital1 5**] as he was not improving @ OSH.  Head CT negative here @ [**Hospital1 5**].\\n   Abdominal CT repeated [**8-29**], unchanged w/peripancreatic fluid\\n   collections, no sign of necrosis.  Worsening bilateral atelectasis &\\n   pleural effusions.  Diuresed w/IV Lasix drip.  Removed  1.8L  on [**8-28**] &\\n   2.1L  on [**8-29**].\\n   Pancreatitis, acute\\n   Assessment:\\n   No c/o pain. He was uncomfortable w/turning.   Patient vomited 150cc\\n   bilious material @ 0315.  Tube feeding turned off @ that time.  No tube\\n   feeding /undigested TF\\ns in emesis.\\n   Action:\\n   Patient received fentanyl 125mcg/hr until midnight, when it was D/C\\n   Response:\\n   As above\\n   Plan:\\n   Medicate w/4-6mg IV morphine as needed for abdominal pain.\\n   Fever (Hyperthermia, Pyrexia, not Fever of Unknown Origin)\\n   Assessment:\\n   T 99.7-100.5 po.   WBC 16.7 (11.7)\\n   Action:\\n   Patient remained on the cooling blanket  until 0330.  T 99.2 po @ that\\n   ime.    Received 1000mg Tylenol per feeding tube @ midnight.  Was pan\\n   cultured [**8-29**] .  UA, urine Cx sent [**8-30**].\\n   Response:\\n   HR increased to 140\\ns w/hyperthermia.\\n   Plan:\\n   Continue to medicate w/Tylenol q 8 hrs prn fever.  Cooling blanket prn.\\n   Delirium / confusion\\n   Assessment:\\n   Patient not oriented to place or time.  Could not identify his\\n   girlfriend, [**Name (NI) **], when asked (called her by an ex-girlfriend\\ns name).\\n   Became agitated from delirium @ midnight.\\n   Action:\\n   Patient\\ns girlfriend, [**Name (NI) **], stayed by patient\\ns bedside all night in\\n   order to orient him & calm him.  Patient given 5mg haldol IV  @\\n   midnight & again @ 0100.  Given 5mg xyprexa per feeding tube @ 0300.\\n   Patient\\ns girlfriend, [**Name (NI) **], sat w/him until 0400.  Coworker & nurse sat\\n   w/patient afterwards until 0700.  B wrists restrained as patient pulled\\n   @ feeding tube, foley, oxygen etc.\\n   Response:\\n   Patient remained agitated, did not sleep all night.\\n   Plan:\\n   [**Month (only) 8**] need 1:1 during day shift.\\n   ------ Protected Section ------\\n   C/o pain w/turning @ 0650.  Received 4mg IV morphine w/relief (0/10\\n   pain) @ that time.\\n   IV Lasix off all night.  Patient is 1 L negative in fluid balance @\\n   0600.  Goal: 2L negative/day.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1534**] [**Last Name (NamePattern1) 3577**], RN\\n   on:[**2114-8-30**] 07:21 ------\\n',\n",
              "  '48 yo female with history of hepatitis C, COPD, & hypothyroidism. The\\n   patient reports nausea and vomiting associated with poor PO intake for\\n   the past five days.  She also reports right sided flank pain and\\n   myalgias for the same amount of time.     She denies sick contacts,\\n   however reports to a methadone clinic daily and has been spending much\\n   time with her husband who is admitted here at [**Hospital1 1**] w/CA.   Of note,\\n   the patient has not been taking her levothyroxine for the past few\\n   months, secondary to the stress of taking care of her husband.\\n   Admitted to MICU from EW [**1-18**] w/bradycardia & hypotension.\\n   A-line placed [**1-18**].  Empirically placed on levoflox IV for\\n   pyelonephritis.  Briefly on IV dopamine for hypotension.\\n   Hypotension (not Shock)/ Bradycardia\\n   Assessment:\\n   BP: 124-136/ 68-75                    MAP: 89-100              HR:\\n   43-55 SB no ectopy\\n   Action:\\n   Monitored HR & BP.  Corticostim test done overnight.\\n   Response:\\n   Patient has been rehydrated.  BP stable.  HR coming up & supporting BP\\n   well.\\n   Plan:\\n   Check w/team re: D/C\\ning A-line\\n   Hypothyroidism\\n   Assessment:\\n   T 96.2-96.9po    Patient says she has been lethargic.  Has had\\n   occasional muscle cramps @ home.\\n   Action:\\n   Given 0.25mcg levothyroxine po @ 2200.\\n   Response:\\n   BP stable.  HR in 40\\ns SB asleep & up to 50\\ns when active.\\n   Plan:\\n   Continue to medicate as ordered w/levothyroxine.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN  14 (18)          Cr  0.6 (0.7)            K4.4 (5.2)           WBC\\n   16.5 (16.3)\\n   Action:\\n   Foley was D/C\\ned before 1900.\\n   Response:\\n   Patient is drinking fluids in copious amounts.  Patient is voiding well\\n   in 100-200cc amounts (patient\\ns baseline).\\n   Plan:\\n   Continue to follow labs & u/o.\\n',\n",
              "  '45yo homeless woman with h/o alcohol abuse, hx ETOH cirrhosis who was\\n   transferred from [**Hospital 880**] Hospital with shock /sepsis. She has been\\n   intubated and on pressors since [**2123-11-21**], presumptively due to septic\\n   shock. She has MSSA from a blood culture from [**11-19**] and GPCs (pending\\n   speciation) on [**11-21**]. On [**11-23**], she received 2 units of FFP, had a left\\n   IJ placed; the Cordis and mid-line from the OSH were d/c\\nd. She was\\n   paralyzed with Cisatracurium from [**2041-11-22**]. Ab U/S revealed a cirrhotic\\n   liver, non-occlusive portal vein thrombus with slow flow, and loculated\\n   fluid collection inferior to the liver.  Diagnostic paracentesis was\\n   negative for SBP.   Had a temporary right groin dialysis line placed\\n   and started on CVVHD. She was on pressors.  Extubated on [**2123-12-4**].\\n   Received additional 5 units FFP [**12-10**] to bring INR down from 2.4 to 1.9,\\n   & new temporary dialysis catheter placed @ L IJ.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   As prismaflex used, blood flow rate was increased to 200.  Patient\\n   tolerated this well.  Citrate was held as patient has hepatic\\n   encephalopathy, & replacement fluid was given pre & post filter.\\n   Filter remained clear w/only small amount of clotting @ edges of\\n   headers.\\n   Action:\\n   Resumed CVVHDF @ 2220 on prismaflex.  Started Bair hugger & started\\n   heaing replacement & dialysate solution as patient\\ns axillary temp was\\n   only 95.8 @ 0600.  Used prismaflo blood warmer on & off as it would\\n   overheat, alarm & then I would shut it off.\\n   Response:\\n   Removed 25cc/hr on levophed.\\n   Plan:\\n    Get orders for increased blood flow.  Continue to evaluate for need\\n   for citrate.\\n   Cirrhosis of liver, other\\n   Assessment:\\n   Patient is jaundiced, her effluent is yellow.  LFT\\ns: AST 321 (222 on\\n   [**12-9**])         ALT 81 (67 on [**12-9**])                  Patient is oriented to\\n   self only.  Identifies all caregivers as\\n[**Name (NI) 461**]\\n.  Occasional foul\\n   language, attempting to strike nurse.  Little strength.  Patient slept\\n   most of night.\\n   Action:\\n   Continues rifampin & lactulose q 8 hrs for hepatic encephalopathy\\n   Response:\\n   INR back to 2.2\\n   Plan:\\n   Continue to monitor LFT\\ns, to give lactulose & rifampin, & to protect\\n   patient w/ soft limb restraints & close monitoring.\\n   Sepsis, Severe (with organ dysfunction)\\n   Assessment:\\n   MAP dropped to low 50\\ns @ 2100.\\n   Action:\\n   Increased levophed to 0.1mcg/kg/min before starting back on CVVHDF.\\n   Continues on zosyn.  R femoral dialysis catheter D/C\\ned [**12-10**].  Source of\\n   fevers may be mouth abcess or\\n   Response:\\n   BP responded & MAP maintained>60.  Able to decrease levophed down to\\n   0.085mcg/kg/min on CRRT.\\n   Plan:\\n   Continue to titrate levophed as patient tolerates.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Patient has allevyne dressings intact to excoriated buttocks from\\n   leakage of mushroom catheter.  .  Draining liquid green guiac + stool\\n   via mushroom catheter  Scant blood from mouth w/subglott [**Doctor Last Name **] Sx\\ning.\\n   Action:\\n   Turned q 2 hrs.  Applied criticaid ointment to area around allevyne\\n   dressing..\\n   Response:\\n   Less leakage noted.\\n   Plan:\\n   Continue critic aid to buttocks as needed..  Change allevyne when\\n   soiled.\\n',\n",
              "  '37 year old female who presented to OSH with 5 days of LLQ/left flank\\n   pain. She was initially seen at [**Hospital3 **] on friday and diagnosised\\n   with a ruptured ovarian cyst on US. On saturday she developed\\n   subjective fevers/ rigors, increased pain, and SOB with excertion. Over\\n   the weekend her pain became more diffuse, across the upper abdomen. She\\n   then presented to [**Hospital6 **] ED and workup showed CT evidence\\n   of pyelonephritis. Labs also showed plt of 69, low WBC, low hct around\\n   32 (stated in reports to represent a 10 pt drop since Friday & heading\\n   towards DIC. She was transferred to [**Hospital1 19**] on [**9-18**] for further\\n   management.\\n   MRI of abdomen  [**9-18**] here showed acute infarction of L kidney\\n   involving much of upper pole & interpolar region.  Necrosis vs abcess\\n   in 2 small discrete regions of L kidney.  Co-existent pyelonephritis is\\n   possible.  Small bilateral pleural effusions & consolidation &/or\\n   atelectasis noted in dependent lower lobes.\\n   Pyelonephritis\\n   Assessment:\\n   Tmax po 102.5 @ [**2115**].   WBC 4.5 (3.3)      BUN 15 (16)       Cr 1.0\\n   (1.0)\\n   Action:\\n   BCX2 & UA, Cx sent.  Received 650mg po Tylenol X1.  Later 1000mg po\\n   Tylenol q 6 hrs prn.  Cooling blanket started @ 0100-0200 for T\\n   102.2po, when T dropped to 100po.  Continues on IV vanco q 12 & IV\\n   flagyl q8.  Received 2L LR as fluid boluses for u/o down to\\n   30-40cc/hr.\\n   Response:\\n   T   down to 100po @ 0200.  U/o up to 60cc/hr.\\n   Plan:\\n   Continue to medicate w/Tylenol prn fever.  All Cx results are negative\\n   or pending so far.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   C/o L flank pain & abdominal pain,which worsens w/movement.\\n   Action:\\n   Started on MS Contin 30mg po bid, 1^st dose @ 1830 on [**9-19**].  Medicated\\n   w/IV morphine 10mg  @ [**2035**] & 0015.  Now ordered for 5-10mg IV morphine\\n   q 3 hrs prn breakthrough pain.\\n   Response:\\n   Patient said pain was reduced from [**9-8**] to [**5-9**] after [**2035**] dose of\\n   10mg IV morphine.  Patient fell asleep for most of night.  Received 5\\n   mg IV morphine @ 0430 & again @ 0630.\\n   Plan:\\n   Give 5mg IV morphine  prn pain while taking MS contin.\\n   Pleural effusions, bilateral\\n   Assessment:\\n   CXR from [**9-19**] showed a small L pleural effusion & a R pleural\\n   effusion.  Lungs are clear throughout by auscultation.  RR: 16-30.\\n   O2 sats 85% on room air.  Now on 3L NP to keep O2 sats @ 93-94%.  C/o\\n   SOB while awake.  Tachypneic while awake, due to pain.\\n   Action:\\n   IS given to patient & explained.\\n   Response:\\n   Using IS w/prompting while awake.\\n   Plan:\\n   Continue to encourage IS.\\n   Thrombocytopenia, acute\\n   Assessment:\\n   PLT  CT  48 (56 p transfusion w/PLT)                 Hct  26.7\\n   (30.4)           INR 1.4 (1.3)\\n   Action:\\n   Response:\\n   Small hematoma @ R IJ insertion site.\\n   Plan:\\n   Transfuse for PLT<10 & Hct <21.\\n   Serum K 2.9., repleted w/40 mEq KCl IV this am\\nto be repleted\\n   w/additional 20 mEq KCl IV per sliding scale.  Serum Mg 1.5,  was\\n   repleted w/4 GM magnesium IV.  HR: [**Street Address(2) 1883**] no ectopy all night.\\n',\n",
              "  'This 46 yr old woman w/hx renal calculi had a lithotripsy [**12-7**] &\\n   cystoscopy & stent rmoval [**12-24**].  Developed fever, chills,  pain, N&V.\\n   went to [**Hospital **]\\ns Hospital & was sent to [**Hospital1 19**] where she is followed\\n   as outpatient in GU.  Received 3L NS for sBP 80\\ns/ w/good response.\\n   Lactate 2.4. Given rocephin @ [**Hospital3 **]\\ns & vanco @ [**Hospital1 19**] EW.    Last\\n   hospitalization in [**Month (only) **]  in  [**Hospital Unit Name 1**] for urosepsis .\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   Lactate up to 3.2.  T 101po on arrival.\\n   Action:\\n   Blood & urine Cx sent.  Given 2Gm cefapime.  Given 650mg po Tylenol @\\n   0200.  Given 2L LR, started 3^rd L @ 0600.\\n   Response:\\n   T 100.4 @ 0400.  U/o 45-110cc/hr  clear amber urine.\\n   Plan:\\n   Await BC, urine Cx results.  Continue to hydrate & replace w/IV fluid\\n   as needed.  Medicate w/abx as odered.\\n   PLT CT anomalous @ 87, down from 280.  Repeat was 198.\\n',\n",
              "  'The is a 59 yo male with multiplemyeloma dx [**10/2129**] after a\\n   vertebral collapse and rod placement.   He was initially tx with\\n   melphalan, steroids, and thalidomide, in [**2130**] he was given cytoxan and\\n   then had an autologous BMT in [**2130**].     He  had a double cord matched\\n   unrelated stem cell transplant 59 days ago.  This has been complicated\\n   with [**Doctor Last Name 976**] [**Doctor Last Name **] viris, ARF, and rising liver enzymes.  On 7 [**Hospital Ward Name 236**]\\n   he became SOB, poor u/o despite lasix TID, RR in the 40s, tachy to the\\n   140.  He was intubated on 7 [**Hospital Ward Name 236**] on [**6-16**] and transferred to the\\n   MICU for further care.  Remained intubated w/ respiratory compensation\\n   for lactic acidosis (lactate 10 on [**6-17**] & [**6-18**]).  Received palliative\\n   chemo (nitrogen mustard) on [**6-17**].\\n   Cancer (Malignant Neoplasm), Bone\\n   Assessment:\\n    Hct 21.7    After 2 units PC\\ns, Hct was 24.2.\\n   Action:\\n   Transfused w/1 unit PC\\ns this am.\\n   Response:\\n    Low Hct from hemolysis per oncologist.\\n   Plan:\\n   To receive  1 more unit PC\\ns this am.    Remains on chemo precautions\\n   until [**2128**] [**6-19**].\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Remains  on A/C 40%/RR25/ Vt 600/ 7 PEEP.  O2 sats 94-97%\\n   Action:\\n   Well sedated on 5mg/hr versed & 125mcg/hr fentanyl IV.\\n   ABG\\ns:7.38/30/95.( 2300  on [**6-18**])\\n   Response:\\n   pH improved after hemodialysis Tx\\n   Plan:\\n   Cont on PEEP 7 & RR no faster than 25 to prevent autopeep.\\n   Liver function abnormalities\\n   Assessment:\\n   PLT 20.  Difficult to stop bleeding from finger stick site.  Stool is\\n   guiac +.  Patient bled from mouth overnight.  Mouthcare done\\n   w/caution.  INR 1.8 (2.0)   Fibrinogen 197 (191).    D-dimer 2219  on\\n   [**6-18**] down from 2632 earlier that day.  PTT 50.5 (60)\\n   Action:\\n   Transfused w/ 1 unit PLT\\ns  Transfused w/2 units FFP.\\n   Response:\\n   PLT CT @ 0430 was 31\\n   Plan:\\n   Transfuse to keep PLT CT>30.  Give 25mg IV benadryl pre transfusion q 6\\n   hrs  (give @ 0815).\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 50 , four hours  after 3.5 hour hemodialysis Tx.  BUN 62 & Cr 2.4\\n   this am.  Patient  put out 7cc urine in last 12 hrs..  Patient went\\n   into SVT w/rate 171-198.  BP initially 80/systolic.  Patient was on\\n   dialysis (last 6 min).\\n   Action:\\n   Given back blood which increased BP to 100\\ns-110\\ns/systolic.  Received\\n   300cc NS & 5mg lopressor IV X2 w/little effect.  Transfused w/2 units\\n   PC\\ns (mentioned above).\\n   Response:\\n   Converted back to ST w/rate 100\\ns w/occasional APC after receiving\\n   unit PC\\ns.  HR dropped to 90\\ns SR as night progressed.  BP stable to\\n   hypertensive (160\\ns/sys).\\n   Plan:\\n   Renal fellow to evaluate for need for HD today\\nwill probably need it\\n   for fluid removal & acidosis.\\n   Patient seen by priest for last rites overnight.  Many family members\\n   came to see patient overnight.  Patient is full code.\\n',\n",
              "  'PMH:  46y/o RH man with a history of left temporal anaplastic\\n   astrocytoma, treated with radiation and limited Temodar, and complex\\n   partial seizures from his brain tumor.  He apparently had increased\\n   olfactory hallucinations, worsening of short-term memory, and cognitive\\n   difficulties. Recent brain MRI showed significant progression of his\\n   tumor. He just underwent biopsy of the lesion to evaluate for any\\n   pathologic change that may make him eligible for treatments with\\n   clinical trials.  Elective admit for stereotactic L temporal lobe bx\\n   [**3-1**] & head CT.  Preliminary report suggests glioblastoma.    Now with\\n   worsening symptoms and 6mm shift to R sig. mass effect.  Pt transferred\\n   to [**Wardname **] 4  for experimental chemo treatment. Pt arrived hemodynamically\\n   stable, expressive aphasia noted, but pleasant and cooperative. Some\\n   altered family dynamics as sister  is health care proxy (& not wife).\\n   Chemo (irinotecan & bevacizumab IV)  given on [**3-4**].  In MICU to monitor\\n   for intracerabral bleeding & cholinergic crisis (diaphoresis, visual\\n   changes, abdominal cramps or diarrhea) after chemo.  Next dose of chemo\\n   scheduled for [**3-18**].     Continued on chemo precautions as\\n life of\\n   bevacizumab is 20 days & it is widely distributed though the body.\\n   Plan: Transfer patient back to the floor today [**3-6**].\\n   Cancer (Malignant Neoplasm), Brain\\n   Assessment:\\n    Neuro vs:  Pupils equal & reactive to light.   Grips equal.  Smile\\n   symmetric & tongue not deviating.    A&OX3.  Some difficulty w/word\\n   finding.  Na 136-138    Osmolality 284-285     Head CT  [**3-5**]\\n   unchanged.       [**3-5**] MRI results pending.       WBC 2.8 (3.7)\\n   Hct 38.7 (39.2)      INR 1.1(no change)         BUN 14(14)      Cr 0.8\\n   (0.9)\\n   Action:\\n   Received mannitol 12.5Gm @ 2130.  Continued to receive decadron 4mg po\\n   q 6 hrs.\\n   Response:\\n   Neuro vs unchanged overnight.\\n   Plan:\\n   Continue to check serum Na & osmolality @ least 2 hrs before each dose\\n   of mannitol.   Next dose due @ 10am [**3-6**].  Monitor for cholinergic\\n   effects from irinotecan,  listed above, as well as rhinitis, increased\\n   salivation, lacrimation, & flushing. Give atropine 0.4mg IV prn\\n   cholinergic crisis. Monitor for diarrhea & give loperimide po  after\\n   1^st episode, to prevent dehydration.    Monitor for hypertension, DVT,\\n   hemorrhage from tumor,  GI bleed & epistaxis  from bevacizumab.\\n   Bradycardia\\n   Assessment:\\n   HR: 42 SB-73 SR no ectopy       BP 92- 107/58-71         Patient  &\\n   family said he was athletic prior to [**Month (only) 572**], running, snowboarding etc.\\n   All hobbies patient engaged in were active.      K 3.9 (no change)   Mg\\n   2.3\\n   Action:\\n   Response:\\n   Patient maintained BP w/HR in 40\\n   Plan:\\n   Continue to monitor HR.   Check w/team re: atropine 0.4mg IV prn HR\\n   <40.\\n',\n",
              "  'This 82 yr old woman , a resident @ [**Hospital 3025**] Health Care Center, was\\n   admitted through the Ew [**5-12**] w/acute dyspnea & mental status changes.\\n   DNR/DNI. Lactate 4.3  WBC 17.5.  Found to have UTI & LLL PNA.    At\\n   baseline despite patient\\ns bipolar dz & schizophrenia, she is supposed\\n   to be conversant.  Note, patient\\ns L leg is contracted & her R leg is\\n   on the the way to being contracted.  At this time, patient is\\n   occasionly verbal w/monosyllabic comments, not always appropriate.\\n     Plan: to place PICC when afebrile.  BC negative to date.  Lactate\\n   dropped to 2.7 today.\\n   Dyspnea (Shortness of breath)\\n   Assessment:\\n   RR 24-35  O2 sats down to 90-92% on room air. O2 sats 96-100% on 35%\\n   humidified O2 via tent mask.  Lungs: clear @ upper lungs, diminished @\\n   bases.  Patient had some difficulty w/eating supper.  Could not chew\\n   soft solids well as she has no teeth.  Did best w/\\n   Action:\\n   On room air @ 0600\\n   Response:\\n   While awake, O2 sat 97-98%\\n   Plan:\\n     Continue humidified O2 via tent mask overnight to liquefy secretions.\\n   Hypernatremia (high sodium)\\n   Assessment:\\n   Na down to 155 @ 2300 [**5-13**] from 161.  Cl 121\\n   Action:\\n   IVF changed to D5\\n NS @ 175cc/hr\\n   Response:\\n   Await results of lytes (am labs pending)\\n   Plan:\\n   Continue IVF as ordered.  Continue to offer fluids as patient\\n   tolerates.\\n   Decubitus ulcer (Present At Admission)\\n   Assessment:\\n   See skin impairment in metavision for despription of wounds &\\n   dressings.  New small wound discovered between L 4^th & 5^th toes\\n   surrounded by ecchymosis.  Seen by intern.  Grm + rods growing from\\n   wound Cx sent [**5-13**].\\n   Action:\\n   Changed R trochanter (R hip), coccyx, & L hip drsgs.  Applied new drsgs\\n   to L ankle & malleolus.  Patient now wearing multipodis boots.  Plastic\\n   surgery changed drsg  [**Name5 (PTitle) **] @ coccyx to NS (wet to dry) w/kerlix\\n   packing wound [**Hospital1 **].  Also accuzyme replaced duoderm gel @ R hip.\\n   Response:\\n   Drainage from coccyx, although still copious, is less purulent than\\n   yesterday.\\n   Plan:\\n   To have lamasil ordered for fungal infection @ toes.  Continue to apply\\n   barrier cream to intact skin on feet.  Continue to place 2X2\\ns between\\n   toes.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient alternates moaning when touched for any reason, to being quiet\\n   when she is left alone.  When asked if she was hungry, she said\\n   Patient mumbles phrases like\\nOh my God\\n  that are becoming\\n   intelligible.\\n   Action:\\n   Attempted to orient patient.\\n   Response:\\n   Patient becoming more verbal.\\n   Plan:\\n   Continue to assess mental status.\\n',\n",
              "  '74F with metastatic stage 4 ovarian cancer on levophed and recently\\n   d/c\\nd from CRRT yesterday for line holiday as fungemic.  Originally\\n   presented to ED [**2138-9-12**] w/ ARF and hyperkalemia now s/p ureteral stent\\n   and s/p chemotherapy.  PMH includes hypothyroidism and hyperlipidemia.\\n   Course C/B hypercarbic resp failure, fld overload, ascitites, pleural\\n   effusions, and hypotension requiring pressors.   On contact precautions\\n   for + sputum Cx (sent [**10-5**]) for resistant enterobacter asburiae\\n   (treated w/meropenum). Extubated & levophed D/C\\ned [**10-10**]. Reintubated\\n   [**10-12**] for hypercarbic respiratory failure.  Restarted on levophed on\\n   [**10-12**]. Fungus growing in blood, sputum and urine,  treated w/IV\\n   caspofungin.  Most IV lines d/c\\nd [**2138-10-15**], only line that remains\\n   without change is the left brachial arterial line.  Off CVVHD @ 1600\\n   [**10-15**].  Plan to stay off X 2 days, will reassess on daily basis.\\n     Oncologist had meeting w/family & team, explained that it would not\\n   be appropriate to treat her w/further chemo.  Family wants 2^nd\\n   opinion. They called oncologist @ [**Hospital3 1956**] and is trying to arrange\\n   for a second opinion.  Family has been meeting w/ [**First Name4 (NamePattern1) 478**] [**Last Name (NamePattern1) 439**],social\\n   worker as well as ICU team. Son has stated to Social Work that he wants\\n   patient transferred from [**Hospital1 19**] to [**Hospital3 1956**]/[**Hospital1 609**].\\n   Patient and family updated by Dr. [**Last Name (STitle) **] about fungal infection and\\n   poor prognosis given fungal infection. Pt\\ns family then asked about\\n   dialysis line placement. Explained to patient and family that kidney\\n   function tests stable at present and will readdress need for dialysis\\n   on daily basis. Do not anticipate placement of dialysis line tomorrow.\\n   Discussed issue of tracheostomy and patient does not want to have a\\n   trach, explained to patient that  she needs assistance of ventilator\\n   and without trach patient would most likely die. Pt continues to not\\n   want trach. Daughter stated they\\nd talk about this later.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Patient remained on A/C 40%/400/16/5 PEEP  to rest overnight.  RR\\n   20\\ns-30\\ns  O2 sats 99-100%\\n   Action:\\n   Sx\\ned X3 for no secretions.  Patient coughed & asked to be Sx\\ned each\\n   time.  Increased versed for anxiety from 1.5 to 3mg/hr overnight.\\n   Response:\\n   Patient awake most of night, frequently needing TLC.\\n   Plan:\\n   Change back to CPAP in morning.\\n   Shock, hypovolemic or hemorrhagic\\n   Assessment:\\n   BP 80\\ns-110\\ns/systolic  MAP 60-80\\n   Action:\\n   Titrated levophed up from 0.03 to 0.05 mcg/kg/min, especially as versed\\n   increased.\\n   Response:\\n   Maintained MAP>60\\n   Plan:\\n   Titrate levophed down as patient\\ns BP tolerates.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Foley pulled [**10-16**] @ 1230.  Voided 100cc @ 1700.   14 hrs since last\\n   void.      BUN 37(29)     Cr 0.9 (0.6) K 5.0  Fluid balance was\\n   positive 608cc  for [**10-16**] & negative 1400cc  for [**10-17**] so far.\\n   Action:\\n   Did not void. Scanned abdomen w/bladder scanner.  Found no fluid.\\n   Response:\\n   As patient has been excreting 25cc/hr urine, @ 0300 she should have\\n   250cc urine in her bladder.  Ascites may interfere w/bladder scanner.\\n   Alternatively, she may have been insensible of an incontinent void.\\n   Patient drains so much edema fluid that we may not be able to tell.  No\\n   urine smell however.\\n   Plan:\\n    Excessive edema fluid will make str cathing her difficult.\\n   Pleural effusion, acute\\n   Assessment:\\n   L chest tube drained 1500cc serous fluid over 10 hrs, 1700cc for 12\\n   hrs.  R chest tube drained 50cc serous fluid in 10 hrs & 175cc in 12\\n   hrs. L CT drainage was straw colored now more milky.  R CT still\\n   straw/clear yellow.\\n   Action:\\n   Response:\\n   Plan:\\n   Clamp chest tube if drainage is excessive &/or hypotensive.\\n',\n",
              "  '69yr old female with h/o diastolic HF, IDDM, COPD, ventilator dependent\\n   after PNA with subsequent tracheostomoy in 03/[**2139**]. Patient received\\n   from [**Hospital 82**] Rehab facility, with clinical presentation of altered\\n   mental status, fever of 102.4 and hypotension. During course being\\n   treated for the PNA,and a VAP, now diuresising. On and off a lasix gtt.\\n   Now  on trach collar w/ 21-35% humidified O2.   Plan is to discharge\\n   her back to [**Hospital1 82**].\\n   .H/O pain control (acute pain, chronic pain)\\n   Assessment:\\n   C/o back pain intermittently, mostly w/moving in bed.\\n   Action:\\n   Has fentanyl patch 50mcg/hr on, placed @ noon [**7-13**].  Received 5mg\\n   oxycodone & 650mg Tylenol @ 0030  on [**7-14**].  Has been receiving 2 doses\\n   of both every day for past 2 days.  Morphine has not been given since\\n   [**7-12**] X1 @0350.\\n   Response:\\n   Back pain well relieved.  Patient more sedated tonight.\\n   Plan:\\n   Hold oxycodone & Tylenol during the day.  Use only fentanyl patch to\\n   relieve pain.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   U/o 5-40cc/hr.  Intern & resident aware.  Cr up to 4.0 ([**7-13**] @ 2300)\\n   from 3.9 ([**7-13**] @ 0300).     BUN 53 (no change).  For [**7-13**] @ 2300, patient\\n   was negative 300cc.  I (total)=600cc   O (total)=900cc\\n   Action:\\n   Further lasix held for increase in Cr.  Fed patient dinner.  Offered\\n   fluids/food q\\n - 2 hrs while somewhat awake.\\n   Response:\\n     Patient ate 2 bites egg salad [**Location (un) 316**].  Refused any further food.\\n   Drank 15cc apple juice.  Refused further fluids.   [**7-14**]   BUN 54 (no\\n   change) & Cr 4.1(from 4.0).  Increased Cr from poor intake in setting\\n   of lasix IV (last dose 6/1).\\n   Plan:\\n   Continue to encourage po by offering food & fluids frequently.  Feed\\n   patient.  Perhaps some IV fluids.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   O2 sats 96-100% on 21-35% humidified O2 via trach collar.  RR 18-24.\\n   Lungs: Inspiratory wheezes all lobes, diminished @ R base.  Refused\\n   mouth care for most of night, allowed it @ midnight.\\n   Action:\\n   Off vent for 2^nd night .  Patient encouraged to deep breathe &\\n   cough.    Sx\\ned for scant to moderate amount of thick yellow to blood\\n   tinged secretions q 3-4 hrs.   CPT given.\\n   Response:\\n   Cough is weak & nonproductive.  Patient has more secretions tonight.\\n   Plan:\\n   Continue to Sx prn.  Cont to encourage deep breathing & coughing.\\n   Continue CPT.\\n   Sepsis, Severe (with organ dysfunction)\\n   Assessment:\\n   Vaginal yeast infection noted  (today is 1^st day).  Urine has\\n   sediment.  UA  from earlier today showed lots of WBC\\ns.  Last foley\\n   placed [**7-1**].  Afebrile.\\n   Action:\\n   Started  miconazole nitrate 2% vaginal cream X 7days.  New foley placed\\n   [**7-13**] & repeat UA, Cx sent.  Finished cipro & ceftazidime today.  Now off\\n   abx.\\n   Response:\\n   New UA showed: a few yeast in urine , up from none.  Moderate\\n   leukocytes (down from large), WBC 46 (down from 514).  Also, 533 RBC\\n   (up from 12) & large blood (up from small).  Blood in urine from trauma\\n   most likely.\\n   Plan:\\n   Continue miconazole for vaginal yeast infection.\\n   Had Doppler studies of R arm [**7-13**] for swelling R arm, showed  patent\\n   vessels, no DVT.\\n   Transfer note started [**7-11**].  Page 2 of referral started.  Please review\\n   & update before discharge.\\n   Repleted w/2 Gm IV magnesium for seum Mg 1.7.\\n',\n",
              "  'This is a 44 year-old female with a history of alcohol abuse and\\n   psychosis N.O.S who initially presented to OSH delirious and\\n   hallucinating. Pt was admitted to inpatient psych unit where pt became\\n   increasingly agitated and combative and pt was sent to [**Hospital1 1**] for ?\\n   acute ETOH withdrawal. Patient has received 600-700mg valium since\\n   admission, including 180mg in EW.  Head CT negative. Restraints applied\\n   [**1-23**] increasing agitation, 1:1 sitter initiated and pt was admitted to\\n   MICU for monitoring of respiratory status/further management.   Patient\\n   has been in the hospital 7 days ([**Hospital3 **] to [**Hospital1 3462**] & then to\\n   [**Hospital1 1**]).\\n   Alcohol withdrawal (including delirium tremens, DTs, seizures)\\n   Assessment:\\n   Patient is oriented to herself, not time or place.  She is aware that\\n   she is not @ home.  Auditory & visual hallucinations: speaking w/people\\n   that are not there & hallucinating responses.  Patient yells out @\\n   times.  Constantly attempting to remove restraints & get out of bed.\\n   Using foul language frequently. Fell asleep @ 0225.  Easily aggravated.\\n   Action:\\n   Evaluated by psych who feel that patient is not withdrawing from ETOH.\\n   Psych note said she  currently appears benzo intoxicated.   Received\\n   10mg IV haldol q 1 hr from 2100-0200  for more intense agitation,\\n   yelling out.  In 4 point leather restraints.  1:1 sitter @ bedside.\\n   Response:\\n    QTc 4.4- 4.7  by EKG & monitor.\\n   Plan:\\n   IV haldol 5-10mg q 1 hr prn severe agitation. ([**Month (only) 11**] give 5mg IVP q\\n   5min).   Check QTc by EKG/monitor  following  each dose.  Once QTc\\n   is>.50, plan is to treat w/depakote (po) instead.  Hold valium (benzo\\n   intoxication).\\n   Serum K [**1-7**] eve was 3.7.  Treated w/40mEq KCl po.  Serum K [**1-8**] am was\\n   unchanged @ 3.7.\\n   New #20 PIV placed @ R AC on [**1-8**].  Old  #18 PIV @ L forearm is\\n   phlebitic.  Patient would not let me remove it last night.\\n   ------ Protected Section ------\\n   #18 L PIV removed @ 0510 while patient was asleep.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2147-1-8**] 05:39 ------\\n   Patient Has been @ [**Hospital1 1**] since [**1-5**].  She was initially admitted to\\n   [**Hospital3 187**] on [**1-4**], then to [**Hospital1 3462**] on [**1-5**] (stayed for 12 hrs).\\n   Therefore she has been in the hospital for 4 days, not  7 as previously\\n   stated.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2147-1-8**] 05:52 ------\\n',\n",
              "  'This 49 yr old woman was admitted through EW w/complaint of  N/V & LLQ\\n   pain since [**4-22**].  T101 BP 80/ & HR 140\\ns.  PMH: metastatic colon CA to\\n   lungs & adrenal gland, ESRD s/p 2 failed renal transplants, on\\n   peritoneal dialysis.  S/p CVA [**8-/2137**] w/no residual.  SLE, osteoporosis,\\n   s/p B leg fx [**2144**], multiple CN palsies, causing dysphagia & vocal cord\\n   paralysis.  Currently on chemo ( 2 or 3 pills/week).\\n     Received 2.3L IVF in EW to bring BP up to 90\\ns/systolic.  Usually has\\n   BP in 100\\ns/systolic.  Cx of PD fluid sent as well as BCX2.  Received\\n   IV vanco & ceftriaxone in EW.\\n     Overnight, the patient\\ns BP ranged from 84-101/systolic.  Her MAP was\\n   >60 most of the time.  HR: 90\\ns SR. At 0200, her HR increased\\n   transiently to 130\\ns.  Received 650mg Tylenol @ that time despite\\n   axillary temp of 97.1.  Received 500cc NS boluses X3 to keep sBP>90/.\\n   Receiving NS w/20 mEq KCL @ 150cc/hr.  Afebrile overnight.  Received\\n   compazine IV X1 w/pills @ 2200.  No N/V overnight.\\n     Had diarrhea X3 overnight.  Stool sent for C-diff, O&P.  WBC 20, down\\n   from 29 earlier.  Hct only 21, down from 30.  Only receives EPO @\\n   [**Hospital 661**] clinic (won\\nt give herself shots).\\n     Started PD @ midnight-0100.  Needs next exchange  @ 0800-0900.\\n     Needs repeat CBC this am\\nphlebotomy coming after 0700.\\n',\n",
              "  'This 44 yr old woman w/MS & known sacral decub was admitted w/fever.\\n   Also had somnulence & hypotension from oxycontin @ home,treated\\n   successfully w/narcan X2.   Found osteo @ sacral decub.  UA showed\\n   possible UTI.  Rx\\ned w/IV vanco,cipro & unasyn in EW.  Sacral decub\\n   debrided in EW by sugery.  Followed by [** 3044**] & surgery.   Has\\n   vaginal yeast infection, started miconazole.  Plan: Call out to floor\\n   today.  Now on contact (MRSA) precautions.\\n   Osteomyelitis\\n   Assessment:\\n   Anaerobic BC from [**5-15**] came back w/+ cocci in pairs & chains.  Covered\\n   adequately w/abx : vanco & unasyn IV.  Aerobic BC & urine Cx pending.\\n   WBC 6.6 (from 6.9 on [**5-16**] & 16.1 on [**5-15**]).\\n   Action:\\n   Placed patient on contact precautions for possible/probable MRSA.\\n   Started NS (wet to dry) drsg  [**Name5 (PTitle) **] [**Name5 (PTitle) **] [**Name5 (PTitle) 3044**].   Seen by IV team [**5-16**] PICC, but not placed as patient was febrile (Tmax 102 on day\\n   shift).  BCX1 drawn @ 0430  [**5-17**].\\n   Response:\\n   Tmax: 99.5po @ [**2140**]  (rec\\nd  tylenol @ 2200)\\n   Plan:\\n   Continue drsg [**Name5 (PTitle) 292**].  Monitor for temp. Treat w/IV abx. Await Cx\\n   results.  Will need 6 weeks abx for osteo & eventual VAC.  Long range\\n   plan is flap by [**Name5 (PTitle) 3044**].  Await temp to normalize & PICC to be placed.\\n   Multiple sclerosis\\n   Assessment:\\n   Patient expressed discomfort w/male coworker bathing her.  Patient\\n   started to cry when saying her feet were cold after her socks were\\n   removed, immediately stopped when new socks were produced.\\n   Action:\\n   Only washed patient\\ns back w/coworker. [**Name (NI) 53**] OK w/this. Patient\\n   remained supine X  60min during bath.\\n   Response:\\n   Patient somewhat emotionally labile.\\n   Plan:\\n   Offer emotional support\\n   .H/O pain control (acute pain, chronic pain)\\n   Assessment:\\n   Has chronic pain in L shoulder, back & arms.  HR:80\\ns SR- [**Street Address(2) 1023**]  BP:\\n   77-126/ 40\\ns-70\\ns.  Uses ice packs @ home to shoulder & back.  Lies\\n   directly on ice packs @ home.\\n   Action:\\n   Received 1 percocet q 4 hrs (prn) alternated w/900mg neurontin.  Also\\n   requested & received ice pack to L shoulder & back.  Would not allow\\n   patient to lie on top of ice pack, after red spot appeared where ice\\n   pack was & eventually disappeared. Given 2mg IV morphine for drsg\\n   [**Name5 (PTitle) **]. Resident aware of low BP & not concerned as patient deeply\\n   asleep, mentating well when awoken & w/good u/o.\\n   Response:\\n   Good relief of pain w/percocet & neurontin.  Still had pain during\\n   dressing (drsg) change, which stopped immediately after drsg [**Name5 (PTitle) **] was\\n   complete.\\n   Plan:\\n   Continue to assess for pain.  Medicate w/neurontin qid & percocet 1 q 4\\n   hrs as needed for pain.\\n',\n",
              "  'This is an 81 yo F with a hx of dementia, HTN, and a large RLL mass who\\n   presents with poor PO intake and a cough for the last three days. She\\n   resides at [**Hospital 2343**] [**Hospital **] Nursing home and the above symptoms were\\n   noted by the staff. Labs drawn on [**5-15**] showed a BUN of 88 and a creatine\\n   of 4. She was started on IVF but stopped after 600cc after ? increased\\n   wetness of cough. Per the NH, prior to ED transfer her UOP was minimal.\\n   Her labs continued to worsen on [**5-16**] so she was sent to the ED for\\n   eval.\\n   InED. a CXR was noted to have a RML/RLL infiltrate so she received\\n   vanc/cefepime/levofloxacin for HAP as well as nebs.   Has chronic LLL\\n   mass.   She was given 2L of NS in the ED but had a persistently\\n   elevated lactate with no hypotension. She was also noted to be markedly\\n   tachypneic with RR in the 30s but without significant hypoxia, satting\\n   95% on 2L. Given these two features, she was admitted to the ICU.\\n   On presentation to the ICU, she notes that she feels \"lousy\" and feels\\n   SOB. Denies chest pain, N/V/D. Notes some occasional R  sided abdominal\\n   pain. Rest of ROS not obtainable due to patient\\'s dementia and poor\\n   historian.\\n   [**5-17**] abd CT showed pancreatitis.  No u/o since admission. Foley placed\\n   in MICU [**5-17**].   Started on CVVHDF [**5-17**] @ 1630.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   On CVVHD  on Prisma machine, w/clear dialyzer & no anticoagulant.\\n   Lines reversed to maintain blood flow (QB) @ 180.    At 2300 on [**5-17**],\\n   Lactate 3.3 (6.9).\\n   Action:\\n   Attempting to keep patient even, removing no weight.  Flushed system\\n   w/200cc NS  approximately q 4 hrs.\\n   Response:\\n   BP & HR stable.  Lactate dropping.\\n   Plan:\\n   Continue CVVHDF on Sun [**5-18**].     [**Month (only) 60**] start hemodialysis Mon [**5-19**](?), if\\n   BP & HR remain stable.\\n   Chronic obstructive pulmonary disease (COPD, Bronchitis, Emphysema)\\n   with Acute Exacerbation\\n   Assessment:\\n   Patient retained CO2 after being medicated w/IV dilaudid 1mg @ [**2170**].\\n   ABG\\ns:@ 2300 (supine, after turning off of R side): 7.22/61/63.  At\\n   2340, (on L side) ABG\\ns: 7.18/69/86.  Lungs: clear w/diminished breath\\n   sounds @ bases.  O2 sats: 98-99% on CPAP; 96-98% on 40% high flow neb.\\n        WBC 18.7 (13.6)\\n   Action:\\n   Started CPAP via face mask @ 40% w/5 PEEP @ 0030.    Back on 40% high\\n   flow neb @ 0545.\\n   Response:\\n   ABG\\ns improved @ 7.30/ 45/ 77 @ 0130, & 7.32/46/75 @ 0420.    Started\\n   to wake up @ 0315.  Desatted on R side.\\n   Plan:\\n   Turn patient from back (supine) to L side.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient  sat up in bed & yelled out in pain @ [**2170**].\\n   Action:\\n   Given 1mg IV dilaudid @ [**2170**] for severe abdominal pain from\\n   pancreatitis.\\n   Response:\\n   Patient was free from pain while not turning, but retained CO2 from\\n   pain med.\\n   Plan:\\n   Dilaudid D/C\\ned.  Will need to find another  means of pain relief.\\n',\n",
              "  '45 yr old man w/CML who was discharged from [**Hospital1 54**] on\\n, readmitted\\n   through EW [**2-11**] w/MS changes.  Oriented to self only.  Had head CT that\\n   showed new 6mm hyperdense focus @ L temporal lobe-?metastatic lesion vs\\n   small hemorrhage.  To get MRI today to better diagnose.\\n   Hypoxemia\\n   Assessment:\\n   O2 sats in mid 90\\ns on 2L NP.  Lungs were clear @ upper lungs &\\n   diminished @ bases.  Tmax 98.7po\\n   Action:\\n   Given vanco, ceftriaxone & flagyl in EW.  Given acyclovir IV  @ 0100 &\\n   levofloxacin IV @ 0600.  Urine Cx sent.  BC sent from EW.\\n   Response:\\n   CXR showed continuing LLL consolidation as well as small bilateral\\n   pleural effusions.\\n   Plan:\\n   Monitor temps, cont abx, start IS.  Try humidified O2.\\n   Delirium / confusion\\n   Assessment:\\n   Patient is oriented to self only.\\n   Action:\\n   Bed alarm on.  Oriented patient prn.\\n   Response:\\n   Patient unable to swallow levofloxacin (3 pills).  Now on IV\\n   levofloxacin.\\n   Plan:\\n   Try crushing po meds & mixing w/applesauce.\\n   Patient does not tear from eyes.  Artificial tears applied after L eye\\n   washed w/arm water.  R eye is taped shut to keep moist per suggestion\\n   of opthamologist  (wife relayed info).\\n   ------ Protected Section ------\\n   HR: 120\\ns-[**Street Address(2) 1965**] overnight (baseline is 100\\ns-[**Street Address(2) 2463**]).  BP:\\n   160\\ns-170\\ns/110\\ns.  Received 5mg labetalol IV  @ 0530 & 0600 to bring\\n   HR down to 119 & BP down to 164/110.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2155-2-12**] 07:34 ------\\n',\n",
              "  'This is a [**Age over 90 **] yo male with CVA, CAD, HTN, diastolic CHF, chronic\\n   kidney disease who was admitted on [**11-21**] with delirium and a UTI.\\n   During his hospital course he had an aspiration pna, NSTEMI, EF 35%,\\n   acute on chronic RF now with a creat of 5.2 today.  His echo from\\n   yesterday showed worsening AS, MR, decreased LV function, last night he\\n   developed SOB, he was started on BIPAP, and a Lasix gtt, he conts to\\n   have pulm edema, he is hypoxic requiring 100% NRB plus 4 liter via NC\\n   to maintain an 02 SAT in the low 90s, he is not a candidate for\\n   valvuloplasty or a valve replacement.\\n   [**Last Name **] Problem\\n [**Name (NI) 580**]\\n   Assessment:\\n   Patient , family & team had family meeting [**11-25**] & decided on comfort\\n   care.  Overnight, patient\\ns wife, son, nephew, daughter-in-law visited\\n   w/patient & confirmed their concensus:  they wanted patient to be kept\\n   comfortable.  They wanted a morphine drip to prevent anxiety & pain.\\n   Patient started c/o SOB\\n   Action:\\n   Patient received 2mg IV ativan @ 0030, followed by 6mg SL morphine\\n   (while he was still awake & anxious)-given over 20min.\\n   Response:\\n   Patient slept.  Started IV morphine @ 0330 to prevent pain/anxiety.\\n   Plan:\\n',\n",
              "  '27 y.o. male w/ a PMH significant for polysubstance abuse, depressive\\n   disorder, and GERD who presents after being found down at [**Hospital1 4598**] where he been admitted for detox.  On the evening of [**2162-3-7**] he\\n   received his last dose of methadone at 8:00 pm.  He also received\\n   citalopram and omeprazole and one dose of trazodone for sleep.  The\\n   next morning he was found around 9:00 am to be unresponsive and\\n   tachypneic with pinpoint pupils.  He was transferred via ambulance to\\n   [**Hospital1 5**] ED, where he received narcan w/ limited effect, and was febrile,\\n   hypertensive, tachycardic.  LP negative for menengitis and Urine tox\\n   only positive for methadone. [**Known lastname 4558**] was started on broad spectrum abx\\n   and transferred to the M/SICU for further management.\\n   Events:\\n   Tmax 101.7 po @ 0400.  BCX2, UA, C&S sent.  Sputum Cx sent [**3-10**].\\n   Tylenol given @ 0700.    WBC 14 ( 21.3)\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient continues to open eyes to stimulation, move all extremities non\\n   purposefully & withdraws to painful stimuli.  His BP increased to\\n   220/systolic w/mouth care, turning & suctioning/coughing.  His eyes do\\n   not focus or track.  Patient stretches out legs & his legs have a\\n   tremor while his eyes remain closed  each time he is turned or receives\\n   mouth care, sx\\ning-- ? seizure activity.  This activity was not seen\\n   when he was left alone.\\n   Action:\\n   Received propofol for a few minutes until his BP was back down to\\n   160\\ns/systolic.\\n   Response:\\n   No stimulation & IV propofol brought patient\\ns BP back down to\\n   160\\ns/systolic.\\n   Plan:\\n   Head CT & EEG planned for today.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 76**])\\n   Assessment:\\n   On CPAP @ 40% w/5 PEEP & 5 PS.      RR: 14-20          O2 sats: 97-98%\\n   Lungs were clear w/exp wheezes @ L base.\\n   Action:\\n   ABG:  7.47/37/114      Sx\\ned for small amount thick tan secretions.\\n   Grm stain shows no bacteria ([**3-10**])\\n   Response:\\n   RSBI: 27\\n   Plan:\\n   Wean from vent as patient is able to protect his airway.\\n   Renal failure, acute (Acute renal failure, ARF)  from rhabdomyolysis\\n   Assessment:\\n   U/o 100cc/hr.         Receiving 110cc/hr + abx/gastric meds.   BUN  45\\n   (47)       Cr 4.2  (4.2)\\n   Action:\\n   Continue to finish 2400cc  D5W (on 2^nd L) @ 100cc/hr.\\n   Response:\\n   CK down to 5360 from 12,746 yesterday.    BUN & Cr unchanged.\\n   Plan:\\n   Continue to hydrate well & follow labs.\\n',\n",
              "  'This is a 55 year-old female with a history of COPD and respiratory\\n   failure, MAT/a-flutter, who was initially admitted to [**Hospital3 **]\\n   with MAT/a-fib, respiratory distress, intubated and treated for UTI and\\n   transferred to [**Hospital1 54**] per family request.\\n   Sepsis, Severe (with organ dysfunction)\\n   Assessment:\\n    MAP maintained>65 on 2 pressors (dopamine & Levophed)  Tmax 101.5 po\\n   HR: [**Street Address(2) 1983**] -[**Street Address(2) 2666**] w/atrial bigeminy & frequent PAC\\n   Action:\\n   Dopamine given @ 5-10mcg/kg/min.  Levophed given @0.2-0.4mcg/kg/min.\\n   Started on IV voricanizole for fungal protection, also had flagyl &\\n   linezolid started IV.  IV vanco D/C\\ned.  Received Tylenol @ 2200.  On\\n   cooling blanket until 2230.\\n   Response:\\n   Lactate up to 5.7-5.8 from 4.2 earlier.  WBC down to 2.6 from 3.1\\n   earlier.\\n   Plan:\\n   Continue to titrate dopamine & Levophed to keep MAP>65.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Patient continues on A/C @ 100% w/ Vt 400/ RR 26/ PEEP 18.     Low pH\\n   w/ABG\\ns due to acidosis from renal failure  & lactic acidosis.\\n   Action:\\n   2L D5W w/3 amps bicarb infused @ 200cc/hr to bring pH up from 7.15 to\\n   7.20\\n   Response:\\n   ABG\\ns @ 0100: 7.17/63/77    At 0500, ABG: 7.20/64/60  At 0600:\\n   7.16/69/60\\n   Plan:\\n   Possible esophageal balloon today to determine optimum PEEP.  Possible\\n   CRRT to remove fluid.  Limit IVF for low pO2 due to fluid overload.\\n   Alteration in Skin Integrity\\n   Assessment:\\n   Patient\\ns feet were merely mottled the previous night, now some toes\\n   are blue bilaterally as well as both heels.  B DP\\ns & PT\\ns dopplerable.\\n   Action:\\n   Titrated levophed down initially.  Titrated levophed back up & stopped\\n   dopamine.\\n   Response:\\n   No change in mottling & color of extremities\\n   Plan:\\n   Continue to keep heels off bed.  Continue to monitor pedal pulses.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 38   Cr 1.3      pH 7.17-7.20 w/ABG\\ns.     Patient is 16-17 L\\n   positive since admission on [**8-16**] evening.  U/o 3-15cc/hr.     Serum\\n   HCO3 was 21-22.  Increased PAC\\ns & then atrial bigeminy w/increased\\n   acidosis.  HR [**Street Address(2) 1983**]- [**Street Address(2) 2666**]  now w/atrial bigeminy & frequent\\n   PAC\\n   Action:\\n   2L D5W w/3 amps bicarb given\\n   Response:\\n   pH up to 7.17-7.20 while bicarb infusing, now back down to 7.16.\\n   Plan:\\n   Renal following patient, called by MICU team to see her early this am.\\n   Possible CRRT today for fluid removal & treatment of acidosis.    L\\n   femoral catheter to be rewired for dialysis catheter if needed.\\n   ------ Protected Section ------\\n   Replaced old foley  w/new one on [**8-17**] @ 2200.\\n   High FS\\ns (361 @ 0600).  Had given sc insulin in arms.  Because of\\n   edema, started to give sc insulin in abdomen.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2165-8-18**] 18:47 ------\\n',\n",
              "  '68 yr female w/ hx diffuse gastric large B-cell lymphoma\\n pt s/p\\n   partial gastrectomy, radiation and CHOP. [**Name (NI) 6910**]\\n pt s/p auto SCT.\\n   Relapse\\n08 and pt has undergone several courses of chemo.\\n   Pt reports presenting to hospital  [**12-4**] for PNA. Pt tx for febrile\\n   neutropenia on floor, and started chemo 19 days ago per Dr. [**Last Name (STitle) 6911**].\\n   Patient was transferred to MICU for hypotension 12/ 7 , relieved w/2L\\n   IVF & 1 unit PC\\ns, PICC line D/C\\ned.   Sent back to floor [**1-8**].\\n   Patient returned to MICU [**1-10**] again w/hypotension\\nrelieved w/1500cc\\n   fluid bolus.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   Hemodynamically stable.  BP101-133/sys  HR: 80\\ns SR, goes up to 120\\n   w/exertion.  [**1-10**] sputum grew gram + cocci in pairs & clusters.  WBC\\n   0.3 on [**1-10**], pending for [**1-11**]\\n   Action:\\n   ID said in note that patient was colonized by VRE, therefore she was\\n   placed on contact precautions.  Received IV daptomycin, IV tobra & IV\\n   meropenum overnight.  Also received po bactrim, flagyl, posonicozole, &\\n   acyclovir.\\n   Response:\\n   Tmax 100.3 po.  BCX1 sent.  Sputum Cx sent.\\n   Plan:\\n   Send 2^nd set of BC.  Follow temp.\\n   [**Last Name **] Problem\\n Increased O2 requirement.\\n   Assessment:\\n   With exertion, RR high 20\\ns-low 30\\ns, HR up from 80\\ns SR to [**Street Address(2) 1983**] &\\n   O2 sats down to 88-90%.\\n   Action:\\n   Titrated O2 up from 2L NP to 4L NP.  Given IV lasix @ 2-4 mg/hr until\\n   0430 when shut off.  CXR done this am.\\n   Response:\\n   O2 sats increased to 96-99% on 4L NP from mid 90\\ns on 2L NP when not\\n   getting up to the commode.  Fluid balance was +500cc on [**1-10**].  It is\\n   -2000cc so far on [**1-11**].\\n   Plan:\\n   Repeat BAL recommended by ID w/bx & Cx\\n',\n",
              "  '68 year old female with AML admitted to MSICU after being found on the\\n   floor on 7F in a supine position with mental status changes and a large\\n   skin year to her right arm and multiple hematomas.  She was unable to\\n   move her right arm or right leg and her speech was garbled.  Her VSS\\n   and she was sent for a head CT Scan which showed an acute left\\n   parietal, thalamic hemorrhage with extension into the lateral\\n   ventricle.   Her platelets at the time of the fall were 17\\n she was\\n   transfused with a total of 3 units of platelets and her 1pm count was\\n   over 200.   She had been having mild confusion on the floor for a few\\n   days which was attributed to the ATG infusions. She is currently in the\\n   process of getting a stem cell transplant and is day -1 with the\\n   transplant planned for Friday [**2-16**]. CT x3 yesterday since event as well\\n   as CT this AM showed no significant changes.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient was oriented X2, to place (\\nhospital\\n) & self  (\\n[**Known firstname 7512**]\\n   Not oriented to date.  Asked year,\\n.  Unable to move on R side &\\n   w/no sensation on R side.  L normal.  Smile symmetric.  Tongue not\\n   deviating.\\n   Action:\\n   Checked neuro vs q 2 hrs.  Seen by speech & swallow.\\n   Response:\\n   Neuro vs improved: has corneal reflex & brisk response w/eyes equal &\\n   reactive to light.  Oriented X2 as above.\\n   Plan:\\n   Continue to check neuro vs.  Speech & swallow recommended nectar thick\\n   liquids; alternating sips of liquid w/pureed food; 1:1 w/feeding; crush\\n   large pills& mix w/pureed food, may give small pils w/sppon of pureed\\n   food.  Will have periodic head CT\\ns to monitor for changes.  Neuro\\n   believes it will reabsorb.\\n   Leukemia, acute (ALL, AML, Cancer, Malignant Neoplasm)\\n   Assessment:\\n   PLT CT  57  (81)      Hct  30.9  (32.5)         INR 1.3 (1.4)\\n   Action:\\n   Followed labs\\n   Response:\\n   As above\\n   Plan:\\n   Transfuse fot PLT CT <50.  BP goal 120-160/systolic.  INR goal <1.4   &\\n   Hct goal 30.  Inform team w/changes.\\n   Keep patient  euthermic.   To transfer to oncology floor for stem cell\\n   transplant [**2-16**].\\n',\n",
              "  'This 69 yr old man was transferred from [**Hospital3 **] w/sepsis on IV\\n   neosynephrine.  On [**8-17**] had transrectal prostate [**Name6 (MD) **] in MD\\ns office.\\n   Complicated by post procedure bleeding from urine (never stopped) &\\n   stool (X2 days).  On [**8-18**] patient developed fever 101.5 & malaise;\\n   admitted to [**Hospital3 **].  Grew 4 out of 4 BC w/gram negative rods.\\n   Treated w/IV zosyn, vanco & levaquin IV. Had pelvic & abdominal CT\\n   which showed no abcess, no free air, small B pleural effusions &\\n   nonobstructive kidney stones.   Sent via ambulance to [**Hospital1 19**] on IV\\n   neosynephrine ( ran @ 30mcg/min to maintain sBP in 90\\ns/ @ [**Hospital1 608**]) & IV\\n   NS @ 125cc/hr.   Switched to levophed here.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   BP maintained >100/sys & MAP>65.   Also received IV NS @ 125cc/hr for a\\n   few hours.  No bolus needed.  Lactate: 1.3  WBC 8.8\\n   Action:\\n   D/C\\ned IV neo & started IV levophed.  Titrated each down but unable to\\n   stop due to hypotension.\\n   Response:\\n   BP maintained @ 110\\ns/sys on levophed @ 0.03mcg/kg/min.  Patient\\n   desatted to 87-88%, requiring O2 @ 4L NP to be increased to 100%\\n   humidified O2 via tent mask.  RR increased to 45.  Patient c/o SOB.\\n   Lungs: changed from clear w/diminished @ bases to diminished\\n   throughout.  CXR done.  10mg IV lasix given @ 0130 w/ more than 1000cc\\n   urine out since then.  Patient still has elevated RR in 30\\ns-40\\n   Sleeping comfortably almost flat  w/100% humidified O2 via face tent.\\n   Plan:\\n   Give lasix if ordered when CXR examined.\\n   .H/O alcohol abuse\\n   Assessment:\\n   Patient says he drinks 2 glasses vodka/day.  Last drink on [**8-18**].\\n   Maintained on serax q 6 hrs @ [**Hospital3 **].  Last dose @ 1800 [**8-20**].\\n   Action:\\n   Checked CIWA scale q 2 hrs\\n   Response:\\n   [**6-21**] on CIWA scale\\n   Plan:\\n   Medicate for CIWA>10.\\n   ------ Protected Section ------\\n   Patient\\ns eyes are icteric; he arrived from [**Hospital3 **] that way.\\n   He is 5L + in fluid balance from [**Hospital3 **].  Last drink was\\n   actually [**8-17**] (Mon).\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2178-8-21**] 07:20 ------\\n   ABG\\ns : 7.40/26/65 on 100% humidified O2 by tent mask.  Intern aware.\\n   Now on 5L NP w/sat 94-96%.  In process of being releted for Mg 1.5 w/4\\n   Gm Mg IV.  Also for K3.6  will receive 40mEq KCl.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2178-8-21**] 07:26 ------\\n',\n",
              "  '44 year old woman admit with nausea, vomiting, abd pain, lactate of 10,\\n   fluid resuscitated in [**Hospital 2916**] transfer to MICU for further management, of\\n   new liver failure, and acute renal failure, ? related to Glevac,\\n   empiric zosyn and vanco  started.\\n   PMH: HTN, asthma, DVT. Recent surgery [**2-15**] for large necrotic\\n   perforated GI stromal  tumor of small intestine, also had TAH BSO,\\n   small bowel resection and [**Doctor Last Name 2912**] procedure, [**2-17**] malignant GIST, [**2-19**]\\n   malignant spindle cell tumor, anastomotic leak, repeat small bowel\\n   resection, and anastamosis repair, in MICU with open abd , [**3-9**] abd\\n   closed, [**3-23**] d/c to rehab. [**4-4**] return to [**Hospital1 54**] with cdiff , abd ct\\n   revealed large recurrent soft tissue mass in left lower abd, with mult\\n   soft tissue mets in abd, enlarging right lower lobe pulmonary node, d/c\\n   to home [**4-13**].\\n   .H/O altered mental status (not Delirium)\\n   Assessment:\\n   Patient oriented to self, nurse & place.  Not oriented to time.\\n   Action:\\n   Bed alarm.  Curtains drawn back for better visibility.  Nurse sat\\n   outside room @ nurse\\ns station where it was easy to glance into room &\\n   see patient, & easy for patient to see nurse.\\n   Response:\\n   Patient becoming more disoriented.  Change in mental staus due to\\n   increased LFT\\ns from Gleevac chemo Tx per oncology.\\n   Plan:\\n   Maintain a close watch on patient, consider 1:1 if patient\\ns mental\\n   status worsens.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Vac drsg [**Name5 (PTitle) 2921**] & VAC running @ 125mm  all night.\\n   Action:\\n   Ensure VAC is functioning properly & drsg [**Name5 (PTitle) **] [**Name5 (PTitle) 2922**].\\n   Response:\\n   Plan:\\n   Contact [**First Name8 (NamePattern2) 1270**] [**Last Name (NamePattern1) 2571**] to provide back up cartridge for very small\\n   portable VAC used w/this patient.  Reinforce VAC drsg w/tegaderm if\\n   drsg [**Name5 (PTitle) 2923**] [**Name5 (PTitle) **].\\n   Cancer (Malignant Neoplasm), Small Bowel\\n   Assessment:\\n   Lactate up to 11.2 @ Mn, from 9.8.  LFT\\ns continue to be elevated (from\\n   Gleevac per oncology)\\n   Action:\\n   Gleevac stopped [**4-17**]. Drew lactate @ 0600.\\n   Response:\\n   Lactate 10.7 @ 0600\\n   Plan:\\n   Draw lactate q 6 hrs.\\n   ------ Protected Section ------\\n   Checked blood glucose sugars (FS) every hour.  Required\\n-1 amp D50\\n   every 4 hours. Intern aware.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2180-4-18**] 07:02 ------\\n   RR mid 20\\ns to upper 30\\ns . O2 sats 100% on room air.  Took O2 off ( O2\\n   @ 2L NP).  Compensating w/respiratory sytem for lactic acidosis.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2180-4-18**] 07:32 ------\\n',\n",
              "  'This is a 76 yo F with h/o metastatic breast CA on chemotherapy who\\n   initially was admitted to the OMED service with diarrhea who is now\\n   transferred to the [**Hospital Unit Name 44**] for hypotension and hypoxia. Patient states she\\n   had been feeling constipated for 1 week after chemo on [**6-6**] and then\\n   took laxatives until she had several large BMs. Due to concern for\\n   dehydration and contniued diarrhea, the patient was admitted directly\\n   from the oncology clinic.\\n   .\\n   Upon arrival to the floor, pt in AF w/vss.  Became hypoxic &\\n   hypotensive.  CXR revealed likely pulmonary edema with worsening\\n   bilateral pleural effusions and possible retrocardiac opacity. She was\\n   transferred to the [**Hospital Unit Name 44**] where code status was confirmed as full and pt\\n   was intubated. Peri-intubation required dopamine at 20 mcg/kg/min,\\n   which was partially transitioned over to levophed gtt once triple lumen\\n   catheter placed.\\n   Shock, septic\\n   Assessment:\\n   Received patient on levophed @ 0.5mcg/kg/min & low dose (renal range)\\n   dopamine.  MAP remained>60. SBP remained >90/systolic as well.  Lactate\\n   was 5.0 @ 2300  but started to rise @ 0047, to 5.7.   Abdomen firm, now\\n   distended.   Bladder pressure @ 0200 was 32.  No BM.   U/o was 10cc/hr\\n   initially, dropped to 8cc & then 0.    T 102po @ [**2173**] w/Bair hugger &\\n   blanket on.  Removed both & po temp dropped to 99 the next hour.  Temp\\n   back up to 102.8ax @ midnight.  T ax down to 100.7 @ 0400.  4 out of 4\\n   blood Cx\\ns from [**6-20**]  grew out gram negative rods.\\n   Action:\\n   Decreased levophed to 0.42mcg/kg/min.  Transitioned vasopressin @\\n   2.4units/hr  as 2^nd pressor & stopped dopamine.  Foley irrigated w/no\\n   clots or obstruction.  Given 650mg tylenol @ midnight.\\n   Response:\\n   Serum glucose 24 @ 0045.  Covered w/1 amp D50 @ 0200.  BP dropped to\\n   high 70\\ns/systolic w/MAP in 50\\ns still on maximum dose of levophed &\\n   vasopressin @ 2.4 units/hr.    Had abdominal x-ray this am.  Too\\n   unstable to leave unit for further testing.  Dr. [**Last Name (STitle) 25**] thinks\\n   it may be an ischemic colitis.\\n   Plan:\\n   Continue pressors until D/C\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   On A/C @ 100% 500Vt/16 RR/20 PEEP w//O2 sats 88-92%\\n   Action:\\n   Decreased Vt to 400 @ 2100.   ABG\\ns:  7.23/34/69 @ 2300.    Decreased\\n   PEEP to 18.  ABG\\ns: 7.12/42/99 @ midnight.    Repeat ABG\\ns @ 0100:\\n   7.14/39/86.  PEEP decreased further to 14 @ 0200, & Vt returned to\\n   500.    Increased sedation earlier in night to 250mcg/hr fentanyl &\\n   5mg/hr versed.  At that time goal was to sedate patient until she no\\n   longer had any dys-synchrony from vent. (The next step would have been\\n   to paralyze her).  Patient was not dys-synchronous @ this level of\\n   sedation.  She continued to overbreathe the vent by [**9-12**] breathes/min\\n   probably  due to metabolic acidosis.\\n   Response:\\n   Patient became very acidotic from  metabolic acidosis due to\\n   oliguria/anuria & lactic acidosis (lactate increased to 5.8 by 0100).\\n   Given 4 amps bicarb @ 0120-0200.\\n   Plan:\\n   Keep patient on present vent settings.   Continue to keep comfortable\\n   by maintaining sedation.  [**Month (only) 60**] increase sedation if needed.\\n   [**Last Name **] Problem\\n Alteration in coping/end of life issues\\n   Assessment:\\n   Son & wife came in & sat w/patient  since 0300 when called.  Husband\\n   took sleeping med & was unable to come in overnight.  Will come in\\n   today.  Patient has another son living in PA who is unable to come\\n   presently due to illness (metastatic renal cell CA).\\n   Action:\\n   Patient\\ns son & husband were called to come in overnight due to\\n   patient\\ns worsening condition.\\n   Response:\\n   Patient\\ns son accepted patient\\ns condition, but did not want to do\\n   anything that would hasten her death.  He said that his father felt the\\n   same way.\\n   Plan:\\n   Family will remain w/patient.  As they are [**Hospital1 **], they may have to\\n   stay @ a nearby hotel in order not to drive on the Sabbath if the\\n   patient is still alive.\\n',\n",
              "  'Hypotension (not Shock)\\n   Assessment:\\n   Patient arrived from EW  receiving  0.018 mcg/kg/min levophed as his BP\\n   dropped to 80/ in EW after versed given. Not responsive to 2L IVF in\\n   EW. BP 100\\ns -110\\ns /sys on levophed. Taken off levophed @ 0400. BP\\n   stable initially but started to drop to 90\\ns & then 80\\ns/sys @ 0645.\\n   Action:\\n   Restarted levophed\\n   Response:\\n   BP up to 100\\ns/sys\\n   Plan:\\n   Give levophed as needed to maintain MAP.65.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Arrived in MICU still [** 1248**] from total of 6mg versed given in EW.\\n   Admitted wchanges in MS. [**First Name (Titles) 1249**] [**Last Name (Titles) 1248**] for an hour & then started to\\n   rouse. Received 12.5mg IV fentanyl & 0.5mg IV versed for sedation q 1\\n   hr until 0630, when he received additional dose  for agitation. Dropped\\n   BP & required levophed to be restarted.\\n   Action:\\n   Used sedation sparingly\\n   Response:\\n   More alert , but fell back to sleep frequently-agitated when awake.\\n   Plan:\\n   Start IV sedation for agitation\\n   Patient arrived from EW @ 0100. Admitted after being out of hospital\\n   for only 1 dayw/ MS changes (unresponsive & intubated to protect\\n   airway).  Ruling in for MI by enzymes in EW. !st lactate level elevated\\n   @ 4.7.   ?Sepsis.\\n',\n",
              "  'This 59 yr old woman was transferred from the EW  @ 0330 w/ fever up to\\n   102 (in the presence of Tylenol 1000mg & ibuprofen 600mg). Came in\\n   w/complaint of N/V X 2days.  No diarrhea.  WBC 14.5.  Recently returned\\n   from  [**Location (un) 1502**], FLA., where she spent a week.  Hx breast CA. S/p B\\n   mastectomies. Last chemo: [**2187-2-7**] : Carboplatin, Taxotere & Herceptin.\\n   Receives this 1X every 3 weeks.  Receives only 1 med on other weeks\\n   1X/week.  All chemo given through portacath.\\n     No c/o N/V since arriving in MICU. Did receive zofran in EW.  UA\\n   clean, CXR negative. Hx MRSA bacteremia in [**2182**], on contact\\n   precautions.\\n     [**Name2 (NI) 317**] insulin pump that takes blood sugars. Blood sugar =90 @ 0655.\\n    Arrived to MICU w/T 99.5po & BP 86/systolic. Received 400cc LR bolus &\\n   started on levophed. BP improved on low doses of levophed.  Patient\\n   refused foley. Intern aware.  Patient continued to refuse after\\n   speaking to intern.  A-line placed.  Patient agreed to central line\\n   placement (yet to be placed).  Only has portacath (1 lumen) &  1\\n   peripheral line (#18G).\\n     EKG taken & cardiac enzymes drawn  after patient mentioned to MD\\n   that she had chest pain earlier (before coming to MICU).\\n     She came from home in [**Location 1503**], where she lives w/her husband, a\\n   psychiatrist.  She has 2 adult children in their 30\\ns: a son who lives\\n   in [**Name (NI) 740**], & a daughter.\\n',\n",
              "  'This 54 yr old woman was admitted [**5-16**] through EW w/ medication\\n   overdose ( + for benzo & opiate toxicity). She was intubated to protect\\n   her airway.  Received charcoal per OGT in EW when her OGT became\\n   dislodged.  CXR subsequently showed effusions.  Unclear if patient\\n   accidentally or deliberately took overdose.\\n   .H/O depression\\n   Assessment:\\n   Patient is pleasant & cooperative.  Said she accidentally took a double\\n   dose of her meds.  Does pour out daily meds into daily holder (holds 1\\n   week\\ns worth).  Ex-husband said he thought she gave herself too much po\\n   morphine.  Family unaware of patient\\ns hx hypertension.  Patient was\\n   [**1-5**] on [**Doctor Last Name 2558**] scale.  Repeat head CT [**5-16**] was negative.\\n   Action:\\n   Had 1:1 sitter for shift.  Family (2 of 3 sons) & ex-husband visited\\n   patient.\\n   Response:\\n   Patient calm during visit.\\n   Plan:\\n   Offer emotional support.  Continue 1:1 sitter until psych OK\\n   discontinuing.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Lungs: clear @ upper lungs, diminished @ bases.  RR 15-25 O2 sat\\n   98-100% on 3L NP\\n   Action:\\n   Coached patient in using IS.   Sputum sent for C&S, gram stain.\\n   Guaifenesin given to loosen secretions.\\n   Response:\\n   Afebrile.  Coughing up tan secretions.\\n   Plan:\\n   Continue to encourage IS.\\n   .H/O hypertension, benign\\n   Assessment:\\n   BP: 164-188/88-107     HR: 69-81 SR\\n   Action:\\n   Received 12.5mg captopril @ 2300 & 50mg captopril @ 0200 .  Held usual\\n   atenolol for  previous sinus pauses.\\n   Response:\\n   Little response to capropril.  Received 5mg norvasc @ 0300 w/ little\\n   response.\\n   Plan:\\n   Monitor BP.  Medicate as needed for hypertension.\\n   Pupils are unequal but are sluggish to brisk in response to light.  L\\n   pupil remains 4mm but R is 2mm.  Patient says she uses cyclosporine eye\\n   drops (restasis) to L eye only for\\ndry eye.\\n  Smile symmetric & tongue\\n   does not deviate to R or L.  Grips equal.\\n   Patient\\ns belongings ( 4 pill bottles:po morphine,flexeril,amidrine,\\n   diazepam & 1 yellow metal necklace) came from EW & locked in [**Hospital Ward Name 51**] 4\\n   safe.\\n   No more cardiac enzymes needed.  Troponin continues to be <0.01.  MB 4\\n   (down from 8). CK 175 (down from 335), LDH 257 (down from 260).  No\\n   increase in nausea, rather a gradual improvement. No c/o SOB or\\n   chest/jaw/teeth  pain or pressure.\\n',\n",
              "  '77F (h/o altered mental status / non-responsiveness, lumbar compression\\n   fracture, c. albicans osteomyelitis, stage IV lumbar decub, aspiration\\n   PNA, hypothyroidism, anemia, IPF) who presented with unresponsiveness\\n   in the setting of fever, elevated WBC and lactate likely [**1-18**] PNA. On\\n   [**10-21**] and [**10-23**] had acute change in mental status with difficulty to\\n   arouse. At that time pt had PNA, CT head neg, CTA head was normal, EEG\\n   was abnormal and neurology thought delirium rather than seizure.\\n   Pt on log roll precautions with HOB @ 25-30 degrees.  She has to wear\\n   TLSO brace if HOB greater than 30 degrees or OOB  to chair.\\n   Pt with stage 4 pressure sore on back and stage 2 on coccyx being\\n   followed by wound  care nurse.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient initially was lethargic & oriented to self only.  Pupils\\n   w/brisk reaction.\\n   Action:\\n   IV narcan drip increased from 0.15mg/hr to 0.25mg/hr  overnight. Narcan\\n   drip was started @ 1400 [**11-1**].  NPO for potential aspiration w/MS\\n   changes.\\n   Response:\\n   Patient more easily awakened as night progressed.  Oriented X2 (to self\\n   & date ie, yr & month).  Knew she was in a hospital but identified\\n   [**Hospital3 422**] as place @ midnight & [**First Name11 (Name Pattern1) 432**]\\n[**Initial (NamePattern1) **] [**Last Name (NamePattern1) **] @ 0400.\\n   Plan:\\n   Continue narcan drip, plan is for a total of 24-48 hrs.  Speech &\\n   swallow to come back today ([**11-2**]) to evaluate her.\\n   Potential for withdrawal\\n   Assessment:\\n   Patient became progressively more sweaty as night progressed.  Not\\n   anxious or restless.  No hallucinations.  BP increased as night\\n   progressed as well\\n   Action:\\n   Intern informed.  [**Doctor Last Name 1264**] started.\\n   Response:\\n   Patient is\\n on [**Doctor Last Name 1264**] scale.\\n   Plan:\\n   Continue [**Doctor Last Name 1264**].  Moderate narcan drip if patient becomes more\\n   symptomatic.\\n   Pneumonia, bacterial, community acquired (CAP)\\n   Assessment:\\n   Upon auscultation, lungs are clear @ upper lobes & diminished @ L base\\n   to both bases.  RR: 23-31        O2 sats on 2L NP: 92-97%   Patient\\n   takes her O2 off on occasion & desats to 84%.   Patient has a strong\\n   productive cough w/white secretions.\\n   Action:\\n   Increased O2 to 3L NP\\n   Response:\\n   O2 sats: 95-100%\\n   Plan:\\n   Continue O2 @ 2-3L NP[**MD Number(3) 9991**] patient is fully awake.\\n   Osteomyelitis\\n   Assessment:\\n   Back wound external opening 2.5x3 cm and underlying wound 7x6.5 cm\\n   noted to be infected with [**Female First Name (un) 474**].  Debrided last admission [**10-25**].\\n   Seen by wound care nurse today and  dressing changed with her. Stage 4\\n   on back has new purple area on wound from last admission.  No c/o back\\n   pain during dressing change to back dut to altered MS. [**Name14 (STitle) 9992**] to L\\n   forearm (for skin tears): D&I.\\n   [**Name14 (STitle) 9992**] to coccyx D/C\\ned, now OTA per wound care RN.  Barrier cream\\n   applied.\\n   Action:\\n   Back dressing changed on day shift (qd drsg [**Name5 (PTitle) 539**]) in accordance with\\n   last wound consult recommendation . (ie.  Wash  with wound cleanser and\\n   pat dry ,AMD\\n in tape with ns packed lightly covered with gauze and\\n   abd pad.).\\n   Response:\\n   Dressings remained intact.  HOB maintained @ 25 degrees all night.\\n   Plan:\\n   Apply brace for HOB > 30 degrees and oob. Pain med and dsg change qd\\n   Continue antibiotics as ordered.  Evaluate frequently for pain.\\n   Patient  has prn orders for pain med--please [**Name8 (MD) **] MD\\ns prior to\\n   administration.  Gabapentin & methadone stopped.\\n   Please call patient\\ns daughter-in-law, [**Name (NI) 4830**], w/any changes in\\n   patient\\ns condition.  Her phone # is on the board in the patient\\n   room.  She is staying in the [**Location (un) **] area until Sat.    She is the wife\\n   of [**Name (NI) **], the HCP, who flew back to their home in [**State 108**].\\n',\n",
              "  'This 79 yr old woman w/hx multiple myeloma was admitted to [**Hospital 1711**]\\n   Hospital w/ 2 weeks nausea, lethargy & decreased u/o.  Dx w/acute renal\\n   failure.  Had dialysis Tx\\nes X3.  Transferred to [**Hospital1 5**] for possible\\n   plasmapheresis.  PMH: diabetes, HTN, peripheral neuropathy, renal\\n   insufficiency, metal plate in foot.  Seen by renal here who wanted\\n   CVVHD for alkalosis (too much HCO3 in dialysate w/hemodialysis).  ARF\\n   may be due to multiple myeloma or amyloid.  A bone marrow bx would help\\n   dx but unable in setting of PTT>150 & INR 1.6.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Started CVVHD @ 0100.  See flow sheet for details.  B small pleural\\n   effusions [**10-5**] ( U/S).  BUN 13    Cr 2.8    HCO3 25       Na 128\\n   Action:\\n   Attempted to remove 50cc/hr.  Collecting 24 hr urine until 1430\\n   [**10-6**].     IV NS infusing @ 50cc/hr per renal according to MICU\\n   intern.  CVVHD system down @ 0645 for increased pressure from\\n   clotting.  It lasted 5.75 hrs w/no anticoagulation except NS flushes q\\n   2-3 hrs.\\n   Response:\\n   BP & HR stable.  Tolerated fluid removal well.  Had hemodialysis [**10-5**].\\n   Plan:\\n   Plasmapheresis possibly in am (0700-0800).  [**Month (only) 8**] need to take off of\\n   CVVHD for plasmapheresis as we both use the same catheter.\\n   Liver function abnormalities\\n   Assessment:\\n   Had abdominal U/S [**10-5**] that showed markedly heterogenous liver\\n   w/ifiltrative process, possibly CA, needs further cross sectional views\\n   after renal failure resolved.  Ammonia ([**10-5**]): 21 (WNL)\\n   Action:\\n   Universal precautions maintained in setting of Hepatitis C positive\\n   patient.  Received 30cc lactulose @ 2245 on 7 [**Hospital Ward Name **].  Lactulose tid\\n   ordered for elevated LFT\\n   Response:\\n   Had 5 loose watery stools in response to 1 dose lactulose.  Barrier\\n   cream applied to reddened skin near rectum.\\n   Plan:\\n   Monitor LFT\\n',\n",
              "  'Mrs. [**Known lastname 1098**] is an 82 year old female with a history of breast cancer,\\n   CVA, and hypertension who presents from [**Hospital3 1152**] after being found\\n   to be in respiratory distress with oxygen saturations in the 70s to 80s\\n   on room air.  Per EMS report the patient was found at approximately\\n   3:30 AM by staff at [**Hospital3 1152**] to be in moderate to severe\\n   respiratory distress.  She received an albuterol nebulizer.  Her EKG\\n   per report was within normal limits.  Her exam was notable for audible\\n   rales and abdominal distension.  She received 40 mg IV lasix, 1\\n   sublingual nitroglyerin and was assisted with bag mouth ventilation.\\n   An oropharyngeal airway was placed in the field.    She wa noted to be\\n   slow to respond and diaphorettic.  She was suctioned with large amounts\\n   of secretions.  Foley catheter was placed with 100 cc dark urine. Sent\\n   to [**Hospital1 54**] EW, where she was emergently Intubated. T103.  Code sepsis not\\n   initiated as BP >100/systolic. Received 3L NS in EW.  Given vanco,\\n   levofloxacin & ceftriaxone IV. Patient arrived in MICU & did well until\\n   1600.  Dropped BP,  received fluid boluses & started on levophed.\\n   Peripheral BC from EW grew 4 out of 4 bottles positive for gram\\n   negative rods.  Started on aztreonam & received 120mg IV gentamycin\\n   X1.  Urine Cx ([**8-17**]) grew nothing yet.  UA from EW shows many bacti but\\n   UA from later in the day shows few.  Sputum Cx shows many organisms\\n   consistent w/oropharyngeal flora.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   MAP ranged 62 to 71 w/systolic BP >90/ @ all times.   Absent bowel\\n   sounds until 0400 [**8-18**].  170cc gastric residual of mixed undigested\\n   tube feedings & bilious fluid.@ [**2183**]; 260cc residual @ 0400.    On\\n   Vigileo, CO:3.4-3.9   CI: 2.0-2.1   SVR (per computer): 1,190\\n 1,394.\\n   CVP: [**9-19**].  Feet & hands cold.  Ax temp 95.8\\n 98.3.  Lactate improved\\n   from 5.3 down to 4.9\\n   Action:\\n   Titrated levophed from 0.15-0.22 mcg/kg/min for MAP <65.  Given 1L LR\\n   boluses X 4 overnight, for a total of 13 liters IVF since arrival in\\n   EW.  Given 500cc albumin 5% for serum albumin 1.8.  Tube feedings\\n   held.  B DP\\ns & PT\\ns dopplerable.  On & off Bair Hugger to maintain\\n   temp.\\n   Response:\\n   Maintained MAP>65.\\n   Plan:\\n   Titrate levophed to maintain MAP>65.  Add vasopressin as next pressor\\n   when required.  NPO..  Evaluate patient for potential ileus.\\n   Pneumonia, bacterial, hospital acquired (non-VAP)\\n   Assessment:\\n   Lungs are clear w/diminished breath sounds @ bases.  Sx\\ned for small to\\n   scant amounts thick tan secretions q 4 hrs.  ON A/C 60%/Vt 500/ RR 22/\\n   8 PEEP.\\n   Action:\\n   ABG\\ns @ 0200: 7.29/34/72\\n   Response:\\n   Repeat ABG\\ns @ 0500: 7.30/33/99\\n   Plan:\\n   CXR done this am ([**8-18**]).\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   U/o 11-30cc/hr   BUN 26 (23)   Cr 1.6 (1.4)    Urine is cloudy\\n   w/sediment.  UA as above.\\n   Action:\\n   Given LR boluses X 4 for u/o as well as BP.  Maintenance IVF @ 150cc/hr\\n   as well.\\n   Response:\\n   Poor u/o.\\n   Plan:\\n   Continue to monitor u/o.  Give fluid as needed.\\n   Electrolyte & fluid disorder, other\\n   Assessment:\\n   K 3.3   Ca 6.0 (adjusted for low serum albumin: Ca:7.5)    albumin\\n   1.8    Mg 1.2       PO4:2.1  Na 146\\n   Action:\\n   Repleted w/80 mEq KCl IV in divided doses.  Repleted w/4 Gm magnesium\\n   sulfate IV.  Given 500cc albumin 5%.  Repleted w/2 GM Ca gluconate IV.\\n   Given 2 packets neutraphos.\\n   Response:\\n   After repletion: K 6.0        Ca 6.8 (adjusted Ca: 8.0)         Mg\\n   2.7      PO4 2.9\\n   Plan:\\n   Follow labs.  Replete w/care in this patient w/poor renal function.\\n   Two hours later, K=5.9, Mg 2.1, Ca 6.6, Na unchanged, PO4 2.7    Follow\\n   serum K.\\n',\n",
              "  'Mr. [**Known lastname 520**] is a 33yr old man living @ a nursing home.  Has an extensive\\n   PMH that started w/taking anabolic steroids for 16mo in his 20\\n   progressed to arthritis for which he had multiple joint replacements, &\\n   led to multiple infections.\\n     He came to EW @ [**Hospital1 19**] from [**Hospital3 521**]\\ns Hospital as no bed available\\n   there.  He had fever, N/V, several green loose stools from colostomy.\\n   Received 3L iIVF @ [**Hospital3 522**]\\ns.  BP 110-138/60 HR 116-130 RR20 O2 sat\\n   96 (room air) @ [**Hospital1 19**] EW.  O2 sat 100% on 2L NP.   Dx sepsis. Lactate @\\n   OSH 4.0, down to 1.2 here.  WBC 18 @ OSH, down to 13.4 here. Received\\n   IV\\n    vanco,unasyn & flagyl @ OSH.\\n   Arrived @ 0445 @ [**Hospital Ward Name 57**] MICU. Vss. C/o generalized arthritis pain for\\n   which he had already received a total of 6mg IV dilaudid in EW.\\n   Received 10mg po oxycodone @ 0600 for pain\\n on [**12-4**] scale & promptly\\n   fell asleep.\\n',\n",
              "  '58F Spanish speaking with cirrhosis and renal failure, gets usual care\\n   at [**Hospital1 183**], presented to [**Hospital1 54**] ER after taking some drugs off the street\\n   and lethargy.  T 100.9, BP88/50 HR 69 O2 99%2L, she was initially given\\n   Narcan 0.4mg with some improvement in mental status and dose was\\n   repeated X 2.  She had a low grade fever T 100.9 and LP was done.\\n   Prior to LP, she was given ceftriaxone 2 grams.  She continued to be\\n   lethargic so received 2mg IV narcan X 2 and planned for narcan gtt,\\n   however, she was arousable to voice so this was not started.  Last dose\\n   of Narcan was 10 AM [**5-26**]. CT head and CXR in the ER were unremarkable.\\n   She also had a several BS in the 64-75 range and received Dextrose.\\n   Per ER notes additional history was obtained from family (2 daughters)\\n   who stated that patient abuses oxycodone, vicodin, T3 (no tyelnol in\\n   tox).  Family denied that patient was on sulfonylureas for diabetes.\\n   .\\n   Hypertension, benign\\n   Assessment:\\n   BP : 172/72-194/86            HR:  88 SR -104 ST no ectopy\\n   Action:\\n   Given 20mg lisinopril per NGT @ 2100.      Given  20mg IV labetolol @\\n   0025.\\n   Response:\\n   No response to lisinopril.   BP dropped from 194/83 to 174/80 after\\n   labetolol.  Started 12.5mg lopressor po/NG tid.  BP dropped to 165/67\\n   from 186/82.  BP soon returns to 170\\ns-180\\ns/systolic  after each\\n   antihypertensive.\\n   Plan:\\n   Monitor BP. Awaiting rounds for team to decide re: increasing lopressor\\n   dose.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient slept all night.  Easily arousable.  Speaks Spanish only.\\n   Responded appropriately to phrases & questions in Spanish.\\n   Action:\\n   Checking [**Doctor Last Name 2558**] scale q 4 hrs\\n   Response:\\n   Assessed [**Doctor Last Name 2558**] scale @ [**1-14**] overnight.\\n   Plan:\\n    [**Name8 (MD) **] MD [**First Name (Titles) **] [**Last Name (Titles) 2760**] order if [**Doctor Last Name 2558**] scale>10.  Awaiting for patient to\\n   be called out soon.\\n'],\n",
              " 4: ['31 yo F w/ a h/o uterine fibroids which were symptomatic presented for\\n   an elective multiple myomectomy on [**2102-10-5**] which was complicated by\\n   massive intraop bleeding for which she received massive transfusion.\\n   She is now s/p 11units PRBCs, 8 units FFP 2 units Platelets.\\n   Transferred to the ICU for further management.\\n   Pt received one unit PRBC\\ns [**10-6**] for hct drop of 5 points.  Post  hct\\n   28.8.   Patient extubated [**10-6**] @ 0815, weaned to 2-3 L NP.\\n   Tachycardia, Other\\n   Assessment:\\n   HR: 119-126 ST no ectopy  CVP 8-11   BP: 112-130/73-94\\n   Action:\\n   Given  1 L NS bolus X2.  Repleted w/ 40mEq KCl IV for serum K 3.1.\\n   Repleted w/ 2 Gm magnesium for serum Mg 1.8.\\n   Response:\\n   HR: 104-116 ST no ectopy\\n   Plan:\\n   Replete w/ 2 Gm Calcium gluconate for serum Ca 7.7 ( in 1X order\\n   section).\\n   Hemorrhage/hematoma, procedure-related (e.g., cath, pacemaker, ICD\\n   bleed)\\n   Assessment:\\n   Hct 25.2 (27.5)     Patient is draining large amount of serosanguinous\\n   vaginal drainage.  Wearing pad.  No clots.  Transverse  lower abdominal\\n   incision , clean w/ no drainage, & OTA.\\n   Action:\\n   Serial Hcts checked q 12 hrs.\\n   Response:\\n   Hemodynamically stable.\\n   Plan:\\n   Next Hct due: 12 noon.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Continues on hydromorphone PCA (0.12/10/0.72).  Abdominal incisional\\n   pain is [**6-8**] @ its worst, down to 2-3 w/ rest.  O2 sats 100% on 3L NP in\\n   chair.  O2 sats dropped to 89% overnight, requiring increased O2 to 4L\\n   NP.  Encouraged coughing & deep breathing as well as IS q 2 hrs\\n   w/supervision.  Patient did not initiate any use of IS w/out prompting,\\n   despite being told she needs to use it q 1 hr.  Cough attempts are\\n   similar to clearing one\\ns throat, very weak.\\n   Action:\\n   Patient pivoted back into bed from chair last evening.  As above.\\n   Response:\\n   Patient was relatively [**Name2 (NI) **] on her feet.  Still requires minimal to\\n   moderate assist of 2.  Pain is better controlled overnight than the\\n   previous night.\\n   Plan:\\n   Get OOB to chair today if possible.  Needs PT consult (could use walker\\n   initially).\\n    T101.5po @ midnight.  WBC 15.7 (13.6)   BCX2 drawn.  Tylenol given.\\n   All Cx\\ns ( BC & urine) still pending-no growth yet.\\n   Tolerating clear liquid diet w/out problems.\\n   [**Name (NI) 149**]: To call out to OB floor.  Needs cordis/trauma line in R neck\\n   pulled by MD as she will need sutures, before transfer to floor.\\n   ------ Protected Section ------\\n   A-line was kinked & clotted @ [**2093**].  Nonfunctioal.  D/C\\ned @ that time.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2102-10-8**] 06:32 ------\\n',\n",
              "  '80W recent inguinal hernia repair @ OSH.   One week later developed\\n   worsening abd pain, readmitted.   Imaging and exam concerning for bowel\\n   obstruction and perforation. Transverse colectomy performed. Drains 2\\n   days ago produced significant bilious fluid.  Transferred to BIBMC per\\n   son as patient not improving, ICU to ICU.   Surgeons worried about new\\n   small bowel perforation and peritonitis.\\n   Possible Peritonitis (non-SBP)\\n   Assessment:\\n   WBC 23.3, down from 31.1 upon arrival.      Lactate 0.9     Abdomen\\n   soft w/+ bowel sounds.  Colostomy had large amount bilious , guiac +\\n   stool.  JP\\ns: #1 @ R lateral abdomen & #2 @ L lateral abdomen\\ndraining\\n   bilious  fluid that looks similar to ostomy output.  Patient had small\\n   to medium formed BM w/lots of mucus, per  rectum X1 overnight.  See\\n   incision section of flow sheet  re: abdominal incisions.\\n   Action:\\n   Patient was pan Cx\\ned.  Received IV vanco & zosyn.  NGT to low wall Sx,\\n   draining bilious, guiac - fluid.  Receiving NS @ 100cc/hr & D10W @\\n   80cc/hr (patient was receiving TPN @ 80cc/hr).\\n   Response:\\n   Yeast grew from JP.  UA negative.  Other Cx\\ns pending.  Patient\\n   continues to be hemodynamically stable.\\n   Plan:\\n   Surgeons want to take patient to OR for exp lap, but she has refused\\n   tonight.  Family feels that she will agree later today.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 120\\ns-150\\ns Afib upon arrival from OSH in [**State 1455**] ( spent 2-3 hrs\\n   on road).  BP 103-135 /42-71\\n   Action:\\n   Received Lopressor 5mg IV X3 w/ decrease in HR to 100\\ns-120\\ns Afib.\\n   Given 15mg IV diltiazem X2 to bring HR down to 70\\ns-90\\ns Afib.  Given\\n   500cc NS bolus for BP 103/42 w/ increase in BP to 112-124/40\\n   Response:\\n   Started IV diltiazem drip @ 5mg/hr to maintain HR in 70\\ns-80\\ns Afib\\n   Plan:\\n   Maintain diltiazem IV drip  today.\\n',\n",
              "  'This 77 yr old woman, aresident of [**Hospital 112**] Nursing Home, was admitted\\n   through EW  after a 5-10min episode of unresponsiveness & O2 sat 88% on\\n   room air.  Sat back up to 94% on NRB.  In EW, sat 89% on room air, back\\n   up to 96% on 2L NP.  Vss.  Found new large PE @ bifurcation of R\\n   pulmonary artery, extending into R middle lobe branches.  Also has more\\n   chronic appering thrombus in R lower labe branches (where old PE was).\\n   Has thrombus in R superior femoral vein extending through R popliteal\\n   vein.  Has thrombus in L common femoral vein.\\n   PMH: advanced dementia, Alzheimer\\ns w/delusions & delirium (baseline :\\n   oriented X1), bipolar, depression & anxiety, HTN, CVA [**2097**], R hip fx\\n   s/p ORIF [**2117-3-8**] course complicated by Morganella infection of hip &\\n   postop PE.  IVC filter placed after PE: not a candidate for\\n   anticoagulation after requiring 14 units for hip hematoma.\\n   Plan: to be called out of the ICU today.  Transfer note started.\\n   Pulmonary Embolism (PE), Acute\\n   Assessment:\\n   No c/o pain.  O2 sats 94-98% on 2L NP.  No c/o SOB.  RR15-25.  Hct\\n   32.4.   Lungs: clear @ upper lungs, diminished @ bases.\\n   Action:\\n   IV heparin infused @ 1150 units/hr since 2330 for PTT  53.4, after 1000\\n   unit bolus.  T&S sent to BB, crossmatched for 2 units PC\\n   Response:\\n   PTT drawn @ 0510 was 146.6.  Stopped IV heparin X1 hr (0550-0650) &\\n   dropped rate by 300 units to 850/hr @ 0650.    Drew blood from #20G IV\\n   L forearm.\\n   Plan:\\n   Titrate IV heparin per heparin  sliding scale orders.  Cardiac echo\\n   ordered for today ([**6-21**])\\n   .H/O altered mental status (not Delirium)\\n   Assessment:\\n   Patient is oriented to herself only, not place (thought she was in a\\n   nursing home) nor date.\\n   Action:\\n   Orient patient prn\\n   Response:\\n   Patient\\ns baseline is oriented X1\\nto self only.\\n   Plan:\\n   Give olanzapine for agitation.\\n   Patient has red raised rash on back.  Also has abrasion on back\\n   involving 1^st layer of skin only\\nlooks like scrape from being pulled\\n   up in bed.\\n   B radial pulses palpable.  B DP\\ns & PT\\ns easily dopplered.  R leg more\\n   swollen than L (arrived from EW that way).  Unable to elevate both legs\\n   on pillows due to leg contractures.  Unable to straighten R leg, only\\n   able to straighten L leg for a short time (while holding leg only).\\n   Awaiting US of upper extremities to be read & interpreted.\\n',\n",
              "  '48 yo male with CAD, ischemic cardiomyopathy, admitted with abd pain\\n   from retained CBD stone (s/p CCY 5 yrs ago) , intermittent episodes of\\n   hypotension. On arrival here he also has a new drop in platelet count,\\n   worsening renal function, +Hep B IgM\\ns. Hard to tie all these findings\\n   into one cohesive picture- possibilities include CBD stone/biliary\\n   sepsis or acute [**Last Name (un) **] both with med-induced thrombocytopenia. Given\\n   loose stools, renal insufficiency and severe thrombocytopenia HUS/TTP\\n   also of concern though course (developed mid-hospitliazation) is odd.\\n   [**Month (only) 51**] have ITP.\\n   Liver function abnormalities\\n   Assessment:\\n   T bili trending up, 2.5->5->now 12.2; +hep A  IgM but thought to be\\n   false + since transaminase wnl and could be + from hx of hep A given he\\n   is from [**Country 3061**].  GI and liver consult -> ?biliary sepsis vs cirrhosis\\n   d/t chronic congestive hepatitis. Pt also has profound\\n   thrombocytopenia, with platelet count at  5000 -> ? TTP-HUS.  ? if pt\\n   has jaundice, difficult to assess d/t Asian background, abdomen is very\\n   firm and distended with ascites, +BS, 2 loose stools overnight,\\n   tolerating clear liquids. Tmax 98.7 po    LFT\\ns  WNL, only total bili\\n   was 11.1 (no change),  amylase & lipase WNL.\\n   Action:\\n   Unasyn 3gm q 8hrs, Abdominal U/S done [**10-9**]\\nresult negative, repeat\\n   platelet count, HIV testing done [**10-10**], NPO since Mn, stool for Ecoli\\n   157 sent [**10-9**].\\n   Response:\\n   All Cx pending except negative for C diff [**10-9**].\\n   Plan:\\n   Monitor Tbili, platelets, repeat hep A IGM, send stools for O&P (sent\\n   [**10-10**]).  Plan: MRI of bili tract, liver & head of pancreas [**10-10**]\\n   (checklist started, in front of chart).  Possible ERCP [**10-10**].\\n   .H/O cardiomyopathy, Other\\n   Assessment:\\n   Since receiving 1L NS on [**10-9**], sBP\\ns have been 90\\ns-100\\ns/.  Patient\\n   has 1+ edema @ B ankles.  HR:80\\ns SR- [**Street Address(2) 918**] no ectopy.    K 4.2\\n   after repletion        Hct 31.7 (34.1)\\n   Action:\\n   Monitored BP & HR& u/o.\\n   Response:\\n   As above\\n   Plan:\\n   Continue to monitor HR & BP\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 39 (52)       Cr 1.5 (2.2)      Na 128 (129)          U/o: 78cc/hr\\n   Edema increased slightly from trace @ ankles to 1+ @ ankles.\\n   Action:\\n   Was hydrated w/1 L NS & clear liqs po on [**10-9**]\\n   Response:\\n   BUN & Cr improved.  Na dropped a little.\\n   Plan:\\n   Continue to monitor lytes, BUN, Cr & u/o\\n   C/o abdominal pain ( [**5-24**] on [**12-23**] scale relieved down to 3-5)  relieved\\n   w/2mg IV morphine X2 overnight.\\n',\n",
              "  \"[**Age over 90 **] year-old female with CAD, thoracic aortic aneurysm, large hiatal\\n   hernia, and gastritis admitted with shoulder pain. Pain began\\n   approximately 3PM on day prior to admission. Described as 'ache', not\\n   associated with movement, chest pain, palpitations, shortness of\\n   breath, or palpitations. Patient also with nausea. Reports she has had\\n   previous pain in the past, but not to this severity or duration. Per\\n   discussion with patient's daughter ([**Name (NI) **]) and review of [**Name (NI) 2040**], pain\\n   previously attributed in part to uncontrolled GERD. Following onset of\\n   pain, patient took 2 SLNTG without relief. Given persistence of pain,\\n   she called EMS.  Per discussion with patient's daughter,\\n   daughter-in-law, often has 'attacks' of gassy pain with radiation to\\n   left shoulder, at times associated with nausea. Episodes often\\n   precipitated by eatting out. This episode different due to\\n   severity/persistence of pain.\\n    Left shoulder pain initially thought to be cardiac equivalent,\\n   initially, now thought to be referred abdominal pain.   First set\\n   cardiac biomarkers within normal limits. EKG showed atrial fibrillation\\n   (known), without acute ischemic changes. CTA showed stable thoracic\\n   aortic aneurysm. Patient subsequently developed abdominal pain,\\n   nausea.  LFTs within normal limits.\\n   CTA of chest & pelvis showed large hiatal hernia containing stomach &\\n   colon appearing larger, now extending 1-1.5cm below carina.  As stomach\\n   is now in area of lungs, there is a concern for possible entrapment.\\n   Abdominal pain (including abdominal tenderness)\\n   Assessment:\\n   Patient c/o mild abdominal pain & worse L shoulder pain (referred\\n   abdominal pain).\\n   Action:\\n   Received 0.5mg IV morphine which caused excessive nausea & dry\\n   heaving.  N&V relieved w/10mg IV compazine.  Received 2.5mg IV vitamin\\n   K for INR 2.5 ([**8-14**]).  NGT to low wall suction drained 300cc dark brown\\n   secretions @ this time.\\n   Response:\\n    Given 15mg IV toredol for pain w/relief (0/10).\\n   Plan:\\n    Tell team prn bleeding per NGT.\\n   Hypoxemia\\n   Assessment:\\n   O2 increased from 3L NP @ 1900 w/O2 sats : 94-96%    to 5L NP w/O2\\n   sats: 93-95%, to 50% cool neb w/sats 96-100%.   RR: 20-33  Lungs: clear\\n   @ upper lungs, diminishes @ bases.\\n   Action:\\n   Increased O2 as above\\n   Response:\\n   O2 sats maintained >92%\\n   Plan:\\n   Awaiting family to speak w/patient about surgery- the only option to\\n   reduce this hernia (may be laparoscopic).  Patient is ready to  consent\\n   to surgery now.\\n   Patient refused foley.  Very difficult to draw blood from patient.\\n   Intern & resident aware.\\n\",\n",
              "  '68 yr female w/ hx of cervical CA, s/p hysterectomy& XRT\\n  Trans\\n   to [**Hospital1 1**] from OSH [**10-17**] for UGI bleed. Per patient, was also passing\\n   clots & fecal matter via vagina. Patient also had significant LE edema\\n   & ascities. Subsequently dx with  Hep C & A with cirrhosis. Pt was\\n   scoped on [**10-17**] revealing 3 cords of grade II-III varices in the lower\\n   third of the esophagus and gastroesophageal junction. Small\\n   ulcerations  & stigmata of recent bleeding were seen. Some of the\\n   varices were protruding through the EG junction and seen on retroflex.\\n   3 bands  placed. Negative paracentesis on [**10-20**]. Patient with hematuria\\n   with large clots, placed on CBI. There was a question for\\n   recto-cysto-vaginal fistula as there was urine and blood draining from\\n   vagina, however was not visible under fluoro. She was at some point\\n   encephalopathic, which is being treated with rifampin, and lactulose.\\n   [**10-30**] pt noted to have extended UE, neck and was unresponsive. Code\\n   blue was called. Pt was put on NRB satting 100% with [**First Name8 (NamePattern2) **] [**Doctor First Name 2021**]-[**Doctor Last Name 2022**]\\n   type of breathing pattern. Her BP 130/80. She was intubated for airway\\n   protection. Trans to ICU for further monitoring. Pt has since been\\n   extubated, now w/ stable airway, stable respiratory status on RA.\\n   Social: pt\\ns son and sister requested to see the social worker\\n   regarding a personal matter they are having a difficult time with\\n   regarding pt\\ns boyfriend [**Name (NI) 1729**] [**Name (NI) **]. Social worker [**Name (NI) 363**] spoke with\\n   pt\\ns son at great length. Pt very emotional about son and her\\n   boyfriend\\ns relationship but not wanting to talk about it to this rn\\n   stating it\\ns personal. See social worker [**Name (NI) **]\\n note.\\\\\\n   Gastrointestinal bleed, upper (Melena, GI Bleed, GIB)\\n   Assessment:\\n   Patient passing multiple clots vaginally.  Also passing clots in\\n   urine.  3-way foley found clotted @ beginning of shift.   Had received\\n   2 units PC\\ns for Hct 21.4 to bring Hct up to 28.5.     Now Hct 25.2.\\n   PLT 66 (69)\\n   Action:\\n   Hand irrigated foley for moderate sized clot.  Ran CBI more rapidly,\\n   changing bag every 2 hrs initially.\\n   Response:\\n   Passing small clots in urine occasionally.\\n   Plan:\\n   Continue to titrate CBI to light pink urine.\\n   Hepatic encephalopathy\\n   Assessment:\\n   Patient continued to be oriented X3.       LDH 278(251)  AST27 (25)\\n   ALT19 (14)\\n   Action:\\n   Received lactulose as ordered (60cc qid).\\n   Response:\\n   Vomited  an hour after lactulose given, despite zofran given.  Turning\\n   seemed to initiate N/V.\\n   Plan:\\n   Perhaps patient would tolerate smaller volumes w/meds\\ngave 120cc to\\n   dilute 60cc lactulose.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Patient\\ns perineum, upper inner legs & rectal areas are reddened &\\n   excoriated.\\n   Action:\\n   Cleaned area w/soft disposable washcloths.  Covered w/criticaid.\\n   Response:\\n   Area continues to be tender.\\n   Plan:\\n   Await wound nurse\\ns f/u visit.  Continue skin care as above.\\n',\n",
              "  \"Mrs. [**Known lastname 3814**] is a 83 yo female with pmh of diverticulosis, iddm c/b\\n   nephropathy,and neuropathy,alzheimers dementia,htns/p chole and s/p\\n   hysterectomy.admitted on [**12-12**] from [**Hospital1 135**] with 2 episodes of hematochezia\\n   on the noc of [**12-11**]. was initially sent to osh ed where ct abd/pelvis was\\n   done showing perirectal stranding and rectal wall thickening. Was given\\n   ivf and transferred to [**Hospital1 **]  ed. in ed pt was tachycardic but\\n   hemodynamically stable. Had 2 more episodes of hematochezia  and then\\n   had sbp of 80\\ns. R femoral triple lumen was placed and 4 L NS were\\n   given and sbp restored to > 140. u/a noted to be dirty and started on\\n   vancomycin and cipro empirically. Lactate 3.4 (after 3L).   Transferred\\n   to [**Hospital Ward Name 29**] MICU for further monitoring. Patient is DNR/DNI.\\n   Gastrointestinal bleed, lower (Hematochezia, BRBPR, GI Bleed, GIB)\\n   Assessment:\\n   Patient oozed scant amount (smear of) pink jelly-like stool X3.  Hct\\n   dropped from 30.3(1300) to 26.4 (2200)on [**12-12**].\\n   Action:\\n   Transfused w/1 unit PC\\ns.  Intern & resident tried several times to\\n   reach son for [**Name2 (NI) 1056**] transfusion consent over the phone, but he did not\\n   answer or call back in response to message.  Kept NPO except for meds.\\n   Response:\\n   Patient received emergent [**Name2 (NI) 1056**] transfusion.  Post  transfusion Hct was\\n   30.6.  Lactate down to 1.1 (from 3.4).\\n   Plan:\\n   Obtain consent from son as soon as he calls back or comes in.  Continue\\n   to check serial Hct\\ns q 6 hrs.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Patient was felt to be dehydrated @ nrsg home.  Required 3L IVF in EW\\n   to keep BP >70/systolic.\\n   Action:\\n   Received additional  2.5 L  IVF in MICU on [**12-12**].  Given another\\n   800-900cc  on [**12-13**] so far.\\n   Response:\\n   BUN dropped from 44 ([**12-12**] @ 0200)  to 39.            Cr (baseline 0.8)\\n   dropped from 2.3 ([**12-12**] @ 0200)  to 1.8\\n   Plan:\\n   Continue to hydrate as needed.  Labs still pending from this am.\\n   .H/O dementia (including Alzheimer's, Multi Infarct)\\n   Assessment:\\n   Patient is disoriented, unable to answer any except the most simple\\n   questions.  She becomes agitated & uncooperative w/painful or\\n   uncomfortable stimuli, for example, a bedbath.\\n   Action:\\n   Gave zyprexa [**12-12**] evening.  Also gave risperidone po.\\n   Response:\\n   Patient slept well overnight.  Still became uncooperative w/any\\n   uncomfortable stimuli.\\n   Plan:\\n   Plan to place PICC on hold until patient is hemodynamically stable\\n   enough for sedation.  Several unsuccessful attempts w/PICC placement\\n   on [**12-12**] due to patient\\ns agitated response.\\n   .H/O diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS 120- 160 overnight.\\n   Action:\\n   Received\\n usual am NPH dose for NPO status.  Also covered w/sliding\\n   scale insulin  (2 units regular @ 0600).\\n   Response:\\n   [**Month/Day (4) **] sugars improved on\\n dose NPH.  [**Month/Day (4) **] sugar in [**Hospital1 5**] EW was 400.\\n   Plan:\\n   Continue as above.\\n\",\n",
              "  \"74-year-old woman with CHF, COPD, and liver mass presented to\\n   outside hospital with dyspnea,  increased right upper quadrant pain and\\n   found to be hypotensive and anemic. Hct 27 at OSH.   Pt transfused 1\\n   unit PRBC's and transferred to [**Hospital1 5**] for further w/u. Upon arrival to\\n   [**Hospital1 5**] she was noted to be in afib w/ HR 110-140, and having increased\\n   02 requirements w/ 02 sat 90-94% on 6l n/c. Sent to [**Hospital Ward Name 29**] MICU for\\n   management.\\n   In addition, Ct of abd/pelvis found large 20cm  hepatic hemangioma that\\n   might be bleeding so pt was transfered to [**Hospital1 5**] for further w/u of this\\n   finding .  No intervention ordered by liver consult  team and pt is\\n   hemodynamically stable. Surgery team noted that this was an old\\n   hemangioma that was visualized in [**2121**].   Pt\\ns son and husband are\\n   requesting that pt be transfered back to [**Hospital3 **]\\ns Hospital for their\\n   convenience in being able to visit and support pt.   Medical team now\\n   trying to facilitate this transfer.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR:80\\ns-110\\ns A-fib.  BP 77-114/systolic.      Hct 25.7 (29.3)\\n   Patient continues to be asymptomatic w/BP in 70\\ns-80\\ns/systolic,\\n   maintaining u/o 70-100cc/hr.\\n   Action:\\n   Diltiiazem 30mg given @ [**2113**] (after1800 dose held).  Midnight- 0200\\n   dose held for sBP 95/ (<100).\\n   Response:\\n   Patient c/o heavy midsternal chest pain [**5-24**] @ 0100, relieved w/NTG\\n   0.3mg SL X2 & position change.  O2 increased from 3L to 5L NP.  EKG\\n   done, no changes.  Cardiac enzymes drawn: troponin 0.03, CPK  178\\n   (254),  MB 5.\\n   Plan:\\n   Stagger lopressor w/diltiazem.  Draw Hct  & cardiac enzymes@ 0800.\\n   Check w/team re: fluid replacement prn BP<90/systolic.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 76**])\\n   Assessment:\\n   Lungs: upper clear, diminished @ bases.  RR 17-24     O2 sats: 90-95%\\n   on 3-5L NP     WBC 11.5 (10.3)\\n   Action:\\n   Given neb Tx\\ns q 6 hrs.  Transferred patient to cardiac chair @ 0200as\\n   patient sleeps & lives in cardiac chair @ home for the last year. ( She\\n   only pivots to the commode w/help from her son).  Had patient lift\\n   buttocks off  the chair every 2 hours & shift position in order to\\n   prevent skin breakdown.\\n   Response:\\n   As above.  O2 sats improved in chair while sleeping from 88-90% to\\n   92-94%.\\n   Plan:\\n   Keep patient in chair for her comfort as long as possible.  If patient\\n   remains @ [**Hospital1 5**] past the w/e, order a  Big Boy bed for her.\\n   Woke up from a deep sleep  @ 0430, not oriented to place (did not know\\n   where whe was), oriented to year but thought it was [**Month (only) **] (it is last\\n   day of [**Month (only) **]).  Reoriented patient easily.\\n\",\n",
              "  '83 yo Russian speaking male who is deaf w/ PMH of  HTN, OSA, elevated\\n   cholesterol, DM II, congenital deafness (needs a Russian sign language\\n   interpreter), CAD (fixed apical myocardial defect with EF 40% [**5-/2121**]),\\n   CRF w/ cre baseline 1.6-1.7, osteoarthritis, bifasicular block, and L\\n   subclavian steal syndrome who presented to [**Hospital1 19**] ED with sharp RUQ\\n   pain, worsening over 2d.  In the ED he was tachy to 115, EKG with\\n   nonspecific changes, increased AST/ALT, lipase 2650, CT abd/pelvis\\n   revealed CBD stones and pancreatic head inflammation.  Admitted to Fin\\n   MICU for ERCP.  Intubated for procedure, two stones retrieved, one in\\n   common hepatic duct and one in ampulla; sphincterotomy performed.\\n   Hypotensive post induction and neo started in GI suite.  He went into\\n   ARF and needed to go on CRRT.  Extubated [**12-25**] am but needed reintubation\\n   by 1500.  Restarted levophed for hypotension [**12-26**] midnight, weaned off\\n   by [**2113**].  WBC up to 40 ([**12-26**]), pan cultured [**12-25**] eve.  Had abdominal CT,\\n   showed pancreatitis, no evidence of obstruction or dlitation of bowel.\\n   Social:  Patient\\ns wife was sent to EW from patient\\ns room w/chest pain\\n   & admitted [**12-26**].\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Remains on CPAP w/10 PS/5 PEEP.  Was @ 40%, now 50%.  O2 sats remained\\n   98-100%.  RR 9-20.\\n   Action:\\n   ABG\\ns improved on 50%: 7.37/34/95.  Sx\\ned for small to scant amounts\\n   thick green secretions.  Receiving fentanyl 50mcg/hr & versed 0.5mg/hr,\\n   only lightly sedated.\\n   Response:\\n   pO2 up from 77 on 40%         RSBI 19  today, improved from 30\\n   yesterday.\\n   Plan:\\n    Attempt to wean from vent as patient tolerates.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   On CVVHDF.      BUN  31 (32)      Cr 1.8 (1.9)      Hct 26.7 (29.4)\\n   Action:\\n   Weaned off levophed by [**2113**].  Attempted to keep weight even until\\n   0200.  Then attempted to remove 50cc/hr.\\n   Response:\\n   MAP remained > 60.  SBP remained >100/.     Increased BUN from\\n   increased protein intake w/TPN.\\n   Plan:\\n   Continue to remove fluid as patient\\ns BP tolerates.\\n   Ileus\\n   Assessment:\\n   Patient\\ns bowel sounds increased in amount overnight from hypoactive to\\n   present (normal amount).  No flatus yet.  No c/o pain but patient was\\n   restless all night despite sedation.  Increased sedation to provide\\n   relief.   NGT put out 400cc from [**2113**] to midnight, green bilious\\n   drainage.  Contrast mixed in w/1^st 200cc.   WBC 38.9 (40).\\n   Action:\\n   Titrated sedation (preferring to increase fentanyl for pain) to provide\\n   relief  of pain while avoiding hypotension.    Maintained contact\\n   precautions for presumed [**Name (NI) 2444**].  Continues on IV flagyl, vanco &\\n   zosyn.\\n   Response:\\n   No BM yet.  Patient probably has cramping abdominal pain, shown by\\n   increased BP & HR, increased bowel sounds & restlessness.  Monitor\\n   Plan:\\n   Send stool for C-diff when patient has BM.\\n   Pulmonary Embolism (PE), Potential\\n   Assessment:\\n   As above, patient remains on CPAP @ 50% w/10 PS & 5 PEEP.  O2 sats\\n   remain 98-100%.  No c/o pain.\\n   Action:\\n   On IV heparin @ 850 units/hr\\n   Response:\\n   PTT remains w/in desired range of 60-100\\n   Plan:\\n   Check PTT w/labs @ 1000.\\n',\n",
              "  '64 y/o male admitted to [**Hospital1 1**] on [**2125-6-18**] from [**Hospital6 **]\\n   with altered MS [**First Name (Titles) 43**] [**Last Name (Titles) 2430**]. Hx of Stage IV Colon Ca with mets to lung dx\\n   last fall, now with bilateral malignant pleural effusions. Last\\n   chemotherapy 4 weeks ago.  Patient has latex allergy. Intubated [**Date range (1) 7615**]\\n   for decompensation and was extubated [**6-20**]; required reintubation [**6-22**],\\n   diuresed with lasix, extubated [**6-25**]. Now w/decreased PLT\\ns, prolonged\\n   clotting times, ?DIC vs TTP.  Had head CT [**6-25**] : preliminary result\\n   negative.\\n   Thrombotic Thrombocytopenic Purpura / Hemolytic Uremic Syndrome\\n   (HUS/TTP)\\n   Assessment:\\n   Foley drained lightly bloody urine until midnight when urine cleared to\\n   yellow from pink, but still passed occasional clots.   Hct 23.5 (down\\n   from 24.4, which was down from 25.7)      INR 1.7(1.6)  PLT CT 45 (49)\\n   Fibrinogen 101 (140) w/am labs.       BUN 26 (31)     Cr 0.9 (0.9)\\n   Action:\\n   Sent stool for Ecoli 0157 ( a cause of TTP/HUS).  Patient received 1\\n   bag of cryoprecipitate @ 1830 for fibrinogen level down to 87 & FDP up\\n   to >1280.\\n   Response:\\n   Fibrinogen level rose to 140 an hour after cryoprecipitate & FDP\\n   dropped to 320-640.\\n   Plan:\\n   Await results of E coli 0157 from state lab.  Transfuse for fibrinogen\\n   level <100 w/cryoprecipitate.  Transfuse w/PLT\\ns for PLT CT <10.    [**Month (only) 11**]\\n   receive unit PC\\ns later today.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient was unable to respond when asked where he was, who he was &\\n   when it was.  Nodded & answered in monosyllables in response to\\nDo you\\n   have pain?\\n    Patient tried to pull out foley (which probably caused\\n   urinary bleeding earlier [**6-25**]).  He was combative, making fists &\\n   grabbing caregiver before midnight.  By 0400, he was not combative,\\n   more alert & answering/nodding  yes/no to\\nDo you want the light on?\\n   Action:\\n   Patient is restrained @ both wrists w/soft limb restraints.  Sat\\n   w/patient off & on as agitation required.\\n   Response:\\n   Patient has been disoriented every night, tonight included.  He\\nsundowns.\\n   Plan:\\n   Continue to attempt to orient as needed.  Wife will sit w/patient if\\n   needed (phone # on board in room).\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   Lungs are clear, diminished @ bases.  Patient is coughing up white\\n   secretions.  Unable to swallow medication (2.5cc vancomycin liquid)&\\n   choked on it.  Able to suction out vancomycin from mouth & throat.\\n   Serum K 3.4 @ 0400.\\n   Action:\\n   Suctioned mouth for secretions which patient swallows mostly.  Placed\\n   NGT ([**Hospital1 **] sump) for oral meds & possible tube feedings.  Continues on\\n   IV lasix 5-8mg/hr to produce u/o of 200-300cc/hr.  Now on KCl sliding\\n   scale & Mg sliding scale.  To receive 60mEq IV KCl for serum K 3.4 (see\\n   prn section of [**Month (only) **]).\\n   Response:\\n   Patient received oral Vanco q 6 hrs for C-diff.\\n   Plan:\\n   Will need (soft) feeding tube placed in future for tube feeds.  Will\\n   continue on oral Vanco for another 10 days after levofloxacin D/C\\n   ([**6-25**]) per resident for high possibility of reinfection.  Continue goal\\n   u/o of >200cc/hr w/titration of IV lasix.\\n   Tachycardia, Other\\n   Assessment:\\n   HR: 100\\ns- [**Street Address(2) 3204**] no ectopy        MAP 68-107      BP 88-128/ 55-94\\n   Action:\\n   Received 10mg IV lopressor @ 2130.  Now receiving 7.5mg IV lopressor q\\n   6 hrs\\n   Response:\\n   HR dropped to 100\\ns-[**Street Address(2) 1148**]  from 130\\ns- ST\\n   Plan:\\n   Give lopressor as long as MAP>65.\\n',\n",
              "  'This is a 54 yr old woman coming from a nursing home w/lower GIB.  She\\n   has an anal fissure which has produced clots in the past & is producing\\n   [** **] & clots now.  To be seen by wound care nurse for suggestions for\\n   care.  PMH: HIV, SLE, adrenal insufficiency, hepatitis C cirrhosis,\\n   depression,DJD R hip, neropathy, muscle weakness.  Last admission\\n   [**Date range (1) 2969**] for bloody stools (hct stable, hemorrhoids, sm ooze from\\n   colon).    Previously left hospital for 5 days before coming back in on\\n   [**5-16**].\\n     Open oozing external hemorrhoid  noted on L external anal sphincter\\n   area during last admission, as was perineal fissure running upwards\\n   from anal region open but w/out purulence.\\n     Hemodynamically stable.  Lactate 2.1.  BP\\ns down to 80-85/systolic\\n   accepatable due to cirrhosis.  Received 2L NS & 1 Gm ceftriaxone IV in\\n   EW.  Has Dobhoff in R nares.  Gets tube feed overnight (6p-6a)\\n   w/regular diet during day.  Says she has poor appetite.   Full code.\\n   Unable to hang tube feedings overnight as nutren 2.0 not available.\\n   Resident did not want nutren pulmonary or replete or other available\\n   canned tube feedings.  Resident said it was OK to do w/out until\\n   tonight.   Dietary to supply it during the day.\\n   .H/O abdominal pain (including abdominal tenderness)\\n   Assessment:\\n   C/o abdominal tenderness & pain, constant but exacerbated by activity\\n   (turning in bed).  Says pain is\\n on [**1-12**] scale.  Says she usually\\n   has it & takes ultram 50mg  for it.\\n   Action:\\n   Received ultram  50mg for abdominal pain\\n   Response:\\n   Some relief, most comfortable when not moving.\\n   Plan:\\n   Continue to assess pain/medicate as needed.\\n   .H/O anal fissure\\n   Assessment:\\n   Stool mixed w/[**Date Range **] noted @ perirectal area.  Has peri-anal fissureby\\n   hx.   Has been exacerbated in past from diarrhea from lactulose\\n   titrated to [**6-10**] BM\\ns/day(in past).  Visualized several ulcers around\\n   rectum\\n   Action:\\n     Left  ulcers OTA after attempting to keep area clean w/soap & water @\\n   first.  Later used wound cleanser & DSD\\ns.  Mushroom catheter (small\\n   size) placed to keep stool out of excoriated ulcers.   Perineal cold\\n   pack applied for comfort & to stop bleeding.\\n   Response:\\n   Lactulose ordered to produce 2-3BM\\ns/day.  Stool already loose.\\n   Patient more comfortable after mushroom catheter placed.  Stool is\\n   brown mixed w/obvious [**Last Name (LF) **], [**First Name3 (LF) **] be from hemorrhoids.\\n   Plan:\\n   Continue to clean ulcers w/wound cleanser.  If mushroom catheter too\\n   small, try next larger size.  Await wound nurse\\n[**Initials (NamePattern4) **] [**Last Name (NamePattern4) 2972**]s\\n   (consult ordered).\\n   Lactate has come up overnight  to 3.1 from 2.1.  Has yeast in urine\\n   (UA).  Urine Cx & BC X2 drawn [**6-4**] in EW & still pending.  To have\\n   transvaginal US today.\\n',\n",
              "  '[**Age over 90 **] yo F with htn, a-fib, [**Doctor Last Name **] disease now hypothyroid,\\n   myelodysplastic syndrome, cri, presents with probable urethral bleed  7\\n   days after urethral polyp excision in context of restarting plavix 2\\n   days ago.  Presented to ED with crit of 25. Evaluated by both urogyn\\n   and urology. A speculum exam did not show bleeding from the baginea or\\n   a fistulous tract. An 18g foley was placed and gauze placed in the\\n   vagine to try to tamponade the bleeding. Urology irrigated the foley\\n   and removed some clots and her urine briefly cleared. However, she\\n   again began to bleed and repeat crit was 20. Pelvic u/s showed large\\n   hematoma in the bladder. She was hypotensive to 80/40 and responded to\\n   1L IVF bolus. She received 1unit PRBC\\ns in the ED and 1unit PRBC\\ns in\\n   the MICU overnight.\\n   [**8-11**] am Hct 28. Repeat Hct was again down to 20. Received an additional\\n   2 units of PRBCs  [**8-11**] during the day. Urology and GYN in at change of\\n   shift. Urology flushed foley catheter until clots cleared. Vagina\\n   re-packed with gauze to attempt to tamponade bleed. CBI to be stopped\\n   at this time per urology recs.\\n   Overnight  [**Date range (1) 8976**], foley clotted off due to blood clots and\\n   Urology/GYN  came to see pt again and replaced foley and manually\\n   irrigated it. Hct remained stable. [**8-12**] am, pt still clotting off and\\n   US of bladder continued to show large volume clots. Patient taken to OR\\n   for cystoscopy & bladder irrigation [**8-12**].\\n   Post  Op Cystoscopy\\n   Assessment:\\n   Urine was pink to amber, w/no clots noted postop.  U/o only 20cc/hr\\n   despite LR bolus 500cc @ 1830.\\n   Action:\\n   500cc LR boluses given @ [**2139**] &  @ 2130 & 0400.  Foley irrigated w/30cc\\n   sterile H2O @ 0300 per resident .  Tiny clots  &  instilled H2O\\n   removed, resident aware.\\n   Response:\\n   U/o 17-35cc/hr\\n   Plan:\\n   Monitor for clots in urine.\\n   Anemia, acute, secondary to blood loss (Hemorrhage, Bleeding)\\n   Assessment:\\n   Hct 33.5 preop [**8-12**].     Postop  Hct @ [**2154**]: 27.7       BP:\\n   106-79/systolic        No S&S  bleeding.\\n   Action:\\n   Given 1 unit PRBC\\ns @ 2300.  Also given LR boluses X3 as above.  LR\\n   infused @ 100cc/hr as well.\\n   Response:\\n   Post Hct: 32.7\\n   Plan:\\n   Continue to check Hct q 4-6 hrs.  Check results from 0630 am labs.\\n   Potential sepsis\\n   Assessment:\\n   T 93ax upon arrival from OR.  Increased to T 98.1ax  on Bair huggar.\\n   U/o as above & patient hypotensive to 79/systolic as above.\\n   Action:\\n   BC X 2 drawn.  Lactate level drawn.\\n   Response:\\n   Lactate: 1.3-1.4         [**8-12**] ([**2154**]) WBC 5.5\\n   Plan:\\n   Continue to monitor temp q 4 hrs.\\n   Altered mental status (not Delirium)/Potential to fall\\n   Assessment:\\n   Patient oriented to self, not place or time. Remembered her daughter\\n   [**Name (NI) 455**] but thought [**Name (NI) 455**] was a child.  Did not remember her own age.\\n   Slept during the early evening & woke up @ 0030.  Initially\\n   cooperative.  Became agitated @ 0400, threatening to pull  this nurse\\n   hair.  Insisted she was in her own room.\\n   Action:\\n   Bed alarm on.  Wrapped IV\\ns w/kerlix as patient started to pull them\\n   out.  Kept curtains open to observe patient in case  she attempts to\\n   get OOB.  Sat  w/patient in her room.  Attempted to orient patient.\\n   Patient\\ns room is near nurse\\ns station.\\n   Response:\\n   Patient was lethargic from sedation in OR till midnight, then\\n   pleasantly confused.  Became agitated @ 0400.\\n   Plan:\\n   Allow patient to sleep @ night.  Orient patient as needed.  Bed alarm\\n   on.  Keep patient under observation as needed.\\n   Alteration in Skin Integrity\\n   Assessment:\\n   Skin @ perirectal area reddened & unbroken  Skin @ back & sacrum w/no\\n   alteration in color.  Skin under breasts red & peeling.  Washed, dried\\n   & micostatin powder applied.\\n   Action:\\n   Lotion applied q 4 hrs.  Patient turned q 2 hrs.\\n   Response:\\n   Plan:\\n   Continue to turn q 2 hrs.  Continue skin & back care.\\n',\n",
              "  '38 yo W with PMH of relapsed ALL admitted on [**6-30**] with neutropenic\\n   fever. Workup at that time was unrevealing. She then began re-induction\\n   on [**7-12**]. She is/p cytarabine chemotherapy with plan for allo BMT. She\\n   is currently at her count nadir. Inpatient course has been complicated\\n   by C diff colitis ([**7-18**]), acute pancreatitis ([**8-10**]), pericardial\\n   effusion with? tamponade ([**8-15**]) and VRE sepsis ([**8-16**]). She has been\\n   found to be more tachypneic over the last several days. She was noted\\n   to have rigors [**8-18**] in AM and received demerol- She has known vaginal\\n   bleeding that is normally treated with Estraderm patch.\\n   PEA arrest at 1500  [**8-19**] when pt dangled in bed for  thoracentesis,\\n   thought to be a hypovolemic event-- epi and atropine given; intubated;\\n   and A-line placed .  Troponin 0.03, CPK 920.\\n   Neutropenic precautions- WBC 0.1(on neupogen); GPC (presumably from\\n   VRE) grew out in BC.   Surveillance BC since [**8-20**] have had no growth to\\n   date.\\n   Remains intubated & sedated.\\n   L subclavian D/C\\ned @ 0130.  Cath tip sent for Cx.  New PIV @ R AC\\n   started (#18G) under U/S.  Also has #18G @ L AC.  Plan: to have midline\\n   placed today (by IV nurse if possible).\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   Remains on A/C  @ 40%/500/16/5 PEEP.  RR 16-20     O2 sats 96-99%\\n   Lungs have rhonci.     Afeb.\\n   Action:\\n   RT Sx\\ned large amount thin white frothy secretions from lungs @ 0430.\\n   Stopped TF\\ns (large residual 290cc @ 0500).\\n   Response:\\n   Stopped TF\\ns.   ABG\\ns: 7.40/34/103  @ 0447.   RSBI 158 today. (147\\n   yesterday).  Patient initiating own breathes ([**12-19**]/min).\\n   Plan:\\n   Await CXR results.\\n   Hypertension, benign\\n   Assessment:\\n   HR 105-118 ST, up 10 points from 12 hrs ago.    BP: 140-161/90\\ns-105\\n   Action:\\n   HR increased after multilumen D/C\\ned.  Increased fentanyl from 75mcg/hr\\n   to 100mcg/hr.   Increased versed from 1mg/hr to 1.5 mg/hr.  Tears noted\\n   in eyes when turned.  Bolused sedation w/turning since then.\\n   Response:\\n   Intern aware re: increased HR.\\n   Plan:\\n   Give IV labetolol for sBP>160/ & dBP>/110.  Bolus  sedation  as needed\\n   to prevent discomfort.  Increase sedation if needed.\\n   Liver function abnormalities\\n   Assessment:\\n   LFT\\ns:  LDH 2237 (1232)   AST 93 (119)  ALT 44 (46)  Alk p\\ntase 253\\n   (210)  tot bili 4.5 (4.5)  direct bili 3.3\\n   (3.3)                                                          Urine\\n   amber, possibly icteric.  Abdomen firm & distended.  Hypoactive bowel\\n   sounds.  LBM [**8-17**] according to 7 [**Hospital Ward Name 476**] nurses who cared for her. No\\n   flatus.\\n   Action:\\n   Ran TF @ lowest possible rate:10cc/hr.  Stopped TF for 140cc residual @\\n   [**2056**].  Resumed for 20cc residual @ [**2126**]. Continued @ Mn for 90cc\\n   residual.  Stopped TF again @ 0500  for 290cc residual.\\n   Response:\\n   Discarded 290cc TF residual @ 0500\\nmostly bilious fluid.\\n   Plan:\\n   Abdominal U/S @ bedside today.\\n   U/o continues to improve @ 100cc/hr but Cr up to 1.2 from 1.1.  BUN 37\\n   (39 yesterday).\\n   Received 1 unit PC\\ns for Hct 23.9 (<25).  Awaiting post Hct drawn @\\n   0450.  Bleeding orally ,suspect bitten tongue.  Placed gauze-wrapped\\n   tongue depressor in mouth to prevent further damage.  Bleeding from\\n   both nares.\\n   Spoke to family (father, uncle & others) , who said they hope for a\\n   miracle, that [**Known firstname 1018**] will walk out of the ICU.\\n',\n",
              "  'Gastrointestinal bleed, other (GI Bleed, GIB)\\n   Assessment:\\n   Hct 30.3  Hemodynamically stable .\\n   Action:\\n   Check Hct w/am labs\\n   Response:\\n   Plan:\\n   Send patient home if Hct >30.  Wife aware of plan to send home.\\n   Patient had new #20 placed @ 2300 by IV RN.  Received IV Magnesium 2 GM\\n   @ 0100.  IV wrapped w/kerlix to prevent its catching on covers per\\n   patient request.  Patient c/o pain initially, no further c/o after IV\\n   infusion slowed. Very large infiltrate found @ R arm.  Hot packs\\n   applied to infiltrate.  IV pulled . R arm elevated.  Intern & resident\\n   & 11 [**Name8 (MD) 89**] RN informed.   IV nurse called back to place new IV.\\n   Patient ambulated in hallway w/nurse , w/no difficulty.\\n   Report called to 11R.  IV to be replaced by IV nurse before transfer.\\n',\n",
              "  'This is a pleasant 89 yo male who was admitted to us from an outside\\n   hospital for RUQ pain, jaundice, elevated LFTs and bili.   They did a\\n   CT which showed CBD and pancreatic duct dilatation so there was concern\\n   for cholangitis or cholecystitis, he was sent to [**Hospital1 1**] for an ERCP.  Of\\n   note, he has recent wt loss, poor appetite and increased jaundice at\\n   home.  Had ERCP [**8-6**].  Abnormal esophagus was found, plastic stent\\n   placed & brushings were done,as concern for pancreatic CA.\\n   [**Last Name 19**] Problem\\n Dilated CBD & pancreatic duct\\n   Assessment:\\n   Patient received @ 1900 still intubated after ERCP.  Patient slowly\\n   woke up.  NGT to low wall intermittent Sx overnight.  Very hypoactive\\n   bowel sounds.  Hct 30.7 @ 2100.    LFT\\ns improved from [**8-6**] .\\n   Action:\\n   Extubated @ 2100.  Suctioned for moderate to large amounts thick tan\\n   secretions while still intubated.\\n   Response:\\n   Maintained O2 sats 96-99% on 40% cool arosol.  Patient did not cough.\\n   IS explained.  [**8-7**] am Hct: 29.4\\n   Plan:\\n   Clamp NGT.  Continue to monitor bowel sounds. Check Hct @ noon  (q 8\\n   hrs).  Possible transfer to floor.\\n',\n",
              "  '39 year old male with PMH ulcerative colitis s/p J pouch admitted to\\n   MICU for management of GI bleed. Patient presented to the ED with one\\n   day h/o rectal bleeding with associated light headedness, blurred\\n   vision, dyspnea with exertion, and SOB. Given total of 2 units PRBC in\\n   ED and transferred to MICU.\\n   Since MICU admission pt received 1 additional unit PRBC at around noon\\n   yesterday with an appropriate bump in Hct. GI scope negative for any\\n   active bleeding as well as a negative red tag study. Pt\\ns Hct has been\\n   stable with no s/s bleeding. C/o some nausea and abdominal cramping but\\n   no pain according to patient.\\n   Gastrointestinal bleed, lower (Hematochezia, BRBPR, GI Bleed, GIB)\\n   Assessment:\\n   BP:  131-151/ 65-82                  HR: 98 SR- 128 ST  no\\n   ectopy                 HCT: 34.7, no change from noontime.\\n   Action:\\n   Patient supervised getting up to commode multiple times, w/out\\n   dizziness or Sx.\\n   Response:\\n   Patient is hemodynamically stable.\\n   Plan:\\n   Transfer patient to floor as soon as bed available.\\n   Ulcerative colitis\\n   Assessment:\\n   Patient having frequent watery green stools.  C/o occasional abdominal\\n   cramping w/nausea.\\n   Action:\\n   Given 10mg IV compazine w/relief of nausea.  Abdominal cramping passes\\n   too quickly for pain med @ this time.\\n   Response:\\n   Tolerated clear liquid diet.\\n   Plan:\\n   Continue to monitor stool output.\\n',\n",
              "  \"Mr. [**Known lastname 8120**] is a 41 yo M with PMH ETOH abuse, cholelithiasis, HTN,\\n   obesity who presented to [**Hospital3 **] with upper GIB.  He reports\\n   that for the past 6 years he has been drinking [**11-27**] of a 1.7L bottle of\\n   vodka daily.  On Friday evening he had several episodes of vomiting of\\n   bright and dark red material for which he presented to [**Hospital1 **].  He had an NG tube which reportedly failed to clear with\\n   lavage and patient self d/c'd the NGT because he was vomiting around\\n   the tube.  He was given 4mg IV morphine for abdominal pain, ativan 2mg\\n   IV for withdrawal, protonix 40mg IV, zofran 8mg IV, octreotide 50mcg\\n   IV, and 1 unit of platelets.  He had a CT scan at [**Hospital3 **] which\\n   per their read showed stigmata of portal venous hypertension and\\n   hepatic cirrhosis with a large amount of ascites and varices,\\n   splenomegaly.  It also showed mild peripancreatic stranding suggesting\\n   mild pancreatitis with no loculated collection.  He has cholelithiasis\\n   and cholecystitis could not be excluded based on the available\\n   images.\\n   .\\n   Pancreatitis, acute\\n   Assessment:\\n   Patient continues to have  firm distended abdomen.  He c/o R sided\\n   abdominal pain [**5-4**]\\n   Action:\\n   Medicated w/ 4mg IV morphine w/ diagnostic paracentesis.  As this did\\n   not relieve his pain, received 0.5mg IV dilaudid for pain X2\\n   overnight.  Given pantoprazole IV & octreotide IV continuously.  LFT\\n   bili & lipase elevated.  WBC 3.9 (2.5)  INR 1.7 (no change)   Serum K\\n   5.3 (3.9)! ( Intern aware)\\n   Response:\\n   After receiving dilaudid, patient said his pain was better, gone.\\n   Plan:\\n   Continue to assess for pain.  Medicate as needed.  Consider drawing\\n   lactate.\\n   Alcohol withdrawal (including delirium tremens, DTs, seizures)\\n   Assessment:\\n   CIWA [**2-17**]\\n   Action:\\n   Received 5-10mg IV valium q 2 -4 hrs overnight.  Given 5mg IV valium\\n   for CIWA [**10-9**].  Given 10mg IV valium for CIWA 19-25.\\n   Response:\\n   Patient\\ns increased anxiety , agitation & trembling controlled by\\n   valium.\\n   Plan:\\n   Continue to check CIWA q 2 hrs & medicate w/valium for CIWA>10.\\n   .H/O hypertension, benign\\n   Assessment:\\n   BP 135-191/75-110  BP increased w/pain , nausea & agitation.  Relieved\\n   w/pain med, relief of nausea & valium.\\n   Action:\\n   Medicated for pain, nausea & CIWA (agitation).\\n   Response:\\n   Patient\\ns BP more elevated this am.\\n   Plan:\\n   Await order for antihypertensive.\\n   Serum magnesium is 1.7, needs repletion.\\n\",\n",
              "  '83 yo woman with h/o bilary obstruction from a choangiocarcinoma s/p\\n   stent placement [**8-12**] and [**9-12**] right and left main bile duct. In [**Month (only) **]\\n   she had ECRP c/b hypoxemia, VRE bacteremia, E coli bacteremia. She was\\n   admitted to [**Hospital3 902**], febrile w/temp 104 and hypotension. Blood\\n   cx + E coli, Klebsiella and GPC. Abd CT showed persistent dilation\\n   behind stents consistent with obstruction, & areas concerning for early\\n   abscess. Also she went into a rapid AF, treated with diltiazem drip and\\n   dig loading. She had + troponin with ekg changes ? demand ischemia.\\n   R/o\\ned for MI by enzymes.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   Afebrile.    Hemodynamically stable.\\n   Action:\\n   Patient had 2 permanent metallic biliary stents cleared of pus & sludge\\n   during ERCP [**2169-1-6**]\\n   Response:\\n   Afebrile.  No c/o pain.  Sent BC [**1-7**] am.      WBC 20.4 (16.3)\\n   Plan:\\n   Continue abx.  Transfer to floor as soon as called out & bed available.\\n   Deep Venous Thrombosis (DVT), Lower extremity\\n   Assessment:\\n   L deep vein thrombosis found in one of paired posterior tibial veins by\\n   US.  No c/o pain.  B DP\\ns & PT\\ns dopplerable, R PT easier to doppler\\n   than L.\\n   Action:\\n   Started IV heparin @ 2315 @ 1400 units/hr.  LLE elevated on 1 pillow.\\n   Response:\\n   PTT : 63.7 @ 0515\\n   Plan:\\n   Continue IV heparin @ same dose.   Next PTT @ 1100.   Awaiting PICC to\\n   be placed by IV nurse today.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 60\\ns-80\\ns SR w/frequent PAC\\ns  BP: 130-150\\ns/systolic.  Digoxin\\n   level 3.5 ([**1-5**])     K    (4.1)\\n   Action:\\n   Digoxin D/C\\n   Response:\\n   Plan:\\n   Continue to monitor Digoxin level, HR & rhythm.\\n   [**Last Name **] Problem\\n Altered gag w/ difficulty swallowing\\n   Assessment:\\n   Patient had difficulty swallowing pills crushed & mixed w/apple sauce.\\n   Much of apple sauce mixture remained on patient\\ns tongue even after she\\n   tried swallowing.  She said she normally took her pills crushed in\\n   apple sauce, but she needed liquid to help her swallow.  After a sip of\\n   liquid, she swallowed & coughed, turning red in the face.\\n   Action:\\n   Attempted to Sx mouth but patient bit down on yankeur & would not let\\n   her mouth be suctioned.\\n   Response:\\n   Lungs sounded unchanged (clear, diminished @ bases) after.\\n   Plan:\\n   Keep NPO until speech & swallow study done.  Consider placing NGT for\\n   meds over weekend while awaiting speech & swallow.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Oriented to self overnight only.  At 0600, als9o oriented to place\\n   ([**Hospital3 389**] Hospital).  Aware of month ([**Month (only) **]), not year or day.\\n   Action:\\n   Continued to reorient patient.\\n   Response:\\n   Plan:\\n   As above.\\n',\n",
              "  'Anemia, acute, secondary to blood loss (Hemorrhage, Bleeding)\\n   Assessment:\\n   Hct 27.6 (up from 24.0 ) @ 1800.  Hct  27.8  @ 00.   No BM since [**5-25**].\\n   Bladder pressure [**7-18**].\\n   Action:\\n   Given senna, bisacodyl, colace & MOM to induce BM.\\n   Response:\\n   Unable to guiac stool until patient has BM.  Bladder pressure is\\n   WNL..    Hct stable.\\n   Plan:\\n   Continue to check Hct q 6 hrs.  Give more bowel meds & get up OOB if\\n   possible.\\n   [**Last Name **] Problem\\n R total hip replacement [**5-26**]\\n   Assessment:\\n   R hip drsg [**Name5 (PTitle) 917**] [**5-28**]: scant sanguinous drainage noted.  Thigh girth\\n   (from 23.75 in): 24in.      B DP\\ns & PT\\ns are weakly palpable (no\\n   change).\\n   Action:\\n   Thigh girths checked for potential compartment syndrome.\\n   Response:\\n   Thigh girth may be increased as different person is measuring it.\\n   Thigh girth up by 0.25in.\\n   Plan:\\n   Transfuse for Hct <24.  Continue to measure thigh girth, check pulses\\n   etc.\\n   This is a 77 yr old man from [**Country 2197**] who had R total hip surgery\\n   [**5-26**].  He lost 1500cc blood intra-op.  He has received 8 units PC\\n   since that time.  Dropped Hct from 34.5 to 24 in PACU, & Hct has only\\n   increased by [**2-11**] points since then.   PMH: DM2, HTN, GI bleeding, BPH,\\n   prostate CA  s/p XRT.\\n   ------ Protected Section ------\\n   0300 Hct 28.5, still stable.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2178-5-29**] 06:36 ------\\n',\n",
              "  \"Mrs. [**Known lastname 8317**] is a very pleasant 69 year old female with past medical\\n   history of esophageal and breast cancer. She is currently undergoing\\n   treatment with cisplatin, 5-FU, and radiation. Her last treatment was\\n   [**2178-9-21**], and her OMED team has been treating her for nausea, fatigue,\\n   and poor PO intake.\\n   .\\n   On [**9-24**] early am, patient reports that she was sleeping and awoke with\\n   substernal chest discomfort. Shortly thereafter, she vomitted\\n   approximately 150 cc of bright red bloody emesis. She was noted to be\\n   slightly tachycardic with a heart rate to the 110's. Of note, her\\n   platelet count was 19,000 on morning of hematemesis.  Sent to [**Hospital Ward Name 77**]\\n   MICU for f/u.\\n   In the MICU, patient received 2 units PLT\\ns to bring PLT CT up from 19\\n   to 101.  She received 1 unit PRBC\\ns for Hct 28.7.  She was treated w/IV\\n   morphine for burning substernal chest pain thought to be esophageal in\\n   origin.\\n   Hematemesis (upper GI bleed, UGIB)\\n   Assessment:\\n   Post transfusion Hct 35.3.\\n   Action:\\n   Patient kept NPO.  LR @ 100cc/hr infusing.  Patient ambulated to\\n   commode w/nurse assisting w/out any hypotension or problems.\\n   Response:\\n   [**Name2 (NI) **] remains hemodynamically stable.  Hct w/am labs: 34.1\\n   Plan:\\n   Endoscopy today.\\n   WBC 0.4 this am.  Remains on neutrapenic precautions.\\n\",\n",
              "  '75F h/o amyloidosis, ESRD on HD, CAD s/p NSTEMI and stent ([**3-5**])\\n   presented to OSH with obstructive jaundice, cholangitis and transferred\\n   here on [**4-6**] for ERCP.\\n   Initially admitted to OSH with abdominal pain and mental status\\n   changes. Reportedly had worsening abdominal pain, episodic SOB, had a\\n   few episodes of diarrhea. Overall had been feeling weak and lethargic,\\n   saying nonsensical things per son. [**Name (NI) 2313**] to have fever to 100.2 and\\n   LFTs with obstructive pattern. RUQ U/S revealed intrahepatic biliary\\n   dilatation, raising concern for cholangitis. Also noted to have\\n   thrombocytopenia, with labs suggestive of DIC. Transferred to [**Hospital1 54**] for\\n   ERCP.\\n   ERCP here showed no gallstones, but a CBD stent was placed and given\\n   zosyn (completed 7 day course on [**4-13**]). On [**4-10**], she developed acute GI\\n   bleeding (both melena and BRBRP) with Hct decrease from 31->21 over 3\\n   days. Given 2 units pRBC with Hct increase and stabilization at 30.\\n   Bilirubin noted to rise from 2.3->10.8. ERCP repeated on [**4-12**] to\\n   evaluate for obstruction and potential bleeding source, which showed no\\n   bleeding but there were 2 gallstones blocking the stent that were\\n   removed. Since this time, Bili trending down. ASA 81mg restarted on\\n   [**4-14**], but then on [**4-16**] Hct again started trending down, associated with\\n   new abdominal pain, nausea, and vomiting. The morning of [**4-17**], she\\n   developed hematochezia and hypotension with BP 60/palp. Hct was 19,\\n   decreased form 30 on [**4-15**]. She was given 1L NS and 1 unit pRBC and\\n   transferred to [**Hospital Unit Name 44**].\\n   On arrival, the patient remained hypotensive with SBP 70s but was alert\\n   and mentating. Given an additional 1L NS, 2 units pRBC, and levophed\\n   started with improvement to SBP 120. ERCP team called as concern for\\n   bleeding from ERCP site. She was intubated for repeat ERCP, which\\n   revealed active bleeding at the apex of the sphincterotomy site with\\n   associated clot. The clot was removed and she was given epi injections\\n   and local cauterization. A second CBD stent was placed. Given continued\\n   concern for obstruction so levofloxacin ordered. ECG with new\\n   inferolateral ST depressions, cardiac enzymes pending. Cardiac enzymes\\n   stable, per team [**4-18**] ekg  changes resolved.\\n   75F h/o amyloidosis, ESRD on HD, CAD s/p NSTEMI and stent ([**3-5**])\\n   presented to OSH with obstructive jaundice, cholangitis and transferred\\n   here on [**4-6**] for ERCP.\\n   Initially admitted to OSH with abdominal pain and mental status\\n   changes. Reportedly had worsening abdominal pain, episodic SOB, had a\\n   few episodes of diarrhea. Overall had been feeling weak and lethargic,\\n   saying nonsensical things per son. [**Name (NI) 2313**] to have fever to 100.2 and\\n   LFTs with obstructive pattern. RUQ U/S revealed intrahepatic biliary\\n   dilatation, raising concern for cholangitis. Also noted to have\\n   thrombocytopenia, with labs suggestive of DIC. Transferred to [**Hospital1 54**] for\\n   ERCP.\\n   ERCP here showed no gallstones, but a CBD stent was placed and given\\n   zosyn (completed 7 day course on [**4-13**]). On [**4-10**], she developed acute GI\\n   bleeding (both melena and BRBRP) with Hct decrease from 31->21 over 3\\n   days. Given 2 units pRBC with Hct increase and stabilization at 30.\\n   Bilirubin noted to rise from 2.3->10.8. ERCP repeated on [**4-12**] to\\n   evaluate for obstruction and potential bleeding source, which showed no\\n   bleeding but there were 2 gallstones blocking the stent that were\\n   removed. Since this time, Bili trending down. ASA 81mg restarted on\\n   [**4-14**], but then on [**4-16**] Hct again started trending down, associated with\\n   new abdominal pain, nausea, and vomiting. The morning of [**4-17**], she\\n   developed hematochezia and hypotension with BP 60/palp. Hct was 19,\\n   decreased form 30 on [**4-15**]. She was given 1L NS and 1 unit pRBC and\\n   transferred to [**Hospital Unit Name 44**].\\n   On arrival, the patient remained hypotensive with SBP 70s but was alert\\n   and mentating. Given an additional 1L NS, 2 units pRBC, and levophed\\n   started with improvement to SBP 120. ERCP team called as concern for\\n   bleeding from ERCP site. She was intubated for repeat ERCP, which\\n   revealed active bleeding at the apex of the sphincterotomy site with\\n   associated clot. The clot was removed and she was given epi injections\\n   and local cauterization. A second CBD stent was placed. Given continued\\n   concern for obstruction so levofloxacin ordered. ECG with new\\n   inferolateral ST depressions, cardiac enzymes pending. Cardiac enzymes\\n   stable, per team [**4-18**] ekg  changes resolved.\\n   Hyperkalemia (high Potassium, Hyperpotassemia)\\n   Assessment:\\n   K 4.3  this am.  Patient requested HOB up @ almost 45 degrees\\n   overnight. Tolerated being flat for short periods of time w/turning.\\n   Crackles heard @ LLL, diminished @ RLL, clear @ upper lungs.  Swelling\\n   L arm more pronounced than previous day despite both arms being\\n   elevated overnight.  O2 sats down to 93-96% on room air.  RR 20\\n   Action:\\n   Received hemodialysis yesterday.\\n   Response:\\n   Came off levophed yesterday & maintained BP well.\\n   Plan:\\n   [**Month (only) 60**] need hemodialysis Tx for fluid removal soon.  Try O2 @ 2L NP[**MD Number(3) 2361**]\\n   if RR increases, or O2 sats decrease.\\n   Gastrointestinal bleed, upper (Melena, GI Bleed, GIB)\\n   Assessment:\\n   Hemodynamically stable.  HR: 80\\ns SR- low [**Street Address(2) 1023**]  BP remained\\n   >110/60.\\n   Action:\\n   Had received  one unit PC\\ns yesterday afternoon.\\n   Response:\\n   Hct 28.9 @ 0230 [**4-20**], down from the previous Hct 32.7\\n   Plan:\\n   Does not need transfusion per overnight resident\\n',\n",
              "  'This is a 75 year old female with a PMH of ESRD secondary to\\n   amyloidosis who presented to an OSH at the beginning of [**Month (only) **] with\\n   cholangitis.  She is s/p multiple ERCP\\ns c/p bleeding at sphinterotomy\\n   site resulting in blood loss anemia, hypovolemic shock and demand\\n   ischemia.  Course further complicated by VRE bactermia, new afib,\\n   thrombocytopenia & finding of a new large liver mass on CT.  She had\\n   her last melanotic stool [**4-27**].  She had dark brown loose guiac +\\n   stools starting [**4-28**].\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient c/o chronic back pain (had it for years she said) exacerbated\\n   by lying flat during dialysis Tx.\\n   Action:\\n   Medicated w/5mg oxycodone w/ a little relief.  Medicated w/2 mg IV\\n   morphine w/better relief (additive).  Requested risperadal (to sleep)\\n   afterwards.\\n   Response:\\n   Needed the oxycodone & morphine after dialysis for relief of pain from\\n on [**1-6**] scale down to\\n.  Fell asleep within an hour after the\\n   risperadal.\\n   Plan:\\n   Offer oxycodone by itself during the day. Give narcotics w/caution in\\n   this elderly dialysis patient. Try getting patient up to the chair for\\n   position change to relieve back pain.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 100- 118 ST  no ectopy.   BP: 90-121/47-63  w/MAP 56-76.\\n   Action:\\n   Finished amoidarone po load on  [**4-28**].  Receiving 200mg po amiodarone qd.\\n   Response:\\n   HR elevated above 100 ( ST) during dialysis [**4-28**].  Removed 2.5 L during\\n   HD. Patient is most likely tachycardic because she is intravascularly\\n   dry.\\n   Plan:\\n   Continue to monitor HR.  Continue to give amio po qd.  Treat pain.\\n   Gastrointestinal bleed, upper (Melena, GI Bleed, GIB)\\n   Assessment:\\n   Had large loose dark brown guiac + stool X2 on [**4-28**].\\n   Action:\\n   Hct @ 2200 was up to 29.6 soon after dialysis, from 27.9.\\n   Response:\\n   Hct  @ 0400 was 27.4.\\n   Plan:\\n   Liver bx in future when bleeding is no longer a problem.\\n   .H/O renal failure, End stage (End stage renal disease, ESRD)\\n   Assessment:\\n   Serum albumin is low @ 1.9 (has been running 1.8-2.0).  She has\\n   generalized edema, 3+ pitting @ sacrum, feet & thighs.  Both arms are\\n   swollen, despite being elevated on pillows (her feet respond better to\\n   being elevated on pillow).  Edema fluid leaks from B arms, abdomen &\\n   legs.   Dialysis is unable to re,move this fluid.\\n   Action:\\n   Liberalized diet to encourage increased protein intake.  Received\\n   dialysis Tx [**4-28**] eve.  Used AVF for 2 needles w/out problems.  Removed\\n   2.5L fluid.\\n   Response:\\n   Patient continues poor po intake but is eating a little.  Low oncotic\\n   pressure w/low  serum albumin allows fluid to remain in tissues where\\n   it is not available to be removed  during dialysis Tx (fluid removal\\n   from intravascular space during HD).\\n   Plan:\\n   Offer ensure.  NPO w/ ice chips since midnight (pre HD  catheter\\n   removal in IR). To have HD permacath removed in IR today.  Check w/\\n   pharmacist re: giving daptomycin today regardless of dialysis.\\n   Thrombocytopenia, chronic\\n   Assessment:\\n   PLT CT 51, down from 58 yesterday afternoon. Previously, PLT CT was\\n   47.  Pettichiae & echymoses on legs, chest, back.\\n   Action:\\n   Monitored PLT CT.\\n   Response:\\n   HIT  negative,\\n   Plan:\\n   Check PLT CT [**Hospital1 **], transfuse if actively bleeding.\\n   Plan: Once HD catheter removed in IR, can have PICC placed.  Once PICC\\n   placed, can have L IJ  multilumen D/C\\n',\n",
              "  '52 yo M with a h/o ALS (vent dependent) with recent admission in [**Month (only) 1563**],\\n   [**2188**] w/pseudomonas/Staph VAP c/b sepsis presenting now with abdominal\\n   distenstion x 2 days and reported hematemesis.  Investigation at his\\n   rehab facility revealed a leukocytosis, low grade temperatures.  He has\\n   a known history of UGI bleeding secondary to ulceration at is G tube\\n   site.  In addition, he has recently been having increased urinary\\n   retention requiring foley placement which was traumatic and resulted in\\n   hematuria necessitating a 3-way foley.  Recently, he had been treated\\n   with 10 days of unasyn and flagyl for a leukocytosis.\\n     In our ED, he was febrile to 102.5, tachycardic, and normotensive.\\n   NG lavage revealed coffee grounds and was given 2L of NS. Surgery\\n   evaluated the patient.  Abd CT revealed no evidence of obstruction but\\n   demonstrated stool impaction.  Additionally, he had bibasilar airspace\\n   disease.  He was disimpacted in the ED with some improvement in\\n   abdominal distension.  In response to the fever, he was given empiric\\n   vancomycin and zosyn\\n       Attempted central line placement @ L subclavian unsuccessfully.\\n   Hematoma present. Circled area w/dotted line.  Ice applied for 20min\\n   intervals.   Hematoma has gotten a little smaller overnight.  R\\n   subclavian placed successfully.\\n       Patient has small rashes (pink, not raised) over trunk & upper arms\\n   which were in place @ 1900 [**5-20**], no change @ 0700 [**5-21**].  Skin reddened\\n   @ all joints as well.  Seen by resident who said maybe a drug rash?\\n   Team will follow.\\n      Patient trached on chronic vent.  Here on A/C 40%/500 Vt/16 RR/ 5\\n   PEEP.  O2 sats remained 99-100%.  Alarms went off 1X all night & that\\n   was w/suctioning.  Sx\\ned for small to copious amounts of thick yellow\\n   to green secretions q 1-4 hrs.  In process of obtaining  sample of\\n   respiratory secretions for Cx.  Lungs sound rhoncorous ,& diminished @\\n   bases.  Has aspiration pneumonia @ bases by CT.  CXR done [**5-21**] @ 0620.\\n   Constipation (Obstipation, FOS)\\n   Assessment:\\n   Patient had a firm distended abdomen w/+ bowel sounds, which gradually\\n   softened overnight & became less distended, as he had more BM\\n   Action:\\n   Given lactulose enema & lactulose per NGT.\\n   Response:\\n   Patient had moderate to large loose (some formed stool mixed in) brown\\n   BM q 2 hrs\\n   Plan:\\n   Place mushroom catheter when it is clear patient no longer has formed\\n   stool to expel,  Had x-ray of abdomen [**5-21**] @ 0620.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   Lactate up to 2.7,  now down to 1.0 @ 2130 [**5-20**].  UA shows UTI.  WBC\\n   16.9 ([**5-20**]).\\n   Action:\\n   Received IV vanco, ceftazidime & flagyl.  Received zosyn in EW earlier\\n   [**5-20**].  Urine Cx & BCX2 sent [**5-20**].\\n   Response:\\n   Afebrile.  WBC down to 9.7  on [**5-21**] am.\\n   Plan:\\n   Continue to follow WBC,lactate & Cx results.  Continue to check temp q\\n   4 hrs & prn.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP: 76-104/51-64  MAP 57-69  U/o remained >100cc/hr\\n   Action:\\n   Received 1L LR bolus @ Mn\\n   Response:\\n   BP: 80/50-99/66  MAP 56-74\\n   Plan:\\n   Goal: MAP>55\\n   Gastrointestinal bleed, other (GI Bleed, GIB)\\n   Assessment:\\n   Hct 25.1, down from 27.3 drawn 12 hrs earlier on [**5-20**].  BP low but MAP\\n   remains >55.\\n   Action:\\n   Hct checked @ least q 6 hrs overnight.  NGT to low constant to\\n   intermittent wall Sx.  PEG in place by auscultation & flushed w/30cc\\n   H2O.  NGT advanced by [**1-11**] inches [**Name8 (MD) **] MD who checked CXR (resident).\\n   NGT placement confirmed by gastric aspiration & auscultation.\\n   Response:\\n   Hct stable w/am labs @ 25.5\\n   Plan:\\n   Possible EGD [**5-21**].  Check Hct q 6 hrs.\\n   Patient\\ns wife, [**Name (NI) 3115**] [**Name (NI) 3110**] ([**Telephone/Fax (1) 3118**]) speaks Spanish only.  Dr.\\n   [**Last Name (STitle) **] would like to have a family meeting w/the wife  present as well as\\n   Palliative Care ([**First Name8 (NamePattern2) 566**] [**Last Name (NamePattern1) 567**]) after 2pm on [**5-21**].  Mrs. [**Known lastname 3110**] has not\\n   been contact[**Name (NI) **] yet about this.  A Spanish interpreter will need to be\\n   arranged for the family meeting.  A consult was placed for [**First Name8 (NamePattern2) 566**] [**Last Name (NamePattern1) 567**].\\n   In addition, the sister-in-law, [**Name (NI) 3119**] [**Name (NI) 3120**] is English speaking.  Her\\n   phone # is [**Telephone/Fax (1) 3121**] @ work.  After 4pm, her # is [**Telephone/Fax (1) 3122**].\\n',\n",
              "  'The patient is a 49-year-old female with PMH of SLE, ESRD on HD, PE on\\n   lovenox, and gallstones with cholagnitis in [**10-23**], now transferred to\\n   [**Hospital1 1**] with septic shock. She had an ERCP earlier today at [**Hospital1 966**] where a\\n   stone was removed from CBD. After ERCP she presented for scheduled HD,\\n   where she had a fever 102.2, tachycardia and hypotension. She was\\n   transferred to [**Hospital 9484**] Hospital ED. She had an SBP in the 60s.    Was\\n   started on phenylephrine and then transferred to [**Hospital1 1**] as [**Hospital1 966**] had no\\n   ICU beds.  In the ED, she was progressively less responsive and she was\\n   intubated for airway protection in light of somnolence. Lactate was\\n   3.0.   A CT-A torso was obtained which showed no free air, +\\n   pneumobilia, no PE. She was started on an additional vasopressor\\n   (levophed) for a BP of 80s with improvement in BP to 90s. Blood\\n   cultures were drawn and she was admitted to the [**Hospital Unit Name 10**].  CXR revealed\\n   volume overload.\\n   [**1-7**] CT TORSO\\n   diffuse ggo in lungs likely pulm edema (ddx includes infxn). small\\n   effusions. markedly dilated cbd up to 1.6 cm, fluid and air within\\n   biliary tree, air within gb, could be due to ercp but cannot exclude\\n   infection. dilated panc duct. multiple renal hypodensities incomp\\n   characterized, nonurgent u/s or mri. also larger splenic hypodensities\\n   incomp characterized. calcified fibroids.\\n   .[**1-7**] ERCP ([**Hospital1 966**]): Per report, the intra- and extra-hepatic biliary\\n   ducts were dilated, the existing stent was removed and multiple round\\n   filling defects were noted.  A balloon sweep was performed, with final\\n   imaging demonstrating persistant dilation of the intra and extrahepatic\\n   biliary ducts, no extravasation of contrast.\\n   [**1-8**] New L femoral triple lumen placed in IR.  Old R femoral D/C\\n   New post pyloric feeding tube placed in IR. Pan cultured (blood, urine\\n   & sputum).\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   On A/C @ 40%  360 Vt/22 RR/ PEEP 5 until 0430  per ARDS protocol.\\n   RR:22   O2 sats: 99-100%         Chest CT  ([**1-8**]) showed small B\\n   pleural effusions, pulmonary edema & possible aspiration.\\n   Action:\\n   Sedated on IV fentanyl 35 mcg/hr & versed 1mg/hr IV.  Titrated versed\\n   down to 1mg/hr (from 5mg/hr)& fentanyl down to 35mcg/hr (from\\n   50mcg/hr)  as patient very sedated.\\n   Response:\\n   ABG\\ns: 7.33/43/123         Metabolic acidosis treated w/ IV bicarb.\\n   Pupils are very sluggish to not responsive & 3mm.  Patient does not\\n   open eyes.  Localizes painful stimuli.\\n   Plan:\\n   Continue to wean.  Unable to do RSBI due to increased RR on CPAP.\\n   Decreased RR to 16 @0445.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   BP: 99-120/ 64-83      MAP: 74-94       HR: 79-89 SR no ectopy\\n   Lactate 2.0 (3.0)         WBC: 8.3  (11.4)\\n   Action:\\n   Titrated  IV neo to off @ [**2114**].       Titrated  levophed down to 0.06\\n   mcg/kg/min.  Treated w/ triple abx IV (see below).  BCX1 drawn this am.\\n   Response:\\n   Tmax 98.7 po overnight.\\n   Plan:\\n   Titrate pressors to keep MAP>65.\\n   Pancreatitis, acute\\n   Assessment:\\n   Amylase 82 (WNL)      Lipase 66 (116)        LDH: WNL & LFT\\ns are\\n   dropping.  Bowel sounds are very hypoactive  to absent.   OGT drained\\n   400cc bilious fluid overnight.\\n   Action:\\n   Given NS X 2 L overnight.  Covered w/IV linazolid, IV gentamycin, IV\\n   meropenum.  IV vanco D/C\\ned.  OGT to low wall Sx.  New post pyloric\\n   tube placed [**1-8**] & confirmed by CXR.\\n   Response:\\n   LFT\\ns: still dropping\\n   Plan:\\n   IV fluid replacement as needed.  Avoid LR as it will increase serum K\\n   until CVVHD started.  Continue to medicate for pain.  Tube feedings\\n   (post pyloric tube) per nutrition reqs, awaiting orders.\\n   Renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   BUN: 46  (45)           Cr: 6.5  (6.5)                 K: 5.5\\n   (5.5)      Facial, periorbital & sceral edema & a little sacral\\n   edema.\\n   Action:\\n   Given 1L D5W w/150mEq HCO3.\\n   Response:\\n   HCO3: 21  (23)   Patient has metabolic acidosis from renal failure &\\n   lactic acidosis.\\n   Plan:\\n   Awaiting decision on starting CVVHD today or tomorrow for potassium\\n   control & acidosis.  Has catheter for HD already.\\n   ------ Protected Section ------\\n    Vent changed to A/C @ 40% Vt360/ 16 RR/ 5 PEEP.  ABG\\ns after this\\n   change: 7.32/41/140. CXR done @ 0530.   Given 2 Gm Ca gluconate IV for\\n   serum Ca 6.7.  Given additional 1 L NS to run over 2 hrs (to make 3L NS\\n   & 1 L D5W w/150 bicarb given overnight).\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2194-1-9**] 06:08 ------\\n'],\n",
              " 3: ['55y.o. male with PMH CML s/[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] transplant day 196 today. Admitted to\\n   7F overnight with fever, increased SOB, cough, congestion. Shortly\\n   after admission temp was 102. Pt required 100% NRB and it was decided\\n   pt need to come to MICU for further care. Now on 70-100% cool neb\\n   w/sats 95-97%.   PMH: GVHD gut & skin, cardiomyopathy, + C-diff  [**8-18**],\\n   HTN.  Patient  ruled in for RSV, for which he is on contact\\n   precautions.  R/o\\ned for PE by CT yesterday.     Lives w/children.\\n   Daughter ([**Doctor First Name 3094**])  is HCP.  Sister  [**Name2 (NI) 142**] is spokesperson & RN\\n   Hypoxemia\\n   Assessment:\\n   Lungs: occasional exp wheezes.  Otherwise clear to diminished lung\\n   sounds throughout.   O2 sats 93-97% on 70% cool neb w/0-3L NP.  O2 sats\\n   95-98% on 100% cool neb.   WBC 5.8 (10.3)\\n   Action:\\n   Atrovent & albuterol neb Tx\\nes q 4 hrs & prn wheezing.  Used O2 @ 6L NP[**MD Number(3) 3095**] patient was eating/taking po meds.  Wore cool neb the rest of the\\n   time.  High flow neb remained on cart outside room if needed. Given\\n   Palivizumab IV X1 per ID for treatment of RSV.  Contact precautions\\n   maintained.\\n   Response:\\n   Wheezes & O2 sats improve w/neb Tx\\nes.  Comfortable most of the time.\\n   Slept w/HOB flat to 15 degrees.\\n   Plan:\\n   Continue to titrate O2 down as tolerated.\\n',\n",
              "  '[**Age over 90 **] year-old female with recent ICU stay for likely aspiration pneumonia\\n   who presented on [**1-3**] unresponsive from her nursing home with fevers,\\n   respiratory distress, and a tension ptx s/p chest tube placement and\\n   intubation with development of subcutaneous emphysema on [**1-6**].\\n   Patient extubated [**1-16**]  after being Intubated X14 days. R chest tube\\n   removed [**1-16**] as well.  Per patient\\ns niece in NY, patient is to be\\n   re-Intubated if needed.  She is a full code.\\n   Pneumonia, aspiration\\n   Assessment:\\n   Lungs: diminished throughout.  O2 sats 97-100% on 35% humidified O2 via\\n   tent mask.  Congested cough, no expectoration.   Klebsiella & staph\\n   aureus(MRSA)  grew from sputum Cx on [**1-14**].\\n   Action:\\n   Used humidified O2 to liquefy secretions.  Scopolomine patch in place\\n   to dry up oral secretions.    Now on vanco & levofloxacin IV for MRSA &\\n   klebsiella in sputum.    C&DB encouraged but patient did not comply.\\n   Turning patient frequently helped patient to cough.\\n   Response:\\n    Afebrile.       WBC 8.4  (11.0)  Mental status precluded use of IS.\\n   Avoided CPT for\\n   Plan:\\n   Keep NPO until speech & swallow study today.  Will most likely be\\n   called out to the floor today.  Transfer note started. OK off po\\n   amiodarone for 1-2 days  (has long half life of days).\\n   No BM X5 days.  Given bisacodyl suppository  & had large loose BM @\\n   midnight, guiac negative.  Stool sent for C-diff.  Remains NPO until\\n   speech & swallow OK\\ns po.\\n   MS @ patient\\ns baseline.    Responds to her name, but does not\\n   verbalize name when asked.   Not oriented to place or time.  Speaks\\n   simply.   Does not engage in conversation.  Gives orders.\\n',\n",
              "  '62 y/o male admitted on [**12-19**] with + for h1n1, pneumonia and bilateral\\n   PE\\ns. Prolonged intubation [**2-8**] increased secretions. Extubated [**12-27**].\\n   O2 titrated down from 60% to 2L NP on [**12-28**].     Off droplet\\n   precautions  (patient has been afebrile since [**12-24**]).\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   O2 sats  92-95% on [**2-9**]  NP[**MD Number(3) 6586**] patient was awake.  Lungs sounds were\\n   clear to exp wheezes @ upper lobes & diminished @ bases.  Nonproductive\\n   cough.  RR: [**1-5**]\\n   Action:\\n   Added 35% humidified O2 by face tent while patient was sleeping to\\n   loosen secretions. Received albuterol & atrovent neb Tx\\ns q 6 hrs.\\n   Given 20mg IV lasix @ 2200 w/immediate response of 400cc & then\\n   50cc/hr.\\n   Response:\\n   O2 sats were 95-97% on 35% humidified O2 via tent mask.\\n   Plan:\\n   Try IS during the day.  To be called out to floor.  Goal was 2L\\n   negative but on [**12-28**], was only 900cc negative, & today is about even.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient was oriented to self, knew he was in the hospital but could not\\n   correctly identify which one.  He knew it was [**2106**], that we passed\\n   [**Holiday 3470**] before he came into the hospital, but could not identify\\n   the month as [**Month (only) 3**].  Could not identify the date.\\n   Action:\\n   Easily reoriented.\\n   Response:\\n   Speech is slow.  Patient is appropriate & cooperative .  Apparently\\n   received a lot of sedation while intubated.\\n   Plan:\\n   Continue to assess mental status.  ? Head CT if MS does not clear.\\n   Pulmonary Embolism (PE), Acute\\n   Assessment:\\n   PT: 21.5        INR: 2.0\\n   Action:\\n   Off IV heparin since [**12-27**] eve.  Started on lovenox [**12-27**].   Receiving\\n   coumadin X 5 days so far\\n   Response:\\n   Plan:\\n   D/C lovenox when INR therapeutic.\\n   Alteration in Nutrition\\n   Assessment:\\n   NGT placed  by MD\\ns  for meds before speech & swallow evaluated\\n   patient.\\n   Action:\\n   Seen by  speech & swallow who OK\\ned meds & diet  (see their note\\n   [**12-28**]).  Tube feeding increased overnight to  25 cc/hr.   Did not\\n   increase TF\\ns further as patient will feel full & not attempt to eat\\n   meals.\\n   Response:\\n   TF residual was only 3-5cc.\\n   Plan:\\n   Per speech & swallow, continue tube feeding until patient is taking\\n   adequate po.  MICU team wanted tube feed to continue overnight.\\n   Re-evaluate po intake @ meals [**12-29**].\\n',\n",
              "  'This 79 yr old woman with hx lung CA, COPD, PVD & CHF was intubated @\\n   OSH for acute respiratory distress [**3-25**] which left patient w/post\\n   pharynx laceration.  Unable to place OGT or NGT due to swelling &\\n   bleeding. Had bronchoscopy X2 on [**3-26**] in attempt to place one.  Has\\n   subcutaneous emphysema @ R neck.  Patient admitted w/elevated WBC &\\n   hypotension treated w/levophed, due to sepsis.  Urine had no bacteria\\n   in UA.  R midline from OSH was D/C\\ned by IV nurse & tip sent for Cx.\\n   Has moderate bilateral pleural effusions & adjacent atelectasis by CT.\\n   Had MI about 12 days ago (by labs).  Had EF 55% in the past, now has EF\\n   20%.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   Afebrile w/ temp> 96 axillary off Bair hugger.  WBC 14.8 (down from\\n   21.7).    Lactate 1.0 ( down from 1.6).\\n   Action:\\n   Received 1000cc NS bolus X1.  Continues on IV levophed @\\n   0.075-0.2mcg/kg/min  to maintain MAP>60.  R midline D/C\\ned & tip sent\\n   for Cx.  IV nurse unable to place peripheral IV due to poor access &\\n   swelling.\\n   Response:\\n   MAP remained > 60 for most of night.  Dipped down to 57 transiently,\\n   easily brought back up w/increased levophed.\\n   Plan:\\n   Wean levophed as tolerated.  Maintain MAP>60.\\n   Airway obstruction, Central / Upper\\n   Assessment:\\n   Had repeat bronchoscopy @ 1900 .  Replaced ET.  ET repositioned @ 0100\\n   for being in R main bronchus.  O2 sats maintained @ 100% on FiO2 40%\\n   even in R main bronchus.\\n   Action:\\n   CT of neck w/out contrast done.  CXR done @ 0430 to confirm position of\\n   ET.\\n   Response:\\n   Unable to place OGT or NGT w/repeat bronchospopy.  CT of neck showed\\n   moderate anterior edema in posterior & inferior oropharynx. Also\\n   extensive subcutaneous emphysema seen, predominately in the R neck.  No\\n   tracheal tear seen on bronch, only a 2-3cm linear horizontal tear in\\n   hypopharynx . ET in good place by CXR @ 0430.\\n   Plan:\\n   Pulmonary will drain neck if collection forms/plan daily CXR/Abx.\\n   Cardiomyopathy, Other\\n   Assessment:\\n   Lungs have exp wheezes @ upper lungs & crackles @ bases from CHF.  Mild\\n   pulmonary edema seen in CXR @ 0300 [**3-26**].  ABG\\ns on 40%/ Vt450/ RR16/ 5\\n   PEEP was 7.45/31/154.  Patient in A-fib all night, confirmed by 12-lead\\n   EKG.  HR: 70\\ns-80\\ns w/ occasional PVC\\ns.  MAP 57-71.\\n   Action:\\n   No lasix @ this time due to hypotension (receiving levophed).\\n   Decreased RR to 12.  CXR done @ 0430. Repeat ABG\\ns done w/RR 12.\\n   Response:\\n   Repeat ABG\\ns (RR12): 7.40/37/146\\n   Plan:\\n   Lasix when BP recovers.\\n   Has minimal upper abdominal ascites per CT [**3-26**] ( patient has hx\\n   cirrhosis).   Patient leaking edema fluid from any skin opening,\\n   especially arms.  Serum albumin only 2.3.  Team considering TPN (\\n   unable to have TF\\ns w/no OGT/NGT).\\n   Ca 7.6, adjusted for low albumin of 2.3, adjusted Ca is 8.5.  This does\\n   not need replacement.  Serum K 3.5 will receive 60mEq IV KCl.  1^st\\n   20mEq hung, the rest @ bedside.  Mg 2.1 does not need replacement.\\n',\n",
              "  'This 79 yr old woman wa admitted through the EW w/tachycardia (HR 120\\n   ST) & fever (Tmax 102).  She was recently discharged ([**2-18**]) to [**First Name4 (NamePattern1) 455**]\\n   [**Last Name (NamePattern1) **] Nursing Home after having a significant subdural hemmorrhage in\\n   [**Month (only) **].  She is nonverbal  since that time.  Received zosyn,\\n   cefipime,clinda& vanco in EW as well as 6L NS over 12 hrs.\\n     Overnight, she was placed on droplet precautions. Her fevers respond\\n   well to 650mg tylenol per PEG.  Tmax was 101.1 po.  Has a productive\\n   sounding cough w/no secretions able to be suctioned orally.\\n   Respiratory therapist to obtain nasal aspirate for influenza & to Sx\\n   nasotracheally for C&S this morning.  RR 19-32. O2 sats 96-99% on 2L\\n   NP.  Came up from EW on room air but started to desat to 92% after CT\\n   to r/o PE. PE was r/o\\ned.  Received 500cc LR X2 & 500cc NS X1 for HR\\n   120\\ns. HR now 114 ST.  NBP dropped as low as 95/sys, now 116/59.\\n   Repleted w/2 Gm Magnesium IV for serum Mg 1.4.\\n     Blood sugars have been low. Received\\n amp D50 X2  overnight.\\n   Received 1 amp D50 @ 0600 for FS 60. Glargine held last night.\\n',\n",
              "  'Mr. [**Known lastname 5687**] is a 57 yoM w/ metastatic renal cell cancer with mets to\\n   his brain and lungs  diagnosed in [**2108**], s/p uncomplicated laparoscopic\\n   L radical nephrectomy [**2109-5-27**]  , R venous sinus thrombosis  , h/o Cdiff\\n   colitis  , hypertension\\n    hyperlipidemia , hypothyroidism , GERD   most recently being treated\\n   with gemcitabine and sutent with known UE / IJ thrombosis on lovenox\\n   presents with shortness of breath x 3 days with an acute worsening the\\n   a.m. of admission.  Patient initially admitted to the ICU and\\n   transffered to floor on [**2111-9-7**].\\n   .\\n   This morning [**9-8**], patient was noted to be audibly stridorous with\\n   increased work of breathing. His sats dropped to mid 80s and he became\\n   cyanotic. Respiratory code was called. It took approx 15 minutes to\\n   intubate the patient .Patient was transferred to the ICU.\\n   CAT scan chest and neck done ,report per onco team ,extensive tumour\\n   through upper airway,  extending to lower airway . Onco team explained\\n   his poor prognosis to family . They understood and are planning CMO on\\n   [**9-9**]. Family visited w/patient.  Wife stayed overnight in patient\\n   room. Continue with vent/sedation overnight .  No more invasive\\n   procedures as per onco. US Rt upper extremity cancelled. Reassure\\n   family as needed.\\n   Dyspnea (Shortness of breath)\\n   Assessment:\\n   Patient maintained sats 96-99% overnight w/RR 13-22.  On A/C\\n   40%/600/12/5 PEEP.\\n   Action:\\n     Increased fentanyl to 125mcg/hr & versed to 3.5mg/hr.\\n   Response:\\n   Patient made comfortable.\\n   Plan:\\n   Ensure patient\\ns comfort.  Offer TLC to family, especially wife.\\n   ------ Protected Section ------\\n   Patient was DNR overnight.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2111-9-9**] 07:52 ------\\n',\n",
              "  '54 yr old woman w/multiple myeloma s/p SCT 194 days ago, admitted from\\n   EW [**5-21**] w/ flu-like Sx.  Son had flu.  PMH: Progression of dz to CNS.\\n   Has multilobular interstitial process  (most likely viral PNA).\\n   .H/O multiple myeloma  (Cancer, Malignant Neoplasm)\\n   Assessment:\\n   WBC  1.1 (1.3)        Total granulocyte count  820  (936)         LFT\\n   more elevated today.\\n   Action:\\n   Droplet & contact precautions D/C\\ned for negative flu screen.\\n   Neutrapenic precautions started.\\n   Response:\\n   Plan:\\n   Transfer to floor (7 [**Hospital Ward Name **]) as soon as bed available.  Will need\\n   private room w/[**Last Name (un) **] filter if transferred to another floor.\\n   Hypoxemia\\n   Assessment:\\n   RR: 15-29.         O2sats 94-96% on 5L NP[**MD Number(3) 6800**]: RUL:clear,\\n   LUL:exp wheezes, RLL:crackles, LLL: diminished.\\n   Action:\\n   Neb Tx (Albuterol) X1 @ 1840 [**5-22**].\\n   Response:\\n   Patient tolerated getting up to commode w/out difficulty.  No c/o SOB.\\n   Some tachypnea w/exertion.\\n   Plan:\\n   Give neb Tx\\nes prn\\n',\n",
              "  '52 yr old Mandarin speaking woman s/ stem cell BMT [**Pager number **] days ago for\\n   ALL.  Admitted to EW from oncologist\\ns office w/3 week hx cough &\\n   fevers, worse over last 2 days.  Required intubation for dyspnea in\\n   EW.  Received 4L IVF there.\\n   Events:\\n   Propofol D/C\\ned  for hypotension ( BP 71/ upon arrival).  Fentanyl &\\n   versed started.\\n   4L NS total given for hypotension here in MICU.  (4L NS given in EW as\\n   well).\\n   Leviphed started for hypotension.\\n   R A-line & R IJ triple lumen placed.\\n   Multiple abx ordered including aztroneam, azithromycin, vanco,\\n   acyclovir, bactrim IV.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Patient currently on A/C @ 80% w/ 300Vt /32 RR/ 15 PEEP.  O2 sats on\\n   those settings were 96-98%.  Patient had desatted down to 81% on vent @\\n   100% FiO2 overnight,after turning from L side to back.  By CXR, R lung\\n   most  affected.    WBC 26.4\\n   Action:\\n   Patient suctioned for scant amount clear blood tinged secretions, sent\\n   for Cx.  Patient had little need for suctioning.  Patient is well\\n   sedated on 300mcg/hr IV fentanyl IV & 10 mg/hr IV midazolam.   This was\\n   necessary to prevent desatting when patient would overbreathe vent &\\n   breathe dys-synchronously.   BP maintained w/ levophed IV\\n   0.2-0.42mcg/kg/min.  Avoided turning patient on R side.  Increased FiO2\\n   to 100% during turning.\\n   Response:\\n   ABG\\ns: 7.16/48/109  Increased Vt to 320cc.  Patient has uncompensated\\n   or only partially compensated acidosis.  Lactate 0.6   BUN 13 & Cr\\n   0.7.     U/o >50cc/hr.\\n   Plan:\\n   Continue to adjust vent settings to normalize ABG\\ns.  Bronch @ bedside\\n   planned for today.\\n   ------ Protected Section ------\\n   FiO2 decreased to 70% as well as Vt up to 320cc,\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2114-11-10**] 06:54 ------\\n',\n",
              "  '52-year-old female with ALL s/p chemo and single cord blood\\n   transplantation complicated by CMV viremia, streptococcal bacteremia,\\n   [** 1685**] UTI, and suspected GVHD-induced hepatitis who presents with\\n   pneumonia/sepsis and respiratory failure.\\n    Events:\\n   Held tube feed for high residuals, restarted @ 0630 [**11-12**] as residual\\n   improved.\\n   Desatted on lower dose sedation, resumed previous dosage to mainatain\\n   sats. No change in vent settings.\\n   Low u/o, responded to 25Gm albumin IV.\\n   Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name 11**])\\n   Assessment:\\n   Continues on A/C @ 50% w/Vt 320/ RR 32/ PEEP 15.   O2 sats: 91-98%\\n   Desatted down to 84% w/CXR.  Aroused & overbreathed vent.  Required\\n   FiO2 100% to keep O2 sats>90% for 15min after CXR  even as patient\\n   received increased sedation.   Hct 22.5 (24.6)\\n   Action:\\n   Sedated while left alone on 200mcg/hr fentanyl & 5mg/hr versed.\\n   Required boluses of 50-150mcg/hr  fentanyl & 1-4mg/hr versed for mouth\\n   care, turning or any stimulation.  Increased fentanyl back to 300mcg/hr\\n   & versed back to 10mg/hr @ 0530 as unable to resolve desatting\\n   w/boluses.  By 0630, O2 sats improved & patient well sedated.\\n   Response:\\n   ABG\\ns: 7.34/25/92\\n   Plan:\\n   Wean vent as tolerated.\\n   Sepsis\\n   Assessment:\\n   [**11-11**] Lactate 1.9 ( up from 0.6 on [**11-10**]).           WBC 9.5\\n   (12.5)          Afebrile but previously hypothermic requiring Bair\\n   huggar on [**11-11**].   Temp po: 97.1 -98           BP: 90-112/57-68   MAP:\\n   71-88     Bladder pressure 6      CVP: [**12-7**].      U/o 5-70cc/hr\\n   Wgt 58.7kg today, up from 47kg on [**11-10**] @ 1830 ( up 11.7 kg).  Serum\\n   albumin 2.2  ([**11-11**]).      BUN 31(21)         Cr 1.3 (1.0)\\n   Action:\\n   Continued vasopressin @ 2.4 units/hr.    Stopped levophed @ 1800\\n   [**11-11**].  Levofloxacin started.  Continues on vanco IV, aztreonam IV &\\n   acyclovir IV.   Azithromycin & bactrim IV D/C\\ned.  Maintained contact\\n   precautions for [**Name (NI) 1685**], droplet precautions for possible flu & airborne\\n   precautions for possible TB.     Received 25Gm albumin for low u/o down\\n   to 5cc/hr.\\n   Response:\\n   MAP maintained>65               U/o responded to IV albumin, coming up\\n   to 25-70cc/hr.\\n   Plan:\\n   Goal u/o: @ least 20cc/hr.         [**11-11**]: negative for influenza\\n   A&B.      From BAL [**11-10**]: need concentrated smear result to r/o TB;\\n   preliminary result negative so far. Gram stain negative & legionella\\n   negative (from BAL).\\n   Bowel sounds: absent to hypoactive.  Tube feeding on hold for TF\\n   residual 180-210cc.    Abdomen firm & distended.  No flatus.  No BM.\\n   Residual down to 95cc @ 0400.  Restarted tube feeding (boost glucose\\n   control, full strength) @ 10cc/hr w/out the 50cc H2O flushes q 4 hrs.\\n   Adjusted serum Ca=8.0.  Repleted w/20 mEq KCL IV for serum K 3.7.    Na\\n   129 (131).\\n',\n",
              "  'This is a 67 year old male pt with history COPD (on 3L home O2) and\\n   newly diagnosed small cell lung cancer with intracranial met who is\\n   transferred from the oncology floor with progressive altered mental\\n   status and hypercarbic respiratory failure.\\n   .\\n   The patient was recently diagnosed on screening chest CT on [**2120-4-23**]\\n   with a new lung mass. While awaiting bronchoscopy he was found to have\\n   confusion, word-finding difficulty and problems with [**Location (un) **]\\n   comprehension. Head CT at an OSH revealed an intracranial lesion. On\\n   [**2120-5-13**], the patient was transferred to [**Hospital1 19**]. Bronchoscopy cytology\\n   suggests small cell lung cancer. Brain MRI confirmed a large left\\n   occipital lobe lesion with some associated edema and mild mass effect.\\n   He was also found to have metastases to bone and liver. The patient\\n   initiated chemotherapy for an expected three consecutive days 27-[**5-19**]/09. Pt was transferred to [**Hospital Unit Name 1**] for intubation and further\\n   management of hypotension.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Patient remains on pressure controlled ventilation.  O2 sats 94-99%\\n   RR   Lungs are clear to rhoncorous @ upper lungs & diminished @ lower\\n   lungs.  CXR done @ 0600.\\n   Action:\\n   Sx\\ned q 1-7 hrs for scant to mod amount of thick blood tinged to tan\\n   secretions.\\n   Response:\\n   ABG\\ns@ 0315: 7.39 /41 /99 (WNL)    RSBI was 64 this am while still on\\n   60mcg/hr fentanyl & 1mg versed/hr.\\n   Plan:\\n   Wean patient as tolerated.  Continue to minimize Sx, only as needed.\\n   Hypotension (not Shock)\\n   Assessment:\\n   Patient\\ns BP varied from low 80\\ns/sys to 120\\ns/sys MAP 50-70.  Cuff BP\\n   in R arm>L arm by 10 points.\\n   Action:\\n   Received 250cc NS/hr X 1000cc.  IV Neosynephrine ran @\\n   0.5-2.3mcg/kg/min. Able to titrate neo down overnight to 0.5\\n   mcg/kg/min.\\n   Response:\\n   BP is labile.    BP drops w/turning & Sx\\ning.\\n   Plan:\\n   Continue to titrate neo down as tolerated.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient able to answer questions approriately by mouthing words.\\n   Obeyed simple commands\\n   Action:\\n   Titrated fentanyl & versed according to patient\\ns c/o\\ns of pain &\\n   agitation.  Titrated fentanyl up to 75mcg/hr from 40mcg for c/o H/A,\\n   back & abdominal pain.  Titrated it back down to 60mcg/hr for relief of\\n   that pain.  Titrated versed up from 1-2mg/hr & back down to 1mg.\\n   Response:\\n   Patient kept comfortable but easily aroused.\\n   Plan:\\n   Continue to titrate fentanyl & versed as needed.\\n   Alteration in Elimination Related to Constipation\\n   Assessment:\\n   Patient has firm distended abdomen w/ unknown LBM.  No BM since arrival\\n   to MICU (2 days).\\n   Action:\\n   Given enema during day w/no results.  Given 60cc lactulose, 200mg\\n   colace, & senna.  Stool sent for C-diff.\\n   Response:\\n   Put out @ least 1200cc loose/liquid brown stool (guiac trace positive)\\n   by midnight [**5-21**].  Placed mushroom catheter to contain stool (WBC 13.4\\n   on [**5-20**]) (PLT CT 412/ PTT 28.3/ INR 1.3 on [**5-20**]).  Put out another\\n   400cc by 0600.\\n   Plan:\\n   Continue mushroom catheter while WBC & INR allow.  Consider  rectal bag\\n   if unable to keep mushroom catheter, while stool output is liquid &\\n   copious.\\n   BUN 32 & Cr 1.3\\nboth elevated & unchanged.  K up to 5.1 this am from\\n   4.9.  Random vanco level subtherapeutic @ 9.6 (drawn @ 0315, vanco\\n   dosed @ 0800).  U/o continues to be copious.  Increased K due to?effect\\n   of chemo vs K in tube feeding.   Nutren pulmonary has 468mg K in\\n   250cc\\nthis is approximately 2Gm K in 24 hrs (while he is receiving\\n   40cc/hr).\\n',\n",
              "  '85 year old with PMH of CAD s/p stent placement and meningioma was\\n   recently admitted to [**Hospital1 **] [**Hospital Ward Name 383**] 3 w/ cp and fatigue. Thought to be\\n   non-cardiac. Had an echo and CTA which showed a left pleural effusion &\\n   a sm pericardial effusion w/ possible diastolic dysfunction.   She came\\n   back [**10-15**] after having a large increase in cough and sob. She has also\\n   had chronic diarrhea ([**3-31**] BM per day) plus vomiting x 2 overnight.\\n   Therefore decided to come to the [**Name (NI) **], Pt admitted to [**Hospital Ward Name 29**] 4 ICU. CT of\\n   chest shows worsening pleural effusion and pericardial effusion,\\n   etiology unknown. TTE showed evidence of Tamponade w/ RV diastolic\\n   collapse. Transfer to CCU pre pericardialcentesis w/ drain in am. [**10-16**]\\n   Pericardial tapped for 400cc bloody drainage, cytology samples sent.\\n   [**10-17**] Pericardial drain D/C\\ned .   Swan pulled, cordis left for IV\\n   access.  CXR showed collapsed L lung. Pleural effusion tapped under\\n   guided US, 600cc clear fluid drained.  Patient began coughing so\\n   procedure stopped.  L upper lobe opened post tap.\\n   Pericardial effusion with tamponade\\n   Assessment:\\n   BP: 88-101/52-60  MAP: 58-67       RR 16-23        HR: 70\\ns AF on IV\\n   Amiodarone.\\n   Action:\\n   Pericardial drain was removed [**10-17**].\\n   Response:\\n   Tegaderm to the site has some blood but no oozing.\\n   Plan:\\n   Monitor for S&S tamponade.\\n   Hypoxemia\\n   Assessment:\\n   Patient\\ns upper lungs clear  w/ absent lung sounds L base & diminished\\n   sounds @ R base.  O2 sats 93-97% on 100% nonrebreather.  When patient\\n   deeply asleep, O2 sats dropped to 88%.    RR 16-23.\\n   Action:\\n   Placed on CPAP w/10 PEEP for O2 sats 88% when deeply asleep.   Given\\n   atrovent neb @ midnight for exp wheezes.\\n   Response:\\n   Exp wheezes resolved after neb Tx.\\n   Plan:\\n   CPAP prn SOB, decreased O2 sats.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 69-119  A-fib w/no ectopy to occasional PVC\\n   Action:\\n   Digoxin D/C\\ned.  Given amiodarone bolus 150mg IV @ 2200 & started IV\\n   amiodarone @ 1mg/hr @ 2230 for 6 hrs then 0.5mg/hr IV amio X 18 hrs.\\n   Response:\\n   HR dropped to 70\\ns-80\\ns A-fib\\n   Plan:\\n   Continue IV Amiodarone until 2230 [**10-18**].\\n',\n",
              "  '58 yr old man w/CML, BMT in [**2121**] & GVHD, admitted through EW\\n   w/hypoxia.  Arrived from [**Hospital3 **] after being discharged from\\n   [**Hospital1 54**] on [**10-11**].  O2 sats 95-96% on 6L NP upon arrival to MICU.\\n   Transferred to [**Hospital Ward Name 51**] MICU for continous O2 sat monitoring & management\\n   of hypoxia.\\n   Hypoxemia\\n   Assessment:\\n   O2 sats: 89-97%   on  4-5L NP.  RR:[**11-5**]      Breathing not labored.\\n   Lungs sound rhoncorous throughout.\\n   Action:\\n   Kept NPO except for meds as patient has no gag reflex.  He coughed\\n   after 2nd sip of water, but did well w/meds mixed in apple sauce.\\n   Response:\\n   Desats down to 89% while asleep on 4-5L NP\\n   Plan:\\n   Send sputum Cx.  Awaiting speech & swallow study (probably Mon). Keep\\n   NPO x meds until he passes speech & swallow.   [**Month (only) 60**] get bronch for BAL.\\n   today\\n   ------ Protected Section ------\\n   Has LLL mod to large pleural effusion & possible pneumonia (infiltrate)\\n   last night by CXR.   CXR done this am.  Labs drawn @ 0600, still\\n   pending.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2124-10-15**] 06:11 ------\\n',\n",
              "  'This 89 yr old woman is a resident @ a nursing home since her hip fx\\n   in [**2-16**].  She was admitted w/SOB, hypoxia & hypotension.  Treated w/abx\\n   IV (vanco,cefepime), tylenol & 1L NS in EW.  DNR/DNI   Treated w/CPAP\\n   by mask ventilation.\\n   PMH: rotated & shortened R leg from  hip fx, myeloproliferative\\n   syndrome ( elevated WBC, elevated Hct), hypothyroidism, GI bleeds from\\n   diverticulitis, R Bell\\ns palsy, HTN, 1 previous episode A-fib,\\n   osteoporosis.\\n   Pneumonia, other\\n   Assessment:\\n   CXR on [**11-14**] showed possible LLL infiltrate, tiny B pleural effusions &\\n   bibasilar atelectasis.  Another CXR was done later that night, still\\n   unread, more wet per intern.  Lungs w/diffuse wheezes & rales @ bases.\\n   RR 12-22\\n   Action:\\n   O2 sats initially allowed to go up to high 90\\ns, later kept 86-94%\\n   Response:\\n   ABG\\ns on CPAP @ 2100: 7.33/58/80 pO2         ABG\\ns later on 70% neb :\\n   7.24/73/112  Patient placed back on CPAP for 2 hrs & then on 4L NP.\\n   VBG\\ns: pH: 7.29 (adjusted they would be 7.37) & pCO2 68\\n   Plan:\\n    Keep O2 sats @ 86-94%.  Alternate mask CPAP w/humidified O2 via tent\\n   mask.  Increased somnulence indicates need for mask CPAP.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   [**11-14**] Hct 56 (usually 45-46)            BUN 54 (53)           Cr 1.5\\n   (1.6)        PO4: 5.8 (5.2)\\n   Action:\\n   Received 1L NS in EW & 1.25 L NS in MICU.  Patient received 40mg po\\n   lasix [**Hospital1 **] [**11-6**] until & including [**11-14**].  Came to EW dehydrated\\n   w/elevated BUN,Cr & Hct.\\n   Response:\\n   [**11-15**] Hct  45.5               BUN 55                 Cr 1.4\\n   PO4: 6.0      Patient is in negative nitrogen balance as demonstrated\\n   by elevated BUN in presence of decreasing Cr.\\n   Plan:\\n   Continue to gently hydrate patient as needed.  Follow CXR\\ns.  Feed\\n   patient.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR 70\\ns SR -140 ST w/ frequent PAC\\ns & occasional PVC\\n   Action:\\n   Given 12.5mg po lopressor @ 2100 when HR [**Street Address(2) 1965**] & BP 148/80.  Given\\n   250cc NS bolus X 5 for BP in 80\\ns/systolic. (for a total of 1250cc NS)\\n   Response:\\n   BP>90/systolic since 0230  HR: 70\\ns SR-[**Street Address(2) 2463**] w/ frequent PAC\\n   occasional PVC\\n   Plan:\\n   Continue to monitor HR & BP.  Hold lopressor for BP<100 systolic.\\n   Patient alert,calm, oriented to self & daughter,& aware she was in\\n   hospital, upon arrival from EW.  She slept poorly on CPAP.  Awoke @\\n   0400, disoriented & distressed.  Asked to go back to her hotel.  Did\\n   not know her daughter visited her earlier.  Did not know where she\\n   was.  Cried easily.  Intern aware of changes in MS.\\n   ------ Protected Section ------\\n   Droplet precautions observed for possible flu pneumonia.  Nursing home\\n   has had several cases of pneumonia recently.  To have nasal aspirate\\n   for influenza today by RT (patient refused early this am).\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2125-11-15**] 06:58 ------\\n   By report of EW nurse, foley catheter was attempted X4 unsuccessfully,\\n   even using crede catheter.  Hit obstruction each time.  Attempted foley\\n   placement in MICU w/14 Fr catheter unsuccessfully\\nhitting obstruction\\n   which prevented passing catheter.  Intern informed.  Patient is\\n   incontinent @ baseline @ nursing home per daughter.  Was incontinent\\n   of urine X2.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2125-11-15**] 07:19 ------\\n',\n",
              "  'This is a 65yo female who presented to EW via EMS with acute shortness\\n   of breath, cyanosis. Found to have sat of 80% on room air. Per patient\\n   she had recently seen her PCP for [**Name Initial (PRE) **] cough for which she was prescribed\\n   bactrim. CXR in EW showed collapse of R middle and lower lobes. CT of\\n   chest showed large mediastinal mass with invasion into and obstruction\\n   of the R mainstem bronchus. Transferred to ICU for further workup.\\n   Bronched [**12-17**], still intubated .  Low sats down to 70\\ns since bronch\\n   w/position change or waking up.  Scheduled for open lung bx in OR on\\n   [**12-18**] @ [**Hospital Ward Name **].  Will need an ICU bed there.  To return here\\n   afterwards depending on pathology/cytology results.\\n   PMH: COPD, GERD, Mitral valve regurgitation, hx. AFIB/Flutter.\\n   Social history: Lives alone. No family members living.\\n   Allergies: NKDA\\n   Hypoxemia\\n   Assessment:\\n   Patient remained on CPAP @ 100% w/5 PEEP & 8 PS.  O2 sats dropped to\\n   74% w/suctioning & awakening.  O2 sats were 89-98%.\\n   Action:\\n   Turned patient from back to L side only to promote oxygenation &\\n   perfusion together.  Patient sedated on IV versed @ 4-2mg/hr  &\\n   fentanyl @ 100-50mcg/hr.\\n   Response:\\n   O2 sats increased up to 97-99% overnight.  ABG\\ns: 7.41/42/78  this am.\\n   Plan:\\n   Keep patient well sedated w/IV fentanyl & versed drips & boluses.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 40 SB-120 ST w/rare to frequent PVC\\ns & PAC\\n   Action:\\n   Maintained MAP>60 on IV phenylephrine @ 0.3-1mcg/kg/min.  Received\\n   flecainide per OGT @ 2230. OGT placed by intern as there was some\\n   question about esophageal compression.\\n   Response:\\n   BP was maintained even w/low HR.\\n   Plan:\\n   Atropine @ bedside.  Defibrillation/pacing pads placed on chest.\\n',\n",
              "  '40 yo Portuguese speaking woman with /unresectable esophogeal cancer dx\\n   [**6-4**].  Admitted [**12-4**] to 7F & transferred to [**Hospital Ward Name 57**] MICU on [**12-6**]\\n   w/stridor  r/t acute laryngeal edema, likely from acid d/t vomiting.\\n   Here for airway observation.  Treated w/decadron  to decrease\\n   swelling.  Patient has esophageal strictures likely due to radiation\\n   changes & cancer complications. Unable to dilate due to s/p XRT.  Has\\n   PEG @ home for TF\\ns.  Takes only swabs/toothbrush in mouth.  MRI done\\n   [**12-6**] shows  esophageal perforation @ level of thyroid.\\n   .H/O airway obstruction, Central / Upper\\n   Assessment:\\n   Patient had no stridor early this evening while awake.  Developed\\n   stridor while sleeping.  No c/o SOB or respiratory distress.\\n   Maintained O2 sats: 97-100% on room air.  HR: 90\\ns SR -[**Street Address(2) 918**] no\\n   ectopy.  HR up to 120\\ns w/exertion (walking to toilet).\\n   Action:\\n   Placed humidified O2 @ 35% via tent mask, overnight, near face as\\n   patient wouldn\\nt wear it as it was uncomfortable.  Neb was set up\\n   w/racemic epi (unopened).  Helio-oxygen tank in back room.\\n   Response:\\n   Preop checklist started.  NPO since Mn.\\n   Plan:\\n   Meeting w/PCP, [**Name10 (NameIs) **], GI  (& thoracics) in am to discuss trach\\n   placement.  If agreed on, patient to have trach placed later today.\\n   Constipation (Obstipation, FOS)\\n   Assessment:\\n   Patient told GI MD that she had no BM since Sun ([**12-3**]).  Abdomen soft.\\n   +Bowel sounds.  Had N/V before admission.\\n   Action:\\n   Patient placed back on lactulose 30cc tid prn.  Received 1^st dose last\\n   evening.  Now NPO for possible trach placement.\\n   Response:\\n   No BM yet.\\n   Plan:\\n   Continue to give lactulose when patient can receive tube feedings.\\n',\n",
              "  '40 year old F [**Location 1276**] [**Location 6679**] speaking with metastatic\\n   esophageal squamous cell carcinoma with recent chemo initiation\\n   carboplatin and 5-FU s/p trach for retropharyngeal and retrotracheal\\n   swelling [**2130-12-8**] which was removed [**2131-1-17**], with J-tube, who was\\n   transferred to [**Hospital Unit Name 1**] from omed for new onset stridor and concern for\\n   narrowed airway. The patient presented on [**3-26**]  to the omed service\\n   from clinic with neutropenia, dehydration, N/V, SOB. Treated\\n   empirically with cefepime for febrile neutropenia (101F, ANC 140). CXR\\n   with old L pleural effusion and R consolidation which are both chronic.\\n   Had progressive stridor during course of day, starting around noon but\\n   severe around 4pm, worse with activity with possible component of\\n   anxiety, with slight improvement with ativan. She was evaluated by ENT\\n   by scope and found to have immobile vocal cords with extremely narrowed\\n   airway of 1-2mm. She received 10mg IV decadron and 4mg PO Q8h decadron.\\n   Thoracics  was consulted for trach eval after patient arrived to ICU,\\n   oncologist aware and agreed with trach eval.\\n   Pt went to OR emergently [**3-27**]   #6 portex placed.  Required mechanical\\n   ventilation x4days..\\n   Post trach pt spiked fever to 103 on [**3-28**], cultured and started on\\n   antibiotics. She became hypotensive requiring fluid boluses and given\\n   2units of RPC..now afebrile since [**3-29**]. was weaned off levophed [**3-29**]. now\\n   tolerating trach collar x 72 hours.\\n   Per Heme/Onc there is no further therapy  to be offered for her cancer.\\n   Multiple family meetings here in ICU..\\n   Family wanted pt treated aggressively.  Pt will probably have permanent\\n   trach and j-tube due to advancing cancer. Had speech and swallow study\\n   for passy-muir valve. (pt has had one in the past). Pt didn\\nt tolerate\\n   Passy-muir valve yesterday d/t continuous coughing.  pt will keep her\\n   #6 portex trach in even though it is very small d/t pt wishing to be\\n   able to speak. Pt\\ns family doesn\\nt wish to change trach over to larger\\n   size d/t pt wouldn\\nt be able to speak per pt\\ns wishes. Issue of hospice\\n   also raised with family. Ideally, pt would like to get back to [**Country **] with her family.\\n   Currently pt is a full code. Husband is deferring to pt to make\\n   decision.\\n   Cousin [**Name (NI) **] is spokesperson..she speaks English very well. Both husband\\n   and pt have limited understanding of English language.\\n   Prior to admission, pt lived with husband. Pt is followed by [**Hospital **]\\n   hospice care [**Telephone/Fax (1) 6808**]\\n   Pt\\ns baseline bp is in the 80s and runs in the 70s at times while\\n   asleep. MICU team ok with sbp in 70s while pt asleep as long as map is\\n   >60. ? if tachycardia r/t tumor pressing on vagal nerve per team.\\n   .H/O cancer (Malignant Neoplasm), Esophageal\\n   Assessment:\\n   RR: 21-28    O2 sats on 35% trach collar: 98-100%    Lung sounds: clear\\n   @ upper lungs w/diminished breath sounds @ bases.  Patient coughing\\n   productively of thick white secretions from trach.  Patient coughed a\\n   lot when cuff inflated by RT, became teary eyed.  Patient c/o\\ned that\\n   trach ties were too tight.  Loosened by RT & nurse.  No stridor.\\n   Action:\\n   Sx\\ned X2 for scant to small amt thick white secretions.     RT left\\n   cuff uninflated per patient\\ns request.\\n   Response:\\n   Patient more comfortable w/uninflated cuff overnight.  Trach sutured in\\n   place & secured w/trach tie.  Patient feeling that trach ties are too\\n   tight &that inflating cuff is too uncomfortable, in part,  due to small\\n   size of portex.\\n   Plan:\\n   Leave cuff uninflated during day.  Sx using 10Fr catheter(s)  due to\\n   small lumen of portex. Monitor O2  sats.  Monitor patient\\ns comfort\\n   w/trach.\\n   .H/O tachycardia, Other\\n   Assessment:\\n   HR: [**Street Address(2) 918**] while sleeping- [**Street Address(2) 1883**] when upset/with activity.   BP:\\n   80\\ns-100\\ns/systolic.  MAP remained> 60.\\n   Action:\\n   Medicated w/0.5mg ativan for anxiety @ midnight as well as tylenol for\\n   L flank pain.\\n   Response:\\n   Patient became more calm, free from pain & fell asleep by 0030.\\n   Plan:\\n   Transfer to 7S when bed available (today).  Continue to medicate for\\n   pain/anxiety as needed.\\n',\n",
              "  '68 yr old man admitted to floor w/PNA on [**12-7**].  Transferred to MICU\\n   w/hypoxia @ 0230.  O2 sats were 81% on room air, up to 96% on NRB.\\n   Arrived w/T 103.8 ax.  Has extensive PMH including DM2, Sz, neuropathy,\\n   neurogenic bladder, GERD, HTN, atypical chest pain. Titrated O2 down to\\n   4L NP on [**12-9**] day shift.  Afebrile since abx given [**12-9**] am.  Able to\\n   swallow & looks comfortable.\\n   Pneumonia, other\\n   Assessment:\\n   O2 sats 93-98% on 3L NP overnight.  RR: 15-21     Lungs sound clear @\\n   upper lungs fields & crackles @ bases.  Patient now has intact gag\\n   reflex & can take his usual diet.  No problems w/swallowing overnight.\\n   WBC 6.0 (8.1)\\n   Action:\\n   Sent sputum (expectorated) for Cx.  Continues on IV levofloxacin,\\n   meropenum & vanco.  Treated w/ibuprofen 400mg po for intercostal pain.\\n   Received oxycontin 10mg , & neurontin 800mg po for back & neuropathy\\n   pain.\\n   Response:\\n   Afebrile\\n   Plan:\\n   Will be called out to floor later  today.\\n   Phosphorus: 1.4   Intern aware, will probably get neutraphos.\\n',\n",
              "  'Mr. [**Known lastname 901**] is a 49 yo M with dwarfism, HTN, spinal stenosis,\\n   chronic LE  lymphedema transferred from [**Hospital3 611**] for CTA to\\n   further evaluate acute onset of dyspnea and tachycardia. Intubated in\\n   [**Hospital1 19**] ED r/t  hypercarbic resp failure, and transferred to M/SICU for\\n   further mgt. Resp failure ?? r/t PNA, R pleural effusion.\\n   Intermittently spiking temps despite broad spectrum coverage and no\\n   culture growth to date\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n    Remained on A/C 50%/500/15 RR/5 PEEP throughout night to rest lungs.\\n   On 4mg/hr IV versed.  Stays awake & alert w/no difficulty.  No longer\\n   restrained, oriented X3.\\n   Action:\\n   Sx\\ned q 1-3 hrs for moderate amount thick yellow to white frothy\\n   secretions.  Patient has strong cough.\\n   Response:\\n   Lungs sounds: diminished throughout.\\n   Plan:\\n   Try back on CPAP today.  Progress towards weaning patient from vent.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   BP & HR stable. Tmax 100.9.\\n   Action:\\n   Given Tylenol @ [**2125**] for T100.9 po.  Cont to medicate w/IV vanco for\\n   leg cellulitis.  Cont to give antibiotic ear gtts to R ear for ear\\n   infection.\\n   Response:\\n   Patient continues to spike temps.  Was pan cultured [**8-14**] w/no growth to\\n   date (sputum,urine & BC) & ear Cx sent [**8-16**] : no growth to date.\\n   Plan:\\n   As above.\\n   Had generalized body aches & pains @ 0200 relieved w/25mg IV fentanyl\\n   X1.\\n   Urine now has some clots, may have been tugged w/turning.\\n',\n",
              "  '38 yo W with PMH of relapsed ALL s/p chemotherapy with febrile\\n   neutropenia, respiratory distress, VRE bacteremia (last positive\\n   culture from [**8-21**]) and recent PEA arrest ([**8-18**]).  Had 2 out of 4\\n   positive BC from [**8-27**] for gram positive cocci .\\n   Events:\\n   Post pyloric feeding tube fell out.  OGT placed ([**Hospital1 **] sump).\\n   TPN started via R brachial DL PICC.\\n   BC  from [**8-27**] positive for VRE.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   On SIMV @ 60%/ 500/ 18 RR/ 14 PS/12 PEEP    O2 sats 99-100%     RR\\n   20-32   No A-line\\n   Action:\\n   Sx\\ned q1-2 hrs for scant to moderate thin white secretions.  Oral\\n   airway in place to prevent patient from biting through ETT.  Initally,\\n   lungs had rhonci @ upper lungs w/diminished @ bases.  Gradually cleared\\n   w/Sx\\ning, coughing & turning.\\n   Response:\\n   Lungs now clear throughout except for crackles @ RLL.\\n   Plan:\\n   Continue pulmonary toilet.  Await CXR results.  Continue airway as bite\\n   block.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   On CVVHD since [**8-31**] @ 1600 w/same setup.  See flow sheet.\\n   Action:\\n   Removed 200-300cc/hr.  Fluid balance for [**9-1**] is negative 4200.  It is\\n   negative 1900 for today so far.  Using Bair hugger for hypothermia\\n   w/CVVHD.  Last temp 97.7po off Bair hugger.\\n   Response:\\n   Citrate for anticoagulation preserved dialyzer from clotting.  Patient\\n   tolerated fluid removal well.\\n   Plan:\\n   Continue to remove 4L/day.  Patient could tolerate > fluid removal\\n   w/out difficulty.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient is more awake & alert.  Using each hand, squeezed her hand on\\n   command.  Turned head w/repositioning ETT.  Spit out airway, then\\n   proceeded to bite down on ETT.  Opened eyes.  When asked to blink,did\\n   not comply.  Raised L arm off bed.\\n   Action:\\n   Asked patient if she had pain, to blink if she did.  No response to\\n   this so asked if she would squeeze hand if she had pain.  She did not\\n   squeeze hand.  Restrained wrists after patient lifted arm off bed.\\n   Response:\\n   BP & HR elevated w/awaking.  Started on IV labetalol.\\n   Plan:\\n   Continue to hold sedation.  Continue to assess mental status.\\n   Malnutrition\\n   Assessment:\\n   Feeding tube in L nare fell out @ 0230 leaving tape securing it intact.\\n   Action:\\n   Stopped tube feed (running @ 10cc/hr) @ 0230.  Continued TPN @ 42cc/hr\\n   via R brachial PICC.  OGT placed for meds.\\n   Response:\\n   CXR done this am & resident confirmed OGT placement.\\n   Plan:\\n    [**Month (only) 11**] have post pyloric pedi feeding tube replaced today.\\n   Hypertension, benign\\n   Assessment:\\n   BP 150\\ns-183/90\\ns-110\\n   Action:\\n   Started IV labetalol @ 2mg/min  @ 0430.\\n   Response:\\n   BP dropped to 140\\ns/90\\ns.  Decreased labetalol to 1mg/min @ 0610.\\n   Plan:\\n   Continue to titrate labetalol.\\n   Pancytopenia\\n   Assessment:\\n   Hct 23.3 (                PLT CT 19 (11)\\n   Action:\\n   Response:\\n   Plan:\\n   Transfuse for hct <21%, PLT CT <10 or bleeding\\n   Bacteremia\\n   Assessment:\\n   Afebrile.  Hypothermic on CVVHD.  WBC remains 0.1 despite neupogen.  BC\\n   taken from midline on [**8-27**] came back + for VRE.  Midline since D/C\\n   Action:\\n   Sent surveillance BC X1 today from dialysis line.\\n   Response:\\n   Plan:\\n   Continue to follow Cx .  Continue to monitor temps.\\n',\n",
              "  '74F with newly diagnosed metastatic ovarian cancer on pressors and [**Hospital 1460**]\\n   transferred from west to [**Hospital Ward Name 1437**] ICU for ureteral stenting and\\n   possible palliative chemo. No increase in u/o after stenting.\\n   Originally presented to ED [**2-22**] ARF and hyperkalemia now s/p ureteral\\n   stent and s/p chemotherapy.  PMH includes hypothyroidism and HLD.\\n   Pleural effusion, acute\\n   Assessment:\\n   Lungs rhoncorous w/diminished breath sounds @ bases.  Patient on & off\\n   noninvasive ventilation: FiO2 40% with16 PS & 4 PEEP.   O2 sats:\\n   96-100% on & off noninvasive ventilation.  Patient had episode of\\n   apparent aspiration [**10-3**] & [**10-4**].\\n   Action:\\n   Daily CXR\\ns.  ABG\\ns soon after coming off noninvasive ventilation to 6L\\n   NP: 7.32/51/88 (@ [**2130**] [**10-5**]).  Kept NPO.\\n   Response:\\n   Patient\\ns small B pleural effusions are essentially  unchanged. Mild\\n   CHF noted [**10-4**].   ABG\\ns after 5 hrs off non invasive ventilation (when\\n   patient c/o SOB): 7.31/52/85 on 6L NP (@ 0115  [**10-6**])  Patient placed\\n   back on noninvasive ventilation 10 min later.\\n   Plan:\\n   Paracentesis under direction of US @ bedside on  [**10-6**].  Speech &\\n   swallow study before patient takes po.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Foley in place, drained 5cc apparent blood overnight.   Patient\\n   remained NPO.  BUN: 39 (30)      Cr: 3.1 (2.6)            K 4.8 (4.9).\\n   Action:\\n   1000cc FR/day maintained.\\n   Response:\\n   Patient is becoming visibly more edematous w/anasarca\\n   Plan:\\n   HD on [**10-6**].  If unable to remove fluid during HD/or if starting TPN,\\n   then will try CVVHD.  Suggestions: 1^st  dialyze, then tap ascites.\\n   Give albumin @ the beginning of dialysis Tx.  Try sequential\\n   ultrafiltration & Na modeling to remove maximum amount of fluid during\\n   hemodialysis.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Skin more excoriated @ buttocks & perineal area, now bleeding from\\n   excoriated areas.    Incontinent of  loose stool & unaware of it,\\n   2X/overnight.\\n   Action:\\n   Used barrier cream mixed w/saran  to reddened areas.  Sent stool\\n   specimen for C-diff.  Turned q 2 hrs.\\n   Response:\\n   Plan:\\n   Continue to clean patient frequently.  Unable to use mushroom catheter\\n   w/ elevated INR.  Skin too excoriated to use rectal bag.\\n   Unable to draw ABG\\ns on noninvasive ventilation as A-line stopped\\n   functioning (unable to get BP or draw blood through A-line).  D/C\\n   nonfunctioning A-line this am.  Intern & resident aware & will attempt\\n   to replace A-line.  Unable to obtain BP by automatic BP.  Unable to\\n   palpate R radial (had L radial A-line).  Able to palpate R brachial but\\n   not well.  Dopplered R brachial for systolic BP 104/doppler @ 0600.\\n',\n",
              "  'Mr. [**Known lastname 3375**] is a 53 year old M with PMH of chronic vent/trach, recent\\n   admission for VAP, severe COPD, prior L CVA with residual R-sided\\n   weakness, seizure disorder, depression and schizophrenia who presents\\n   from rehab ([**Hospital3 3376**]) after being found unresponsive overnight.\\n   According to notes the patient was checked on at 430 and found\\n   unresponsive in his bed.  He did not respond to sternal rub.  He was\\n   taken off of the ventilator and bagged with improvement in mental\\n   status.  He was then found unresponsive again at 7am and brought to\\n   [**Hospital1 54**] for further evaluation.\\n   Arrived @ EW w/BP86/53 HR 98 sat98% on A/C 50%/500/12/5.  BP back up to\\n   100\\ns/sys after 2L IVF.  WBC 19.5  Lactate 1.9\\n   CXR showed R middle & lower lobe collapse, increased airspace opacities\\n   @ L lung base which could be pneumonia or aspiration.  Patient later\\n   became diaphoretic w/fixed gaze & BP 188/84 & sat 99%. No\\n   incontinence.  2mg IV ativan given.  Patient awoke w/no recall of event\\n   , A&OX3.  Transferred to MICU as he is on vent.\\n   .H/O chronic obstructive pulmonary disease (COPD, Bronchitis,\\n   Emphysema) without acute exacerbation\\n   Assessment:\\n   On A/C 50%/500 Vt/12 RR/5 PEEP.  O2 sats 96-98%.  T99.5po-98.1ax on\\n   Tylenol (for pain) & steroids (for adrenal insufficiency).  Given\\n   vanco, tobra & cefipime IV, bactrim per NGT.\\n   Action:\\n   Sx\\ned q 4 hrs for small to moderate amounts thick tan secretions.\\n   Response:\\n   [**7-7**] WBC down to 8.4 (from 19.5 in EW)\\n   Plan:\\n   Continue to turn patient as he consents.  Sx as needed.  Cont to give\\n   abx.\\n   .H/O seizure, without status epilepticus\\n   Assessment:\\n   No S&S Sz activity.  Has Sz hx.\\n   Action:\\n    Received usual anti-Sz meds.\\n   Response:\\n   As above\\n   Plan:\\n   Monitor for Sz activity\\n   Patient c/o R leg pain.  Refused to lie on L side because of pain.\\n   Turned patient from his back to his R side for this reason. Received\\n   5mg oxycodone  @ [**2133**] w/relief of pain.  Received 650mg Tylenol  to\\n   potentiate oxycodone, as Tylenol alone did not work.  Received 400mg\\n   motrin @ 0315 w/ some relief of pain. Patient mouthed that oxycodone\\n   gave the best relief of pain.  Given another 5mg oxycodone @ 0415\\n   w/relief of pain.           Troponon < 0.01 @ 2300 [**7-6**].\\n',\n",
              "  'Mr. [**Known lastname 7495**] is a 62 year-old man with esophageal cancer with mets to\\n   lung and brain, s/p several rounds of [**Last Name (LF) 2051**], [**First Name3 (LF) 3004**] and whole chest xrt,\\n   who presents from [**Hospital 2461**] hospital with one day of shortness of\\n   breath. He was diagnosed by his oncologist with pneumonia after several\\n   days of productive cough and was started on levofloxacin and flagyl. Pt\\n   O2 dependant at home. Requested transfer to [**Hospital1 5**] for further\\n   management. Pt being treated for pneumonia and gram negative rod\\n   bacteremia.\\n   CT chest and Xray show progression of CA with numerous nodules, pleural\\n   effusions associated with atelectasis and a small pericardial\\n   effusion\\nfamily meeting done yesterday resulting in DNR/DNI status as\\n   pt/family informed of progression of CA and depletion of\\n   [**Hospital1 2051**]/radiological\\n   treatment.\\n      Patient is NOT CMO, but no further escalation of care.  Palliative\\n   care following patient, as well as social service.    Family wants\\n   patient discharged to hospice but no beds available @ 2 facilities near\\n   family.  [**Month (only) 8**] take patient home (w/home hospice). Some concern about how\\n   son will handle father\\ns illness especially @ home.\\n   Hypoxemia\\n   Assessment:\\n   O2 sats 88-92% overnight on 50% high flow neb & 6L NP.  Lungs:\\n   diminished throughout except L upper lobe was clear.\\n   Action:\\n   Given 10mg IV lasix @ midnight.  Given atrovent & albuterol neb Tx\\nes q\\n   6hrs\\n   Response:\\n    After neb Tx, lungs: clear throughout except diminished @ R lower\\n   lobe.      BUN 26 (up from 22-25 yesterday)  & Cr 1.2 (from 1.1-1.2\\n   yesterday)\\n   Plan:\\n   Home O2 company coming in during am to evaluate for receiving O2 @ home\\n   or hospice.\\n',\n",
              "  '25 year old female admitted to MICU for treatment of sepsis r/t\\n   infected left knee joint, of note pt also has abscess in left thumb\\n   from an apparent fight according to patient, however pt has told\\n   healthcare team varying stories. Pt\\ns PMH significant for IVDU-\\n   admitted to last use yesterday, Hep C, sepsis, PNA, and asthma w/30-40\\n   intubations as a child. Recent bilateral knee replacements r/t\\n   arthritis secondary to chronic steroid use for treatment of asthma\\nleft\\n   knee done in [**3-5**] and right done [**2142**]8 per pt.\\n     Admitted w/sepsis from infected L knee prosthesis, w/same organism\\n   growing in abcess @ L thumb.  [**Month (only) 8**] have vegetation on mitral\\n   valve\\nvisualization on TTE was suboptimal.\\n      Patient was delirious [**10-3**], occasionally combative w/auditory &\\n   visual hallucinations. Remained restrained as patient pulled out foley\\n   & pulled @ central line.  Required close 1:1 supervision by nurse &/or\\n   MD.   Psych consult recommended no further use of valium, but to use\\n   5-10mg haldol prn agitation.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   BP:  93/50-121/83 by cuff               HR: 88 SR-111 ST no ectopy.\\n   Action:\\n   Patient had & washing of L knee & I&D of L thumb abcess.  BP maintained\\n   on 0.16-0.20 mcg/kg/min Levophed IV.  Genta, vanco & ceftriaxone IV\\n   D/C\\ned.  Continued on clinda IV & started on PCN G IV q 4 hrs.\\n   Response:\\n   Afebrile overnight.  Initial dressing to L hand & L knee: D&I.  CMS @ L\\n   foot & L hand : warm extremity w/normal color & palpable pulse.\\n   Plan:\\n    TEE & MRI of head to r/o septic emboli, planned for today.\\n   Asthma\\n   Assessment:\\n   O2 sats: 100% w/FiO2 down from 100% to 30%.  Intubated for OR &\\n   testing.  Has small R pleural effusion on CXR.\\n   Action:\\n   Intubated on A/C @ 30%/ Vt 400 /RR24/ PEEP 5.  MD\\ns attempted A-line\\n   placement unsuccessfully overnight.\\n   Response:\\n   Lungs: clear throughout.\\n   Plan:\\n   Continue to monitor lung sounds & O2 sats.\\n   Delirium / confusion\\n   Assessment:\\n   Patient is intubated & sedated.  No S&S agitation.\\n   Action:\\n   Patient is sedated on 100mcg/hr fentanyl IV & 1.5mg versed IV.\\n   Resident able to examine patient for possible tampon placement\\n   (possible toxic shock)- she didn\\nt have one.\\n   Response:\\n   Well sedated on above, received  bolus for attempted A-line placement\\n   &  patient slept through attempt.\\n   Plan:\\n   Keep intubated & sedated until TEE & MRI of head done.\\n   OGT advanced by 10cm per CXR results ([**10-3**])as instructed by intern,\\n   [**Doctor Last Name 977**].\\n',\n",
              "  'Ms. [**Known lastname 9470**] is a 50 yo F with breast cancer metastatic to [**Last Name (LF) **], [**First Name3 (LF) 503**],\\n   liver and lung admitted for seizures/PNA and transferred to the ICU for\\n   respiratory distress.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   O2 sats: 91-97% on 95% high flow neb.  RR:8-33.    Lungs are diminished\\n   @ bases w/ crackles @ upper lungs.\\n   Action:\\n   CXR done this am.  Crushed meds & mixed w/applesauce.  Kept on soft\\n   solid/nectar thick liquid diet.  HOB remained 30 degrees or higher.\\n   Received 80mg IV lasix @ 0300.\\n   Response:\\n   Breathing not labored overnight.  Comfortable sleeping.  U/o after\\n   lasix: 650cc since 0300.\\n   Plan:\\n   Family wants discharge to  inpatient (hospice) facility near [**Hospital1 97**].\\n   Alteration in mental status\\n   Assessment:\\n   Patient was oriented to self & place, not time.  Thought it was [**Month (only) **]. in\\n   19\\ns. Patient was restless, pulling off BP cuff, O2 mask.\\n   Action:\\n   Easily reoriented.  Sat w/patient  to remind her to keep O2 on.  Pulled\\n   back curtains in room to observe patient.  Bed alarm on.  Patient\\n   room near nursing station to allow easy observation.  Provided for\\n   relief of pain w/oxycodone & Tylenol.  Provided for relief of anxiety\\n   w/ativan.\\n   Response:\\n   When left alone, patient removed O2 mask.\\n   Plan:\\n   Continue to provide sitter for patient when possible.\\n   Drew labs @ 0600.  portacath drew poorly.  Unable to obtain enough\\n   blood for PT, PTT.\\n',\n",
              "  '50 yo female with history of MVC and T2 paraplegia now with admission\\n   [**2147-10-8**]  with recurrent fever and sepsis with likely urinary source with\\n   complication of respiratory failure and now with persistent respiratory\\n   compromise following extubation with right sided collapse seen in RLL\\n   and RML in the setting of rib fractures and weakness. Pt was\\n   reintubated and extubated [**10-15**]. her CXR has shown worsening R lobe\\n   collapse, she received 40mg iv lasix [**10-15**] and her resp status slowly\\n   improved. Her chief complaint has been pain control (chronic back pain\\n   from her MVA.\\n   Anxiety\\n   Assessment:\\n   Patient c/o SOB due to anxiety, unable to speak easily @ that time.\\n   Refused to be turned for most of the night.  Only did IS X2 in early\\n   to late evening.  Refused CPT all night.  Refused sc heparin.\\n   Action:\\n   Received clonazepam 1mg po @ 2330 & again @ 0600.  Intern informed of\\n   all that patient refused.\\n   Response:\\n   Patient slept well after 0030.  Noncompliant w/care upon awakening @\\n   0600.  Refused CXR, temperature, auscultation of lungs,IS,  lidocaine\\n   patch removal.  Expressed anger @ not receiving methadone 2 hrs early,\\n   @ 0600. Expressed anger @ having light turned on in room @ 0600.\\n   Plan:\\n   Give methadone no earlier than 0700, 1 hr earlier than scheduled 0800\\n   dose.\\n   Hypoxemia\\n   Assessment:\\n   O2 sats: 95-100% on 80% high flow neb.  O2 sats 95-98% on 50% high flow\\n   neb.  O2 sat 92% when she took O2 off.  RR 11-18 for most of night.  RR\\n   up to 28 w/anxiety.\\n   Action:\\n   Oxygen slowly titrated down from 80% high flow neb to 50% high flow\\n   neb.\\n   Response:\\n   No change in O2 sats unless patient took O2 off.\\n   Plan:\\n   Continue to titrate O2 down.\\n',\n",
              "  '83 yo with COPD and chronic diastolic CHF well until day of adm when\\n   developed fatigue and progressive SOB.  Neighbor took her to PCP where\\n   she was lethargic, confused, febrile, hypoxic. Sent to ED\\n   hypotensive, febrile, hypercarbic. CX done, abx started including\\n   Tamiflu. Admitted to [**Hospital Ward Name 51**] MICU.  Low dose IV levophed ran overnight\\n   [**Date range (1) 10876**].  Levophed off since 0800 [**12-15**].   Positive for H1N1\\n   droplet precautions.  On contact precautions for hx MRSA.\\n   At home, patient is on continuous O2 @ 2L NP for COPD.    Has OSA &\\n   should be on CPAP but refused it.\\n   Pneumonia\\n   Assessment:\\n   Lungs are both rhoncorous &w/exp wheezes throughout.  RR: 16-27\\n   Coughing up tan secretions.  Tmax 100.7po          WBC 18.4 (17.7)\\n   Tolerating house diet well.\\n   Action:\\n   Received albuterol & Atrovent neb Tx\\nes q 6 hrs.  Received 650mg po\\n   Tylenol for c/o H/A @ 2330 w/relief.  Repositioned for c/o back pain\\n   from arthritis.\\n   Response:\\n   O2 sats: 95-100% on 2L NP.  SOB w/exertion (of washing up in bed).\\n   Fell asleep eating cereal for dinner.\\n   Plan:\\n   Will  be called out to floor today.\\n   Renal failure\\n   Assessment:\\n   BUN 23 (36)   Cr 0.9 (1.0)    K 4.0 (4.6)     U/o 70-120cc/hr clear\\n   yellow urine\\n   Action:\\n   Patient is drinking fluids on house diet.\\n   Response:\\n   Increased BUN & Cr was from the pre-renal cause of dehydration.  She\\n   received 3L IVF in ED ([**12-14**]) & 1 L IVF on [**12-14**], & another 1.5 L on\\n   [**12-15**] in MICU\\n   Plan:\\n   Continue to follow labs & u/o.\\n   Pain\\n   Assessment:\\n   Patient c/o achy H/A @ Mn.that was [**6-7**].   C/o neuropathy pain in both\\n   legs @ 0400 that was [**7-8**].  C/o achy generalized back pain from being\\n   in bed that was\\n   Action:\\n   Repositioned frequently for back pain w/relief.  Received Tylenol for\\n   H/A w/relief down to 1/10.  Received 15mg  morphine IR po for\\n   neuropathy pain  w/relief down to 3/10.   Also received neurontin 300mg\\n   po bid.\\n   Response:\\n   As above.  Neurontin was decreased from 400mg tid po (@ home dose) to\\n   300mg [**Hospital1 **] for lethargy from neurontin & morphine IR  @ home & in ED.\\n   Plan:\\n   Continue to assess for pain.  Medicate as needed.\\n',\n",
              "  'This [**Age over 90 **] yr old resident of [**Location 2111**] House  Hospice in [**Location (un) 250**] was\\n   admitted w/change in mental status X2 days.  Recently discharged ([**8-20**])\\n   from [**Hospital1 19**]. Speaks Italian & a few words of English.  Daughter (HCHP)\\n   was unhappy w/his care & was in process of getting him transferred to\\n   the palliative care unit @ the [**Hospital 328**] Rehab.  In EW, vs:101.9 R -112\\n   ST- RR 27-36 on 3L NP.  BP dropped from 203/systolic to 140\\ns-150\\ns/sys\\n   w/relief of hypoxia.  Patient was 100% on nonrebreather. Patient\\n   responded to commands in Italian, & squeezed w/both hands.  He did not\\n   speak or nod.  Very lethargic, slept since arrival.  PMH: diastolic\\n   CHF, CRI (baseline Cr 1.5), s/p [**5-20**] herpes zoster,BPH, HTN.\\n    HCHP wants patient to be DNR/DNI.  She says she does not want a\\n   feeding tube.  She is OK w/IV abx, blood draws, induction of sputum by\\n   NT Sx.\\n   Patient will probably be called out to the floor today.\\n   Pneumonia, bacterial, community acquired (CAP)\\n   Assessment:\\n   T 98.3 ax   Lungs: rhonci throughout, diminished 2 bases.  RR20\\ns  O2\\n   sats 96-100%\\n   Action:\\n   Titrated O2 down from 100% nonrebreather to 50% high flow neb\\n   Response:\\n   Maintained O2 sats @ 96-100%.  Congested sounding cough but no\\n   expectoration.\\n   Plan:\\n   Titrate high flow neb down to regular neb.  [**Month (only) 51**] change mask to face\\n   tent (@ bedside) if preferred.\\n',\n",
              "  'Ms. [**Known lastname 1715**] is a 57 year old female with a PMH significant for\\n   schizophrenia admitted on [**2153-11-9**] with diagnosis of laryngeal CA. The\\n   patient has recently begun having difficulty with speech and increased\\n   erythema with purulent drainage from her neck.  A CT neck from [**11-8**]\\n   demonstrated a 5.1 x 3 x 2.3 cm mass at the level of the supraglottis,\\n   with extension through the thryohyoid membrane, narrowing of the\\n   airway, and multi-focal adenopathy. She was admitted for ENT and\\n   Oncology evaluation, who identified the mass on the anterior pharyngeal\\n   wall. The patient has remained stable without airway compromise.\\n   Pt. went to OR [**11-15**] trach by ENT for airway protection, g-tube by\\n   thoracic surgery for continued aspiration, and dental extraction by\\n   oral surgery d/t multiple abscesses in teeth. Biopsy of mass also\\n   done.  Transferred to MICU post-op. Extubated [**11-16**].  Oncology following\\n   as pt. will need chemo/radiation in near future.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 76**])\\n   Assessment:\\n   Patient\\ns O2 sats were 96-99% on 40% O2 via trach collar.  RR: [**1-2**]\\n   Action:\\n   Suctioned X1 for moderate amount tenacious tan to blood tinged\\n   secretions.\\n   Response:\\n   Lungs sounds were clear to diminished throughout.\\n   Plan:\\n   Transfer to floor in near future.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Large open area on skin  under plastic trach flange,  superior aspect\\n   to trach.\\n   Action:\\n   Cleaned w/ sterile NS.  Iodoform guaze applied to open area.\\n   Response:\\n   Had some thick yellow drainage w/no odor.\\n   Plan:\\n   Needs wound care nurse consult.\\n',\n",
              "  '70 y/o F admitted from home with resp failure and flu-like symptoms\\n   requiring intubation, high dose sedation and pressure controlled\\n   ventilation 2/2 ARDS and continued Dysynchrony.  Ms [**Known lastname 10054**]\\ns course has\\n   been further complicated by ARF (which is now resolving) and an\\n   intermittent dependence on Levophed. She has had no positive culture\\n   data to date, & has ruled out for flu multiple times.\\n   Had family meeting [**8-21**] re:goals of care.   Family felt that patient\\n   did not want tracheostomy.  Patient made DNR overnight while more\\n   family members are being contact[**Name (NI) **].  On [**8-22**], patient will be made CMO.\\n   Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name 11**])\\n   Assessment:\\n   On  PCV @ 50% w/ RR 24/pressure control level 21/ PEEP 5.  Lungs clear\\n   w/diminished breath sounds @ bases.       RR: 24         O2 sats:\\n   93-96%\\n   Action:\\n   Suctioned for mucous plug X1, after instillation of NS.\\n   Response:\\n   ABG\\ns: 7.47/41/66  Pressure control level changed to 18 for increased\\n   pH & decreased pO2.\\n   Plan:\\n   After daughter & family are ready, patient will be made CMO on [**8-22**].\\n   Hypernatremia (high sodium)\\n   Assessment:\\n   Na: 147 on [**8-21**] @ 1500.\\n   Action:\\n   Patient received 2400cc IV D5W @ 100cc/hr, ending @ 0800.  Patient also\\n   received 300cc free water boluses per OGT q 3 hrs until 0215.\\n   Response:\\n   Na: 143 w/am labs [**8-22**].\\n   Plan:\\n   Will D/C OGT when patient is made CMO.\\n   Comfort\\n   Assessment:\\n   Patient\\ns BP increased to 160\\ns-180\\ns/systolic after turning, mouth\\n   care.\\n   Action:\\n   Increased fentanyl IV from 150mcg/hr to 250mcg/hr throughout the\\n   night.  Increased versed from 6mg/hr to 8 mg/hr overnight.\\n   Response:\\n   Patient is more sedated & more comfortable.\\n   Plan:\\n   Provide for patient\\ns comfort.\\n',\n",
              "  '71 year old  English speaking male with NSCLC  receiving chemotherapy\\n   with carboplatin and paclitaxel, presented to the ED on [**2162-6-1**] with 4\\n   days of subjective fevers, loose but non-productive cough, sob, fatigue\\n   and arthralgias. Has been using oxygen 3L at home.  R/o\\ned for flu.\\n   Past medical history: HTN, Type 2 DM, COPD, obstructive sleep apnea (\\n   does not use BIPAP though recommended), cardiomyopathy, hyperlipidemia.\\n   Foot surgery after falling off a roof. Squamous cell carcinoma (\\n   diagnosed in [**2161-11-27**] from endobronchial biopsy. R hilar mass with\\n   involvement of R mediastinal lymph nodes.\\n   Transferred to [**Hospital Ward Name 29**] MICU [**2162-6-4**] early am after his blood sugar\\n   dropped to 33 & he lost consciousness for a short time.  Had a syncopal\\n   episode w/in  the previous 12 hrs ([**6-3**]) w/normal blood sugar.\\n   Hypoglycemia\\n   Assessment:\\n   FS 63 @ [**2152**].  No c/o\\ns.  Ate no breakfast, a sub for lunch & no\\n   supper.  Said he was not hungry.  Low blood sugars due to patient not\\n   eating & patient still covered w/lantus 30 units sc (X24 hrs) given on\\n   [**6-3**] @ 2230.\\n   Action:\\n   Given [**Location (un) 257**] juice, peanut butter & crackers & milk @ [**2152**].  Ambulated\\n   w/assist only.  Bed alarm on. Reminded patient to only get out of bed\\n   w/nurse assist.\\n   Response:\\n   FS 99-117  @ 2100-0000. Ate\\n chicken [**Location (un) **] @ 0030.   FS @ 0300=\\n   Plan:\\n   Decrease dose of lantus.  Encourage po intake, especially protein (eats\\n   carbs mostly).  Nutrition consult for diet teaching.  Check FS q 3\\n   hrs.  OOB w/assist only.\\n   Cancer (Malignant Neoplasm), Lung\\n   Assessment:\\n   WBC     (1.6)    Afebrile.   Lungs:  clear to rhoncorous @ upper lungs,\\n   diminished @ bases.  C/o pain in multiple areas of back, said it was\\ncancer pain\\n   Action:\\n   Given atrovent & Albuterol neb Tx\\nes q 6hrs.  Received 2 percocet @\\n   2130 w/relief.\\n   Response:\\n   Patient had O2 sats 96-100% on room air after neb Tx @ [**2152**].  Fell\\n   asleep @ 0130, by 0200 was satting in low 80\\ns.  On 2L NP, O2 sats 100%\\n   @ 0205.\\n   Plan:\\n   Patient said he no longer wanted chemo.  Will need social service\\n   consult.\\n',\n",
              "  'Delirium / confusion\\n   Assessment:\\n   Patient had garbled speech so unable to assess orientation. Attempted\\n   to swing legs over side of bed, but easily redirected. Pulled off O2\\n   overnight.\\n   Action:\\n   Kept all siderails up. Bed alarm on. Placed pillows on either side of\\n   patient to prevent him from getting out of bed. Kept NP on @ low flow\\n   (1-2L) O2 so that when he pulled his O2 mask off he did not desat. Hid\\n   lines/foley under pillows.\\n   Response:\\n   Patient remained in bed\\n   Plan:\\n   Continue as above.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   RR 16-31 w/O2 sats @ 92-95% on 4L NP.  Lungs: clear @ RUL, crackles @\\n   LUL, diminished @ bases.  NPO as he failed speech & swallow exam\\n   earlier. Dr. [**First Name (STitle) 1161**] attempted X3 to place feeding tube unsuccessfully.\\n   Action:\\n   CPT done.  Humidified O2 via tent applied to liquify secretions.\\n   Attempted to orally Sx secretions in back of throat after patient had\\n   productive sounding cough.\\n   Response:\\n   Patient mostly refused to open his mouth for oral suctioning. Had\\n   productive sounding cough. Swallowed secretions. O2 sats 96-100% on\\n   1-2L NP & 35% humidified face tent.\\n   Plan:\\n   Change to NP during day if needed.  Continue humidified O2 via face\\n   tent overnight. Continue CPT.  Start IS if patient becomes more\\n   oriented & able to use it.  Plan is for IR to place Dobhoff later\\n   today.\\n   R leg hematoma:\\n   A: Patient continues to have swollen R leg from hematoma, possibly\\n   source is R hip. Followed by vascular team.  B DP\\ns & PT\\ns palpable.\\n   A: Ace wrap from thigh to foot intact. Serial Hcts followed q 6 hrs.\\n   R: Last Hct was 32.2 @ 0330, up from 31.3\\n   P: Continue to check serial Hcts.  Continue to maintain ace wrap to R\\n   leg thigh to foot.\\n',\n",
              "  '61yr  YO with HX cutaneous squamous cell Ca to L temporal lobe & mets\\n   to regional lymph nodes, CLL (dx\\n05), HTN, a-flutter s/p ablation.\\n   Admitted w/neutropenia/fever & multilobular pneumonia.\\n   Started chemo in early [**Month (only) 280**].  Currently receiving, XRT, s/p chemo 9\\n   days ago.   Recent bone marrow bx reveals extensive marrow replacement\\n   by  LL.  Course has been c/b chemo/transfusion reactions, neutropenia,\\n   pleural effusions w/ hypoxia.  He was recently d/c\\nd from MICU to 7S\\n   after tx for sepsis.\\n   Transferred back to [**Hospital Ward Name **] 4  [**8-6**] after developing IVIG reaction where\\n   he developed, fever, hypoxia, resp distress, MS changes.  Received IVIG\\n   [**8-12**] w/out reaction (received pre benadryl & steroids; ran @ rate\\n   120cc/hr max).\\n   Neutropenia\\n   Assessment:\\n   WBC =               Total granulocyte count =\\n   Action:\\n   Maintained neutropenic precautions.  No Cx for fever per team @ this\\n   time.\\n   Response:\\n   Tmax 101.2 on [**8-12**].  Afebrile  [**8-13**].  Patient runs intermittent fevers.\\n   Plan:\\n   Continue giving meropenum/acyclovir/caspofungin IV.\\n   Pneumonia, other\\n   Assessment:\\n   Upon auscultation, lungs sounds: diminished throughout to diminished @\\n   bases.   Patient expectorates small amounts of thick yellow to tan\\n   secretions q 3-4 hrs.\\n   Action:\\n   Patient uses yankaur to remove secretions\\n   Response:\\n   Plan:\\n   Get patient OOB to chair @ least 1X/day.\\n   Diarrhea\\n   Assessment:\\n   Patient stools frequently in small amounts loose stool.\\n   Action:\\n   Held colace & bowel meds.\\n   Response:\\n   Skin around rectum excoriated.\\n   Plan:\\n   Apply Aloe Vesta barrier cream to perirectal area.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient is A&OX3.  He is depressed & withdrawn.\\n   Action:\\n   Given prosac qd as ordered.\\n   Response:\\n   Plan:\\n   Offer emotional support.  Encourage verbalization.\\n   Cancer (Malignant Neoplasm), Other\\n   Assessment:\\n   Action:\\n   Received IVIG on [**8-12**]\\n   Response:\\n   Patient was free from reaction.\\n   Plan:\\n   Transfer to heme/onc floor\\n   Alteration in Nutrition\\n   Assessment:\\n   Poor appetite.  Drinking more (po) since water flushes w/TF\\ns were\\n   decreased to 30cc from 100cc q 6 hrs.\\n   Action:\\n   Receiving tube feeds (nutren pulmonary) since [**8-9**].\\n   Response:\\n   Tube feeding running @ goal rate of 55cc/hr.  Now w/30 cc water flushes\\n   q 6 hrs.\\n   Plan:\\n   Encourage patient to cough/ swallow/ cough per speech & swallow study\\n   [**Date range (1) 370**].\\n   Liver function abnormalities\\n   Assessment:\\n   LDH=        AST=             ALT=\\n   Action:\\n   Avoid Tylenol  if possible.  Voriconazole was D/C\\ned on [**8-10**] for\\n   elevated LFT\\n   Response:\\n   Plan:\\n   Continue to follow LFT\\n',\n",
              "  '75 YO  with HX  COPD, pneumonia, systolic CHF (EF 15-25%) s/p ICD,\\n   a-fib s/p ablation, hx PE on coumadin,who presented to ED with\\n   respiratory distress, fevers and cough.  In ED, CXR showed bilateral\\n   PNA with infiltrates. Intubated in ER for increased resp distress.\\n   [**11-1**] levophed d/c\\nd & extubated.\\n   DNR but OK to intubate short term.\\n   Pneumonia, other\\n   Assessment:\\n   Patient coughing productively, & using yankauer suction.  Upon\\n   auscultation, lungs sounds are I/E wheezes w/some rhonci.  O2 sats\\n   maintained @ 96-100% w/ NP @ 3L & 50% high flow neb via tent mask.\\n   Desats to 85% w/out NP as he takes mask off so frequently.  Patient\\n   continues to have absent gag.  Expectorated  small to moderate amount\\n   blood tinged yellow secretions.  WBC 8.1 (14.2)\\n   Action:\\n   Started on mucinex  po bid.  Given Albuterol & atrovent nebs X2\\n   overnight.\\n   Response:\\n   Still has difficulty coughing secretions all the way up.\\n   Plan:\\n   Frequent mouth care.  Aspiration precautions.\\n   CHF\\n   Assessment:\\n   Patient was 500cc in negative fluid balance for [**11-3**], which was\\n   desired.     BUN 39 (36)        Cr 1.5 (1.4)                   K3.2\\n   (3.9)      Patient is thirsty.  Patient\\ns weight  today is down by 2kg\\n   since yesterday.\\n   Action:\\n   Titrated IV lasix  between 4-7mg/hr to remove  500cc/day.   Patient is\\n   negative 300 cc so far for [**11-4**].    Repleted  w/40 mEq KCl IV.\\n   Response:\\n   U/o ( 150-360cc/hr clear light yellow urine) responded well to 7mg/hr\\n   IV lasix.\\n   Plan:\\n   Continue to remove 500cc for the day on [**11-4**].\\n   Impaired Skin Integrity\\n   Assessment:\\n   R buttock has 2 small round areas ( approx 1cmX 1cm) where 1^st 2\\n   layers of skin are gone: stage 2 pressure ulcer.  Skin intact around\\n   areas. Wound base pink.  L arm laceration has small to moderate amount\\n   serosanguinous drainage absorbed by softsorb.\\n   Action:\\n   Aloe Vesta applied to buttocks.  L arm dressing done.\\n   Response:\\n   Patient turned side to side to keep off buttocks.\\n   Plan:\\n   Turn frequently.  Continue to apply aloe vesta to R buttock.\\n   Had large soft brown guiac positive BM X2 on commode.\\n   Hct 22.8  (26.0)             INR 2.4 (2.7)\\n',\n",
              "  'This 60 yr old woman came to [**Hospital1 54**] on the BMT/Leukemia service on\\n   [**2173-1-30**] w/new onset acute promyelocytic leukemia (APML). Admitted to\\n   the MICU w/pulmonary edema, received masked ventilation & diuresis, &\\n   returned to 7F.  Returned to MICU on [**2-13**] w/ acute SOB, increased FiO2\\n   requirements & increased work of breathing. Intubated [**2-15**].\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   This patient was extubated on [**2-24**].  Went into flash pulmonary edema\\n   while attempting a BM on the bedpan.  BP went up to 190/105, HR 100\\n   ST.  C/o SOB w/crackles & rhonci, especially on R.\\n   Action:\\n   Treated w/IV hydralazine, lopressor, morphine, nebs & 80mg IV lasix. On\\n   high flow neb for a few hours.\\n   Response:\\n   Good urine response of 1000cc in 1 hr. Anxiety & discomfort relieved\\n   w/morphine. BP dropped to 160\\ns/systolic w/hydralazine & HR dropped to\\n   80\\ns SR w/lopressor.  SOB improved. Lungs had crackles on R (not\\n   rhonci), improved from earlier.  O2 titrated down to 3L NP w/sats in\\n   mid 90\\ns. Patient slept 3 hrs total.\\n   Plan:\\n   Check CXR, evaluate for CHF.  Treat hypertension.\\n   K 2.8 this am . Started to replete w/ 20mEq of a total of 60mEq KCL.\\n   Mg 1.6, ordered for repletion as well.   ABG\\ns this am were\\n   7.51/34/122/ w/base xs4. Last ABG\\ns yesterday after extubation were:\\n   7.48/32/108.  Patient more tachypneic today after flash pulmonary\\n   edema. CXR done.  Intern & resident covering aware.\\n',\n",
              "  'This 50 yr old woman was admitted [**4-9**] w/asthma exacerbation.\\n   Hospitalized 3X in past for asthma but no intubation.  Last\\n   hospitalized in [**2173-1-22**].  PMH: asthma/COPD, OSA (uses CPAP w/full face\\n   mask w/12 PEEP every night @ home), ulcerative colitis, depression,\\n   obesity, GERD, allergic rhinitis, HTN, excema.\\n   Asthma\\n   Assessment:\\n   Lung sounds: expiratory wheezes @ upper lungs, diminished @ bases.\\n   Nonproductive cough.\\n   Action:\\n   On CPAP w/12 PEEP & 4L NP overnight.  Had neb Tx q 6 hrs overnight.\\n   Response:\\n   RR 20\\ns.  Increases to low 30\\ns w/exertion.  O2 sat 94%\\n   Plan:\\n     To have IV solumedrol changed to po prednisone.  To be called out\\n   soon (as long as neb Tx\\ns aren\\nt more often than q 4 hrs).\\n   LBM [**4-8**].  Hx ulcerative colitis.  Given 100mg colace po & 1 senna po\\n   .  Had large golden formed BM [**4-11**].\\n   Foley D/C\\ned @ [**2094**] on [**4-10**].  Voided 200cc X2 since then.  Steady on\\n   feet. Needs commode next to bed. Needs assist w/wires/O2 & supervision.\\n   ------ Protected Section ------\\n   Patient has her period.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2173-4-11**] 06:40 ------\\n',\n",
              "  'This 87 yr old woman was living @ home w/24 hr care & home hospice.\\n   She used home O2 for her lung CA & COPD/emphysema.  Dx w/vascular\\n   dementia [**4-22**] during hospital stay, & it was deemed unsafe to leave her\\n   alone. PMH: DVT, marginal zone lymphoma, hemolytic anemia, GERD, hx\\n   asbestos exposure, oral HSV, hx pulmonary mycobacterium kansasii\\n   infection.   EMS called for MS changes over a few hrs.  Unresponsive on\\n   arrival to EW.  Became more responsive after 4L NS, levofloxacin\\n   &flagyl IV. Found large RLL PNA by CXR.  WBC 10.6.  Head CT -.\\n   T102.8R  HR 130\\ns-[**Street Address(2) 2463**]  RR 30\\ns-20\\ns on 100% nonrebreather w O2\\n   sats 94-97%.  [**First Name9 (NamePattern2) 5710**] [**First Name5 (NamePattern1) 167**] [**Last Name (NamePattern1) 5711**] (dtr) said mother wanted DNR/DNI &\\n   no central line.\\n   Came to [**Hospital Ward Name 51**] MICU on 100% nonrebreather w/tachypneic labored\\n   breathing.  O2 sats ranged 85-95%.  Best sats after leaving patient\\n   alone in room to rest.  ABG\\ns: 7.32/55 pO2/ 49 pCO2.  Put on\\n   noninvasive CPAP w/sats 92-94%.  NT Sx\\ned for undigested food in back\\n   of patient\\ns throat.  Needs to be NPO until speech & swallow evaluate\\n   her when she regains strength to swallow.\\n',\n",
              "  '79 yo Portuguese speaking male w/ a PMH significant for HTN, SBO &\\n   Alzheimers Dementia, admitted for aspiration PNA/Sepsis, he was\\n   intubated in the ED for hypoxic resp distress, and was transferred to\\n   M/SICU for further management.  He has remains on broad spectrum abx\\n   and his CXR shows evidence of chronic aspiration. His code status was\\n   confirmed as FULL after a discussion with his oldest son/HCP [**Name (NI) **].\\n   [**Name2 (NI) **] was extubated @ 1100 on  [**11-21**].\\n   Pneumonia, aspiration\\n   Assessment:\\n   Lungs: rhoncorous, diminished @ bases.  RR: 20\\ns   O2 sats 92% on room\\n   air,   94-99% on 35% cool neb, 95-100% on 2L NP.  Patient unable to\\n   take deep breaths or cough on command, even when asked in Portugese by\\n   his son.  [**Name (NI) 8**] have receptive as well as expressive aphasia.  WBC 8.7\\n   (10.8)\\n   Action:\\n   35% cool neb by tent mask reapplied to face frequently (patient removes\\n   it) to loosen secretions.  Turned frequently.  Kept HOB @ 30-45\\n   degrees.\\n   Response:\\n   Productive sounding spontaneous cough\\n   Plan:\\n   Continue pulmonary toilet.  Nasotrachially Sx patient if necessary.\\n   .H/O small bowel obstruction (Intestinal obstruction, SBO, including\\n   intussusception, adhesions)\\n   Assessment:\\n   Patient remains NPO until speech & swallow have seen him.  Colace (po)\\n   held. +Bowel sounds.  No recent flatus.  Soft,distended abdomen.  LBM:\\n   [**11-19**] @ home.\\n   Action:\\n   Given  dulcolax supp this am.\\n   Response:\\n   No BM yet.\\n   Plan:\\n   Speech & swallow consult Monday.  Consider lactulose once patient can\\n   take po, if no BM.\\n   Eyes are bloodshot & red.  No drainage.\\n   A few clots in foley, most likely from patient tugging @ catheter.  Hid\\n   foley so patient could not reach it.  Urine drained well, mostly clear.\\n   To be called out this am.\\n   ------ Protected Section ------\\n   Had 1 moderate brown formed BM @ 0600.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1534**] [**Last Name (NamePattern1) 3577**], RN\\n   on:[**2173-11-22**] 06:53 ------\\n',\n",
              "  'This is a 24 yr old woman who traveled to Camaroon in [**Month (only) **] ,\\n   contracted malaria, which was dx in [**Month (only) 8**] & confirmed in [**Month (only) 1646**].  She took\\n   no meds for malaria.  She was found unresponsive by boyfriend & went by\\n   ambulance to [**Hospital3 **] .  from there she was transferred to [**Hospital1 5**]\\n   EW.  She has +gag, but not strong.  She is here in MICU for possible\\n   intubation.  She will receive a variety of meds including vanco,\\n   acyclovir IV  & IV quinidine (continuous drip (per ID).  At [**Hospital1 **], she had a negative head CT, negative LP, & negative tox\\n   screen.\\n     Upon arrival to MICU, her eyes were open.  She was unable to obey\\n   commands.  She moved arms randomly &then  kept them tense & close to\\n   body.  She did not support her head w/her neck  muscles.  Her R leg was\\n   bent initially but straightened later.  L leg straight.    No\\n   tonic/clonic movement.  Patient placed on side for airway protection.\\n   BP stable.  Making\\nsnoring sounds\\n .  O2 sat 100% on 2L NP.  T99.3ax.\\n   Swallows on occasion.  HOB @ 30degrees.\\n   ------ Protected Section ------\\n   Vanco noted in IV intake @ 0645 actually given in EW @ 0510.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1534**] [**Last Name (NamePattern1) 3577**], RN\\n   on:[**2184-7-14**] 07:20 ------\\n',\n",
              "  'Pt is a 53 yo M with AML Day+333 s/p cord SCT. Admitted w/O2 sat 85%(2\\n   L), fever, chills& BP85/ on [**10-18**] to [**Hospital Unit Name 44**].   Readmitted to [**Wardname **] 4 MICU\\n   after few hours on floor evening of [**10-19**]: patient experienced rigors,\\n   acute respiratory distress approx 30 mins after Hickman cath was\\n   flushed-- Pt has bld cx pos for GNR.  Hickman removed [**10-19**]. Patient\\n   felt to have [**Doctor Last Name **]/early ARDS in addition to intrinsic lung dz (& fluid\\n   overload).  Uses 1.5-3L O2 @ home.   On contact precautions for\\n   possible resistant  stenotrophomonas in blood.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   BP& HR stable    T 99.1-99.6 po.\\n   Action:\\n   Received ceftazidime 2 GM IV (bid) & bactrim po (bid) for GNR in blood\\n   ( S to both).  Received voriconazole po for aspergillosis.  Sent\\n   surveillance BC w/am labs.\\n   Response:\\n   Tmax 99.6\\n   Plan:\\n   Monitor results of surveillance Cx.  Monitor temps.\\n   Hypoxemia\\n   Assessment:\\n   Lungs clear except for diminished breath sounds @ L base.  RR\\n   20-28        O2 sats 95-99% on 40% high flow neb & 3L NP.  Only desatts\\n   (to 82- 84%)  when he takes neb off to eat or urinate.  Achieved -1L\\n   goal in fluid balance after 40mg po lasix [**10-21**] am.\\n   Action:\\n   Given 2  atrovent & albuterol neb Tx\\nes  for coughing\\n   Response:\\n   O2 sats return to high 90\\ns% after high flow neb mask back on.\\n   Tolerates moving in bed well.\\n   Plan:\\n   Give 40mg po lasix in am.  Attempt to get patient OOB [**10-22**].\\n   .H/O renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 33 (31)   Cr 1.5 (1.4)   K4.3   Mg 1.9    Ca 7.5 (7.4)\\n   Action:\\n   Given lasix 40mg po yesterday\\n   Response:\\n   As above, slight increase in BUN & Cr\\n   Plan:\\n   Continue to follow BUN & Cr.\\n',\n",
              "  '40 y.o. F w/ metastatic Breast CA to liver, lungs, and brain & bones,\\n   dx\\nd initially in [**1-29**], who initially presented to [**Hospital3 519**] on\\n   [**5-20**] with dyspnea.  Found to have large R sided pleural effusion;\\n   transferred to [**Hospital1 5**] as this is where her oncologist is. Admitted to 7\\n   [**Hospital Ward Name 200**].  Overnight [**5-26**], had witnessed clonic tonic seizure on the\\n   floor with a PEA arrest requiring compressions but no IVP meds.\\n   Intubated for agonal breathing and transferred to the M/SICU.  Her ICU\\n   course has been complicated by multiple extubations/re-intubations, she\\n   was extubated on [**5-27**] @ the insistence of her HCP and she self extubated\\n   later that night both times requiring immediate re-intubation.  Had R\\n   posterior chest tube placed [**5-30**] to drain R malignant pleural effusion.\\n    On [**6-3**], CXR showed small R pleural effusion & moderate L pleural\\n   effusion.  PMH includes s/p bilateral mastectomy, malignant pericardial\\n   effusion, malignant pleural effusions.  As patient has failed chemo &\\n   radiation , she has a dismal prognosis.  Her husband [**Name (NI) 225**] has not\\n   truly accepted this.  She continues to be a full code.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 76**])\\n   Assessment:\\n   Was on CPAP @ 40% w/5 PEEP &15PS. Tidal volumes 285-420.   RR 12-30.\\n   With anxiety, RR up to 50 & shallow.  O2 sats 98-100%  Lungs: clear,\\n   diminished @ bases.  Afebrile.   WBC 7.4     R posterior chest tube now\\n   + for crepitus laterally towards patient\\ns back.  Drsg :D&I.  CT\\n   continues to drain serous fluid : 125cc over last 12 hrs.\\n   Action:\\n   Changed to 12 PS @ 2100.  Sx\\ned q 2-4 hrs for scant thick white\\n   secretions.  On zosyn IV q 6hrs only.  Weaned propofol IV off & started\\n   versed 1-2mg/hr for anxiety.  Held ativan.  Continues on fentanyl IV\\n   75-125mcg/hr & patch (25mcg/hr).\\n   Response:\\n   ABG\\ns: 7.42/42/121 on 12 PS.  By 0130, RR 20-40 w/Vt 260-320 & minute\\n   volume [**8-31**].\\n   Plan:\\n   Continue to wean PS as tolerated.  Titrate sedation to comfort &\\n   alertness.\\n   .H/O cancer (Malignant Neoplasm), Breast\\n   Assessment:\\n   C/o generalized discomfort.  Denied anxiety but displayed it in\\n   restlessness, increased HR & increased BP.  As patient became more\\n   anxious,husband\\ns anxiety escalated, making patient again more anxious.\\n   Action:\\n   IV fentanyl infused @ 75-125mcg/hr.  Fentanyl patch in place as above\\n   (25mcg/hr). IV versed infused @ 1-2mg/hr.\\n   Response:\\n   Patient rested well after husband left.  [**Name2 (NI) 222**] well controlled on\\n   fentanyl 75-100mcg/hr & fentanyl patch 25mcg/hr.  Anxiety improved\\n   overnight.\\n   Plan:\\n   Provide emotional support to patient & husband.  Continue to medicate\\n   w/fentanyl IV for pain as needed.\\n   F&E:\\n   Assessment: Na: 148(143) &  Cl: 111 (107)           BUN 31(31)   Cr 1.3\\n   (1.6)\\n   Action: NS @ KVO turned off between doses of zosyn.  Patient not being\\n   diuresed.\\n   Response: Cr improving.  Na elevated.\\n   Plan: Continue to follow BUN,Cr & electrolytes.   Avoid NaCl.  Use D5W\\n   instead.\\n   GI:\\n   Assessment: Patient having frequent nonfoul smelling loose brown\\n   stool.  +Bowel sounds.  15-25cc residual overnight.\\n   Action: Restarted tube feedings @ 2100 @ 15cc/hr.\\n   Response: After 4.5 hrs, residual was 25cc.\\n   Plan: Continue to titrate tube feedings up q 6hrs as long as residual\\n   remains<200cc.\\n   ------ Protected Section ------\\n   Addendum\\n   Respiratory: RSBI was 193 this am.  Fentanyl is presently @ 100mcg/hr &\\n   versed is @ 1mg/hr.  Patient looks comfortable.\\n   CA: Patient is scheduled for PICC placement in setting of B\\n   mastectomies.   Awaiting team to decide which side to have PICC placed.\\n   GI: Residual was 45cc @ 0600.  Would advance TF\\ns slowly.  Running @\\n   25cc/hr presently.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1534**] [**Last Name (NamePattern1) 3577**], RN\\n   on:[**2186-6-4**] 06:31 ------\\n',\n",
              "  '83 y/o M with PMH: HTN, CHF s/p R TKR complicated by septic joint, s/p\\n   washout and R gastronemious muscle graft to knee, who was transferred\\n   to the ICU on [**2188-4-10**] for hypoxic respiratory failure.\\n   Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name 11**])\\n   Assessment:\\n   Patient remained off ventilator on 70% trach collar  from 1700 on [**4-28**]\\n   to 0300 [**4-29**].  Coughing productively of thick yellow to brown\\n   secretions.  RR: [**8-23**]         O2 sats: 92-98% on 70% trach  collar.  O2\\n   sats 93-95% on CPAP.\\n   Action:\\n   Suctioned q 1-3 hrs for thick yellow secretions.\\n   Response:\\n    ABG\\ns @ midnight: 7.38/64 pCO2/75 pO2. Placed back on CPAP @ 0300 for\\n   desatting (85-92%)\\n   Plan:\\n   Take patient off vent later this am & place back on trach collar.\\n   Impaired Skin Integrity\\n   Assessment:\\n   L thigh STSG donor site is clean & healing.  Small amt serous drainage\\n   from small abrasion @ donor site, L thigh.  R knee had scant thin\\n   yellow drainage.  No purulence.   Scant redness @ trach suture site\\n   from irritation.\\n   Action:\\n   Dressings changed @ 0000 [**4-29**].\\n   Response:\\n   Afebrile.  No S&S infection.\\n   Plan:\\n   Continue to change dressings qd.\\n   Impaired Physical Mobility\\n   Assessment:\\n   Patient able to nod head & squeeze w/ both hands on command.  Able to\\n   grimace & show facial expressions.  Unable to move arms or legs.\\n   Action:\\n   Restarted CPM to R knee @ 45 degrees maximum for 2 hrs total from\\n   1900-2100  ([**4-28**]).\\n   Response:\\n   No bleeding @  R knee wound or dressing.  No c/o pain.\\n   Plan:\\n   Team will re-evaluate for continued use of CPM this ([**4-29**]) am.\\n   Arousal, Attention, and Cognition, Impaired\\n   Assessment:\\n   Patient answers questions appropriately w/nods &  facial expressions.\\n   Action:\\n   Patient obeyed commands consistently when asked to squeeze hands or\\n   open mouth.  Procedures explained to patient before performing them.\\n   Patient eyes were open until he fell asleep.  Has fentanyl patch for\\n   pain control.\\n   Response:\\n   Patient is alert & appropriate.  No c/o pain.\\n   Plan:\\n   Continue to evaluate  mental status level.  Continue to assess for\\n   pain.\\n   ------ Protected Section ------\\n   ABG\\ns (0600) on CPAP @ 50% w/5 PEEP & 8 PS were: 7.37/60/72.  Hct was\\n   25.1 this am after receiving 1 unit PC\\ns [**4-28**] for earlier Hct of 22.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2188-4-29**] 06:29 ------\\n',\n",
              "  'Pneumonia, bacterial, ventilator acquired (VAP)\\n   Assessment:\\n   Afebrile.  Sx\\ned in-line for small amts thick white secretions q 4\\n   hrs. Orally Sx\\ned for moderate amts clear secretions.\\n   Action:\\n   Vanco D/C\\ned (finished 2 week course).\\n   Response:\\n   No changes. Remains afebrile.\\n   Plan:\\n   Cont VAP prevention w/oral care q 4 hrs. Cont HOB>30 degrees.\\n   Tracheobronchomalacia (tracheomalacia, bronchomalacia)\\n   Assessment:\\n   Continued on A/C 50%/500 Vt/12 RR/. PEEP increased overnight from 5 to\\n   8.   ABG overnight was 7.35/78 pO2/69 pCO2.\\n   Action:\\n   Decreased sedation  in the hope of changing to CPAP w/PS this am.\\n   Response:\\n   Biting ET & coughing producing facial cyanosis.\\n   Plan:\\n   Bolus sedation for biting ET & to reduce coughing episodes.\\n',\n",
              "  \"Admitted from [**Hospital3 213**] with fever, worse resp distress past 24\\n   hrs.  PMH sig for dementia, recurrent asp PNA, S/P G-tube placement\\n   [**2-28**], SZ, depression, osteoarthritis, , chronic hypernatremia, MSSA\\n   bacteremia, In EW temp 102.6 125/70, RR 30's. HR 90's-100 SR, ST. Sats\\n   94% on NRB.  Lactate 3.8, WBC 18.6  Able to wean to 6L NP in EW.\\n   Transferred to [**Hospital Ward Name 51**] 4 for further management.   R/o\\ned for the flu.\\n   Pt has DNR order.  Would be intubated and started on pressors\\nclarified\\n   with HCP.\\n   Airway, Inability to Protect (Risk for Aspiration, Altered Gag, Airway\\n   Clearance, Cough)\\n   Assessment:\\n   Patient has no gag reflex & unable to cough secretions up.\\n   Action:\\n   HOB remained @ 30 degrees.  Mouth care given q 4 hrs.\\n   Response:\\n   Patient remains NPO except for meds & free water boluses qid  per PEG\\n   Plan:\\n   Continue aspiration precautions & VAP prevention.\\n   Aspiration pneumonia\\n   Assessment:\\n    Lactate: 3.4 ( down from 3.8) @ [**2186**].        Afebrile.\\n   Action:\\n   Received linazolid IV, zosyn IV & cipro IV.   NT suctioned q 2-5 hrs\\n   for small to moderate amount of thick yellow secretions.  Started\\n   humidified O2 via tent mask to loosen secretions.\\n   Response:\\n   Lung sounds are rhoncorous @ upper lobes & diminished @ bases before\\n   being suctioned.  He had expiratory wheezes after being suctioned.\\n   Plan:\\n   Continue NT suctioning as needed.     Consider starting CPT.\\n   Impaired Skin Integrity\\n   Assessment:\\n    Heel pressure ulcer 1X 0.5 cm. Surrounding tissue -2cm by 2cm. is\\n   reddened though blanchable, only area of 1cm by 0.5cm is purple,non\\n   blanchable\\n    Excoriated coccyx, both gluteal muscles,and upper portion of posterior\\n   aspect of thighs,  Tissue is purple to reddened. All areas are\\n   blanchable.\\n   Perianal area with  various areas of excoriation\\n   Action:\\n   Aloe vesta applied to all affected areas as well as dry skin.   Waffle\\n   boots on.  Pillows to protect bony prominences such as knees.\\n   Response:\\n   No change\\n   Plan:\\n   Turn  side to side frequently.   Monitor skin.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP: 91-129/49-66  MAP: 62-71\\n   Action:\\n   Received 2L D51/2NS @ 150cc/hr.\\n   Response:\\n   U/o: 60-70cc/hr\\n   Plan:\\n   Keep sBP>90/  & MAP>60.\\n   Dementia (including Alzheimer's, Multi Infarct)\\n   Assessment:\\n   Patient is verbal w/monosyllabic responses. Contracted.  Only lifts\\n   arms off bed. No movement yet in legs.  Allows himself to be NT\\n   suctioned w/out moving head or touching catheter.    Hx of severe\\n   dementia.\\n   Action:\\n   Bed alarm on.  Curtains pulled back in order to observe patient @ all\\n   times.\\n   Response:\\n   Unchanged.\\n   Plan:\\n   Orient patient  frequently.\\n   Patient has R midline only that is leaking serosanguinous fluid from\\n   exit site.  Seen by IV RN @ [**2186**].  Requested new peripheral be placed &\\n   IV nurse said she would & none placed, perhaps unable to place.  Unable\\n   to draw labs this am  as patient has very  small fragile veins, as well\\n   as being contracted.\\n\",\n",
              "  '[**Age over 90 **]yo male with pmh HTN, COPD with asbestosis, CAD (hx MI), who\\n   presented with new hypoxic episode with likely aspiration event in\\n   setting of hemoptysis vs GI bleed.  Persistent elevated INR in setting\\n   of coumadin use for PAF @ home.    Hx of endotracheal bleed seen on\\n   bronch RUL [**8-7**].  No further bleeding until [**8-9**] @ 0700 when ~150cc frank\\n   red blood suctioned from ET tube.  [**8-9**] INR 2.2  Given 2 units FFP &\\n   vitamin K, w/drop in INR to 1.5.  Differential dx for pulmonary\\n   bleeding includes lung mass (CA) --not visualized, TB\\nPPD negative,\\n   1^st AFB negative & 2^nd AFB (sent [**8-8**]) preliminary results negative.\\n   3^rd AFB sent [**8-9**]-pending.  Patient on contact precautions (MRSA, +\\n   screen on admission) as well as respiratory isolation.  Patient remains\\n   DNR.\\n   .H/O respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Patient remained on CPAP @ 40% w/5 PEEP & 10 PS.  O2 sats: 100%  RR:\\n   [**10-24**]  Has CHF on top of COPD/emphysema, asbestosis, ? PNA.\\n   Action:\\n   Patient was suctioned X 1for 5cc old blood.  Tube feeding was turned\\n   off @ midnight so that patient could be extubated today.  Sedated on\\n   40-50mcg/kg/min propofol.\\n   Response:\\n   ABG\\ns @ 0200: 7.38/54/82 a little changed from [**8-9**] am: 7.36/52/90.\\n   Plan:\\n   Extubate today following SBT.   Daughter, [**Name (NI) **], requested that a family\\n   member be present during extubation.\\n   .H/O hypertension, benign\\n   Assessment:\\n   BP very labile: ranging transiently from 270/80\\ns while agitated during\\n   turning & mouth care, to 190/systolic necessitating increase of\\n   propofol, to 103/systolic while sleeping.  HR: 60\\ns-70\\ns SR no ectopy\\n   Action:\\n   Increased propofol to 50mcg/kg/min  & given boluses for elevated BP.\\n   Response:\\n   BP dropped to 103/44 MAP 62  while sleeping.  HR:45-50\\ns SB\\n   w/0-1pvc/min on 45-50mcg/kg/min propofol.  Decreased propofol to\\n   40mcg/kg/min to increase BP to 110\\ns/systolic.  HR: 48-50\\ns SB.\\n   Plan:\\n   Patient may need anti-anxiety med pre-extubation  when propofol turned\\n   off.\\n   Coagulopathy\\n   Assessment:\\n   Hct 30.7, little changed from [**8-9**] am Hct of 30.8.      INR 1.4\\n   (1.5)        PT 15.5 (16.9)\\n   Action:\\n   Continue to monitor Hct & INR.\\n   Response:\\n   Hct stable.  INR continues to slowly return to normal.\\n   Plan:\\n   Transfuse for Hct<27.\\n   Constipation (Obstipation, FOS)\\n   Assessment:\\n   No evidence of BM since admission on [**8-5**] (X 5 days).\\n   Action:\\n   Started on colace & senna [**Hospital1 **].  Given dulcolax suppository @ [**2190**] [**8-9**].\\n   Response:\\n   No BM from dulcolax.  Given 30cc lactulose per OGT @ 0200.  No results\\n   @ this time.\\n   Plan:\\n   Give lactulose 30cc q 8hrs until BM achieved.  Continue to give colace\\n   & senna.\\n   ------ Protected Section ------\\n   RSBI was 89 this am , up from 33 yesterday.  Turned propofol off for\\n   5min during RSBI.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2199-8-10**] 05:03 ------\\n   Spoke to daughter, [**Name (NI) **], who was asked to come in between 1000 & 1100\\n   am.  She will ask other members of her family to come @ that time as\\n   well.\\n   Patient had liquid light brown guiac negative stool @ 0600.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2199-8-10**] 06:12 ------\\n',\n",
              "  '84 y/o M with high grade cardiac lymphoma, s/p 2nd cycle R-[**Hospital1 988**]\\n   3/16-27/09 and DVT w/ IVC filter transferred from OSH ED after he\\n   became acutely short of breath while visitng home from his rehab. Per\\n   his family,  SOB x2 days and worsening lower extremity edema. At the\\n   OSH ED, he was intubated on arrival, received solumedrol for concern of\\n   COPD exacerbation for wheezing. After CXR revealed findings concerning\\n   for acute heart failure, he received nitropaste and lasix and his\\n   pressures dropped requiring a dopamine gtt and he was transferred to\\n   [**Hospital1 5**] ED.  CTA Chest neg for PE that showed a LLL infiltrate.\\n   .\\n    A right IJ triple lumen was placed; blood cultures were sent x2. Pt\\n   was extubated on [**2-24**] and became initially dyspneic, flashed, treated\\n   with bipap and iv lasix, diuresing very well. Was taken off bipap by\\n   2pm [**2-24**] and placed on cool neb, w/initial dyspnea w/movement.   Did\\n   very well with little dyspnea [**2-25**].\\n   Presumed sepsis from pulmonary source versus PICC line.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 76**])\\n   Assessment:\\n   Lungs: diminished throughout.  RR: 22-34   O2 sats 98-100% on 4L NP &\\n   95-96% on 2L NP overnight.  Patient refused humidified O2 via mask.\\n   U/o 40-100+ cc/hr.  Tolerated head of bed down w/turning w/out SOB.\\n   Action:\\n   Received neb Tx X1 per patient request before bedtime.\\n   Response:\\n   Autodiuresing as above.  Not requiring neb Tx\\nes as frequently.  No\\n   wheezing noted.\\n   Plan:\\n   Transfer to floor soon.  ABG\\ns to be drawn  by intern\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   PICC line tip from [**2-24**] Cx: negative.  All other Cx\\ns from [**2-24**] negative\\n   or pending.  WBC: 10.4 (13.3)\\n   Action:\\n   Continues on IV vanco & zosyn\\n   Response:\\n   Continues to be afebrile, BP stable.\\n   Plan:\\n   Continue to check Cx results.\\n   No BM X3 days.   NPO X 2 days.   Started on colace & senna (in prn\\n   section of [**Month (only) **]) [**2-25**] evening.\\n   CVP: [**1-22**]\\n'],\n",
              " 2: ['Diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS 111-155.  Finished 120cc custard  by 2100.\\n   Action:\\n   Checked FS q 3-4 hrs\\n   Response:\\n   Insulin on hold. No need for D50 @ this time.\\n   Plan:\\n   Continue to check FS q 2-4 hrs.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Patient experienced another acute episode of SOB @ 00 w/RR up to 35. O2\\n   sat dropped to 90% on 5L NP. HR increased to 127 ST  during albuterol\\n   Tx.   BP increased to 207/ systolic during albuterol Tx. Diaphoretic.\\n   LUL wheezes, crackles @ bases & diminished breath sounds in all areas\\n   except RUL.\\n   Action:\\n   Given abuterol neb Tx, 1\\n NTP, 40mg IV lasix, & 2mg IV morphine. EKG\\n   done.\\n   Response:\\n   HR dropped to high 90\\ns SR, BP dropped to 90\\ns/systolic requiring\\n   removal of NTP, RR dropped to 20\\ns, sats came up to 93-97% on 6L NP.\\n   EKG showed no acute changes per intern. Lungs sounds returned to clear\\n   @ upper lungs & diminished @ bases.\\n   Plan:\\n   Continue to assess respiratory status.  Do EKG prn SOB/resp distress.\\n   Try\\n  NTP next time.\\n   This 83 yr old man was admitted w/hypoglycemia & associated MS changes\\n   after recent dx  DM type 2. PMH includes L hemidiaphragm paralysis, HTN\\n   & stage IV  adenocarcinoma . However may have 2 cancers, a primary\\n   hepatocellular  carcinoma & another CA that metastasized to liver &\\n   colon.  Prognosis is poor.\\n     Extubated [**1-29**].  Has had episodes of SOB & respiratory distress,\\n   probably from pulmonary edema [**Date range (1) 1106**]. Treated w/NTP,albuterol neb\\n   Tx, & IV lasix.  Passed swallow eval [**1-30**].\\n     Retired, divorced parent of 5 children.  Emigrated from [**University/College 1107**] 35\\n   yrs ago. Spanish speaking.  Lives alone in retirement community. Will\\n   need placement  upon discharge, either rehab, nursing home or hospice.\\n   Daughter, who works part-time, has 3 children @ home, & plans to have B\\n   carpal tunnel surgery in near future, wants to take her father home &\\n   care for him.  Her husband is in Bolivia caring for his parent.\\n     Plan: Colonoscopy when more stable. Patient is full code.\\n',\n",
              "  'Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name **])\\n   Assessment:\\n   Patient continues on APRV @ FiO2 70% overnight.   Dropped FiO2 to 70%\\n   @ 1800 [**2-28**].  O2 sats 89-94%. ABG\\ns show SaO2 91-92% w/pO2 65-68/pCO2\\n   51-52/pH 7.39-7.40. Lungs:clear, clear to diminished @ bases.\\n   Action:\\n   Triadyne  rotation turned off until O2 sats came up to 91% -94%\\n   Response:\\n   O2 sats stable @ 93% on rotation via Triadyne bed. ABG\\ns good @ 0600 @\\n   7.41/51/77.\\n   Plan:\\n   Give 100% O2 & bolus sedation w/turning for back care.\\n   Ineffective Coping\\n   Assessment:\\n   Husband said he didn\\nt know what to do about a trach for his wife, or\\n   plan for her care.  He said the patient never said she didn\\nt want a\\n   trach.  He said that he & his wife made a pact before her aneurysm\\n   repair.  He said she was afraid of ending up physically & mentally\\n   impaired, so they agreed that he would not let that happen.\\n   Action:\\n   Family meeting scheduled for 1500.  Encouraged patient to speak to\\n   minister/priest/rabbi about  issues raised.\\n   Response:\\n   Husband said he would be present for family meeting.\\n   Plan:\\n   Provide emotional support. Encourage husband to allow patient\\ns other\\n   close family members to be part of the  process, even if it  is just\\n   informational.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Patient was only negative for 724cc on [**2-28**] on 4mg lasix/hr.\\n   Goal:1-2L  negative/day.\\n   Action:\\n   Increased IV lasix to 5mg/hr starting @ midnight.\\n   Response:\\n   Patient is negative 300cc today @ 0600 so far.\\n   Plan:\\n   Continue on lasix IV @ 5mg/hr unless u/o decreases.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP 105/53-130/66 MAP 72-91\\n   Action:\\n   Remains on vasopressin 2.4units/hr. Titrated levophed down from\\n   0.03mcg/kg/min to  0.01mcg/kg/min.\\n   Response:\\n   MAP remains >65 & systolic BP remains>100/. Shut off vasopressin &\\n   levophed for 60seconds & BP dropped to 90/systolic, & came back up w/in\\n   60 seconds to 100/systolic.\\n   Plan:\\n   Slowly titrate levophed down & off as BP allows\\n   Constipation (Obstipation, FOS)\\n   Assessment:\\n   Patient continues to have soft distended abdomen w/hypoactive bowel\\n   sounds .  Last BM: 3 large BM\\ns [**2-23**], 75cc stool out [**2-24**] & 50cc stool\\n   out [**2-26**].  Last tube feed on [**2-22**].  Stools negative for C-diff X3.\\n   Action:\\n   Continued to rest gut.\\n   Response:\\n   Bowel distension decreasing per x-ray.  Ileus resolving.\\n   Plan:\\n   Continue to give IV flagyl until toxin B (C-diff) comes back, per ID.\\n   Fracture, other\\n   Assessment:\\n   R DP & PT easily palpable. Color of R foot normal.  Unable to assess\\n   sensation or movement due to sedation for  ARDS.  R leg splint\\n   re-applied to leg.\\n   Action:\\n   DSD  to R ankle changed.\\n   Response:\\n   Staple lines on either side of R ankle well approximated & healed. No\\n   redness. Cleaned staple lines w/NS.\\n   Plan:\\n   Call ortho to remove staples.\\n   This 52 yr old woman w/PMH cerebral aneurysm repair &\\n   hyperfibrinolysis  syndrome was admitted [**2-1**] for ORIF R ankle [**2-2**].\\n   Developed influenza A while in the hospital & pneumonia. Transferred to\\n   the [**Hospital Ward Name 51**] MICU [**2-10**] w/SOB & worsening respiratory status.  Intubated\\n   [**2-13**] for respiratory failure/ARDS.  Difficult to ventilate due to ARDS.\\n   Placed on APRV.   Received NMB [**Date range (1) 1723**].\\n   On pressors: levophed since [**2-22**] & vasopressin since [**2-23**].  Treated\\n   w/broad spectrum abx.  Now on IV linezolid & flagyl & levofoxacin.\\n   Caspofungin D/C\\ned ( transaminitis), & Aztreonam D/C\\ned.   Vanco po,PR\\n   & IV D/C\\ned for C-diff negative stools.\\n',\n",
              "  'Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name **])\\n   Assessment:\\n   O2 sats 92-96%.  On 70mcg propofol  & 100-150mcg/hr fentanyl.\\n   Action:\\n   Continues on pressure controlled ventilation.  fiO2 60%/PEEP14/ RR24\\n   Response:\\n   ABG\\ns [**3-5**]: 7.33/65/71 On [**3-6**] am, ABG\\ns 7.30/70/90\\n   Plan:\\n   Switch sedation from propofol IV to ativan per NG& fentanyl IV to\\n   methadone IV.  Follow ABG\\ns. Given 1mg IV Ativan for dysysnchronous\\n   breathing producing increased CO2 retention.\\n   Constipation (Obstipation, FOS)\\n   Assessment:\\n   Hypoactive bowel sounds. Soft abdomen. Remained NPO until 0200.\\n   Action:\\n   Received 2mg ativan per NG & 15Gm kayexelate @ 0200\\n   Response:\\n   Still w/very hypoactive bowel sounds, although abdomen remains soft.\\n   Plan:\\n   Check w/pharmacy about giving Ativan IV instead of per NGT.\\n   Hypotension (not Shock)\\n   Assessment:\\n   SBP 90\\ns-130/sys.\\n   Action:\\n   Remains on levophed 0.06-0.12 mcg/kg/min.  Off vasopressin.\\n   Response:\\n   BP remained >100/sys overnight.\\n   Plan:\\n   Keep BP>100sys & MAP>65.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   K5.5-5.6.   TPN found to have 200mEq in bag. Patient received 50 mEq\\n   this evening.  Lasix has been off since this morning.\\n   Action:\\n   TPN stopped.  D10 w/amino acids & multivits hung overnight.  Given 15Gm\\n   kayexelate per NG.\\n   Response:\\n   Serum K w/am labs: 5.7\\n   Plan:\\n   Deplete KCl from TPN.\\n   Called ortho to D/C staples. One staple line pink from irritation of\\n   wearing splint.  Will try to call ortho again this later (after 7a) am.\\n',\n",
              "  'This 63 yr old man was transferred from 5 South w/hypoxia from\\n   pulmonary edema (confirmed by CXR), after undergoing a laparoscopic\\n   sigmoid colectomy & umbilical hernia repair on [**1-28**].  PMH:DM2, HTN, OSA\\n   on CPAP @ home, ETOH abuse, depression & obesity.\\n   Hypoxemia\\n   Assessment:\\n   Patient slowly increased his O2 sats from 89 to 99% on 100% NRB.\\n   Patient relaxed, not anxious or restless.  K3.8  Mg 2.7  Desatted to\\n   87% during neb Tx @ 0600.\\n   Action:\\n   Monitored u/o\\n   Response:\\n   Foley drained >1L since arrival @ 0035. (Received 160mg IV lasix before\\n   leaving the floor)\\n   Plan:\\n   Givin 80mg IV lasix @ 0630.  Change to high flow neb later in day when\\n   respiratory status improves.\\n   .H/O alcohol abuse\\n   Assessment:\\n   Patient said he drank 4-6 beers/day.\\n   Action:\\n   1mg ativan prn CIWA>10\\n   Response:\\n   CIWA remains <10.\\n   Plan:\\n   Monitor CIWA q 2 hrs\\n   .H/O hypertension, benign\\n   Assessment:\\n   Patient arrivaed w/BP 187/systolic & HR : [**Street Address(2) 1592**]\\n   Action:\\n   Received 10mg IV lopressor q 6 hrs & 20mg hydralazine IV q 6 hrs.\\n   Response:\\n   BP dropped as low as 132/ystolic, then slowly came back up.\\n   Plan:\\n   Continue to medicate w/antihypertensives\\n   .H/O diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS 198 upon arrival.  NPO.\\n   Action:\\n   Covered w/sliding scale\\n   Response:\\n   Plan:\\n   Continue to check FS q 6 hrs & cover w/SS\\n   Cancer (Malignant Neoplasm), Colorectal (Colon Cancer): Postop sigmoid\\n   colectomy\\n   Assessment:\\n    Incision near umbilicus: clean & healing w/DSD D&I.  Area around\\n   incision is pink, thought to be bruise by member of surgery team.  DSD\\n   to JP exit site @ LLQ is  D&I.    JP drained 10cc serosanguinous\\n   fluid.  + Bowel sounds.\\n Flatus.  Kept NPO.\\n   Action:\\n   No c/o pain.\\n   Response:\\n   Has dilaudid PCA (0.25mg/ 6 min/ 2.5mg), used once sonce arrival..\\n   Only has pain w/movement.\\n   Plan:\\n   Monitor need for PCA.\\n',\n",
              "  '76 yo F w/chronic resp failure on vent, sz d/o, and recent progressive\\n   neurologic decline of unclear [**Name2 (NI) 2663**] admitted following tube feed\\n   aspiration and witnessed sz w/ altered mental status and hypoxemia.\\n   Coourse complicated by\\n   non-convulsive status epilepticus, MOSF with hypotension, requiring\\n   pressors, recurrent VAP, progressive ARF w/ anasarca, presumed PE,\\n   sepsis\\n   .H/O seizure, with status epilepticus\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP ranged from 84/44 MAP 53  to 133/57 MAP 76.  Lactate down to 4.4\\n   from 7.9 yesterday.  WBC 22.9 (15.8).\\n   Action:\\n   Titrated levophed 0.10-0.3 mcg/kg/hr  & dopamine 2.5-4 mcg/kg/hr to\\n   keep MAP>60\\n   Response:\\n   MAP remained >60 for most of the night\\n   Plan:\\n   Will not add other pressors.   Keep MAP>60.\\n   Seizure, without status epilepticus\\n   Assessment:\\n   No S&S Sz activity.  No movement.  Muscles flaccid.  No response to\\n   sternal rub, or care.\\n   Action:\\n   Remains on continuous pentobarb gtt, intermittent valproate, keppra &\\n   dilantin given as well.\\n   Response:\\n   Remains on continuous EEG monitoring w/video.\\n   Plan:\\n   Assess for Sz activity.  Monitor medication levels.\\n   Ineffective [**Name2 (NI) 2858**]\\n   Assessment:\\n   Both sons in & [**Name2 (NI) 2859**] of room all night visiting mother.\\n   Action:\\n   [**Name2 (NI) 2860**] goals of care to [**Doctor Last Name 2429**].  Priest came by to bless patient ,\\n   sons responded well to him.\\n   Response:\\n   [**Doctor Last Name 2429**] understood.  [**Doctor Last Name 435**] focused on patient keeping her scapula in her\\n   hand.\\n   Plan:\\n   Assess [**First Name7 (NamePattern1) 435**]\\n[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] when patient passes.  Assess possibility if priest\\n   could come @ that time.  Encourage [**Doctor Last Name 435**] to identify his support\\n   system.   Contact security if needed.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Patient  maintained on CVVH since 0430  [**5-8**].  Patient dependent on\\n   CVVH for treatment of acidosis & fluid balance ( so as not to\\n   accumulate more fluid ).  Venous pH 7.18-7.20 (from 7.11 earlier).  BUN\\n   39 (48) & Cr 1.5 (1.9).  LFT\\ns WNL.\\n   Action:\\n   Attempted to keep patient even, removing fluid given w/medications\\n   overnight.  Titrated levophed to do so.\\n   Response:\\n   Emptied 300cc urine (actually 400cc, assumed 100cc given w/bladder\\n   pressure).\\n   Plan:\\n   Continue CVVH as BP tolerates.\\n   Alteration in Elimination Related to Constipation\\n   Assessment:\\n   Patient has absent bowel sounds, a firm & distended abdomen.\\n   Action:\\n   Kept NPO, PEG to gravity, draining small amt brown fluid.  Had smear of\\n   brown loose stool @ rectum @ 0400.\\n   Response:\\n   Has ileus from excessive edema.\\n   Plan:\\n   Give meds IV.  Check for bowel sounds.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Patient has anasarca, weeping edema fluid from any opening in her\\n   skin.  Also has stage 1 @ coccyx.\\n   Action:\\n   PICC drsg [**Name5 (PTitle) 917**] X2, used absorbent IV drsg .  Applied barrier cream\\n   to stage 1.\\n   Response:\\n   Patient continues to saturate pads under arms  & buttocks.\\n   Plan:\\n   Try softsorb to arms.\\n',\n",
              "  'Mrs. [**Known lastname 6512**] is a 65 yo woman with hx myasthenia [**Last Name (un) **] and stroke.\\n   Baseline she has lower extremity weakness and uses a walker at home.\\n   After her stroke in [**2121**] she had a prolonged hospitalization requiring\\n   intubation, trach and 9 weeks in rehab. [**3-26**] she underwent endovascular\\n   repair of AAA and R common femoral artery angioplasty. She was\\n   transferred [**3-31**] from vicu for worsening resp status secondary to\\n   Myasthenia [**Last Name (un) 249**] flare, now with worsening weakness had need for\\n   intubation tansiently in the setting of increased secretions.  She was\\n   extubated [**4-2**] with continued improvement in NIF, until [**4-3**] @ MN when\\n   CO2 66, pt C/O fatigue, and NIF-25. She was reintubated, sedated, Foley\\n   cath reinserted.\\n   Airway, Inability to Protect (Risk for Aspiration, Altered Gag, Airway\\n   Clearance, Cough)\\n   Assessment:\\n   Patient remained on A/C @40% 550 Vt /RR 18/ 5 PEEP overnight.  O2 sats\\n   remained 98-99%.   Suctioned many times for copious amounts of thin\\n   white secretions.  Alert &  awake on versed 5mg/hr & fentanyl\\n   100mcg/hr.   K3.6  Ordered for 60mEq KCl per OGT.  Mg 1.8, ordered for\\n   20mEq IV mag sulfate.\\n   Action:\\n   Given 10mg IV lasix @ 2230 w/negative fluid balance [**4-7**] by 721cc &\\n   negative fluid balance [**4-8**] by 638cc @ 0600.   Continues on diamox per\\n   OGT 500mg q 8 hrs ( for elevated serum HCO3).   Continues to be alert\\n   on 5mg IV versed/hr & 100mcg IV fentanyl/hr.  Hydralazine held @ 0600\\n   for BP 90\\ns/systolic @0500-0530.\\n   Response:\\n   HCO3 this am: 35 (no change)\\n   Plan:\\n   Attempt to extubate after pheresis Tx today.\\n',\n",
              "  \"Pt lives in nursing home with a chronic trach x 1 year.  History of\\n   COPD.  Not vent dependent.  Currently with passy-muir valve.  Over the\\n   past 2 days pt has lost appetite and has had sats in 70's-80's on RA.\\n   Required more suctioning.  Presented to ED today.  Found to have RML\\n   PNA and partial lung collapse.  BNP WNL.   Received 1 g Vanco, 2mg IV\\n   Morphine, 4.5g Zosyn, and 300ml NS.  VSS.  Transferred to [**Hospital Ward Name 51**] for\\n   further management on 4LNC.\\n   [**Last Name **] Problem\\n Impaired gas exchange\\n   Assessment:\\n   RR 16-26  O2 sats: 83-98%    ABG\\ns @ 1900: 7.26/ 86 pCO2/ 76 pO2\\n   Patient suctioned himself every 2-4 hrs for a moderate amount of thick\\n   yellow secretions.\\n   Action:\\n   On 4L NP & humidified O2 @ 40% via trach collar.  Received Albuterol &\\n   atrovent neb Tx\\ns q 4 hrs.  Received vanco IV & meropenum IV via #20\\n   PIV.\\n   Response:\\n   ABG\\ns ([**5-8**]) 0100: 7.26/ 82 pCO2/ 81 pO2  Overnight, patient desatted\\n   down to 83% while asleep lying back & later to 85% sitting up in\\n   cardiac chair.  Easily aroused & Sx\\ned.  Did not occur again.\\n   Plan:\\n   Patient will need larger cuffed trach if he is to be placed on CPAP\\n   overnight.  Team will evaluate him for this  in am.      PICC ordered\\n   to be placed for abx (vanco & meropenum)  today.\\n   GI: LBM: [**5-6**].  Given prn senna as well as colace.  No problems taking\\n   [**Name2 (NI) **]\\n   Pain:  Patient preferred 2 percocet (q6 hrs prn) for pain but said it\\n   was infeffective alone.   Also received 2 mg po dilaudid  (q 8 hrs\\n   prn)  5 hrs after first percocet given, and 3 hrs after 2^nd dose of\\n   percocet given.   See [**Month (only) **] for details.  Patient c/o back pain.  Said he\\n   sneezed in past & broke upper back.\\n   CV: Cardiac enzymes negative per intern (troponin <0.01). Hemolized\\n   specimen @ 0100.  EKG done [**5-7**].  Patient says he has chronic\\n   tachycardia.  HR dropped to 90\\ns SR while sleeping.\\n\",\n",
              "  '69 y/o M pmh sig for CAD s/p MI, bladder CA s/p cystoectomy with\\n   neobladder formation in [**2-24**], presents [**10-21**] for revision of urethral\\n   stents, planned as outpt, procedural complicated by calcifications, in\\n   PACU found to have HR up to 180s afib c rvr, bp down to 70s systolic,\\n   given neo and metoprolol and transferred to MICU, here received dilt\\n   and metoprolol and was loaded with amiodarone and started on gtt,\\n   continued on neo for hypotension, CVL placed. Neo changed to levophed\\n   and vassopressin\\n   Hypotension (not Shock)\\n   Assessment:\\n   Sbp 84/-130/ cvp 5-13 lungs clear crackles at bases denies sob but resp\\n   rate 25-44 o2 sats > 93%\\n   .\\n   Action:\\n   Continues on levophed .3mg/kg/hr and vasopressin 2.4u. given total of\\n   1.5 liters of NS for cvp <6\\n   Response:\\n   Urine output improved with fluid gtts unable to wean at present\\n   Plan:\\n   Continue to monitor closely, titrate pressors to sbp 90/, give fluid\\n   low cvp monitor closely signs of chf\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR 80-113 afib occasional PVC\\n   Action:\\n   On aminodarone gtt .5mg/min\\n   Response:\\n   Continues in AF more rate controlled\\n   Plan:\\n   Continue on .5mg gtt x 18hrs then give po\\n   Delirium / confusion\\n   Assessment:\\n   Patient alert oriented x3, very restless moving constantly sitting up\\n   on side of the bed. Stating that his arthritis is killing him and he\\n   needs to move\\n   Action:\\n   Given morphine 2mg IV\\n   Response:\\n   No change in restlessness or pain\\n   Plan:\\n   ? trying  ativan, haldol or zyprexa needs someone with him for safety\\n   bed alarm on\\n   Sepsis, Severe (with organ dysfunction)\\n   Assessment:\\n   Wbc 29.7 then 25.4  temp max 101.4 po on two pressors venous ph 7.25\\n   lactate 3.4\\n   Action:\\n   Antibx flagyl, zoysn and linezold, vanco po. On levophed and\\n   vassopressin\\n   Response:\\n   Sbp > 84/ with maps > 60\\n      Plan:\\n   Continue antibx as ordered, await bld cx, monitor temp and wbc\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Cr 3.7-4.3 u/o > 30cc qhr cvp >10 . urine bloody with clots. K+\\n   increased 5.4 ekg unchanged\\n   Action:\\n   Given fluid bolus low cvp low urine output, flushed q 3-4hrs\\n   Response:\\n   Urine output > 30cc\\n   Plan:\\n   Monitor closely, monitor cr, lytes, urine lytes sent, u/o hrly, flush\\n   foley prn\\n',\n",
              "  \"84 yr old woman  w/Hx of HTN.TIA, Dementia, hypothyroidism, hx [**Doctor Last Name 3691**]\\n   disease.   Admitted to [**Hospital Unit Name 4**] w/hypotension with systolic 84-88/,\\n   inability to obtain oxygen saturation, irregular breathing patterns,\\n   and hypoxia on ABG (pO2 65) from 11R.\\n   Hypoxemia\\n   Assessment:\\n   O2 sats: 94-99% on 4L NP[**MD Number(3) 6800**]: clear w/diminished breath sounds\\n   @ dependent base.\\n   Action:\\n   CXR showed pulmonary edema.  Given 20mg IV Lasix @ 2145.\\n   Response:\\n   O2 sats 93-97% on 2L NP[**MD Number(3) 4928**] awake.    O2 sats on 2L while asleep:\\n   87-95% on room air.\\n   Plan:\\n   Increased O2 to 4L NP[**MD Number(3) 4928**] asleep.    Restrain arms if necessary if O2\\n   sats drop significantly.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP 92-110/52-78 until 0100, when she dropped to 81-88/51 w/MAP 60.\\n   U/o was low @ 15cc over 2 hrs @ 1900.  Given 20mg IV lasix & u/o\\n   increased to 30cc or > X4 hrs.  Then it dropped to 15cc X2, then 10cc,\\n   then 5cc.\\n   Action:\\n   Given 250cc NS bolus @ 0410 for BP 77/sys w/ post BP 81/sys.\\n   Response:\\n   Given 12.5Gm (25%) albumin followed by 10mg IV lasix after 30min.  BP\\n   increased to 101/sys but u/o still poor ( 5-10cc/hr).  Given another\\n   20mg IV lasix @ 0625.  0700 u/o is only 5cc.\\n   Plan:\\n   Continue to monitor u/o & BP. Sent urine for lytes, osmolality.  Await\\n   decision re: Tx.\\n   .H/O dementia (including Alzheimer's, Multi Infarct)\\n   Assessment:\\n   Patient is oriented to herself only, not to time or place.  She is\\n   pleasant but forgetful.  She does take her O2 off frequently.\\n   Action:\\n   Replaced O2 & reminded her of need to keep NP in place, prn.   Bed\\n   alarm on.  Bed in low position, near floor.  Patient checked q 1 hr.\\n   Nurse\\ns call light placed in patient\\ns hand.\\n   Response:\\n   Patient remained pleasantly disoriented all night.  Did not try to get\\n   out of bed.\\n   Plan:\\n   Continue to orient patient as needed.  Continue above safety\\n   precautions.\\n\",\n",
              "  'This is a 79 yr old Portugese speaking woman admitted on [**1-29**] from OSH\\n   w/ respiratory failure & renal failure. Dx w/ARDS, CMV viremia & VRE\\n   bacteremia.   Admitted to OSH [**2129-12-7**] w/PNA & COPD. Intubated [**1-15**].\\n   S/p trach [**2-7**]. Still vented.  Had been improving but decompensated\\n   last week due to VAP.  Failed trach collar [**2-24**] due to tachypnea &\\n   tachycardia.\\n   Developed renal failure.  Started CVVHD [**1-15**].  now receiving\\n   intermittent hemodialysis.  Last HD [**2-24**] w/3.5 L off. PEG placed [**2-22**]\\n   through which she is now receiving TF\\ns @ goal of 35cc/hr. Well\\n   tolerated.  Maintained on insulin sliding scale, fixed doses of NPH &\\n   fixed doses of regular insulin (on [**2135-12-31**]-20 schedule).\\n   Renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   Incontinent of medium amount  urine @ midnight.   Previously voided on\\n   [**5-10**] & [**2-26**].   BUN=40     Cr= 2.4\\n   Na=145  .  Received 200cc H2O flushes q 4 hrs via PEG for elevated Na.\\n   Last HD on [**2-24**].\\n   Action:\\n   Wgt [**2-27**] @ midnight is 106.4 kg.\\n   Response:\\n   Plan:\\n   Next HD planned for today [**2-27**].\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 80\\ns-100\\ns A-fib.  BP: 100\\ns-130\\ns/systolic.\\n   Action:\\n   Digoxin D/C\\ned.  Still receiving diltiazem 90mg qid.\\n   Response:\\n   HR & BP as above.  No digoxin level @ this time.\\n   Plan:\\n   Continue to monitor HR on diltiazem.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient frequently scratched @ PEG dressing & monitor leads.  No\\n   response when asked if she had pain.\\n   Action:\\n   Medicated prophylactically for pain @ midnight w/5mg oxycodone & for\\n   anxiety @ [**2121**] w/0.5mg ativan.\\n   Response:\\n   Patient slept well.  Easily aroused to voice. Spontaneously opening\\n   eyes.\\n   Plan:\\n   Medicate less frequently during daylight hours.\\n   Pneumonia, bacterial, ventilator acquired (VAP)\\n   Assessment:\\n   On CPAP 30%/5 PS/5 PEEP via trach.  Upper lung sounds are coarse\\n   w/inspiratory & expiratory wheezes.  Diminished sounds @ bases.  Weak\\n   cough. Patient disconnected vent tubing from trach several times.\\n   ABG\\ns soon afterwards: 7.32/50/57(pO2).\\n   Action:\\n   Sx\\ned for small amount thick green secretion to moderate amount thin\\n   tan secretions.  Explained to patient that she was not ready to come\\n   off the vent yet.  Explained to  the patient that if she disconnected\\n   herself again , she would be restrained for her own safety.  Intern &\\n   resident aware.\\n   Response:\\n   O2 sats 91-96%.  Patient gestured to her wrists & shook her head\\n   Patient refrained from disconnecting herself from the vent.  Repeat\\n   ABG\\ns: 7.31/47/57.  FiO2 increased to 40%.\\n   Plan:\\n   Draw repeat ABG\\ns @ 0730-0800.  [**Month (only) 60**] need less FiO2 after fluid removed\\n   in hemodialysis.\\n   Diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS 125 @ 2100.  Covered w/3 units regular sc on sliding scale.  At\\n   0200, FS 106, covered w/6 units regular bedtime fixed dose.  Received\\n   nutren renal full stength w/beneprotein @ 35cc/hr.  Abdomen soft &\\n   obese w/+ bowel sounds.  LBM (recorded): [**2-18**].\\n   Action:\\n   As above.  Started on bowel meds: colace, senna & bisacodyl.  On a\\n   different time schedule for FS & insulin per endocrinology:\\n   0200-0800-1400-[**2121**],as they want NPH to be given @ 0800 & [**2121**].\\n   Response:\\n   No BM yet.\\n   Plan:\\n   Try lactulose or fleets (PO4 only 2.1).\\n',\n",
              "  'This  71 yr old man was admittied to [**Hospital1 54**] [**6-12**] w/FUO.  Hx Hodgkins &\\n   nonhodgkin\\ns lymphoma s/p chemo & XRT (last chemo [**6-9**]); paroxysmal AF\\n   w/RVR.  Transferred from floor (11R) after converting from SR to AF,\\n   rate 150\\ns.  BP maintained 100-110/systolic.  Converted back to SR\\n   after 20mg IV diltiazem (already takes 120mg diltiazem extended release\\n   po qd).  R/o\\ned for PE by chest CT for swelling in L leg> R leg.\\n   Lactate on admission 3.4.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 70\\ns-90\\ns SR  w/rare PVC\\ns & frequent PAC\\ns.  Received 120mg po\\n   diltiazem extended release [**6-14**] @ 0730. (odered qd).\\n   Action:\\n   Repleted w/60 mEq KCl po for serum K 3.4.  Repleted w/ 1 packet\\n   neutraphos for serum phosphorus of 2.2.\\n   Response:\\n   Plan:\\n   Monitor PO4, electrolytes.\\n   Anemia, other\\n   Assessment:\\n   Repeat Hct @ 2300 was 23.3\\n   Action:\\n   Transfused w/1 unit PC\\n   Response:\\n   Post Hct:\\n   Plan:\\n   Monitor Hct & Hgb.  Goal Hct was 25 or >.\\n   Fever, unknown origin (FUO, Hyperthermia, Pyrexia)\\n   Assessment:\\n   poT 99.1-99.6\\n   Action:\\n   Received 2GM cefepime IV @ [**2121**], ordered [**Hospital1 **].  Sent UA.\\n   Response:\\n   BC X2 from [**6-12**] still pending.  WBC: 43.4 @ 2315 on [**6-14**] up from 23.1 @\\n   0700 the same day.  WBC only 15.4 on [**6-13**].   Team aware.  [**Month (only) 60**] be effect\\n   of neulasta/neupogen.  Lactate was 3.2 on [**6-14**] am, down from 3.4 on\\n   [**6-12**].  Patient was last discharged from [**Hospital1 54**] on [**6-9**].  On [**6-8**] when he\\n   was transferred out of ICU, his lactate was 3.2.\\n   Plan:\\n   Continue to follow WBC.  Hold neulasta/neupogen.\\n   Patient received 1 out of 2 doses po mucomist post CT scan w/contrast &\\n   300cc IV  D5W w/150 mEq HCO3 for renal protection.\\n',\n",
              "  'This is an 86 yr old man transferred from [**Hospital **] Hospital  w/ common\\n   [**Hospital **] duct obstruction.  Here for ERCP in am ([**8-3**]).  Transferred from\\n   ICU.  PMH: Afib, anemia, seizures, CAD, s/p MI [**2114**], HTN,\\n   Diverticulosis, sciatica, TIA, probable AAA.  Had EGD, showed mild\\n   gastritis.  Colonoscopy showed Diverticulosis, & Abd CT showed\\n   cholelithiasis, CBD stone, cirrhosis, calcified mitral valve.  Patient\\n   is allergic to PCN.  Patient is DNR/DNI.\\n   [**Last Name 19**] Problem\\n [**Name (NI) **] [**Name2 (NI) **] Duct Stone\\n   Assessment:\\n   No c/o pain @ all, even before coming into [**Hospital **] Hospital.  No c/o\\n   N/V. T 100.2 po.  LFT\\ns improved since coming from [**Location (un) **] Hosital.\\n   [**8-2**]  2200 LFT\\ns: LDH 214 (WNL)      AST 63      ALT 144      alk p\\ntase\\n   343\\n   Action:\\n   NPO since arrival to MICU. ( Had 490cc po intake [**5-3**] @ [**Hospital **]\\n   Hospital ).\\n   Response:\\n   Patient remained comfortable overnight.  LFT\\ns in am [**8-3**] dropped\\n   further: AST 45  ALT 111  alk p\\ntase 303.\\n   Plan:\\n   RUQ ultrasound in am.  Send for ERCP if patient has not already passed\\n   gallstone\\nof which dropping LFT\\ns may be sign.\\n   .H/O seizure, without status epilepticus\\n   Assessment:\\n   Neuro vss.  CIWA scale =0.  Hx drinking 2 mixed drinks/day.  Patient\\n   took last drink 4-5 days ago.  Has not had Sx of withdrawal.\\n   Action:\\n   Given 300mg po dilantin @ HS.  Checked CIWA scale q 4 hrs.\\n   Response:\\n   No S&S seizures or withdrawal.\\n   Plan:\\n   Change dilantin to 300mg extended release, which he takes @ home.\\n   Atrial fibrillation (Afib)/ Hx Afib\\n   Assessment:\\n   HR: 70\\ns Afib no ectopy  BP 90\\ns-110\\ns/systolic.  INR 1.2   Patient\\n   required 4 units PC\\ns [**8-1**] to bring Hct up from 19 to 26.6.  Hct was\\n   25.8 upon arrival to MICU [**8-2**].   INR 1.2 (1.2)\\n   Action:\\n    Received 1000cc NS bolus to keep sBP>90/.  Followed by 1000cc NS @\\n   100cc/hr.  Patient has not been on anticoagulation since duodenal GI\\n   bleed 18 mo ago.\\n   Response:\\n   BP remained >90/systolic.  [**8-3**] am Hct: 24.0, dropped 1.8-2.6 points\\n   since yesterday.\\n   Plan:\\n   Continue to follow Hct.  Continue to monitor HR.\\n   .H/O renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   Baseline Cr =1.4.  On [**8-2**] 2200, BUN 65  & Cr 3.4\\n   Action:\\n   Bolused w/1000cc NS @ 2300 & given NS @ 100cc/hr for hydration.\\n   Protein for electrophereses sent to r/o multiple myeloma (a possible\\n   cause of RF).\\n   Response:\\n   [**8-3**] am  BUN 58      Cr 3.0\\n   Plan:\\n   Continue to follow BUN & Cr.\\n   Na 129 (130).  IVF changed from\\n NS to NS.\\n',\n",
              "  '84 yr old man admitted through EW from PCP\\n[**Name Initial (PRE) **] office [**Name Initial (PRE) **]/hypotension (BP\\n   70-80/40) & ARF.  Hypotension unresponsive to 2L NS in EW.   Arrived in\\n   MICU w/BP110/56.  PMH includes s/p MI, CHF, pacer & ICD for CHB,\\n   diabetes, Parkinson\\ns, gout.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP 84-110/25-57            HR: 79-88   AV paced w/ intrinsic beats &\\n   PVC\\n   Action:\\n   Received 250cc NS bolus @ 0330 for BP 83-87/25.\\n   Response:\\n   BP back up to 94/51.\\n   Plan:\\n   Continue to follow BP\\ns.   Bolus for hypotension as needed.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 94 (106)        Cr 2.9 (3.4)        K5.1 (5.4)   U/o: 100cc/hr\\n   Action:\\n   Received kayexalate in EW, had large loose BM\\ns X3 since.\\n   Response:\\n   K dropped from 6.2 in EW to 5.1 this am.  Patient in diuretic phase of\\n   renal  recovery.\\n   Plan:\\n   Continue to follow u/o.  Continue to follow labs.  Renal to see today.\\n   Wife slept on cot in waiting room overnight.\\n   ------ Protected Section ------\\n   Patient lost 0.8kg overnight.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1534**] [**Last Name (NamePattern1) 3577**], RN\\n   on:[**2130-8-30**] 07:13 ------\\n',\n",
              "  'Atrial fibrillation (Afib)\\n   Assessment:\\n   Patient\\ns HR  in 60\\ns SR. BP stable.  QT .48\\n   Action:\\n   Given po lopressor 25mg @ [**2124**] & po diltiazem 30mg@ 0000\\n   Response:\\n   HR dropped to 50\\ns SB no ectopy. BP remained stable.\\n   Plan:\\n   Continue to medicate as ordered, continue to assess HR q hr\\n   Heart failure (CHF), Diastolic, Acute on Chronic\\n   Assessment:\\n   Crackles @ bases to\\n the way up. Exp wheezes @ upper lungs. O2 sats\\n   93-97% on 4L NP. HOB up 45 degrees even sleeping for respiratory\\n   comfort.  Patient was over 2L negative for [**12-31**].\\n   Action:\\n   Given 40mg IV lasix @ 2220.\\n   Response:\\n   u/o 40-120cc/hr in moderate response to lasix\\n   Plan:\\n   Continue to gently diurese, cont to follow  I&O\\ns & daily wgts\\n   Delirium / confusion\\n   Assessment:\\n     Awoke disoriented in the middle of the night. Grandson slept in\\n   waiting room overnight.  No restraints.\\n   Action:\\n   Grandson reoriented patient easily.\\n   Response:\\n   Patient calmed down & fell asleep.\\n   Plan:\\n   Have grandson sit w/patient as needed. Keep bed low & locked. Keep bed\\n   alarm on. Keep curtains pulled fpr greater visibility.\\n   Constipation (Obstipation, FOS)\\n   Assessment:\\n   Patient says she has had no BM in 4 days. Soft distended abdomen w/+\\n   bowel sounds.\\n   Action:\\n   Given colace & senna & po bisacodyl\\n   Response:\\n   No BM yet\\n   Plan:\\n   Try dulcolax suppository\\n',\n",
              "  \"Gastrointestinal bleed, upper (Melena, GI Bleed, GIB)\\n   Assessment:\\n    Hct @ 2300 was 29.7, dropped from 31.4. Hemodynamically stable. O2\\n   sats 95-100% on 2L NP.  Lungs difficult to assess w/patient continually\\n   moaning, but she was clear @ upper lungs & diminished @ bases. NPO p\\n   Mn. INR =1.3 this am .\\n   Action:\\n   Transfused w/1 unit PC\\n   Response:\\n   Post Hct = 34%\\n   Plan:\\n   Continue serial Hcts q 6-8 hrs. Assess for S&S fluid overload. NPO p MN\\n   in case patient needs\\nscope.\\n   Coronary artery disease (CAD, ischemic heart disease)\\n   Assessment:\\n   Troponin =0.48 @ 2300. This is up from 0.44. CK & MB going down.\\n   Lopressor held [**2-2**] for HR <60 & inability to take meds po (even\\n   crushed in applesauce).  BP stable @ 100\\ns-130\\ns/60\\ns-70\\n   Action:\\n   Lopressor held.\\n   Response:\\n   HR 57SB -65 SR no ectopy.\\n   Plan:\\n   Give lopressor IV  when needed. Continue to draw cardiac enzymes q 6 -8\\n   hrs.\\n   Dementia (including Alzheimer's, Multi Infarct)\\n   Assessment:\\n   Patient nodded\\n to\\nbeleet\\n (pain in Russian). Otherwise, she\\n   moaned constantly all night. Could not take po trazedone or Tylenol as\\n   she could not take crushed meds in applesauce. Slept only for 10min @ a\\n   time.\\n   Action:\\n   Provided comfortable quiet environment w/dim lights overnight. Checked\\n   patient often. Bed alarm on. Bed low & locked.  Nurse\\ns call light w/in\\n   easy reach on bed. Increased visibility by drawing curtains back.\\n   Response:\\n   Patient continued to moan.\\n   Plan:\\n   Will need means of giving meds & eventually feeding patient. Check\\n   w/son about how she eats/takes meds @ [**Hospital 12**] Rehab. Assess for need for\\n   feeding tube. Continue bed alarm, bed low & locked, frequent checks,\\n   etc.\\n\",\n",
              "  'This 73 yr old man w/CLL X10 yrs  fell out of bed [**1-6**] onto his R hip,\\n   & hit his head.  No LOC.  Head CT negative.  However has R hip fx.\\n   Went to OR [**1-6**] for ORIF w/nail of R hip. PMH: PNA, recent RSV, chronic\\n   B pleural effusions recently tapped. Transferred to [**Hospital Ward Name 77**] MICU for\\n   failure to wean easily from vent.  Transferred on CPAP @ 50% on 5 PEEP\\n   & 12 PS.  On IV propofol.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   Weaned down to CPAP @ 40% w/5 PS & 5 PEEP.  Although reported to have\\n   copious thick secretions in PACU, patient had no secretions when Sx\\n   @ 0400.  Patient is lightly sedated on propofol 20mcg/kg/min.\\n   Action:\\n   ABG\\ns on above were : 7.42/41/117\\n   Response:\\n   RSBI 70\\n   Plan:\\n   Patient ready to be extubated this am.\\n   Hip fracture (Femoral neck fracture, Femur)\\n   Assessment:\\n   3 primary dressings on R lateral hip down to R lateral knee are D&I.\\n   No obvious swelling @ R upper leg.  R DP & PT were weakly palpable\\n   since she arrived from the [**Hospital Ward Name **] PACU.  HR :  90\\ns SR- [**Street Address(2) 3429**]\\n   w/frequent PAC\\ns & rare PVC\\ns.  BP : 140\\ns-110\\ns/systolic.\\n   Action:\\n   D51/2 NS w/20 mEq KCl infused @ 75cc/hr.  Patient was given 40mg IV\\n   lasix in PACU around 2200 [**1-6**].  Patient takes 40mg po lasix qd @ home\\n   for his B pleural effusions.\\n   Response:\\n   Hct up to 30 from dehydration.  BUN up to 23 from 21 preop.  Cr\\n   unchanged @ 0.9.     U/o 80-400cc/hr.\\n   Plan:\\n   Continue to follow fluid status.  Continue to assess for bleeding into\\n   leg.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient had changes in vs : increased HR sometimes accompanied by\\n   increased BP w/turning.  As patient woke up from sedation, he would\\n   grimace and grasp R hip, placing his hand over his dressings.  He\\n   continues to wear a fentanyl patch delivering 25mcg/hr which he wears @\\n   home.\\n   Action:\\n   Medicated patient w/2-4mg IV morphine q 1 hr until pain was relieved as\\n   shown by decreased HR.\\n   Response:\\n   By 0630, patient\\ns pain was in good control w/HR  90\\ns SR-[**Street Address(2) 1112**]\\n   w/frequent PAC\\ns.  No grimacing @ a time when he was only lightly\\n   sedated.\\n   Plan:\\n   Continue to medicate as needed.\\n   Patient arrived w/extensive bruising from his fall.  Both arms, back &\\n   buttocks, R leg are bruised.\\n',\n",
              "  \"86 y/o F h/o CAD, CHF, DM, AFib on coumadin, and chronic c. diff\\n   colitis on PO vanco a/w vomiting and diarrhea x 2 days labored\\n   breathing and O2sats in the low 90s on room air, requiring oxygen in\\n   the daytime. She was seen in cardiology clinic the day prior to\\n   admission, at which time routine labs revealed BUN 38/Cr 2.1/K 5.9. She\\n   was instructed by her cardioligst's office to stop taking the [**Last Name (un) 239**],\\n   potassium, and diuretics and to come to the ED.\\n   In the ED, initially afebrile HR 83 BP 100/48 RR 20 O2sat 96% RA 100%\\n   4LNC. She was reportedly guaiac negative. K+ peaked at 6.9 (D50 &\\n   insulin given) WBC 11. Lactate 5.5 f/b 4.1. INR 3.4. A left IJ was\\n   placed. She was given just 1 L NS in light of severe systolic\\n   dysfunction. SBP never dropped below 100, MAP ranged 55-78, with HR\\n   50's-70's. CVP ranged 6-11 cmH20, ScvO2 65-78. She had minimal urine\\n   output.\\n   She was treated with IV flagyl for presumed C. diff colitis, and IV\\n   ampicillin and cefepime for +U/A. CXR revealed bilat effusions R>L c/w\\n   CHF. Abd/pelvis CT w/o contrast preliminarily showed intraperitoneal\\n   free fluid and colonic wall thickening predominantly on the right c/w\\n   third-spacing or infectious colitis. She was transferred to the ICU for\\n   observation and further management of CHF and ARF.\\n   Since then has stool sent for C-diff A&B X2: negative.  Sent 3^rd spec\\n   for C-diff on [**7-9**].  BC are negative to date.  Urine has low level of\\n   contamination from urine Cx.\\n   Heart failure (CHF), Systolic, Acute on Chronic\\n   Assessment:\\n   BP: 86-110\\ns/20\\ns-50\\ns   HR: 70 V-paced      Hct 27.1(30.8 on [**7-9**] & 35\\n   on [**7-8**]) : Intern aware.\\n   Action:\\n    NS bolus 250cc given @ 1900 for BP 86/systolic (despite previous bolus\\n   @ 1800 which failed to elevate BP).    Carvedilol 6.25mg given @ [**2157**].\\n   Hydralazine 10mg po q 6 hrs held @ 2230 for BP 86/21 but given @ 0400.\\n   Response:\\n   BP came up to 110-112/systolic @ [**2057**]-[**2157**] after 250cc NS bolus @\\n   1900.  BP >90/sys p 0400 hydralazine.\\n   Plan:\\n   Hold hydralazine for sBP<90.  Continue to give hydralazine as BP\\n   tolerates.\\n   C. difficile infection (C Diff, Cdiff Colitis, Clostridium Difficile)\\n   Assessment:\\n   Afebrile.  T97-97.6 po.  Medium soft brown unformed BM this evening.\\n   Previous 2 samples were C-diff A&B negative.\\n   Action:\\n   Sent 3^rd sample for C-diff.  Patient continues on vanco 250mg po  once\\n   a day.  Allergic to flagyl.\\n   Response:\\n   No diarrhea\\n   Plan:\\n   Take patient off C-diff contact [**Name (NI) 3742**] if 3^rd sample is negative\\n   for C-diff.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 55 (62)   Cr 1.8 (2.1)    K3.0:  labs from 1900 on [**7-9**].\\n   Action:\\n   Repleted w/60 mEq po KCl [**7-9**] eve.\\n   Response:\\n   On [**7-10**], K: 3.5          Bun 53 (55) & Cr 1.7 (1.8) on [**7-10**]\\n   Plan:\\n   Additional repletion for K this am\\n   Patient oriented X2 (place & self, not date/yr) & in evening & X1 ( to\\n   self only).  Has 24 hr care in her home.  PCA\\ns who normally care for\\n   her in her home come here & sit w/her.  Evening aide fed & conversed\\n   w/her.  Night aide slept in a chair @ her bedside after conversing on\\n   phone till after lights were turned off in patient\\ns room (as patient\\n   was asleep).  Patient slept 2200-0200.  Then catnapped through the rest\\n   of the night.\\n\",\n",
              "  '76yo gentleman who is s/p redo replacement aortic arch with presumed\\n   anoxic brain injury and post-op bacteremia as well as cholecystitis s/p\\n   cholecystosomy admitted for sepsis, found to have serratia bacteremia.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Now on CPAP @ 40% w/5 PS & 8 PEEP.       O2 sats: 97-100%        RR:\\n   [**12-25**]        Patient coughed up most of his secretions, requiring\\n   suctioning  @ entrance of trach.\\n   Action:\\n   Suctioned much less frequently overnight.  Trach care done including\\n   changing inner cannula of portex.\\n   Response:\\n   Tolerated decreased vent settings of PS down to 5 from 10.\\n   Plan:\\n   Continue to suction as needed, continue to turn frequently.  Continue\\n   VAP prevention.\\n   Heart failure (CHF), Diastolic, Chronic\\n   Assessment:\\n   HR:  60-64    A-paced   no ectopy          BP: 98-146/ 51-69   MAP:\\n   66-88\\n   Action:\\n   Continued on IV lasix @ 5-7mg/hr, titrated for maximum u/o & to keep\\n   sBP>100.   Held lopressor per PEG @ midnight for hypotension.\\n   Response:\\n   Patient was positive 1.3L on [**12-10**], due to late start of IV lasix.  On\\n   [**12-11**], patient is          cc negative so far.\\n   Plan:\\n   Keep patient in negative fluid balance by 1L /day.\\n   Cholecystitis, calculous\\n   Assessment:\\n   T tube drained 18cc bile overnight.  Patient is afebrile.  WBC: 5.7\\n   (6.5)    Had medium  guiac negative soft  brown BM.  Tube feeding\\n   residuals are 2-5cc.  Tube feeding held for 1 hr preceding & following\\n   administration of phenytoin per PEG as directed by pharmacy.  No c/o GI\\n   discomfort.\\n   Action:\\n   Response:\\n   Patient tolerating tube feedings.  Gastric motility OK.\\n   Plan:\\n   Patient will need cholangiogram in future to confirm that cystic duct\\n   is patent.\\n   Atrial fibrillation (Afib)/ B UE  DVT\\n   Assessment:\\n   Both arms continue to be edematous.\\n   Action:\\n   Elevated arms on pillows.   IV heparin infused @ 1650 units/hr.  Double\\n   lumen midline catheter was placed in R arm, as PICC was not able to be\\n   advanced.  Received coumadin during day.\\n   Response:\\n   Drew am labs from midline.   [**12-10**] INR was  2.2.    [**12-11**] INR: pending\\n   Plan:\\n   Am labs drawn @ 0600.  Results pending.  Vanco level drawn.\\n   ------ Protected Section ------\\n   On [**12-11**], patient is 600cc negative so far.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2137-12-11**] 06:49 ------\\n   RSBI is 50.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2137-12-11**] 06:59 ------\\n',\n",
              "  '69 F w/ MMP w/ copd, diastolic chf, dm2, recent prolonged\\n   hospitalization w/ rectal sheath hematoma, pna w/ highly resistant\\n   pseudomonas, resp failure s/p trach presents with urosepsis and arf .\\n   Possible  RLL  VAP.  Seen by ID. Started on ciprofloxacin\\n   (broadspectrum), ceftazidime (grm neg, some grm +) & linezolid (grm +)\\n   to cover grm neg rods in urine as well.  Vanco D/C\\ned (not needed on\\n   linazolid).\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n    R pleural effusion on CXR,\\n which MD interpreted as wet.  Lungs:\\n   Expiratory wheezes throughout.  Continued on A/C  50%/400 Vt/22 RR/ 10\\n   PEEP.  O2 sats 100%.  RR 22-30.  Sx q 4 hrs for scant to small amt\\n   thick yellow secretions.  Continues to bite down during oral care.\\n   Refuses nystantin.  No thrush seen when patient yawns.\\n   Action:\\n   Lasix 40mg IV given @ [**2131**].  ABG\\ns@ 2130: 7.35/33/223\\n   Response:\\n    Decreased FiO2 to 40% @  2300.\\n   Plan:\\n   Await RSBI when PEEP is lower.  Continue to monitor O2 sats, RR, work\\n   of breathing.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   As above, CXR looked wet.  U/o 35-38cc/hr  initially.   BUN:56 (52)\\n   Cr:3.7 (3.6)\\n   Action:\\n   Given lasix 40mg @ [**2131**].\\n   Response:\\n   U/o 30-130cc/hr after lasix\\n   Plan:\\n   Monitor u/o, BUN & Cr.  Renal following.\\n   Hypertension, benign\\n   Assessment:\\n   BP ranged from 101/55 (MAP 68)  to 198/109 to 202/98.  BP labile\\n   w/anxiety & pain\\n   Action:\\n   10mg IV hydralazine given @ 0200 & 20mg IV labetolol given @ 0330  for\\n   HTN (BP 198/109- 202/98), as well as 1mg ativan IV.  650mg Tylenol\\n   given for pain @ 0400.\\n   Response:\\n   BP down to 165/84 @ 0400 & remained in 160\\ns/sys\\n   Plan:\\n   Re-evaluate pain medication in am on rounds\\n   Sepsis, Severe (with organ dysfunction)\\n   Assessment:\\n   Tmax 98.9 axillary, was up to 100.8 ax @ 0800 [**7-4**].    WBC 12.5\\n   (13.3)   Lactate 1.3 (0.9)\\n   Action:\\n   BC X1 drawn @beginning of shift.   Given cipro, ceftazidime & linazolid\\n   .  Vanco D/C\\n   Response:\\n   Afebrile.\\n   Plan:\\n   Check Cx results.  Give abx.   Continue to monitor temp.\\n   Patient woke up @ 1900.  Initially nonverbal, then responding\\n   appropriately w/nods to questions.  Appears anxious. Admitted to back &\\n   abdominal (wound) pain.  Now treated w/acetaminophen 650mg per NGT q 8\\n   hrs for pain. Needs more effective pain med.   Morphine IV & fentanyl\\n   patch held per resident ( for potential serotonin interaction\\n   w/linezolid\\n high fevers, malignant HTN).    Ativan IV given for\\n   anxiety.\\n',\n",
              "  'Pt is an 85 yo Female with recent [**Hospital1 54**] hospitalization for C. diff\\n   colitis (from [**Date range (1) 3443**]/08; discharged to rehab; sent home on [**2141-5-31**]).\\n   Afternoon of [**6-8**] presented from home to [**Hospital1 **] ED with rigors and\\n   diarrhea.  The diarrhea has been non-bloody and began 3-4 days ago; it\\n   had not been associated with abd pain/cramping or N/V but pt has\\n   experienced increasing distention, supraumbilical tenderness w/\\n   palpation and nausea over last 24hrs. Patient treated w/IV neo & then\\n   levo  for sepsis from C-diff colitis.  Had ileostomy & colectomy [**6-10**]\\n   for toxic megacolon.  ? Ischemic bowel.\\n   Pt has h/o paroxysmal afib, on coumadin and lasix as well as\\n   betablockers at home.\\n   Shock, septic\\n   Assessment:\\n   MAP remained >65.  Systolic BP 90\\ns-120\\ns/     U/o 20-35cc/hr.   WBC up\\n   to 34.9 from 23.5 [**Month/Day (1) **].   Lactate down to 1.8  from 3.6 [**Month/Day (1) **].\\n   Action:\\n   Titrated levophed down from .11mcg/kg/min & then D/C\\ned it @ 0500.\\n   Received 3L LR  for u/o down to 20cc/hr & BP down to 80\\ns/sys off\\n   levophed.\\n   Response:\\n   MAP remained >65.\\n   Plan:\\n   Continue to replace w/LR as needed  for  u/o <20cc/hr , or low BP.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR 100\\ns-135 Afib w/ one episode PVC\\n   Action:\\n   Monitor HR.  Treat pain w/ IV fentanyl 75mcg/hr & versed 2 mg/hr.\\n   Response:\\n   Patient appears comfortable when not being turned, no grimacing, moving\\n   arms etc.  Opens eyes, moves arms when turned.\\n   Plan:\\n   Bolus pain med if needed.  IV lopressor being considered by surgery for\\n   rate control.\\n   [**Last Name **] Problem\\n [**Name (NI) 3496**] colectomy & ileostomy\\n   Assessment:\\n   Hct 27.9 @ 1800.  Ileostomy drained 12 cc serosanguinous (pink)\\n   drainage. Stoma pink & healthy appearing.  Midline abdominal incision\\n   covered by DSD stained w/moderate to large amount serosanguinous\\n   drainage.  + bowel sounds.  No flatus.  NGT drained 50cc bilious\\n   drainage from stomach overnight.\\n   Action:\\n   Received 1 unit PC\\ns.  Circled drainage @ beginning of shift.  Circled\\n   again @ 0300 as it increased.  Surgery team aware.\\n   Response:\\n   Post transfusion Hct 31.1 @ Mn.\\n   Plan:\\n   Continue to monitor Hct & electrolytes.\\n   Patient intubated & vented since surgery [**6-10**].  On A/C 40%/450/26/8\\n   overnight.  Changed to CPAP 40%/[**4-10**] @ 0430.  HR up to 135\\n   intermittently since being placed on CPAP.  BP up to 150\\ns/sys on levo\\n   & 130\\ns/sys off levophed on CPAP.  Last ABG\\ns on CPAP: 7.36/40/97.\\n   Surgery wants patient to remain intubated today because of quantity of\\n   fluid given.  [**Month (only) 60**] remain on CPAP.\\n   CXR done @ 0630.\\n',\n",
              "  '73 yr old woman admitted to floor on  [**9-10**] w/back,flank & LLQ pain\\n   associated w/vomiting.  PMH includes DM2, CAD, s/p CABG X2, hx MI,\\n   systolic heart failure w/EF 50% in [**2138**], mild pulmonary HTN, s/p\\n   pacemaker for Mobitz 2/SSS since [**2123**].  Chronic A-fib (no anticoagulant\\n   due to bleeding hx), chronic renal failure, + MRSA, gout, lower  GIB\\n   [**3-31**].\\n   During this hospitalization she had been having several episodes of\\n   chest pain- seen by cardiology [**9-12**].  Developed chest pain overnight\\n   [**9-14**].  Received 3 SL NTG & 2mg IV morphine.  LOC & witnessed Vfib\\n   arrest.  CPR & defibrillated X2, to return to perfusing rhythm.\\n   Upon arrival to CCU, BP 150\\ns/ quickly dropped.  Levophed had been\\n   started & then held before transfer.  Restarted levophed @ maximum dose\\n   & started phenylephrine IV.   1000cc IV NS bolused.  HR:  102-118\\n   idioventricular rhythm.  No ectopy.  Pacemaker fired regularly but did\\n   not initate QRS complexes (it was not functioning correctly ).\\n   Line in R groin identified as a-line had ABG\\ns drawn.  They came back\\n   as VBG\\ns & thus this undressed line was identified as venous.    L\\n   venous line bled from exit site & was re-dressed several times.     R\\n   groin had moderate sized hematoma upon arrival to CCU.  MICU\\n   intern/resident held site X 10min.  Hematoma continued to enlarge.  Dr.\\n   [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] & Dr. [**First Name8 (NamePattern2) 5741**] [**Last Name (NamePattern1) 10636**] informed re: enlarged hematoma R groin.\\n   Nurse applied manual pressure X 10min & then  pressure bag weighing\\n   2.2kg applied to site, where it remained until 0730.\\n   MICU resident  placed R IJ triple lumen catheter.  CXR done post.\\n   Sedation (fentanyl & versed)  bolused initially , until BP stable on\\n   pressors, & then run as continous drips.  Arterial ABG: 7.35/47/402.\\n   A/C @ fiO2 100% dropped to 50%.  O2 sats remained @ 100%.\\n   Artic Sun started @ 0530, achieved desired coldness by 0645.  See\\n   metavision for details.\\n',\n",
              "  '69 yo woman with h/o AVR dx\\nd with AML [**1-29**].  S/P chemo and now stem\\n   cell tx. s/p allo double cord transplant.  Initial induction c/b\\n   anthracycline induced cardiomyopathy.  Transferred to MICU for\\n   progressive SOB, deteriorating MS, worsening renal failure and volume\\n   overload in setting of new VRE bacteremia.   Receiving lanezolid and\\n   coverage for febrile neutropenia.  Period of neutropenia expected to be\\n   at least 7d.  ejection fraction was 50% a few montha ago but now noted\\n   to be 15 %. Had card echo, bedside ult of liver and abd and renal\\n   ultsnd. Pt has known hx of gall stones.\\n   Heart failure (CHF), Systolic and Diastolic, Acute on Chronic\\n   Assessment:\\n   HR 80\\ns-90\\ns SR .  After milnirone started, increased PAC\\ns (frequent),\\n   occasional PVC\\ns, & HR elevated.\\n   Action:\\n   Started IV milnirone @ 2100 @ 0.375mcg/kg/min after  bolus of 50mcg/kg\\n   over 10min.\\n   Response:\\n   BP unchanged initially, then hypotensive( may be from elevated HR) HR\\n   up to 130\\ns & 141 in short bursts.  Given IV neo for MAP<60, needed\\n   only 0.2-0.5mcg/kg/min.  Given 10mg IV lopressor @ 0500 for HR 130\\n   Plan:\\n   Maintain MAP>65 w/IV neo.  Control HR w/ lopressor: 5mg IV q 6hrs\\n   ordered-may need more.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN  99 (95)         Cr  3.1 (2.8)        K 4.2 (4.8)\\n   Action:\\n   HD catheter placed last night & CXR done after.  Check w/team for\\n   results.  Renal deferred CRRT overnight to evaluate effectiveness of\\n   milnerone on u/o.  Also trialed IV lasix X 1 hr & started zaroxyln per\\n   NGT [**Hospital1 **].\\n   Response:\\n   U/o only 5cc/hr.  No increase from milnerone, lasix or zaroxylin.\\n   Plan:\\n   Start CVVHD w/prismaflex  as soon as renal gives OK.  Remove 50cc/ hr\\n   as patient tolerates.  Back off for hypotension.  Increase to 100cc/hr\\n   if patient\\ns BP (&HR) tolerate.\\n   Pulmonary edema\\n   Assessment:\\n   On A/C @ 50% w/500Vt/ RR14/ 5 PEEP.  Overbreathed vent by [**4-30**]\\n   breathes/min.\\n   Action:\\n   Suctioned X2 for small amt thick white secretions.  ABG\\n   7.41/36/103   &   7.45/31/128\\n   Response:\\n   [**6-15**] CXR shows mild pulmonary edema & moderate R pleural effusion.\\n   Plan:\\n   Cont to follow ABG\\ns.  Had CXR this am.  Attempt to remove fluid\\n   w/CRRT.\\n',\n",
              "  'This is a 69 year old woman with AML, s/p 7+3. day 15 of\\n   non-myeloablative allogeneic double cord transplant, with PMH of\\n   bioprosthetic aortic valve, now in the ICU intubated after worsening\\n   mental status, increasing oxygen needs, and evident fluid overload in\\n   the setting of acute renal failure and heart failure as well as recent\\n   VRE bacteremia.\\n   Tachycardia, Other\\n   Assessment:\\n   Patient\\ns HR increased to 142 AF w/frequent runs V-tach  @ 2110.    MAP\\n   maintained>55 but required higher doses of neo.  MAP\\ns dropped to 50-55\\n   after cardioversion.\\n   Action:\\n   Neo increased from 1.5mcg/kg/min @ 1900 to 3.5mcg/kg/min by 2100.\\n   Cardioversion attempted @ 2300.  No success w/100  joules.  200 joules\\n   converted AF w/rate up to 150 to junctional rhythm rate 80\\ns for a few\\n   seconds.  Then patient converted back to AF.  Patient placed on\\n   amiodarone @ 0050.  Initial bolus given over 1.5hrs to prevent\\n   hypotension. Per intern.\\n   Response:\\n   BP responded well to 200cc NS bolus after cardioversion.\\n   Plan:\\n   Continues on IV amio.  Decrease to 0.5mg/hr @ 0820 X 16 hrs.\\n   Lopressor IV increased to 10mg IV q 4 hrs.  Received 5mg IV lopressor\\n   X1 @ 0500.   [**Month (only) 51**] cardiovert again this am.\\n   Heart failure (CHF), Systolic and Diastolic, Acute on Chronic\\n   Assessment:\\n   Hct 27.7   CVP 13-14   HR increased from 90\\ns SR w/occasional PVC\\ns to\\n   130\\ns-140\\ns AFib, initially w/runs V-tach, now HR: 110\\ns-140\\ns AF\\n   w/rare PVC.\\n   Action:\\n   Milnerone decreased @ 2115  from 0.625 mcg/kg/min to 0.5mcg/kg/min  for\\n   hypotension & AF w/RVR.  2Gm magnesium sulfate given IV & 2Gm IV\\n   calcium gluconate given @ 2100-2130.  Given additional 250cc NS X2 for\\n   hypotension less successfully.  Neo increased to 4mcg/kg/min after\\n   cardioversion.  Increased further in early morning to 5mcg/kg/min to\\n   keep MAP>55.\\n   Response:\\n   Runs V-tach stopped but patient remained in AF w/RVR w/rate 110\\ns-140\\n   (mostly 120\\ns-130\\ns)  Neo @ 4-5mcg/kg/min maintains MAP>55.\\n   Plan:\\n   Fluid removal w/CRRT when patient is stable.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   CVVHD continued until 2110.  From [**2136**]-2100, patient received 400cc NS\\n   for hypotension (& routine flush), as well as having IV neo increased.\\n   At 2110, patient went into Afib w/RVR w/frequent runs V-tach.  BUN 44\\n   (42)        Cr 1.7  (1.5)        K 4.1 (3.9)\\n   Action:\\n   Returned patient\\ns blood @ 2110 [**6-17**].  Informed renal fellow.  Did not\\n   resume CRRT as patient was too unstable.\\n   Response:\\n   Patient\\ns V-tach ended as soon as she received her blood back.  She\\n   continued Afib w/RVR.\\n   Plan:\\n   Resume CRRT when patient\\ns HR is under better control, & when she\\n   requires less neo (1mcg/kg/min) to maintain MAP>55.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   On A/C @ 40% w/500Vt/14RR/10PEEP.  Lungs: clear w/diminished BS @\\n   bases.\\n   Action:\\n   Received 25mcg/hr Fentanyl.  Versed ran @ 2mg/hr until 0230 when it was\\n   decreased to 1mg/hr for dilated  (equally) very sluggish pupils.\\n   Patient bites on ET, & moved R foot 1X overnight.  Otherwise no\\n   movement.\\n   Response:\\n   ABG\\ns: 7.42/37/101.\\n   Plan:\\n   No RSBI w/PEEP 10.\\n   ------ Protected Section ------\\n   Renal failure:\\n   Fluid balance for [**6-17**] was positive 1,077cc.  Fluid balance for [**6-18**] @\\n   0700 is positive 2000cc\\noff CRRT since 2100 [**6-17**].\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2145-6-18**] 06:52 ------\\n   GI:  Absent bowel sounds.  Residual 270cc bilious fluid @ 2200.  Intern\\n   & resident aware.  Tube feeds held.  Will need po meds changed to IV\\n   when possible.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2145-6-18**] 07:38 ------\\n',\n",
              "  'This 83 yr old man comes in through the EW w/probable aspiration PNA,\\n   possible cholecystitis, UTI, probable C-diff infection.  PMH: multiple\\n   CVA\\ns w/\\nlocked in\\n syndrome, dementia, depression,  aspiration PNA,\\n   atypical psychosis, PE, thoracic aortic aneurysm.  He is a nonverbal\\n   resident of [**Hospital3 213**] Nursing Home.\\n   Pneumonia, aspiration\\n   Assessment:\\n   Received patient on nonrebreather w/O2 sats 96-100%\\n   Action:\\n   Placed patient on high flow neb  @ 80-40 % O2.  RT suctioned patient\\n   nasotracheally for moderate amount of thick yellow secretions.\\n   Response:\\n   Patient had O2 sats of 96-98% on 40% high flow neb\\n   Plan:\\n   Continue to titrate O2 down as tolerated.\\n   .H/O constipation (Obstipation, FOS)/ Fecal impaction\\n   Assessment:\\n   CT showed fecal impaction w/no  bowel obstruction.  L femoral CVL\\n   placed for IV access in EW.\\n   Action:\\n   Fecal collection bag placed over rectum as patient is constantly oozing\\n   stool (around impaction). Stool sent for C-diff.\\n   Response:\\n   L femoral CVL kept clean.\\n   Plan:\\n   Patient needs line placed elsewhere before fecal impaction is treated\\n   w/enemas etc.\\n   .H/O CVA (Stroke, Cerebral infarction), Other\\n   Assessment:\\n   Patient is stiff, w/legs & arms extended.  Jaw clenched preventing\\n   access into mouth (for suctioning, mouth care, po temps).\\n   Action:\\n   Patient wearing waffle boots.  Patient turned q 2 hrs.\\n   Response:\\n   Has vascular sores on R foot, otherwise skin is intact.  Dressing last\\n   changed @ nursing home on [**6-24**].  Cleaned w/NS & placed adaptic & kerlix\\n   to wounds.  Will change R foot drsg [**Last Name (NamePattern4) **].\\n   Plan:\\n   Continue skin care.  Consider kinair bed.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 80s-120\\ns Afib  BP 99-110\\n   Action:\\n   Coumadin held for INR 5.0-5.4.    Lopressor held for low BP requiring\\n   500cc LR bolus @ 0030.\\n   Response:\\n   Plan:\\n   Continue to monitor HR.\\n',\n",
              "  '75 y/o M w/ a PMH significant for ESRD on HD DM, COPD,OSA who is\\n   chronically trached, CHF, A-fib on coumadin, & R BKA  presented with\\n   hypotension after  dialysis @ [**Hospital 630**] Rehab. In ED, patient was\\n   non-responsive. Given IV fluid, Vanco, levofloxacin, flagy; pressors\\n   started.  CXR suggested possible pneumonia started on broad-spectrum\\n   abx and transferred to M/SICU for further management.  Of note on\\n   admission multiple stage IV and un-stageable decubitus ulcers to lower\\n   back/coccyx/ R and L glutes bilaterally.  Plastics debreded sacral/\\n   coccyx wounds on [**11-4**].  Currently following wound care recommendations\\n   closely.  Pt is being followed by the following services,\\n   Renal/Plastics/Vascular surgery/ ID/ Wound Care.\\n   Since admission MS improved became alert, able to track and follow\\n   commands, levophed weaned off on [**11-7**].   Remains on heparin gtt for\\n   paroxysmal A-fib, tolerating CVVHDF and has been off vasopressin since\\n   [**11-10**] am.\\n   Renal failure, End stage (End stage renal disease, ESRD)\\n   Assessment:\\n   Continues on CVVHDF @ Qb 120 on citrate.         BUN 25       Cr\\n   1.4        K 3.4       serum albumin 2.2  Weight is 106.2kg this am,\\n   down 3 kg from yesterday.  It is only 3kg > admission weight.\\n   Action:\\n   Dialyzer cleared well during flushes despite low PTT.  Patient run even\\n   since midnight due to hypotension each time even 50cc fluid removal is\\n   attempted.  I believe that this (106.2kg) is his EDW in the presence of\\n   a low serum albumin of 2.2.\\n   Response:\\n   Patient is tolerating CRRT well.\\n   Plan:\\n   Continue to attempt to remove fluid as patient\\ns BP tolerates.   Await\\n   renal\\ns decision re: hemodialysis.  Consider a   1 hour dwell of\\n   altepace in venous lumen before hemodialysis for some increased\\n   resistance to flow (no problems w/[**Name2 (NI) 6751**] 120 but may have high venous\\n   pressure w/Qb 350-400).  Perhaps after patient is better nourished in\\n   the future, his EDW can be challenged more effectively.\\n   Impaired Skin Integrity\\n   Assessment:\\n   All wounds essentially unchanged since yesterday.  Patient is now\\n   stooling more frequently, soiling dressings & wounds w/small to\\n   moderate amounts of stool.\\n   Action:\\n   Changed all coccyx & trochanter dressings @ 2200 & 0130 & 0515.\\n   Response:\\n   C/o nausea after lying flat for 60min + for each dressing change,\\n   necessitating tube feeding to be shut off while flat for dressing\\n   change & afterwards as well.  Nausea not relieved w/zofran but equally\\n   relieved over 30-45min w/antacid & by doing nothing.  Resumed tube\\n   feeding after 1.5-1.75 hrs off for each dressing change.\\n   Plan:\\n   Deep debridement planned @ bedside @ 0900 by plastics.  IV heparin shut\\n   off @ 0300.  Tube feeding shut off @ 0600 in preparation for this.  IV\\n   levophed is pressor of choice: @ bedside  just in case its needed.\\n   0600 dose lactulose held for debridement.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Lungs w/crackles @ L base & diminished @ bases. Otherwise clear except\\n   for occasional wheezes.  O2 sats 98-100%.  Patient expectorated a\\n   moderate amount thick yellow secretions mixed w/brown dry secretions X1\\n   @ 0500.\\n   Action:\\n   Albuterol & atrovent MDI\\ns q 6 hrs by RT helped to clear wheezes.\\n   Response:\\n   Inner cannula to trach in place.\\n   Plan:\\n   Continue to encourage C& DB.\\n   Given 60cc lactulose @ [**2141**] [**11-13**] w/ results w/in 2 hrs & lasting 6 hrs\\n   afterwards.  Held 0600 dose to prevent stooling onto wounds during\\n   debridement  @ 0900.  Stool more liquid.  Draining from flexiseal as\\n   well as around flexiseal onto dressings & wounds.  Unable to seal\\n   dressings (including large debrided coccyx wound) proximal to rectum as\\n   skin is impaired all the way to the rectum.\\n',\n",
              "  '89 yr old man admitted through EW from OSH w/RUQ pain,  Dilated CBD &\\n   pancreatic duct on CT.  PMH:diabetes, HTN & Afib.  Transferred to ICU\\n   for hypotension (BP in high 80\\ns/ in EW ) & tachycardia (HR 100-130 AF\\n   in EW).  For ERCP today or tomorrow.  Allergy: PCN\\n   [**Last Name 19**] Problem\\n Dilated CBD & pancreatic duct\\n   Assessment:\\n   No c/o pain. Afebrile.  Hypoactive bowel sounds.  BP:\\n   90\\ns-140/systolic.\\n   Action:\\n   NGT to low intermittent Sx.  No drainage overnight.  Had brown drainage\\n   in tubing,guiac positive (resident aware).  Given 1L NS after CXR\\n   checked to confirm no CHF.  Given 1L LR later in early am.  Started on\\n   Flagyl & levoflox IV.\\n   Response:\\n   BP maintained >90\\ns/systolic.  U/o >35cc/hr.\\n   Plan:\\n   ERCP today or tomorrow.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 100\\ns-140 Afib w/occasional PVC.  Intern & resident aware.\\n   Action:\\n   EKG taken.  Cardiac enzymes (troponin 0.02 in EW) trending down.  No\\n   beta blocker given due to BP dropping into 90\\n   Response:\\n   Takes atenolol @ home.  [**Month (only) 11**] not be absorbed po due to absent to\\n   hypoactive bowel sounds &large NG output in EW.\\n   Plan:\\n   When BP higher, check re: IV beta blocker (lopressor) instead of\\n   atenolol.\\n   ------ Protected Section ------\\n   Patient now DNR/DNI.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2151-8-6**] 06:59 ------\\n',\n",
              "  'Pt is 33yo M w/poorly controlled HTN (dx\\nd ~8yrs ago) w/ resultant ESRD\\n   admitted from [**Hospital1 54**] EW for hypertensive crisis, eevated K+  Also had\\n   hemoptysis x1 in ED; CTA showed severe diffuse b/l ground glass opacity\\n   consistent with pulmonary edema vs pulm alveolar hemorrhage  r/t\\n   hemoptysis\\nsmall likely chronic pulm embolus in RUL segmental branch.\\n   On [**5-7**], Pt found with maroon colored gastric contents w/ coffee ground\\n   flecks via OGT which was hooked to LWS.  Gastroccult pos. Sxn stopped,\\n   lavaged with only very small amt maroon solid.   Has remained NPO with\\n   no additional hemoptysis or emesis.  Pt states that he has experienced\\n   hemoptysis x1 in past with no follow up.  Plan is for am endoscopy.\\n   [**5-8**] Hct 30.7(down from 33.1).  No BM, no emesis or nausea overnight.\\n   Remained NPO except for meds.\\n   Hypertension, benign\\n   Assessment:\\n   BP ran in 130\\ns/sys most of night.  BP up to 151/65  @ 0400\\n   Action:\\n   Held all antihypertensives for BP<150/ except nifedipine 40mg po @\\n   0400.\\n   Response:\\n   BP 155/64 @ 0500 & then dropped to 139/60\\ns @ 0530.  C/o H/A @ 2200 &\\n   0530 when BP in 130\\ns/60\\ns.  Given 5mg oxycodone w/relief for pain [**6-4**]\\n   on [**12-6**] scale\\n   Plan:\\n   Offer Tylenol  next time.\\n   Renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   BUN 77   Cr 13.9    K4.5   PO4 10    Ca 7.6 (no change)  CaXPO4 is\\n   elevated @ 76.\\n   Action:\\n   Kept NPO for possible endoscopy\\n   Response:\\n   Patient asked for food, g-ale, crackers\\n   Plan:\\n   Hemodialysis today.\\n',\n",
              "  'Pt is an 82 y/o woman who went to shelter after loosing heat from ice\\n   storm,  was found unresponsive in a chair. Usually on home O2, no O2 @\\n   shelter.  At OSH pt was hypothermic, bradycardic, and hypoxic, Pt was\\n   intubated, pacing wire place and warmed. Bradycardia responded to\\n   warming & oxygenation.   Her hospital course was complicated by failed\\n   extubation. Pt was transferred to [**Hospital1 54**] on [**11-9**] for further\\n   management.  Her course here has also been complicated by three failed\\n   extubations. Now she is trached and with PEG tube ([**11-20**]). She is being\\n   screened for rehab.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Remains ventilated via trach on CPAP @ 35% w/5 PEEP & 10PS.  O2 sats\\n   remain 98-100%.  No A-line.\\n   Action:\\n   Sx\\ned for small to moderate thick tan blood tinged secretions q 3-4\\n   hrs.  Turned q 2 hrs.\\n   Response:\\n   RSBI: 78\\n   Plan:\\n   Continue pulmonary toilet.  Perhaps SBT today?\\n   Impaired Skin Integrity\\n   Assessment:\\n   Allevyne dressing to coccyx remains D&I.  Flexiseal in place to drain\\n   stool.\\n   Action:\\n   Adaptic, softsorb & kerlix applied to weeping lacerations both arms [**11-26**]\\n   @ midnight.\\n   Response:\\n   Large amount serous drainage from both arms.\\n   Plan:\\n   Continue to change dressings as needed.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   Patient remained in SR 70\\ns-80\\ns w/frequent PAC\\ns & occasional PVC\\n   Action:\\n   Given diltiazem 15mg per PEG q 8 hrs.   Medicated w/40mg IV KCl\\n   w/lasix  @ 2155.\\n   Response:\\n     HR remained in SR w/PAC\\ns.   [**11-26**] am serum K: 4.6  Mg 2.2\\n   Plan:\\n    Diltiazem 15mg increased to qid.  Continue to replete electrolytes as\\n   needed.\\n   .H/O hypertension, benign\\n   Assessment:\\n   BP elevated @ 170\\ns-180\\ns/systolic while awake & asleep.  C/o constant\\n   anxiety.  BP down to 130\\ns/systolic X1 while asleep @ midnight.  Sleep\\n   is restless.\\n   Action:\\n   Medicated w/coreg 6.25mg  @ [**2075**].  Given 10mg IV Lasix @ 2155.\\n   Medicated w/0.5-1mg IV ativan  q 4 hrs as needed.  Provided\\n   reassurance.  Explained  procedures & plan to patient.  Given\\n   hydralazine 10mg per PEG X1 @ 0300 for continued HTN.\\n   Response:\\n   U/o improved from 18cc/hr to 30-240cc/hr.  Urine no longer cloudy, but\\n   clear.  BP 205/79 after 10mg po hydralazine given.  Additional 10mg IV\\n   hydralazine given @ 0308 to bring BP down to 130\\ns-160\\ns/systolic.\\n   Plan:\\n   Continue to provide emotional support to patient.  Keep\\n   sBP>140/systolic to facilitate mentation in this patient w/elevated\\n   BP\\ns @ home.\\n   ------ Protected Section ------\\n   Started Tube feed @ 10cc/hr @by 2200.  No c/o\\n   pain/nausea/vomiting/stomach distress.  Residuals 0-5cc.  Increased to\\n   20cc/hr @ 0606.  Treated w/simethicone for gas (seen in flexiseal tube\\n   & bag) @ [**2075**].  Also received reglan 10mg per PEG qid.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2154-11-26**] 06:40 ------\\n',\n",
              "  'This 59 yr old woman was transferred from 12R w/Afib w/RVR, rate\\n   140\\ns.  After being treated w/lopressor & diltiazem 10mg IV, her BP\\n   dropped to the 80\\ns/systolic, w/out effecting her HR & rhythm.  Sent to\\n   MICU for f/u.   Had perc nephrostomy earlier in day for obstructive\\n   ureterolithiasis, UTI w/infected stone.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   Patient arrived to MICU w/HR in 140\\ns-150\\ns AFib.\\n   Action:\\n   Given 12mg IV lopressor (out of 15mg ordered, last 3 mg held for\\n   hypotension), w/no improvement in HR.\\n   Response:\\n   Given 15mg IV diltiazem @ 0035.  By 0100, patient converted to SR w/HR\\n   in 70\\ns, no ectopy.  Remained in SR 70\\ns-80\\ns w/no ectopy all night.\\n   Plan:\\n   Started on 30mg po diltiazem po q 6 hrs.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP in 80\\ns/sysupon arrival, soon improved to 100/50.\\n   Action:\\n   Patient given 500cc NS bolus on floor immediately before transfer.\\n   Given another 1L LR after lopressor 12mg .  Given 1 unit PRBC\\n   0130.  Pre Hct was 24.5.\\n   Response:\\n   BP came up to 90-106/systolic.    Post Hct was 25.6.\\n   Plan:\\n   Continue to monitor  BP.  Hold dilt for BP<90.     Low BP thought to be\\n   from dehydration.\\n   Nephrolithiasis (Kidney Stones)/s/p perc nephrostomy\\n   Assessment:\\n   Patient drained 320cc pink urine into drainage bag from nephrostomy\\n   overnight.  C/o [**6-17**] pain @ L flank.   DSD to L nephrostomy exit site:\\n   clean, dry & intact.     BUN 40 (46)     Cr 3.3 (3.6)      HCO3 is 17\\n   (no change)\\n   Tpo 100.1.  Per report , Tmax was 103 po on [**10-14**] (after\\n   nephrostomy).      WBC 9.2 (7.8)\\n   Action:\\n   L flank pain relieved down to 2/10 w/0.5mg IV dilaudid.\\n   Response:\\n   As above.\\n   Plan:\\n   Continue to monitor drsg, u/o.  Assure that nephro tube remains\\n   unkinked & urine is flowing.\\n   Serum magnesium 1.5 this am, needs repletion.  PLT 125 (152).\\n',\n",
              "  'Impaired Skin Integrity\\n   Assessment:\\n   Patient\\ns drsg [**Name5 (PTitle) **] [**Name5 (PTitle) 1377**] [**Name5 (PTitle) 1378**] injury @ coccyx is D&I.\\n   Action:\\n   Turned q 2 hrs. On kinair bed.  Change drsg [**Name5 (PTitle) **] [**Name5 (PTitle) 1379**].\\n   Response:\\n   Patient  has discomfort w/turning. Relieved once turning finished.\\n   Plan:\\n   Medicate w/Tylenol for ease w/turning.\\n   Delirium / confusion\\n   Assessment:\\n   Patient was alert in early evening & oriented X1. As she became more\\n   sleepy, she became more confused.  Talked to herself for most of the\\n   night.\\n   Action:\\n   Unable to use bed alarm on kinair bed. Increased visibility by pulling\\n   curtains back. Bed locked & low. All siderails up as kinair bed is off\\n   the ground by a good amount even in low position.  Checked patient\\n   frequently.  Given zyprexa. Held off on feeding patient while she was\\n   so confused.\\n   Response:\\n   Patient continued to be confused.\\n   Plan:\\n   Orient patient [**Name5 (PTitle) **].  Check w/MD\\ns re: plan to feed patient.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Lungs sound clear @ upper lungs, crackles to diminished @ bases.\\n   RR20-35 O2 sat 93-99% on 2-3L NP.  Desatted to 88% on room air.  CXR\\n   [**1-25**] am showed large R pleural effusion & suggestion of substantial\\n   pleural fluid on L as well.\\n   Action:\\n   Given 120mg IV lasix @ 2245.\\n   Response:\\n   Patient is 1L negative as of 0530 [**1-26**].\\n   Plan:\\n   Continue to monitor for resp distress. Continue to monitor O2 sats.\\n   Continue to minitor u/o.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   Patient was in SR w/frequent PAC\\ns & occasional PVC\\ns until 0415.\\n   Converted to A-fib rate 128.\\n   Action:\\n   Given 5mg IV lopressor.  Started on 12.5mg po lopressor [**Hospital1 **]. 1^st dose\\n   [**2154**] [**1-25**].\\n   Response:\\n   Converted back to SR in 70\\ns-80\\ns w/frequent PAC\\ns & occasional PVC\\n   Plan:\\n   Give 5mg IV lopressor [**Month/Day (4) **] A-fib w/RVR\\n   This is an 86 yr old woman with c/o L hip pain, admitted w/urosepsis.\\n   Required fluid  resuscitation & levophed. Also intubated. Extubated\\n   [**1-23**]. Stable off pressors for days. Treated w/zosyn for pseudomonas in\\n   urine.  Several episodes of conversion to A-fib w/RVR.  Treated w/IVF &\\n   lopressor successfully.\\n',\n",
              "  '61 yo M s/p BMT for multiple myeloma, his hospital course has been\\n   complicated by  e coli bacteremia, respiratory failure/ARDS in setting\\n   of parainfluenza,  and renal failure now on CVVHD for volume removal.\\n   Prior to the start of CVVHDF Mr. [**Known lastname **] had been persistently\\n   febrile.  His course has been further complicated by a new onset of\\n   A-fib with RVR, treated w/ IV amiodarone and has now been converted to\\n   IV dig & lopressor with improved rate control.   Changed from fentanyl\\n   & versed to  propofol [**3-28**].  Very labile BP since.  Deferred tunneled\\n   dialysis catheter placement in IR [**3-28**] for labile BP (\\n   70\\ns-190\\nsw/sys). On IV heparin for presumed PE (TTE poor quality,\\n   couldn\\nt r/o it ).\\n   Family meeting planned for Mon or Tues w/BMT, renal, ID etc & wife per\\n   social service.\\n   H/O Hypertension, benign\\n   Assessment:\\n   Patient  had very labile BP: 80\\ns/systolic-170\\ns/systolic in 5 min.\\n   Propofol infused @ 15-20mcg/kg/min.\\n   Action:\\n   Increased  propofol for BP 170\\ns/ & >.    Attempted to awaken patient\\n   for BP in 90\\ns/ or <.  Decreased propofol for BP 120\\ns/ & <.     All\\n   doses 15mg IV lopressor q 4 hrs held since 0800 [**3-28**] dose given.  5mg\\n   IV lopressor given @ 0500 [**3-29**].\\n   Response:\\n   Patient\\ns BP quickly responded to shaking shoulder.  BP more slowly\\n   responded to titration of propofol.  NS boluses not required.\\n   Plan:\\n   Continue to titrate propofol as needed.  Patient may benefit from\\n   ativan or more long acting anti-anxiety med.  Resident says they will\\n   try haldol later in morning.\\n   [**Last Name **] Problem\\nAltered Gas Exchange\\n   Assessment:\\n   Patient remains on A/C @ 40% w/Vt 500X14 & 5 PEEP.    RR: 14-24\\n   O2 sats: 98-100%         Lungs: clear w/ diminished breath sounds @\\n   bases.   Remains comfortably dys-synchronous w/vent.\\n   Action:\\n   Suctioned X2 (q 8 hrs) for moderate amt thick white secretions.\\n   Response:\\n   ABG\\ns: 7.40/40/99       RSBI 28\\n   Plan:\\n   [**Month (only) 51**] tolerate CPAP better now that he is less sedated.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 80\\ns-110\\ns Afib\\n   Action:\\n   Held [**2155**] & midnight  doses of 15mg IV lopressor for intermittently low\\n   BP down to 80\\ns-90\\ns/systolic.  Gave 5mg IV lopressor only @ 0500 for\\n   HR in 120\\ns (BP 180\\ns/sys)\\n   Response:\\n   HR remained 80\\ns-110\\ns Afib.  HR dropped to 80\\ns-90\\ns AF & BP dropped\\n   to130\\ns/systolic.\\n   Plan:\\n   Give lopressor IV if HR increases to 120\\ns ( & titrate propofol down if\\n   needed).\\n   [**Last Name **] Problem\\n Mental status\\n   Assessment:\\n   Patient is more alert, opening eyes to people talking.    Not focusing\\n   however.  Lifted both arms off bed.\\n   Action:\\n   Restrained both arms so as to prevent self-extubation.  Given  IV\\n   propofol 15-20mcg/kg/min for sedation.  Had head CT [**3-28**] which showed\\n   no changes since [**2165-3-15**].\\n   Response:\\n   Patient is more awake on this dose IV propofol than he was on\\n   100-150mcg/hr fentanyl & 2-3mg/hr versed.\\n   Plan:\\n   Continue to assess mental status, alertness.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Patient has been off CRRT since 1000 on [**3-28**].       BUN: not\\n   ordered       Cr  3/0 (1.8)        K3.3 (3.6)    Wgt is up 2kg since\\n   yesterday :131.9 kg (129.8 on [**3-28**]).\\n   Action:\\n   Given 1 unit PC\\ns for Hct 20.7  down from 26.7 earlier in the day.\\n   Patient had received 1500cc NS since CRRT stopped.\\n   Response:\\n   No S&S bleeding\\nno BM.  Guiac negative residual from OGT.\\n   Plan:\\n   Check K w/post transfusion Hct.   Tunnelled dialysis catheter placement\\n   when  vs stable.\\n',\n",
              "  'This is a 63 yr old recently retired schoolteacher, w/hx  glaucoma, DVT\\n   [**2162**], multiple myeloma s/p auto stemcell [**2162**].  He was admitted w/L\\n   foot pain X4 days w/CPK 5000.  Dx compartment syndrome & underwent\\n   fasciotomy to LLE [**10-1**].  Had MS changes the morning before fasciotomy on\\n   [**10-1**] w/negative head CT.  Respiratory & cardiac arrested after\\n   extubation in OR requiring emergent trach.  Transferred to [**Hospital Ward Name 77**]\\n   MICU/SICU on vent. Underwent fasciotomy to RLE on [**10-2**] again for\\n   compartment syndrome.  Elevated CPK\\ns since before admission (\\n   especially in setting of muscle damage from surgery).\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   O2 sats: 97-100%   RR: 17-23      Lungs: clear @ upper lungs,\\n   diminished @ bases.\\n   Action:\\n   Patient weaned off propofol by 2115 [**10-2**].  Was on A/C 70%/550 Vt/12\\n   RR/15 PEEP.  Changed to CPAP 50%/ 5 PS/ 10 PEEP @ 2200.  Sx\\ned for\\n   small to scant amounts bloody secretions every 2-4 hrs.\\n   Response:\\n   ABG\\ns after vent change: 7.47/34/98 (note: IV w/HCO3 running @\\n   150cc/hr).  ABG\\ns iseveral hours later: 7.48/35/129.\\n   Plan:\\n   Continue to wean vent settings w/goal of placing patient on trach\\n   collar  today.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Patient had large amount sanguinous drainage from both leg dressings,\\n   saturating bed linen or chux under each leg.  Bilateral DP\\ns & PT\\ns are\\n   weakly palpable.\\n   Action:\\n   BLE\\ns elevated slightly by 1 pillow to keep heals off bed.  LLE drsg\\n   [**Name5 (PTitle) 15**] @ 0430 this am.  Muscle tissue exposed: red & moist w/old clots\\n   @ edge of incision.  Rinsed w/sterile NS & drsg [**Name5 (PTitle) 390**] as described\\n   below.\\n   Response:\\n   Hct dropped from 23.7 preop [**10-2**] to 20.5 @ midnight  [**10-3**] (EBL only\\n   30cc).\\n   Plan:\\n   RLE has primary dressing\\nreinforce as necessary.  Change LLE drsg [**Last Name (NamePattern4) 384**] &\\n   prn: Cover open fascia w/single layer of plain xeroform (no packing).\\n   Follow by gauze & ABD pads, then wrap w/kerlix.  Cover loosely w/chux\\n   as needed.   In future may have VAC.  Transfused w/1 unit PC\\ns before\\n   am labs.  Received 2^nd unit PC\\ns after.\\n   Rhabdomyolysis\\n   Assessment:\\n   Postop CPK @ 1800 ( [**10-2**]) was 15,681, up from admission CPK of 5000.  At\\n   0030 [**10-3**], CPK was: 17,133\\n   Action:\\n   D5W w/150 mEq NaHCO3 infused @ 150cc/hr X 1000cc.  Did not continue as\\n   pH was 7.48 this am.\\n   Response:\\n   U/o increased from 50- 100cc/hr to 200cc +/hr\\n   Plan:\\n   Continue to keep u/o 100-150cc/hr.  Draw CPK\\ns  as needed ( q 8 hrs).\\n   Patient can get up to chair today (pivot into chair w/walker & 2\\n   assist) once he is on trach collar & stable , per surgical resident.\\n   Just check w/Dr. [**Last Name (STitle) 113**] 1^st.   PT consult ordered.  Need order for\\n   another pain med off vent, as Fentanyl 25-100mcg IV will no longer be\\n   appropriate @ that  time.\\n   ------ Protected Section ------\\n   NGT held per resident as patient most likely to come off vent 9/4.\\n   Colace held therefore.  Bisacodyl suppository given @ 0530 instead\\n   after patient passed flatus overnight & unsuccessfully attempted BM on\\n   bedpan this am.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2165-10-3**] 07:05 ------\\n',\n",
              "  'Shock, septic\\n   Assessment:\\n   Patient\\ns MAP ranged from 55-71 w/systolic BP 79-90/.   SvO2 57-73%.  C\\n   O was 2.9-4.0  CI was 1.8-2.3.\\n   Action:\\n   Increased levophed to maximum amount w/refractoey sepsis of\\n   42mcg/kg/min.  Continues on vasopressin 2.4 units/hr.  Gave 500cc LR\\n   boluses X2 to keep MAP>65. Started dobutamine for a short time\\n   w/increase in CO & SvO2.\\n   Response:\\n   Still dropped MAP to<60   Changed desired MAP to >60 per resident.\\n   Received 500cc LR boluses X4 to keep MAP>60 ( for a total of 3L LR\\n   overnight)\\n   Plan:\\n   Keep MAP> 60 w/LR boluses .  Assess need for 3^rd pressor.\\n   Pulmonary Embolism (PE), Acute\\n   Assessment:\\n   Action:\\n   Remains on IV heparin @ 750 units/hr (turned off X1 hr 1^st) for\\n   PTT>150.\\n   Response:\\n   PTT drawn @ 0630\\n   Plan:\\n   Check results when available.\\n   Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name **])\\n   Assessment:\\n   On CMV 80%/RR 30/PEEP 10/Vt 400.  O2 sats 91-100%\\n   Action:\\n   Increased PEEP to 12  w/ABG unchanged  (7.27/36/62  & SaO2 91%)\\n   Response:\\n   Decreased PEEP back to 10. Checked next ABG  8 hrs later.  Much\\n   improved @ 7.33/33/104.\\n   Plan:\\n   Check next ABG after next vent change ( probably decreased FiO2)\\n',\n",
              "  'Pulmonary edema\\n   Assessment:\\n   Lungs are diminished @ bases, otherwise clear.  No c/o SOB.  RR 20\\n   O2 sats 94-97% on 4L NP. BP 110\\ns- 130\\ns/systolic.\\n   Action:\\n   Received 80mg IV lasix @ midnight & 1745 on [**3-6**]. On diltiazem 120mg po\\n   q 6 hrs.\\n   Response:\\n   Patient was 2L negative for [**3-6**].  Achieved goal.\\n   Plan:\\n   Maintain rate control to prevent CHF.\\n   Urinary tract infection (UTI)\\n   Assessment:\\n   Foley draining clear light yellow urine. Afebrile.\\n   Action:\\n   Started macrodantin [**Hospital1 **]  [**3-6**]. Continues on flagyl 500mg po tid (for\\n   mouth flora) Bactrim D/C\\n   Response:\\n   Continues to be afebrile. No urinary c/o\\n   Plan:\\n   Continue to medicate w/macrodantin.  Continue to check temp.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR 50\\ns SB-70\\ns SR no ectopy.\\n   Action:\\n   Given diltiazem 120mg po qid, as well as carvedilol.\\n   Response:\\n   Patient remains in sinus bradycardia to sinus rhythm.\\n   Plan:\\n   Give amiodarone IV prn  conversion to A-fib.\\n   This 68 yr old woman was admitted to [**Hospital1 19**] from [**Hospital1 189**] on [**2167-2-19**]\\n   w/changes in MS in setting of UTI & sedation. PMH includes CAD, CHF,\\n   HTN, CLL ( had chemo), chronic thrombocytopenia, hypothyroid, gout,\\n   several admissions for hypertensive urgency, chronic pancytopenia, CRI\\n   (baseline Cr 1.3), DM type 2. Discharged from [**Hospital1 19**] [**2167-2-2**] afyer\\n   airway compromise, fever, UTI, acute on chronic renal failure,&\\n   worsening anemia/thrombocytopenia.\\n     Transferred from floor on [**3-4**] w/BP 199/107, chest pain, hypoxia from\\n   pulmonary edema in setting of Afib w/RVR & hypertensive urgency.\\n   Treated w/ CPAP, NTP,nebs & lasix, & contolled rate w/diltiazem.\\n     Has thrush. Refused nystantin  tonight. Has dental pain (ongoing).\\n   Relieved w/tylenol 1000mg q 6 hrs prn. Avoid narcotics as sedation\\n   caused MS changes that brought patient into hospital.\\n     Patient is called out of ICU. Awaiting bed on floor.\\n',\n",
              "  \"58 yo male with end stage cirrhosis from Hep C with HCC with SBP,\\n   encephalopathy, refractory ascites, varices.\\n   Admitted [**2168-4-7**] for umbilical hernia repair then transferred to\\n   medical floor 3-4 days ago for ongoing care. Yesterday he developed\\n   mild abdominal pain. Dx paracentesis today notable for SBP with 6000\\n   WBC's with 90% PMN's. BG's have started increasing to the 500's, WBC\\n   increased to 19. Prior peritoneal cultures + for MRSA. Given known\\n   septic source with hyperglycemia, worsening renal insufficiency, and\\n   concern for sepsis, he was sent to the ICU.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Oliguric, icteric U/o 0-20cc/hr,  rising BUN/Creat  104/5.1,\\n   hypokalemic K+3.2 repleted KCL 40meq.  @ 1400 started HD responding\\n   Hypotension SBP70\\ns requiring Fluid return via HD.  Awake alert\\n   oriented x3  @ times slow to respond.  [**First Name8 (NamePattern2) **] [**Last Name (un) 5106**] equal strength.\\n   Action:\\n   Electrolyte repletion KCL 40Meq, Ca+phos replacement.  To IR for HD\\n   line placement LSC. HD@ 1400\\n   Response:\\n   Symptomatic Hypotension during HD requiring fluid,\\n   Plan:\\n   Seriel Labs electrolytes  repletions per parameters.\\n   HD [**4-19**]\\n   Hepatorenal syndrome\\n   Assessment:\\n   HR 80-100 NSR no ectopy,  NBP 80-110 Maps >60 transient hypotensive\\n   episodes SBP<80 MAPS<55, Jaundice warm and dry, abd lg firm + BS\\n   ascites, paracentesis site dsg intact . Mid abd surgical site\\n   steristrips intact. Mod amt serosang drainage. dependent  4+ edema\\n   sacral back. Awake alert oriented x3 @ times slow to respond. Pupils\\n   3mm equal react brisk. MAE random equal strength.  No tremors/seizures.\\n    Stool x 2 lg amt golden brown liq stool.\\n   Action:\\n   Received Octreotide/midrdine, rifaximaine, albumin per routine.\\n   Lactalose.  Fluid return per HD with responding ^BP.\\n   Response:\\n   BP responsive to fluid and albumin\\n   Plan:\\n   Cont meds\\n   Goal SPB>80 and MAPS>55\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   T-mac 98.5, WBC 8.8.  + culture from paracentesis fluid (+) MRSA, Bl\\n   cult + x1 GPC.\\n   Action:\\n   ID consult , afebrile , abx daptomycin.\\n   Response:\\n   Plan:\\n   Follow cultures ,\\n   Follow vancomycin levels\\n   Hyperglycemia\\n   Assessment:\\n   Received pt NPO, Off IV insulin,  IV d5NS 10cc/hr  FSBP 93-161.\\n   Action:\\n   Seen by [**Hospital1 **], resume diet and TF s/p HD.\\n   Response:\\n   BS control.\\n   Plan:\\n   Restart  Insulin sliding scale.\\n\",\n",
              "  'This is a 33 yo male pt with h/o large B cell lymphoma s/p allo-BMT in\\n   [**2166**] c/b severe GVHD of skin/mucosa, TPN dependent,  and recent PE on\\n   lovenox a/w tachycardia.  Pt was recently admitted w/SOB and [**Female First Name (un) 188**]\\n   fungemia.  Discharged to rehab then home 5d ago.  On [**4-7**] he  presented\\n   to [**Hospital 2629**] clinic w/several days of malaise, SOB, F (102 at home).\\n   +nonprod cough.  +N, vomited x1 on day PTA.  Initial VS: temp 103, HR\\n   160, BP 114/88, 91% RA.  Got 2L IVF and outpt BB.  PE CT negative.\\n   Post CT HR decreased to 130s but SBP 70s, so transferred to [**Hospital Unit Name 44**] for\\n   further w/u, management.  Dx w/strep pneumoniae bacteremia.  By CXR\\n   [**3-11**], new L pleural effusion (due to 3^rd spacing post fluid\\n   resuscitation when hypotensive on admission) & R LL infiltrate.  On IV\\n   heparin to pevent PE (hx PE\\n   Tachycardia, Other\\n   Assessment:\\n   HR: 101-119 ST no ectopy     BP maintained @ 110-130/72-93.  Tmax 98.3\\n   axillary.  WBC   on immunosuppressive therapy.\\n   Action:\\n   Received lopressor 25mg po tid. Also medicated for pain w/4mg IV\\n   morphine X2.  Medicated w/0.5mg ativan X2, to help patient sleep.\\n   Nafcillin D/C\\ned &  Ceftriaxone  IV started [**4-11**] (strep pneumoniae\\n   sensitive to ceftriaxone).\\n   Response:\\n   Slept in naps. HR not improved yet.\\n   Plan:\\n   Check w/MD re: increasing lopressor.    Continue to monitor temp\\n   Serum Mg 1.6.  Repleted w/2 Gm IV magnesium sulfate @ 0700.  PTT was\\n   56.4.   Increased IV heparin by 150 units from 1150 units/hr to 1300\\n   units/hr, after 1,300 unit [**Last Name (LF) 774**], [**First Name3 (LF) **] [**Hospital1 54**] heparin dosing guidelines.\\n   Will need PTT @ noon.   K3.5.  To have potassium sliding scale ordered.\\n   ------ Protected Section ------\\n   Patient is called out of MICU but does not have bed.  Awaiting bed on 7\\n   [**Hospital Ward Name 669**].\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2170-4-12**] 06:41 ------\\n',\n",
              "  'Mrs [**Known lastname 185**] is a 47 yo pt with no PMH exept for the following. Pt has hx\\n   of left upper arm DVT with hx of recent flying who presented to ed with\\n   c/o sudden worsening tachypnea over baseline tachypnea over the last 3\\n   mos. Had leg cramping 4 months ago. Pt had left DVT I yr ago in the\\n   setting of bunionectomy, @ the site of her peripheral IV. At that time\\n   ot was sent home with lovenox bridge to coumadin. Pt flies every week\\n   for work and her last flight was last week. This past weekend the\\n   dyspnea became suddenly and acutely worse so she came to ed for\\n   evaluation. In ed she underwent CTA which was notable for multiple\\n   bilateral PE\\ns and CT evidence of RV strain.remained hemodynamically\\n   stable but was tachycardic to 110\\ns. o2 sats 92-93% on room air. Was\\n   bolused with 4800 units heparin and gtt initiated at 1100u/hr.\\n   Plan is to watch her for hemodynamic instability.  If patient\\n   decompensates, then she will have lytic therapy.\\n   .H/O pulmonary Embolism (PE), Acute\\n   Assessment:\\n   RR 17-35  O2 sats 96-98 on 4L NP.  O2 sat drops to 93-94% off O2 but RR\\n   increases to 35.  No c/o pain in chest , legs or arms.  Dyspnea on\\n   exertion.  Up to commode to void.\\n   Action:\\n   IV heparin infused @ 1100 units/hr.  Decreased O2 to 3L NP @ 0400.\\n   Response:\\n   PTT  was still therapeutic @ 64.2-64.8 overnight.  O2 sats  97% on 3L\\n   NP.\\n   Plan:\\n   TTE in am ([**7-28**]) to evaluate enlarged RV.  Continue IV heparin.  Lytic\\n   therapy for hemodynamic compromise.\\n   Needs additional IV placed.  Anxious & teary-eyed over this last night,\\n   strongly wanted to wait until daytime [**7-28**] for IV placement.  Said it\\n   was difficult to place an IV or obtain blood from her.  Drew blood from\\n   her #18G IV in R AC after withdrawing & discarding appropriate amount\\n   of blood.\\n',\n",
              "  '85 yr old Portugese speaking man admitted through EW w/melena X 3 days\\n   & Hct 15.9.  Received 2 units PC\\ns in EW to bring his Hct up to 21.5.\\n   Also received 2000cc NS.  PMH: CAD, CHF, COPD, CRF stage 4 (recent\\n   baseline Cr 2.7).  Family translates for patient.\\n   Gastrointestinal bleed, other (GI Bleed, GIB)\\n   Assessment:\\n   HR stable @ 60\\ns-90 SR w/rare PVC  & BP stable @ 125-140/39-67.\\n   Action:\\n   Received 1 unit PC\\ns.  Started on IV pantoprazole @ 8mg/hr.\\n   Response:\\n   Post Hct: 24.6   Transfused w/another unit PC\\n   Plan:\\n   Draw post Hct 1 hr after transfusion complete. Transfuse to Hct 27.\\n   Once Hct 27,check serial Hcts q 6 hrs.    EGD/colonoscopy planned for\\n   Fri.\\n   .H/O renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   BUN 150 & Cr 5.3  in EW.   Voiding in 350cc amounts clear yellow\\n   urine.  UA : no infection.  Urine for osmolality, & lytes sent.\\n   Patient is 2,300cc positive in fluid balance since admission last\\n   night.\\n   Action:\\n   Transfused as above.  Received 60mg IV lasix @ 2230.  Usually receives\\n   160mg po lasix  [**Hospital1 **].\\n   Response:\\n   BUN 137       Cr  4.8    w/am labs.\\n   Plan:\\n   Continue to transfuse as above.  Follow BUN & Cr.  Continue lasix as\\n   needed.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   C/o abdominal & bilateral leg pain,\\n on a 1-10 scale.\\n   Action:\\n   Received morphine 1mg IV @ 0015\\n   Response:\\n   Pain dropped to\\n on [**1-15**] scale\\n   Plan:\\n   Continue to assess for pain.  Medicate as needed: 1mg IV morphine q 6\\n   hrs prn pain.\\n   .H/O heart disease, other\\n   Assessment:\\n   [**9-7**] @ 1500, CPK  1605       MB 25         troponin 0.45\\n   Action:\\n   Drew cardiac enzymes again @ 0300.  EKG done @ 2130\\nno changes from\\n   previous per resident.\\n   Response:\\n   Elevated CK from myositis (pain/muscle damage in legs), elevated\\n   troponin from demand ischemia.  CK2419  MB 35   &  troponin 0.38  w/am\\n   labs   Cardiac enzymes are trending down.\\n   Plan:\\n   EKG (done by floor) ordered for [**9-8**].  Follow cardiac enzymes.\\n   ------ Protected Section ------\\n   Ecchymosis @ R upper arm noted upon arrival from EW.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2174-9-8**] 06:17 ------\\n',\n",
              "  'This 77 yr old man was admitted w/weakness, SOB &hyperglycemia.  Had\\n   inpatient stay @ [**Hospital3 887**] recently for PNA.  Had a CTA & a large\\n   PE in R & L main pulmonary arteries ( & straightening of\\n   intraventricular septum) was discovered.  Started on IV heparin & sent\\n   to [**Hospital Ward Name 51**] MICU on O2 @ 4L NP.\\n   Speaks Albanian as 1^st language. Speaks Italian.  Speaks some\\n   English.  Moved from [**Country 2348**] 13 yrs ago.  Patient & his wife live w/\\n   son, [**Name (NI) 2359**], & daughter-in-law.\\n   .H/O cancer (Malignant Neoplasm), Pancreas\\n   Assessment:\\n   Patient c/o L flank pain fromn unresectable pancreatic mass (referred\\n   pain)\\n   Action:\\n   Given oxycontin 20mg po @ 200 & 10mg oxycodone @ 0030\\n   Response:\\n   Relief of pain from\\n on [**1-5**] scale to\\n   Plan:\\n   Continue to offer oxycodone prn pain q 4-6 hrs.\\n   [**Last Name **] Problem - [**Name (NI) **] Description In Comments: Pulmonary embolism\\n   Assessment:\\n   RR 20\\ns.   O2 sats 97-99% on 4L NP.\\n   Action:\\n   IV heparin @  800 units/hr  Mn until 0400, bolused 500 units &\\n   increased to 850 units/hr for PTT 40.9.\\n   Response:\\n   Plan:\\n   Next PTT due @ 1000 am\\n   .H/O diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS  329 ([**2166**])\\n   Action:\\n   Covered w/10 lantus & 8 humalog sc (per sliding scale)\\n   Response:\\n   FS dropped from 329 ([**2166**]) to 152 (0200).\\n   Plan:\\n',\n",
              "  'Ms. [**Known lastname 5996**] is a 60 yo woman with ALL who has been in an out of the\\n   [**Hospital Ward Name 77**] ICU during her prolonged hospital course, currently on her 76th\\n   day since admission.  She transferred to the [**Hospital Unit Name 10**] in the setting of\\n   sudden onset tachycardia in association with chest pain and respiratory\\n   distress as well as sepsis.\\n   While being treated on the [**Hospital1 **], pt has required 500 cc bolus of IVFs\\n   for hypotension and then found to be more tachypneic. Given ativan for\\n   anxiety then upon reeval, pt still tachypneic and appeared to be\\n   tiring. Respiratory code called, pt intubated by anesthesia and\\n   transferred to [**Hospital Unit Name 10**] on [**5-7**]/9. patient was extubated successfully to 35%\\n   cool neb [**5-10**].  Patient placed on tube feedings for nutritional support\\n   until speech & swallow can verify ability to take po.  Needs video\\n   exam.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   Maintained O2 sats @ 95-100% on 35% humidified oxygen via tent mask.\\n   Lungs: clear @ upper lungs, diminished @ bases.\\n   Action:\\n   Given atrovent neb Tx @ midnight  & 0600.\\n   Response:\\n   Occasional tachypnea from anxiety.  Can relieve anxiety w/TLC &/or\\n   ativan.\\n   Plan:\\n   Provide emotional support.  Offer ativan as needed.\\n   Hyponatremia (low sodium, hyposmolality)/ Alteration in Nutrition\\n   Assessment:\\n   Na 140 (139).\\n   Action:\\n   Remained on tube feeding overnight w/50cc flushes q 6 hrs given as NS\\n   instead of water.  Increased tube feeding to maximum amount ordered:\\n   35cc/hr.\\n   Response:\\n   Residuals only 0-5cc.\\n   Plan:\\n   Check w/team re: changing NS flushes w/tube feeding back to water.\\n   Oliguria\\n   Assessment:\\n   Patient initially had 13-  cc u/o q hr.  Patient was intravascularly\\n   dry while having total body edema.\\n   Action:\\n   Given 500cc of 5% albumin followed by 40mg IV lasix.\\n   Response:\\n   U/o increased to 100-500cc/hr.\\n   Plan:\\n   Continue to monitor u/o.  Consider transferring to floor.  Continue to\\n   increase TF rate so as to increase protein intake.  Await video swallow\\n   exam in future.\\n',\n",
              "  '52 yr old woman w/hx Crohn\\ns dz.  Had abdominoperineal resection, end\\n   (descending) colostomy & vental hernia repair w/mesh on [**9-1**].\\n   Developed SBO involving proximal jejunum.   Had exp lap w/lysis of\\n   adhesions [**9-20**].\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   Hr 60\\ns to 120\\ns Afib w/ occasional PVC\\ns & 3-8 beat short runs of\\n   V-tach.  Pt is ordered for 20mg IV lopressor q 4 hrs but only received\\n   10mg @ [**2167**] & 0000. BP dropped into high 80\\ns/sys for hour after\\n   receiving lopressor 10mg IV.  0400 dose was held for low BP in\\n   90\\ns/systolic.\\n   Action:\\n   Monitoring hemodynamic status closely.  Lopressor dosed as above.  Able\\n   to tolerate Diltiazem 60mg via NGT q 6 hrs since noon on [**9-22**].   Nausea\\n   well controlled w/ compazine 10mg IV  given w/each dose of diltiazem.\\n   Response:\\n   HR controlled on current regimen.  Pt has remained A+OX3 and has denied\\n   dizziness. Pt w/ several short self-limiting runs V-tach. Pt remained\\n   asymptomatic.\\n   Plan:\\n   Continue diltiazem per NGT as ordered for rate control.  [**Month (only) 51**] have\\n   lopressor changed to per NGT.  Consider having IV dose changed to 10mg\\n   or less.  Monitor hemodynamic status closely.\\n   Small bowel obstruction (Intestinal obstruction, SBO, including\\n   intussusception, adhesions)\\n   Assessment:\\n   S/p exp lap w/ [**Doctor Last Name 9487**] on [**9-20**] as above. JP drains in place X3.  Changed\\n   DSD to  midline abdominal incision qd & prn after antimicrobial scrub\\n   to abdomen qd.  Had moderate serosanguinous drainage over upper\\n   incision (the\\n w/staples).  Colostomy in place w/ 50cc liquid green\\n   stool.   Pt continues to wear abdominal binder @ all times.   Abdomen\\n   soft w/ BS present. NGT to low wall snx\\n draining small to moderate\\n   amounts dark green bile. Pt has remained afebrile.\\n   Action:\\n   Monitoring abdominal assessment. Continued NGT to low wall snx.\\n   Monitoring output from all tubes and drains. Monitoring for s/s\\n   infection. Flagyl and levofloxacin have been D/C\\nd and pt continues\\n   vancomycin as ordered.\\n   Response:\\n   50cc liquid green stool  in colostomy bag.  Srosanguinous drainage\\n   from JP drains, see flowsheet for details.  Pt remains afebrile.\\n   Plan:\\n   Continue to monitor abdominal assessment. Monitor for s/s infection..\\n   Continue abx as ordered. Wound care for abdominal incisions as ordered,\\n   ie, hibiclens scrub to abdomen qd.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Abdominal incision pain has been controlled on just morphine PCA &\\n   toredol, bringing abdominal pain down from [**2177-10-17**] to [**6-16**].  With\\n   (toredol RTC)& fentanyl patch & 2-4mg IV morphine q 1.5-3 hrs for\\n   breakthrough pain, pain was relieved down to [**2177-4-10**].\\n   Action:\\n   Monitoring pain assessment closely.  Continues torodol 15mg IV q 6 hrs\\n   ordered prn but given round-the-clock per patient\\ns request. Started on\\n   fentanyl patch 50mcg on [**9-22**] @ 1600.  Also received 0.5mg ativan q 4\\n   hrs for anxiety & restlessness.\\n   Response:\\n   This was reviewed w/ surgical team. Pt has been  on fentanyl 50mcg/hr\\n   patch and started on morphine PCA (1mg/6/10mg) @ 0700 this am.  BP:\\n   105-113/systolic since starting PCA.  Has been hypotensive to high\\n   80\\ns/systolic overnight.\\n   Plan:\\n   Continue to follow pain assessment closely. Continue fentanyl patch w/\\n   morphine PCA. Assess for hypotension.\\n',\n",
              "  \"69y.o. female transferred from [**Hospital6 **] with increased SOB,\\n   GIB, Dizziness. Originally admitted to [**Hospital3 **] with INR 11.0 hct\\n   23. Passing black tarry stools for days. Received 3U PRBC, 3U FFP, Vit\\n   K. Deveolped CHF treated with lasix and family asked for her to come to\\n   [**Hospital1 1**]. Arrived initially admitted to 11R then [**Hospital 3593**] transferred to\\n   MICU due to resp distress, tachycardia, hypoxia. Arrived here with two\\n   infiltrated IV's. Unable to draw labs and unable to insert IV's.\\n   Discussions ongoing regarding pt's wishes regarding code status. Pt\\n   arrived with HR 140, BP 110/70, RR 40\\n   Plan was discussed with pt and family and decision was made and pt is\\n   full code. Pt had access issues, resolved w/placement R femoral\\n   multilumen (unable to lie flat for another line) & R radial A-line\\n   [**2-6**].   She is ruling in for MI by elevated troponins.   [**Month (only) 11**] need to be\\n   intubated.\\n   PMH: A-fib, COPD, HTN, High Cholesterol, CVA, TIA\\ns, PUD, CHF,\\n   Fibromyalgia, renal insufficiency (baseline Cr 1.3).\\n   Allergies: Codeine, azithromycin,  morphine.\\n   Tachycardia, Other\\n   Assessment:\\n   HR: 90\\ns-140 AFib/flutter\\n   Action:\\n   Per cardiac consult, patient was ordered for the following.  Received\\n   150mg IV amiodarone bolus @ 2130.  Received amiodarone @ 1mg/hr for 6\\n   hrs until 0225, & then 0.5mg/hr for 18 hrs.  Also received 200mg po\\n   amiodarone X1 (ordered [**Hospital1 **]).\\n   Response:\\n   HR slowed to 90\\ns-100\\ns AF/flutter for 2 hrs after bolus & then rate\\n   increased up to 140.  Received 2^nd 150mg amio IV bolus @ 0640 w/ HR\\n   down to 120\\ns @ 0700.\\n   Plan:\\n   Po lopressor ordered to start in am.  Finish IV amiodarone @ [**2194**]\\n   tonight.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   O2 via high flow neb initially @ 50%.  O2 sats maintained @ 95-99%\\n   overnight.  Lungs: rhonci throughout.  Patient was not in respiratory\\n   distress.  Appeared comfortable.  RR 20\\ns-30.   BUN 26 (20)  & Cr 1.2\\n   (1.2)\\n   Action:\\n   Increased O2 to 60% & then 80% for pO2 61-63.  Started IV lasix @\\n   1mg/hr @ 0040.  Titrated lasix to keep u/o>50-60cc/hr.  See flow\\n   sheet.   CXR done @ 0530.\\n   Response:\\n   On 80% high flow neb, ABG\\ns: 7.52/33/91 (up from 7.54/27/63 on 60% high\\n   flow neb).\\n   Plan:\\n    Titrate IV lasix to maintain u/o 50-60cc/hr.  Titrate high flow neb as\\n   needed.\\n   Myocardial infarction, acute (AMI, STEMI, NSTEMI)\\n   Assessment:\\n   [**2199**]  Troponin 0.37 (0.38) Now  troponin 0.23.     CK 115 (139), now\\n   98.     CK-MB 7 (9), now 5.\\n   Action:\\n   EKG done @ [**2199**], showed AF rate 117-138.\\n   Response:\\n   Cardiac enzymes trending down\\n   Plan:\\n   Cardiac echo today.\\n   Gastrointestinal bleed, lower (Hematochezia, BRBPR, GI Bleed, GIB)\\n   Assessment:\\n   [**2199**] Hct 33.2 (35.4)   Now  Hct 30.         INR 1.3 (1.2)         Soft\\n   abdomen w/hypoactive bowel sounds.\\n   Action:\\n   NPO.  IV protonix infusing @ 8mg/hr.\\n   Response:\\n   No BM yet.\\n   Plan:\\n   Guiac  stool.   Gi writes that in setting of MI & no active acute UGIB,\\n   will hold endoscopy.  Plan: Hct q 6 hrs, keep INR<1.5.  If patient has\\n   active bleeding including maroon stools or BRBPR: place NGT, lavage &\\n   call GI fellow.\\n    The patient initially refused to be intubated & was made DNR on\\n   admission.    After son, [**Name (NI) 1247**] spoke to her, the pt agreed to be\\n   intubated/receive care for a few days, & was made a full code.\\n   Overnight, the intubation issue came up & patient again refused.  She\\n   also refused bipap/CPAP by mask ventilation.  Needs another family\\n   meeting including the patient.\\n     Patient has trust issues w/her care, frequently begging that no one\\n   sneak in & put her on bipap or intubate her\\ndespite being reassured\\n   that nothing would  happen w/out her consent.  Needs social service\\n   consult.\\n   [**2199**] WBC 22.4 (23.1)   Now WBC 18.7     Lactate 2.2\\n\",\n",
              "  \"Mrs. [**Known lastname **] is a 35 y.o. F with history of SLE and restrictive lung\\n   disease who was transferred to the [**Hospital Unit Name 44**] for further management of new\\n   CHF in the setting of intra-uterine fetal demise at 21wks, detected\\n   [**7-24**].  Had D&E on [**7-25**].\\n   PMH:  - SLE diagnosed in [**2168**] manifested by kidney disease (membranous\\n   nephropathy by report of biopsy), facial rash, Sjogren's syndrome,\\n   Raynaud's phenomenon, and pleuritis\\n   - Gastritis\\n   - Restrictive lung disease, followed by Dr. [**Last Name (STitle) 885**], noted to be\\n   moderate to severe on PFTs completed 5/[**2179**].\\n   - h/o pancytopenia associated with varicella zoster infection\\n   - h/o persistent thrombocytopenia\\n   - Baseline proteinuria (Cr 0.8-0.9 pre-pregnancy)\\n   [**Last Name **] Problem\\n S/p D & E\\n   Assessment:\\n   Patient\\ns fundus is @ -1 to -2 & firm.  Progressed from moderate\\n   serosanguinous vaginal drainage w/pad changed every hour to scant\\n   sanguinous drainage w/pad changed every 2 hrs.    WBC 20.3(22.5)\\n   Action:\\n   Transfused w/1 unit PRBC\\ns for Hct 27.4   (down from 34.5  before\\n   D&E).  Given 20 units oxytocin in 1L NS which ran @ 100cc/hr.  Advanced\\n   to clear liqs (H2O), w/out problems.\\n   Response:\\n   [**Name2 (NI) **] Hct: 29.0\\n   Plan:\\n   Draw serial Hcts q 4 hrs.      Hct drawn  @ 0700.    Results\\n   pending.    Goal: Hct>30.\\n   .H/O heart failure (CHF), Systolic, Acute\\n   Assessment:\\n   Lungs: clear @ upper lungs, rales @ R base to diminished @ bases-no\\n   change overnight.  HR: 90\\nsSR-110\\nsST no ectopy.  BP: 111-126/88-98\\n   O2 sats 96-100% on 2L NP.  Patient is 1.6L positive in fluid balance.\\n   Action:\\n   Response:\\n   Weight is down by 0.4kg after D&E.  Patient has generalized 2+ edema\\n   after receiving IV oxytocin.\\n   Plan:\\n   Gently hydrate patient.\\n   .H/O renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   BUN 52(48)    Cr 1.2 (1.1)   U/o 40-80cc/hr\\n   Action:\\n   Response:\\n   Plan:\\n   Continue to follow u/o & labs.\\n\",\n",
              "  '26yo G4P4  at 34weeks w/hx DM2 admitted from OR after patient had\\n   urgent cesearean/hysterectomy for accreta/percreta involving the bowel\\n   and bladder walls on [**6-15**].  Intraoperatively she was medically stable\\n   but had EBL of 15L.  Received  8.7L IVF,  15u pRBC, 10u FFP, 1 cryo, 3\\n   plt. In OR.   Admitted to ICU for monitoring.  Kept intubated until she\\n   is brought back to OR on Mon. for removal of packing.\\n   .H/O abdominal compartment syndrome / Intraabdominal Hypertension (IAH,\\n   ACS)\\n   Assessment:\\n    Peak pressures variable according to stimulation of patient (turning,\\n   mouth care etc).    Abdomen soft & distended.\\n   Action:\\n   Abdominal girth was 25 inches @ 0100 & 0600, up from 22 inches on [**6-15**].\\n   Resident aware.\\n   Response:\\n   Plan:\\n   [**Month (only) 51**] go for embolization in IR today ([**6-17**]) to decrease bleeding from\\n   vascularized bladder & bowel & cervical stump.\\n   .H/O anemia, acute, secondary to blood loss (Hemorrhage, Bleeding)\\n   Assessment:\\n   Fibrinogen 622 ( up from 578).  Hct down to 26.4 (from 28.5).  PLT CT\\n   94 ( up from 82)\\n   Action:\\n   Serial Hcts checked q 4 hrs.  Given 1L LR this evening.\\n   Response:\\n   Hct dropped from 28.5 to 26.4 after receiving 1L LR.  No change since.\\n   No transfusion overnight.\\n   Plan:\\n   Transfuse for Hct <25 w/PC\\ns.  Transfuse w/PLT\\ns for PLT CT<50.  Give\\n   cryoprecipitate for fibrinogen level <100.\\n   .H/O diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS ranged from 91-122\\n   Action:\\n   Received IV insulin per ICU protocol.\\n   Response:\\n   Patient\\ns glucose was maintained in euglycemic control on 1 unit\\n   regular insulin/hr  all night.\\n   Plan:\\n   Continue to check FS q 1 hr & maintain IV insulin drip.\\n   .H/O respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   O2 sats 98-100%  RR 14\\n   Action:\\n   Patient maintained on A/C 40%/RR 14/ Vt 500/ 5 PEEP\\n   Response:\\n   RSBI 72 this morning on full dose fentanyl & versed (lightly sedated).\\n   Plan:\\n   Unable to draw ABG\\ns as unable to withdraw from A-line.\\n   .H/O pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient only lightly sedated, waking easily to any stimulation: mouth\\n   care, talking, turning.\\n   Action:\\n   Patient given maximum sedation of 275mcg/hr fentanyl & 10mg/hr versed.\\n   Response:\\n   As above.\\n   Plan:\\n   Bolus patient before turning or mouth care.\\n   .H/O [**Last Name **] Problem - [**Name (NI) 244**] Description In Comments/ Anxiety\\n   Assessment:\\n   Patient never saw baby after she was born (asked patient).\\n   Action:\\n   Patient given pictures of baby taped to bed.  Husband & sister visited\\n   patient overnight @ 0300.\\n   Response:\\n   Patient smiled & spent some time looking @ pictures.\\n   Plan:\\n   Offer emotional support.  Tell patient about her baby as much as\\n   possible.\\n   Repleted w/2 GM IV  magnesium sulfate for serum magnesium 1.4.\\n   Repleted w/2  Gm calcium gluconate for ionized calcium 1.09.\\n   ------ Protected Section ------\\n   OGT found on floor @ 0600.  Replaced.  Bilious drainage & air noted\\n   from stomach.\\n   HR remained 122-136ST no ectopy overnight.  BP stable.  A-line\\n   positional so checked NBP as well.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2181-6-17**] 06:56 ------\\n',\n",
              "  'Atrial fibrillation (Afib)\\n   Assessment:\\n   HR:70\\ns-90\\ns A-fib.   BP stable @ 100\\ns-110\\ns systolic.\\n   Action:\\n   Continues on digoxin 0.125 mg qd & lopressor 100mg tid per PEG.  Off\\n   diltiazem since 0600 [**4-3**].\\n   Response:\\n   No significant bradycardia noted .\\n   Plan:\\n   Continue to monitor HR.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Patient continues on A/C @ 40%/ RR 15/500/PEEP 5.  O2 sats 95-100%.\\n   Lungs are clear @ upper lungs& diminished @ lower. Sx for moderate amt\\n   thick white secretions q 3-4 hrs.  Patient has had minimal amount\\n   sedation(12.5mcg fentanyl & 1mg versed) until 0500.    ABG\\ns @ 0600:\\n   7.52/106 /31\\n   Action:\\n   Increased sedation (fentanyl @ 20mcg & versed @ 2mg) to decrease\\n   chronic respiratory alkalosis\\n   Response:\\n   Patient more sedated. Still overbreathing vent by 3-4 breaths/min.\\n   Plan:\\n   Await eventual trach placement.\\n   Heart failure (CHF), Diastolic, Acute on Chronic\\n   Assessment:\\n   Pleural effusions by CXR\\n   Action:\\n   Given 40 mg IV lasix @ 2300.\\n   Response:\\n   U/o 900cc in 2 hrs after IV lasix.\\n   Plan:\\n   Continue to monitor u/o q 1 hr.\\n   This patient has a reddened & excoriated perirectal area. Antifungal\\n   barrier cream applied. Patient has small amts loose stool ,\\n   insufficient for rectal tube.\\n   ------ Protected Section ------\\n   RSBI only 41, but muscular weakness will not support prolonged\\n   independent inspiration off vent.  Therefore patient has trach planned.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2185-4-5**] 06:51 ------\\n',\n",
              "  'Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   On A/C 40%/Vt 450/RR15/PEEP 5. Tidal volume decreased by 50  for\\n   chronic respiratory alkalosis.   ABG\\ns: 7.49/33/95, improved from\\n   7.51/31.\\n   Action:\\n   Increased sedation slightly.  Kept NPO p Mn.\\n   Response:\\n   Patient continues to overbreathe vent w/RR 18\\n   Plan:\\n   Trach placement [**4-6**].\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 70\\ns-90\\ns A-fib. Off plavix & anticoagulants for bleed in back of\\n   mouth. No bleeding noted tonight.\\n   Action:\\n    Pneumoboots on. Given lopressor 100mg tid & digoxin 0.125mg qd.\\n   Response:\\n   No episodes bradycardia.\\n   Plan:\\n   Continue to monitor HR.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient grimaced in pain & BP elevated.\\n   Action:\\n   Turned patient frequently. Cleaned stool promptly. Increased fentanyl\\n   to 20mcg/kg/min.  Removed R wrist splint in place for pseudogout. R\\n   hand swollen & splint applying pressure to parts of skin. Elevated R\\n   hand & arm. Patient grimaced when R fingers were straightened.\\n   Response:\\n   BP dropped to 90\\ns/systolic.  Patient no longer grimaced. BP came back\\n   up.\\n   Plan:\\n   Dropped fentanyl to 15mcg/kg/min initially, then increased it slowly to\\n   25mcg/hr.   Increased versed to 1.3kg/hr & then slowly to 2mg/hr.\\n',\n",
              "  '60 yo female with history of CKD, idiopathic dilated cardiomyopathy EF\\n   50-55%, hypothyroidism, hypertension, PAD, DM admitted for hypothermia\\n   and hypoxia.  Bilateral moderate to large pleural effusions & moderate\\n   pulmonary edema by CXR.  Infiltrate cannot be excluded.  LENI\\n   negative.\\n   Hypoxemia\\n   Assessment:\\n   O2 sats 92-97% on high flow neb via tent mask @ 60% & 4L NP.  RR:\\n   13-27   Lungs: clear @ upper lungs, diminished @ bases.\\n   Action:\\n   Given  5mg po metolazone followed by 160mg IV lasix @ 1830.\\n   Response:\\n   U/o 40-140cc/hr clear yellow urine following lasix.  Fluid balance for\\n   [**12-31**] is negative 200cc so far.\\n   Plan:\\n   Goal: for patient to be negative by 1L/day.  CXR this am.\\n   Hypothermia\\n   Assessment:\\n   T 94.3 ax @ 1800 --w/rectal temp lower than 96 so unable to measure\\n   w/tempDOT.   Patient is mouth breather, so po temp is lower than\\n   axillary temp.\\n   Action:\\n   Used Bair huggar 1800-midnight.\\n   Response:\\n   Axillary temp increased to 96.2 @ midnight.\\n   Plan:\\n   Bair huggar prn T<96.\\n   Hypernatremia (high sodium)\\n   Assessment:\\n   Na 146 after receiving  150cc D5W IV & 1L po free water, down from 152.\\n   Action:\\n   D5W infused @ 50cc/hr for 1000cc (all night).\\n   Response:\\n   W/am labs, Na down to 144.\\n   Plan:\\n   Continue to monitor Na.\\n   .H/O diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS 132-145               Patient has poor appetite.  Only drank H2O\\n   overnight & had no c/o hunger.\\n   Action:\\n   Held lantus [**12-30**] evening.  Old R toe amputation site had dressing\\n   changed by member of vascular surgery team @ 0500 this am.  Wound is\\n   dry w/eschar.  No S&S infection.\\n   Response:\\n   No need for insulin coverage despite D5W infusing.\\n   Plan:\\n   Continue to monitor FS.  Restart lantus ( @\\n dose)  when patient\\n   requires insulin coverage on sliding scale.\\n   .H/O renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   BUN 103 (105)     Cr 4.0 (3.9)         K 4.2            HCO3: 17 (17)\\n   Action:\\n   IV lasix 160mg w/metolazone  5mg po given [**12-30**] evening.\\n   Response:\\n   Patient was fluid balance positive  1100 cc  on [**1-2**].   Since\\n   admission, her fluid balance is positive 500cc.\\n   Plan:\\n   Patient may receive 2^nd dose of lasix this am.  Followed by renal.\\n   Check vanco level results  (drawn [**12-31**] 0610)  before dosing.\\n   INR 1.5     Had 2 loose brown trace guiac positive stools\\n   overnight.     Hct 21.9 (24)\\n',\n",
              "  '64 yo F with MMP and complicated hospital course.  H/o a-fib, DM II,\\n   and obesity, presented to OSH with b/l hydronephrosis, ARF, Hyptension,\\n   and b/l DVTs in setting of newly diagnosed pelvic mass.  Transferred to\\n   [**Hospital1 19**] [**1-4**].  Now s/p supracervical TAH/BSO/tumor debulking (likely\\n   endometrial vs ovarian CA, path pending), with intraop course c/b\\n   Hypotension requiring pressors and a-fib with rvr.  S/p IVC filter\\n   placement.  Remains  off pressors.  Extubated [**1-12**].\\n   Airway, Inability to Protect (Risk for Aspiration, Altered Gag, Airway\\n   Clearance, Cough)\\n   Assessment:\\n   Patient extubated @ noon.  O2 sats 93-97% on room air while awake.  O2\\n   sats 100% on 2L NP.  RR: 20\\ns.  Lungs clear, diminished @ bases.\\n   Action:\\n   Given 20mg IV lasix @ [**2100**].\\n   Response:\\n   U/o 900cc in 1^st hour.\\n   Plan:\\n   Continue to monitor O2 sats.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 60\\ns-80\\ns Afib       INR 1.3 (1.4)\\n   Action:\\n   Given lopressor 25mg [**First Name8 (NamePattern2) **]  [**Hospital1 **] sump tid.  Received digoxin @ 0800.  On\\n   IV heparin @ 1250 units/hr.\\n   Response:\\n   No RVR.      PTT this am: 65.9\\n   Plan:\\n   Continue to monitor HR, continue on IV heparin (no change in rate),\\n   await decision re: coumadin.\\n   Alteration in Nutrition\\n   Assessment:\\n   TF residual 5-22cc.  Tolerated TF\\ns well. Receiving 10-15cc/hr nutren\\n   2.0 w/beneprotein.   Passed flatus X1 this evening ([**1-12**]).  +Bowel\\n   sounds.\\n   Action:\\n   Given 30cc po g-ale X2 per intern.\\n   Response:\\n   No c/o N/V.  TF residuals <50cc.\\n   Plan:\\n   Increased TF to 15cc/hr @ 0400.\\n   .H/O arthritis, osteo (osteoarthritis, OA)\\n   Assessment:\\n   C/o back pain from arthritis, worst while turning.  Less so while lying\\n   flat on back.\\n   Action:\\n   Given 2mg IV morphine @ 2200 ; given 1mg IV morphine @ 0200 & 0400.\\n   Response:\\n   Morphine relieved pain.\\n   Plan:\\n   Continue to medicate as needed for pain.  Check re: starting NSAID for\\n   arthritis pain.\\n   Scant sanguinous vaginal drainage overnight.\\n   To have PICC placed in IR today.\\n   To be called out soon.  Needs L radial A-line D/C\\ned before transfer.\\n',\n",
              "  \"This 78M with PMH: atrial fibrillation , asbestosis, idiopathic\\n   retroperitoneal fibrosis, long-term h/o abdominal and inguinal hernias\\n   presents with history of erythematous rash over abdomen and scrotum,\\n   increasing distension of abdomen, scrotum in addition to swelling of\\n   lower extremity. His original operation occurred during work up  of\\n   hematuria & ureterolysis & omental wrap led to significant incisional\\n   hernia  with hydrocele.  The patient was found to have an extensive DVT\\n   in the context of coagulation reversal.. Transferred to surgery service\\n   here on [**10-26**] from OSH for huge inguinal hernia repair but had diffuse\\n   inguinal/scrotal rash, surgery  postponed. U/S LE showed DVT.. [**11-13**]\\n   Triggered for tachypnea in the 30-40's.  Transferred to [**Hospital Ward Name 77**] MICU.\\n   Pt s/p thoracentesis x2. pt started on iv heparin drip for treatment of\\n   LE DVT. Chest CT done [**11-14**] to check new opacity in his R lung. Pleural\\n   effusions shown on CXR. Pigtail placement to drain pleural fluid done\\n   [**11-15**].\\n   .H/O hypoxemia\\n   Assessment:\\n   O2 sats 90-94% on 2-3L NP.  O2 sats 93-96% on 4L NP.  Pigtail drained\\n   250cc chylous (milky) fluid from [**Telephone/Fax (1) 9265**].      Ascites increasing over\\n   the last 3-4 days.\\n   Action:\\n   Received NS @ 200cc/hr to replace fluid losses.  Started on ocreotide\\n   sc bid per GI.  Metoprolol 25mg po bid restarted for tachycardia (HR up\\n   to [**Street Address(2) 3429**] w/frequent PAC\\n   Response:\\n   Patient has required more O2 overnight, back up to 6L NP[**MD Number(3) 9266**] he\\n   required last night. (he was only decreased to 2L NP[**MD Number(3) 9267**] [**11-16**]).\\n   Plan:\\n   Continue to titrate O2 to sats>92%.\\n   .H/O deep Venous Thrombosis (DVT), Lower extremity\\n   Assessment:\\n   B DP\\ns are weakly palpable, as are B PT\\ns.  L leg is more swollen than\\n   R.\\n   Action:\\n   Elevated both legs.  IV heparin infusing @ 1300 units/hr.  No change\\n   was made for 2100 PTT of 72.2.\\n   Response:\\n   As above.\\n   Plan:\\n   Continue IV heparin.\\n   Alteration in skin integrity\\n   Assessment:\\n   Patient has drug rash on trunk both chest & back, upper legs & both\\n   arms.\\n   Action:\\n   Received steroid cream applied to rash @ [**2187**].  Given [**Hospital1 **].  IV\\n   antibiotics D/C\\ned for presumed drug rash.\\n   Response:\\n   Rash still present.\\n   Plan:\\n   Monitor ras. Apply steroid cream as ordered.\\n   Patient transferred overnight to 11 R after being called out of ICU.\\n\",\n",
              "  '85 year-old female with a history of CAD s/p CABG, chronic CHF and\\n   recent hospitalized for rectal perforation, small bowel prolapse with\\n   necrosis s/p rectocolectomy and percutaneous cholecystectomy for acalc\\n   cholecystitis with course c/b pneumonia and c diff. transferred from\\n   OSH on [**12-4**] with septic shock. Patient wishes not  to have further\\n   surgery and is DNR/DNI but does want to continue aggressive care with\\n   fluids/antibiotics/pressors.  Off levophed since [**12-10**].  Systolic\\n   BP>100 & MAP> 60.   She remains very tired but  A&OX3.  Niece is HCP.\\n   Dyspnea (Shortness of breath)\\n   Assessment:\\n   Patient continues to have SOB, noticeable while taking a breath  to\\n   talk.  O2 sats 99-100% on 2L NP\\n   Action:\\n   Titrated O2 down to 1L NP.  Had received 20mg IV lasix for SOB, fluid\\n   overload on [**12-11**].\\n   Response:\\n   O2 sats were 99%  on 1L NP\\n   Plan:\\n   Continue to monitor for SOB, RR, O2 sats & u/o.  Titrate to room air.\\n   Atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 80\\ns-110\\ns A fib/flutter\\n   Action:\\n   Rate controlled on 12.5 mg po lopressor [**Hospital1 **]\\n   Response:\\n   As above\\n   Plan:\\n   Continue to monitor HR.  Continue to give lopressor.\\n   Renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   BUN 37 (39)      Cr 1.2 (1.3)       U/o 23cc/hr       More thirsty\\n   overnight.  Fluid status is even for [**12-11**] & +140cc for today so far.\\n   Action:\\n   Had received lasix 20mg IV on [**12-11**].\\n   Response:\\n   U/o decreased by 2cc/hr from last night.  BUN & Cr dropping despite\\n   lasix.\\n   Plan:\\n   Continue to monitor u/o, BUN & Cr.  Encourage increased protein intake.\\n   ------ Protected Section ------\\n   Abdominal dressing has more green drainage. Pseudomonas was one of\\n   three organisms cultured from it in the past.  Colostomy appliance was\\n   changed @ that time so as to prevent stool from contaminating the\\n   abdominal wound (the seal on the appliance was loosening).  Patient\\n   continues to weep from every opening in skin because of her anasarca.\\n   Last serum albumin level was 2.0.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 391**] [**Last Name (NamePattern1) 392**], RN\\n   on:[**2196-12-12**] 06:31 ------\\n',\n",
              "  'Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Patient remains on PCV  + assist: @ 50%/8 PEEP/ 20 PS/28 RR.  O2 sats\\n   remain 97-99%.  Patient is beginning to wake up, moving head &\\n   extremities.\\n   Action:\\n   ABG: 7.45/34/113 @ 2200.\\n   Response:\\n   Patient is not  ready for RSBI yet.\\n   Plan:\\n    RSBI when patient is more awake.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   Patient  received amiodarone 25mg/hr & esmolol 50mcg/min until his BP\\n   dropped.\\n   Action:\\n   Amiodarone was turned off @ midnight.   Esmolol was decreased from\\n   50mcg/kg/min to 25mcg/kg/min & then turned off  @ 2240 & turned back on\\n   @ midnight.\\n   Response:\\n   BP dropped again.  Esmolol was turned off @ 0250.\\n   Plan:\\n   Esmolol turned back on @ 12.5 mcg/kg/min @ 0410 for HR 110.\\n   .H/O renal failure, End stage (End stage renal disease, ESRD)\\n   Assessment:\\n   On CVVHDF overnight.  Off CVVHDF X3.5 hrs for clotted\\n   hemofilter/dialyzer & for machine malfunction.  Now using new machine.\\n   INR 1.7, down from 3.5.\\n   Action:\\n   No problems w/new machine\\nless clotting w/better function.\\n   Response:\\n   Frequent (q 1hr) NS flushes  moderately( w/old machine) to very\\n   successful (w/new machine)\\n   Plan:\\n   Continue to prime w/heparin.  Continue q 1-2hr NS flushes (150cc).\\n   Shock, septic\\n   Assessment:\\n   Patient\\ns MAP ranged from 54-70 w/systolic BP\\ns ranging from 84-116/\\n   Action:\\n   Required titration of esmolol down & off as well as amiodarone off.\\n   Also required 250cc NS boluses X3.\\n   Response:\\n   Patient is positive by  450cc so far today.\\n   Plan:\\n   Remove fluid during CVVHD as BP allows.\\n',\n",
              "  '67 y.o. man with hx polycystic liver disease with end stage liver and\\n   renal disease, on chronic HD. Pt presented to EW from OSH with\\n   increased cough, weakness, and SOB- LLL pna noted on CXR, sputum + for\\n   influenza A. Temp at OSH 101.3, sbp 70s-pt was started on levophed. Pt\\n   was transferred to [**Hospital1 54**] for further management. Pt developed\\n   progressive resp. distress requiring intubation and CVVHD. Pressors\\n   have since been weaned off, pt extubated [**4-12**]. CVVHD was stopped\\n   Saturday morning thinking pt could transition to intermittent HD on\\n   Monday. Pt became progressively more volume overloaded by Sunday\\n   afternoon that CVVHD restarted by 3pm [**4-13**]. By 12:15am [**4-14**], CVVHD system\\n   clotted and pt became hypotensive with sbp as low as 79. see below for\\n   details.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Maintaining adequate sats of mid to upper 90s-100% on 50% high flow\\n   shovel mask. Very congested sounding becoming wheezy and tight by 1am.\\n   Dry junky sounding nonproductive cough. Abg excellent.\\n   Action:\\n   Given albuterol and atroven mdis with relief. Encouraged to cough and\\n   deep breathe.\\n   Response:\\n   Less wheezy sounding with nebs but still remains very congested\\n   sounding.\\n   Plan:\\n   Continue high flow shovel mask and encourage to cough and deep breathe.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   Remains in afib with hr initially in 80s-90s.\\n   Action:\\n   Given 12.5 mg lopressor via ngt.\\n   Response:\\n   Hr down to 70s-80s, occasionally 90s. sbp stable while on cvvhd until\\n   system clotted, unable to return blood, sbp as low as 79. treated with\\n   ivf.\\n   Plan:\\n   Hold lopressor per parameters.\\n   .H/O renal failure, End stage (End stage renal disease, ESRD)\\n   Assessment:\\n   Cvvhd infusing with 150cc ns flushes q1hour. System slowly clotting\\n   over time and completely clotted by 12:15 am\\nunable to return blood in\\n   setup to pt. pt 750cc + since mn.\\n   Action:\\n   CVVHD on hold until bp improves with MAP > 70. pt required 500cc ns\\n   fluid boluses.\\n   Response:\\n   Sbp slowly rising s/p small amt volume resuscitation.\\n   Plan:\\n   Restart CVVHD  when map >70.\\n   Shock, septic\\n   Assessment:\\n   Action:\\n   Response:\\n   Plan:\\n',\n",
              "  'This is an 86 year old female with a past medical history of occipital\\n   stroke with memory difficulties and atrial fibrillation who presents\\n   from home with cough for one week found in the emergency room to be\\n   hypotensive to the 80s sysotlic non-responsive to fluid challenge.\\n   Hypoxemia\\n   Assessment:\\n   O2 sats 93-95% on 50% high flow neb, & 93-96% on 60% high flow neb.  O2\\n   sats 96-99% on 80% high flow neb.   Patient took off O2 frequently from\\n   [**2221**]-0000 despite restraints.  Patient desatted to 81% on 6L NP[**MD Number(3) 6586**]\\n   eating snack @ [**2191**].  She desatted to high 70\\ns after taking off O2.\\n   CVP 11-13    BUN 26 (27)     Cr  1.9 (2.1)    Note that BUN 14 & Cr\\n   1.0 on [**8-30**].  O2 sats improved to 98% on 60% high flow neb after 0.5mg\\n   IV morphine.  Patient arouses to stimulation after IV morphine.\\n   Action:\\n    Given albuterol & atrovent neb Tx @ [**2191**].  Given 0.5mg IV morphine @\\n   midnight.  Continues on IV lasix which was increased to 15mg/hr @ 1900\\n   & 16mg/hr @ 0300\\neach time for a u/o of 45-50cc/hr.  U/o since has been\\n   50-140cc/hr.\\n   Response:\\n    ABG\\ns on 60% high flow neb:   7.37/47/93    (last ABG\\ns on same O2 on\\n   [**9-2**]: 7.40/34/115)   [**Month (only) 51**] be retaining CO2 due to sedation from 0.5mg IV\\n   morphine.   BUN & Cr improving despite increased doses of IV\\n   lasix.\\n   Plan:\\n   Recheck ABG\\ns when patient more alert.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient was oriented X2 (self & place)  until [**2221**] when she became\\n   agitated & oriented X1 (to self) only.  At that time she  removed O2\\n   mask. As she was combative, this nurse was unable to replace O2 mask\\n   until patient was restrained.   She continued to remove O2 mask even\\n   while restrained\\n   Action:\\n   Restrained wrists @ [**2221**] as well as keeping all 4 siderails up.  Used\\n   NGT to give meds after [**2191**] as patient refused to take meds po.\\n   Response:\\n   Patient\\nsundowns\\n.  0.5mg IV morphine sedated patient.  Although she\\n   was easily arousable, she was @ risk for aspiration from decreased\\n   alertness & could not take po meds (so meds given per NGT).\\n   Plan:\\n   Remove restraints during the day when patient\\ns mental status clears.\\n   Reschedule meds for day time only when NGT D/C\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 70\\ns-90\\ns Afib no ectopy     BP: 95-136/50-62     A-line continues\\n   to be positional, requiring frequent repositioning.  K3.6\\n   Action:\\n   IV diltiazem shut off @ 1630.  Patient received 30mg po diltiazem qid\\n   (short acting, which can be crushed). Given 20 mEq KCl IV (1^st dose).\\n   Response:\\n   HR remained <100, still in Afib.\\n   Plan:\\n   Change po diltiazem to extended release when NGT is D/C\\ned.  Give 2^nd\\n   dose 20mEq KCl IV.\\n   C. difficile infection (C Diff, Cdiff Colitis, Clostridium Difficile)\\n   Assessment:\\n   Patient had a medium loose to liquid  green BM.     Tmax 98.6\\n   axillary     Patient was C-diff positive [**2200-8-31**].\\n   Action:\\n   Flexiseal placed.  Vanco 125mg po given q 6 hrs.\\n   Response:\\n   No further stool overnight.\\n   Plan:\\n   Continue to give po Vanco as ordered.\\n',\n",
              "  '53 y/o M with CAD, DM2 transferred from OSH with septic shock,\\n   tachycardia, DKA &  thrombocytopenia. Has SBE w/vegetations on pacer\\n   leads & R coronary cusp.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   Continued on CPAP @ 30% w/5 PEEP & 12 PS.  Continues to need suctioning\\n   q 3-4 hrs for small amounts thick white secretions.  Patient desatted\\n   to 88% for several minutes  each time he was turned on his L side.  His\\n   ABG\\ns: 7.44/42/68 reflect this,  as they were drawn soon after turning\\n   to his L side.\\n   Action:\\n   Sx\\ned q 3-4 hrs for small amounts thin white secretions.  Continued on\\n   versed 2-4mg/hr for sedation.\\n   Response:\\n   RSBI   108  today   (165 yesterday).  ABG\\ns (on R side): 7.49/37/79\\n   still on same settings.  Intern aware.\\n   Plan:\\n   Attempt SBT  as patient tolerates.\\n   .H/O cardiac dysrhythmia other/ SBE\\n   Assessment:\\n   HR:  77-86   V-paced\\n   Action:\\n   Patient had TEE [**2-10**] which showed a mobile 2 cm vegetation on R\\n   coronary cusp, a large mobile mass on RV pacer lead, & other small\\n   vegetations on atrial AV leads.  Patient had CT of head, chest ,\\n   abdomen & pelvis on [**2-10**]\\nresults pending.\\n   Response:\\n   Patient is receiving IV gentamycin & PCN per ID recommendations.\\n   Plan:\\n   Evaluate mental status as patient is weaned from sedation.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   BP maintained w/MAP>60.  CVP 9-11.   WBC 8.5 (10.7)     Tmax 99 po\\n   overnight\\n   Action:\\n   Patient started briefly on IV Lasix @ 1mg/hr for u/o 45cc.  D/C\\n   Lasix @ 0130 for MAP 62, later restarted lasix for u/o <60cc/hr @\\n   0510.     Sent stool spec for C-diff.\\n   Response:\\n   U/o improved on Lasix to 60cc/hr & >.\\n   Plan:\\n   Evaluate need for Lasix.\\n   .H/O diabetic Ketoacidosis (DKA)\\n   Assessment:\\n   FS 138-150 on IV insulin  ( 3 units/hr).\\n   Action:\\n   IV insulin stopped @ 2130.  Resumed lantus 15 units sc q pm & sliding\\n   scale insulin.\\n   Response:\\n   Covered w/4 units regular insulin sc @ Mn for FS 185 & 10 units regular\\n   sc for FS 310 @ 0600.  At 0700, FS 324.  Covered w/another 10 units\\n   regular @ that time.\\n   Plan:\\n   Check FS more frequently-- @ 0800& 1000.     Patient will have more\\n   aggressive sliding scale per intern & resident..\\n'],\n",
              " 5: ['This 48 yr old man was found unconscious &\\nblue\\n in a car by EMT\\n   after overdosing on heroin.  Had a pulse.  Aroused after given 1mg\\n   narcan IV in the field.  Transferred from EW to MICU for monitoring.\\n   [**Last Name **] Problem\\nHeroin Overdose\\n   Assessment:\\n   Patient lethargic but easily aroused.  A&OX3.\\n   Action:\\n   Narcan IV infused @ 0.4mg/hr until midnight, when it was decreased to\\n   0.2mg/hr & ran through night.\\n   Response:\\n   Slept throughout night.  Aroused easily.  More awake this morning.\\n   Plan:\\n   Transfer to floor when patient becomes more alert.\\n   .H/O asthma/ sleep apnea\\n   Assessment:\\n   Upon auscultation, lungs had diffuse expiratory wheezes upon arrival.\\n   O2 sats 94-98% on 1-2L NP overnight.  RR8-30.\\n   Action:\\n   Given albuterol neb Tx & started on fluctinisone inhaler [**Hospital1 **].\\n   Response:\\n   Lungs clear w/diminished sounds @ bases.\\n   Plan:\\n   Patient\\ns family to bring in his CPAP tomorrow.\\n   K3.6  Ordered for 40mEq po KCl this am.\\n',\n",
              "  'Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name 11**])\\n   Assessment:\\n   Patient aroused, became dys-synchronous w/vent & desatted to 76% after\\n   being turned.\\n   Action:\\n   Bolused patient w/75mcg IV fentanyl & 2mg IV versed.  Sedation had been\\n   dropped earlier in day to 200mcg/hr fentanyl  (from 300mcg/hr) & 5mg/hr\\n   versed (from 10mg/hr) per MICU attending.\\n   Response:\\n   Patient became more synchronous w/vent & O2 sats increased to 93%.\\n   Discussed w/intern & resident.\\n   Plan:\\n   Bolus patient before any turn, mouth care, or procedure.\\n',\n",
              "  'This 57 yr old woman was admitted through EW after attempting to commit\\n   suicide.  Said she swallowed 120 klonapin, also percocet.  ETOH level\\n   elevated.  BP dropped from 90\\n/sys to 60\\ns/sys.  Received 3L NS in EW\\n   to bring BP back up to 90\\ns/sys.  No narcan given. Patient refused\\n   charcoal for acetaminophen in percocet (said she took 43).  Slurred\\n   speech.  A&OX3.  Slept after being interviewed.  Vss. This nurse\\n   remained w/patient as 1:1 sitter until 7a shift  took patient.\\n',\n",
              "  'Please see Nursing Progress note started @ 2103 on [**7-11**] for information\\n   on the 7p-7a shift  [**Date range (1) 2955**].  Thanks!\\n',\n",
              "  'Patient  dropped HR to 30\\ns w/no pulse.  Patient DNR. MD assessed\\n   patient.  Family was notified.  Patient passed away before family could\\n   arrive to hospital.\\n',\n",
              "  'This 53 yr old woman was transferred from [**Hospital **]\\ns Hospital on [**12-12**]\\n   for management of hypotension & respiratory failure.  Admitted to [**Hospital **]\\ns for B LE cellulites.  Found to lethargic w/poor ABG\\n   (7.17/70/70) on admission, tried bipap unsuccessfully, then intubated.\\n   Treated w/dopamine for hypotension.  PMH: COPD/asthma, DM2,\\n   schizophrenia, morbid obesity, obstructive sleep apnea, HTN, EF55%,\\n   recurrent lower extremity cellulites & lymphedema.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Patient arrived intubated on A/C @ 40%/ Vt 520/ RR 12 / PEEP 7.\\n   Maintained O2 sats 95-97%.\\n   Action:\\n   Increased propofol from 10mcg/kg/min to 24 mcg/kg/min overnight.   Kept\\n   on A/C overnight, as desatted to 92% from 96% on short trial w/CPAP\\n   soon after arrival.\\n   Response:\\n   ABG\\ns: 7.30/60 /88.  RSBI 106 this am.\\n   Plan:\\n   Wean  as soon as patient tolerates.\\n',\n",
              "  'Patient expired @ 0355.  Comfort care provided.  Attempted to call son,\\n   [**Name (NI) **], w/phone #\\nes posted in chart, & to call wife, [**Name (NI) 3648**] as well.\\n   Unsuccessful @ this time.\\n',\n",
              "  'This 86 yr old resident of a nursing home was admitted through the EW\\n   w/hypoxia & wheezing.  Hx COPD.   Poor O2 sats on room air &\\n   ventimask.  Good sats but MS changes on 100% NRB.  Intubated @ 2200.\\n   Patient dropped BP by 40 points on propofol, & also w/0.5mg/hr versed,\\n   in the stting of dehydration.  Received 2L NS.   Patient received\\n   ativan 0.50mg q 20-25min by report.  Last doses in EW were @ 0040 &\\n   0135.   PMH: ulcerative colitis, diverticulitis, HTN, COPD, DJD.\\n   .H/O chronic obstructive pulmonary disease (COPD, Bronchitis,\\n   Emphysema) with Acute Exacerbation\\n   Assessment:\\n   Patient arrived vented & quickly had 100% FiO2 decreased to 40%.\\n   Remained on A/C 400/20/5 PEEP.  Patient remained sedated only requiring\\n   0.25mg ativan @ 0400.  ABG\\ns: 6.85/19/136\\n   Action:\\n   Decreased volume to 300cc on vent in this 41kg 4ft 10in. woman.\\n   Received NS @ 100cc/hr.\\n   Response:\\n   ABG\\ns: 7.29/68/131  U/o responded well @ 40 cc/hr.\\n   Plan:\\n   Allow sedation to lighten.  Assess effectiveness of ativan.\\n',\n",
              "  \"89 year old male admitted to MICU 7 days ago with respiratory failure\\n   most likely related to aspiration. Significant past medical history\\n   consists of advanced Parkinson\\ns, dysphasia, dementia, and recurrent\\n   aspiration pneumonia. Course complicated by ARDS, failure to wean,\\n   fever, MRSA in sputum, rapid a flutter.\\n   Trach & peg placed [**9-29**]. He has since been weaned to pressure\\n   support.. To be transferred to [**Hospital1 82**] in AM\\n   Acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name **])\\n   Assessment:\\n   Remained on CPAP overnight @ 40%/ 12 PS/ 5 PEEP.  RR 24-31   O2 sats\\n   96-99%    Tmax 100.2 po off abx\\n   Action:\\n   Sx\\ned q 1-2 hrs for small to moderate amounts thick tan secretions\\n   Response:\\n   Patient looked more comfortable.  Rr dropped after suctioning.\\n   Plan:\\n   Assess need to change vent settings if patient appears fatigued.\\n   .H/O atrial flutter (Aflutter)\\n   Assessment:\\n   HR: 60\\ns-70\\ns SR   BP:  MAP 54-60\\ns         sBP 88-100\\n   Action:\\n   Given 20mg IV lasix @ 2330 [**10-1**]\\n   Response:\\n   Fluid balance was -300cc  for [**10-1**] &  -800cc for [**10-2**] so far.\\n   Plan:\\n   Continue to monitor HR & BP.  Continue to follow serum K\\n   Parkinson's Disease\\n   Assessment:\\n   Patient opens eyes to stimulation & bites on toothbrush.  No movement\\n   of flaccid limbs overnight.\\n   Action:\\n   Head CT done [**10-1**]\\n   Response:\\n   No acute process by CT\\n   Plan:\\n   Transfer patient to [**Hospital1 82**]\\n\",\n",
              "  'Shock, septic\\n   Assessment:\\n   Patient  continued to be very hypotensive, requiring neo @ maximum\\n   dosage as well as vasopressin & LR fluid boluses.  Went into AF/MAT @\\n   rates 140-170\\ns @ [**2087**]-[**2157**]. Received carotid massage to temporarily\\n   decrease HR until amiodarone IV could be given. Received 150mg bolus &\\n   then 1mg/min until 0300, then 0.5mg/min.  Patient converted to SR @\\n   midnight.  After 0400, patient\\ns BP dropped, & patient began to\\n   noticeably fail.  More frequent ABG\\ns were drawn during the night as\\n   unable to obtain O2 sats ( patient was clamped down).\\n   Action:\\n   ABG\\ns were very poor. FiO2 increased to 100%.  Dobutamine started.\\n   Steroids started.\\n   Response:\\n   Patient expired  before he could receive bicarb or Ca gluconate.\\n   Plan:\\n   Patient expired @ approximately 0552.  Patient\\ns family were @ bedside.\\n',\n",
              "  'Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Patient remained off vent w/trach mask for over 12 hours [**4-28**].   O2\\n   sats remained 96-100%.  Patient slept quickly & more deeply overnight.\\n   Reattached to vent support @ 2300 [**4-28**]. On MMV @ 40%/Vt450/PEEP 5/PS\\n   5.  Fell asleep as soon as he was attached to vent.   Patient appeared\\n   tired in late evening .\\n   Action:\\n   Followed  O2 sats closely while on trach mask.  Sx\\ned by RT several\\n   times this evening.  Morphine changed from 15mg per NGT q 8hrs to\\n   10-20mg q 12 hrs prn.  Midnight dose of morphine held.\\n   Response:\\n   Appeared very comfortable overnight.\\n   Plan:\\n   Continue to wean off vent.\\n   Altered mental status (not Delirium)\\n   Assessment:\\n   Patient continues to refuse mouth care by clenching  teeth & shaking\\n   head.  Also appeared to throw objects that were not present.\\n   Action:\\n   Oriented  patient\\n   Response:\\n   Plan:\\n   Continue to assess orientation.\\n',\n",
              "  '[**Last Name **] Problem - [**Name (NI) **] Description In Comments: angioedema & urticaria\\n   Assessment:\\n   Patient\\ns O2 sats were 97-100% on room air. She continued to be able\\n   to swallow. Her speech became more clear as night progressed.\\n   Action:\\n   Monitored O2 sats continuously & assessed patient\\ns respiratory status.\\n   Response:\\n   Patient\\ns respiratory status remained stable & Sx (such as slurred\\n   speech from angioedema) improved.\\n   Plan:\\n   Continue to monitor O2 sats continuously. Continue to assess for airway\\n   obstruction. Avoid allergens (ie. Any nuts such as peanut butter),\\n   provide hypoallergenic EKG leads etc. Discharge to home as soon as MD\\n   OK it.\\n',\n",
              "  'Patient  had no respirations or HR by 2135.  Wife & friend remained @\\n   bedside w/patient.\\n',\n",
              "  'Pneumonia, bacterial, community acquired (CAP)\\n   Assessment:\\n   Tmax 99.7 ax.  Productive sounding cough but unable to cough anything\\n   up @ this time.\\n   Action:\\n   CPT given q 4 hrs while awake. Is used X10 q 1 hr while awake.\\n   Response:\\n   Desats down to upper 70\\ns when HOB dropped, ie during CPT\\n   Plan:\\n   Continue IS, stop CPT until patient can tolerate lying flat.\\n   Diabetes Mellitus (DM), Type II\\n   Assessment:\\n   FS 405 @ 2145 after eating during day.  Patient needed to be fed.\\n   Action:\\n   Received 10 units humalog sc @ 2145.\\n   Response:\\n   FS 350 @ 2330. Given another 6 units humalog @ 2330.\\n   Plan:\\n   Continue to check FS qid & prn.  Check w/team re: restarting oral\\n   hypoglycemic.\\n   Obstructive sleep apnea (OSA)\\n   Assessment:\\n   Lungs sounds: insp & exp wheezes throughout, w/diminished BS @ RLL.  O2\\n   sats were 85-90% on 3L NP.  Albuterol & atrovent neb Tx\\n   Action:\\n   Placed on nasal Bipap @ 2215\\n   Response:\\n   O2 sats improved to 89-94% (better while sleeping)\\n   Plan:\\n   Continue Bipap while sleeping.  Tolerates NP 3L  during day when more\\n   awake.\\n   Patient wasDTV by midnight, p foley D/C\\ned.  Condom catheter placed on\\n   patient & he voided 350cc @ 0100.\\n'],\n",
              " 1: ['This is a 68 y.o.male pt with PMH of T4 paraplegia secondary to\\n   inflamatory disease of the spinal cord of uncertain etiology, CAD, CHF,\\n   sacral decubitus ulcers, UTIs, PE w/p IVC filter on anticoagulation who\\n   presented to ED from [**Hospital **] rehab with 5 days intermittent chest pain\\n   on right side, abdominal discomfort, decreased appetite, and nausea.\\n   Also with SOB over last couple of days and increasing cough over last\\n   couple of weeks.  Abdominal pain is chronic and has been present for\\n   years. Dx w/sepsis.\\n    Impression was for abdominal source [**3-13**] to sacral decub -> CT\\n   Abd/Pelvis showed large infra sacral decub fluid collection with\\n   possible abscess formation and associated rectal thickening.  Plastic\\n   surgery evaluated sacral decubs & did not feel they were the source of\\n   his sepsis.  Found to have gram negative rods in urine. Now covered\\n   w/tobramycin IV.\\n   .Of note, the  patient has had multiple admissions in the past, the\\n   most recent from [**Date range (1) 2442**] for hypotension requiring pressors.  Etiology\\n   unclear but felt to be either line vs. UTI vs. sacral decub.  He was\\n   treated with meropenem, vancomycin, flagyl, and ciprofloxacin , foley\\n   changed.  Influenza negative.  Plan was to receive two week course of\\n   meropenem and vancomycin given no clear source of infection (completed\\n   [**5-27**]).\\n   .H/O decubitus ulcer (Present At Admission)\\n   Assessment:\\n   Afebrile.\\n   Action:\\n   Changed sacral dressings @ 0230.\\n   Response:\\n   Continues to have foul smelling thin tan drainage from all wounds.\\n   Less noted tonight than last night.  More sanguinous drainage.\\n   Granulation tissue present @ all the wounds Undermining noted on R,\\n   most lateral wound medially. It took [**3-14**]  4X4\\ns in undermined pocket.\\n   Wound on L has eschar still present @ outer edges.\\n   Plan:\\n   Continue tid drsg [**Name5 (PTitle) 292**].\\n   Pneumonia, aspiration\\n   Assessment:\\n   Patient desatted down to 89 @ 0300 after coughing ineffectively\\n   (productive sounding). Patient wore 35% cool  humidified O2 via face\\n   tent all night to loosen secretions. Lungs were clear @ upper lungs,\\n   diminished @ bases to coarse through out.\\n   Action:\\n   NT Sx\\ned for copious amount thick yellow secretions @ 0300 by RT.\\n   Continued atrovent & albuterol nebs q 6 hrs.  Increased O2 to 95% via\\n   high flow neb w/desatting.  Only came back up to 95%.\\n   Response:\\n   All lung fields clear after being Sx\\ned.  O2 sats returned to 98-100%\\n   on 35% humidified O2 via face tent.  Practiced using IS w/patient.\\n   Plan:\\n   IS, CPT.  Check w/team re: robitussin  po or mucomist neb to loosen\\n   secretions\\n',\n",
              "  'This 81 yr old man, admitted [**3-28**] w/perforated appendix, was\\n   transferred to the [**Hospital Ward Name 77**] MICU on [**4-2**] for SOB & Afib w/RVR, HR up to\\n   180\\ns.  HR controlled w/lopressor.  SOB treated w/IV lasix on the floor\\n   & neb Tx\\ns.  PMH: Adenoid CA of lung s/p resection, prostate CA, EF\\n   35%.\\n   .H/O abdominal pain (including abdominal tenderness)\\n   Assessment:\\n   Patient went for CT of abdomen.  Stomach & jejunum are dilated & fluid\\n   filled but no clear obstruction.  Appendix still showed bubbles of gas\\n   & small pockets of fluid .  Patient had black tarry guiac + melenotic\\n   stool overnight. X1.   Hct dropped after 2 units PC\\ns given this\\n   afternoon from 24.4@ noon   to 23.9 @ midnight.  Lactate 1.0.  WBC 13.7\\n   (12.0)\\n   Action:\\n   Transfused w/ 2 additional units PC\\ns overnight.  Flagyl D/C\\ned, vanco\\n   started & zosyn started.\\n   Response:\\n   Post Hct 38.8 drawn 1 hr after transfusion.  Will draw again @ 1000.\\n   Plan:\\n   Continue to  check Hct frequently & transfuse as needed.  To IR today\\n   if possible for tagged blood scan.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR 90\\ns-150\\ns Afib    BP 72-112/ 40\\ns-60\\n   Action:\\n   Given 50mg po lopressor @ [**2098**].  Given 5mg IV lopressor @ 2200 for HR\\n   in 150\\ns.  Given 500cc NS bolus @ 0130 for BP 72/37.  Given 2 units\\n   PC\\ns over 1-2 hrs each for  sBP  70\\ns-80\\n   Response:\\n   HR up to 150\\ns after po lopressor but down to 100\\ns-130\\ns after IV\\n   lopressor.\\n   Plan:\\n   Continue to medicate w/ lopressor po.  Check w/team re: giving 1X IV\\n   dose if po lopressor ineffective.\\n   Chronic obstructive pulmonary disease (COPD, Bronchitis, Emphysema)\\n   without acute exacerbation\\n   Assessment:\\n   Patient went for CTA.  No PE found, but RLL collapse & B effusions\\n   visualized.  Tachypneic w/RR 28-40.  O2 sats 92-94% on 2L NP.  ABG on\\n   2L: 7.50/33/60 pO2.  Lung sounds were wheezes on L , diminished @ bases\\n   to clear @ upper lungs, diminished @ bases.\\n   Action:\\n   Increased O2 to 3L  NP.  Started IV steroids.  Given frequent neb Tx\\n   (q2 hr xopenex) until wheezing improved & q 6 hr atrovent.\\n   Response:\\n   As above.\\n   Plan:\\n   Continue to titrate O2 to O2 sats & ABG\\n',\n",
              "  '54 y/o F w/ a PMH significant for multiple SBO\\ns for which she has been\\n   tx both medically and surgically in the past.  Aadmitted to 5S [**12-26**] w/\\n   abd pain/N/V. On [**12-27**]  developed ARF, renal u/s revealed bil.\\n   hydroureter and a pelvic cyst. Ct scan showed SBO  ->OR & surgery found\\n   that the small dead bowel was wrapped around her ileoconduit. Pt.\\n   underwent SBO resection & required a revision of her ileoconduit .\\n   [**Month (only) 51**] be called out to floor today.\\n   Small bowel obstruction (Intestinal obstruction, SBO, including\\n   intussusception, adhesions)\\n   Assessment:\\n   NGT draining yellow-green bilious drainage.  Bowel sounds continue to\\n   be absent.  Midline abdominal dressing clean, draining  moderate\\n   amounts serous drainage X2 overnight.   JP drained serous fluid, 70cc @\\n   2300 & 20cc @ 0500.      .\\n   Action:\\n   Drsg [**Name5 (PTitle) 1728**] [**Name5 (PTitle) **]/ABD\\ns only  ( used softsorb in past).\\n   Response:\\n   Patient\\ns u/o was: 50-175cc/hr overnight.\\n   Plan:\\n   Continue to change abdominal dressing as needed.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Lungs clear @ upper lungs, diminished @ bases.  O2 sats: 96-100% on 2L\\n   NP.   RR: [**1-15**]\\n   Action:\\n   Patient turned q 2 hrs.  Coughing & deep breathing encouraged q 2 hrs.\\n   CPT done.\\n   Response:\\n   Productive cough of small amounts yellow secretions.  ABG\\n   7.39/53/96  ( is CO2 retainer from previous ABG\\nanatomical from spina\\n   bifida).\\n   Plan:\\n   Try Incentive Spirometry as patient\\ns alertness improves & anxiety\\n   decreases.\\n   .H/O anxiety\\n   Assessment:\\n   Patient anxious throughout night.\\n   Action:\\n   Given 0.5mg SL xanax @ 0100, 0.5mg ativan @ 0300 & 2mg morphine IV @\\n   0440.\\n   Response:\\n   Became sleepy but not apneic or hypotensive.  BP decreased down to\\n   120\\ns-140\\ns/sys from 150\\ns-190\\ns/sys.  HR decreased to mid 100\\n   from 117-120 ST.  Held 0615 am dose of xanax which was requested\\n   adamantly, but patient was asleep 5min later when this nurse went into\\n   room to give it.\\n   Plan:\\n   Medicate patient as needed w/SL xanax prn & IV ativan prn.  Patient\\n   prefers xanax as she takes 2mg po q 8hrs @ home.\\n',\n",
              "  '82 yr old woman was admitted [**2-12**] to 11R w/abdominal pain, wgt loss &\\n   1X1 cm mass next to bile duct.  Fell today & developed bilateral\\n   parasagital subdural hematomas. No LOC or change in baseline neuro\\n   vs.   Transferred to ICU for q 1 hr neuro vs checks.\\n   Subdural hemorrhage (SDH)\\n   Assessment:\\n   Neuro vss.  Some difficulty remembering which hospital she was in ,\\n   after falling asleep & being woken up, improved as night progressed\\n   into morning.\\n   Action:\\n   Checked neuro vs q 1 hr.  Was  NPO  since Mn.  Received 1580mg loading\\n   dose of phosphenytoin IV @ 2330.\\n   Response:\\n   As above.\\n   Plan:\\n   Head CT w/o contrast planned for today.  Draw dilantin level before\\n   giving 0800 dose dilantin.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Had abdominal pain since mid [**Month (only) 2287**].  Being treated w/10mg oxycontin\\n   [**Hospital1 **] & oxycodone 5mg for breakthrough pain.\\n   Action:\\n   Oxycontin held this evening as were xanax 0.25mg & zyprexa 5mg po this\\n   evening, all per MICU resident so as not to cloud neuro presentation.\\n   Response:\\n   Patient denied pain all night , & she was surprised to do so.\\n   Plan:\\n   Medicate w/Tylenol q 6 hrs (not prn).\\n   Cancer (Malignant Neoplasm), Pancreas\\n   Assessment:\\n   Patient was scheduled for GI surgery on [**2-15**] @  [**Hospital Ward Name 1074**].\\n   Action:\\n   Kept NPO for possible procedure.\\n   Response:\\n   Plan is for eventual GI surgery.\\n   Plan:\\n   Once neuosurgically stable, to be transferred to [**Hospital Ward Name 1074**]\\nmay be\\n   today.\\n',\n",
              "  '74 year old female with recently diagnosed gastric CA, s/p resection\\n   transferred from [**Hospital3 4838**] for esophageal stenting, initially\\n   admitted to [**Hospital Unit Name 10**] for respiratory failure [**2-13**] pulmonary edema, then\\n   extubated and called out to medical floor.  Readmitted to MICU s/p\\n   pulseless VT/VF arrest, then diagnosed with splenic laceration\\n   requiring massive transfusion and splenic artery embolization.\\n   .\\n   # Splenic artery laceration: s/p embolization by IR with recently\\n   stable Hcts. Patient had known old splenic laceration, but reason for\\n   re-bleed is unclear.  It is possible that the bleeding was exacerbated\\n   by CPR, but the patient had abdominal pain prior to her arrest,\\n   suggesting that the bleed could have begun before the arrest.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 2**])\\n   Assessment:\\n   Patient continues on A/C @ 40%  w/ 450Vt/ 18 RR/ 5 PEEP.  O2 sats:\\n   92-97%, improved from 90% earlier today.      RR: 18-23.\\n   Action:\\n   Suctioned q 4 hrs for small amounts of thick white secretions.  Patient\\n   suctioned orally for bilious secretions hourly.  Increased fentanyl to\\n   125mcg/hr.    Continued on versed @ 1mg/hr.\\n   Response:\\n   ABG\\ns: 7.33/36/89   Still grimaces w/turns.  Comfortable the rest of\\n   the time.\\n   Plan:\\n   Continue present  vent settings.  Make patient as comfortable as\\n   possible.\\n   Hypotension (not Shock)\\n   Assessment:\\n   BP: 85-129/47-65               MAP: 58-86            HR: 108-131 ST\\n   w/frequent PAC\\ns      CVP: [**9-21**]\\n   Action:\\n   Given 2.5L NS in boluses overnight.\\n   Response:\\n   BP increased to  113-136/55-68, &   MAP: 72-89              HR  dropped\\n   to  108-119 ST w/occasional PAC\\ns   CVP increased to 12.\\n   Plan:\\n   Continue to hydrate as needed.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN: 105  (100)              Cr:3.6 (3.5)                 K:\\n   3.9              U/o: 66cc for last 12 hours, urine is amber\\n   w/sediment.  Abdomen is firm & distended.   Hct is stable.\\n   Action:\\n   Fluid boluses as above, given for BP.     Bladder pressure was 21\\n   yesterday.\\n   Response:\\n   U/o does not respond to fluid boluses.  Patient is in ARF.\\n   Plan:\\n   Family meeting needs to be initiated.  Unable yesterday because of\\n   HCP\\ns plans w/grandchildren.\\n   Hyperglycemia\\n   Assessment:\\n   FS: 84-102 while IV insulin running @ [**10-13**] units/hr.\\n   Action:\\n   Started on TPN w/ insulin.  Receiving 1.5 units/hr w/TPN.\\n   Response:\\n   Turned off IV insulin @ 0300.\\n   Plan:\\n   FS 82-96 since IV insulin turned off.\\n',\n",
              "  '85  yr old man w/bladder CA , lung CA  (s/p excision) & mets to head of\\n   R femur had R hip replacement in OR [**12-13**].  Sent to MICU to recover (\\n   already extubated).  Received IV neo in OR briefly for hypotension.\\n   Foley placed in OR: traumatic insertion.  Neuro changes ( L pronator\\n   drift, disorientation) upon arrival, quickly resolved.\\n   Bone mets to R femur, s/p R hip replacement\\n   Assessment:\\n   R lateral hip dressing :D&I.  Hemovac exiting from that same dressing\\n   drained 180cc for the last 12 hrs.  Abducting cushion remained between\\n   legs all night.   U/o 30cc/hr after foley irrigated w/60-120cc sterile\\n   H2O per hour from 2100-0000.  (U/o includes L nephrostomy & foley).\\n   Foley had sludge composed of some clots ( urine was pink) & cqncer\\n   cells.\\n   Action:\\n   TEDS removed this am so that R heel dressing could be done.  TEDS\\n   replaced but very tight.  Patient may need extra large TEDS ( has\\n   large).  Medicated w/4mg IV morphine q 3 hrs for incisional  pain\\n   w/relief from [**8-16**] down to [**2121-5-12**].\\n   Response:\\n   As above.\\n   Plan:\\n   [**Month (only) 8**] transfer to floor.\\n   Renal failure, Chronic (Chronic renal failure, CRF, Chronic kidney\\n   disease)\\n   Assessment:\\n   Poor u/o as above initially.  K was 5.9 @ [**2141**].  Repeat K @ 0100 was\\n   5.6.\\n   Action:\\n   Received 1000cc LR @ [**2026**], & 1000cc NS @ 2300.  Received 1 amp D50 & 10\\n   units IV regular insulin to drop serum K down to 5.4 an hour later.\\n   Response:\\n   After midnight, patient\\ns u/o was 30cc/hr.\\n   Plan:\\n   Serum K & vanco level drawn @ 0630\\ncheck results.\\n',\n",
              "  '87 y/o man with PMH volvulus s/p colostomy (since reversed), who\\n   presented with LLQ abdominal pain of several days duration and found to\\n   have SBO. Went to OR on [**1-8**] with removal of significant amount of\\n   ischemic bowel and illeostomy placement.  Admitted to M/SICU for\\n   post-op mgt and course complicated by septic shock and volume\\n   overload.  Difficulty weaning vent support. Now thought to have VAP.\\n   Bronched on [**1-17**] & again [**1-18**].  Removed mucous plug & secretions.  Pt\\n   is DNR/DNI.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Patient decreased to CPAP @ 40% w/8 PS & 5 PEEP this am  (from 12 PS &\\n   8 PEEP).         RR: 20-28       O2 sats: 97-100%.  Patient had mucous\\n   plug @ 0400, desatted to 92% & became tachypneic.  Recovered\\n   w/suctioning.\\n   Action:\\n   Suctioned for moderate amounts thick yellow secretions.  Mucomist given\\n   by RT per vent.  Viscous lidocaine applied to painful mouth ulcers\\n   after VAP mouthcare.  Tube feedings stopped @ midnight.\\n   Response:\\n   Patient\\ns secretions are tenacious, requiring lavage w/NS to loosen in\\n   order to remove w/suctioning. Patient has very weak cough.   Patient\\n   wife said that she is coming in around noon.  She said that the patient\\n   will be extubated tomorrow & that she expects him to live.   RSBI 75\\n   this am.\\n   Plan:\\n    The plan is then to extubate patient, w/no reintubation.  The\\n   patient\\ns wife & adopted son are coming in between noon & 1pm.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient grimaced w/mouth care & turning.\\n   Action:\\n   Given 5mg oxycodone per PEG @ 2320.  Given viscous lidocaine to mouth\\n   ulcers after VAP mouth care.\\n   Response:\\n   Patient was able to sleep after pain med given, once light were turned\\n   off.\\n   Plan:\\n   Given IV dilaudid 0.5mg @ 0545 before surgical team changed abdominal\\n   dressing.  Surgical team to be back @ 0645.\\n   Elevated temp\\n   Assessment:\\n   Tmax 101 po overnight.         WBC 13.7 (16)\\n   Action:\\n   BCX2 & urine Cx sent.  Bronch done [**1-18**] so BAL sent.  Received IV\\n   zosyn & cipro overnight.  Received IV vanco q am.\\n   Response:\\n   As above.  No tylenol given.\\n   Plan:\\n   Continue to monitor temp.  Await Cx results.\\n   Small bowel obstruction (Intestinal obstruction, SBO, including\\n   intussusception, adhesions)\\n   Assessment:\\n   Midline abdominal incision stapled w/purulent serosanguinous drainage\\n   expressed by surgical team members.  Manipulation near wound is painful\\n   to patient.  Ileostomy functioning\\ndraining yellow\\ngreen guiac\\n   negative liquid.  Patient continued to tolerate increased tube feeding\\n   (nutren pulmonary) rate up to 20cc/hr w/only 20cc TF residual.\\n   Action:\\n   Medicated w/dilaudid IV for dressing changes (by surgical team).\\n   Stopped tube feeding @ midnight for extubation [**1-19**].\\n   Response:\\n   Needs wound Cx.\\n   Plan:\\n   Increase tube feeding rate up to 40cc/hr as patient tolerates,  if\\n   patient tolerates extubation.\\n',\n",
              "  '82 yr old COPD, HTN, s/p open chole, gallstone pancreatitis with ERCP\\n   drainage  c/b hypoxic arrest [**9-12**]. Tx with therapeutic hypothermia,\\n   intubated, found to have a large biliary leak.  Extubated [**9-21**].\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Extubated @ 1430 on [**9-21**].  Lungs: expiratory wheezes throughout.  RR:\\n   29-42   O2 sats: 93-97% on 3L NP.  ABG ([**2116**]): 7.43/58/70 on 40%\\n   humidified O2 via facemask.\\n   Action:\\n   Received Albuterol q 4 hrs & atrovent nebs q 6 hrs for diminished BS &\\n   O2 sats down to 93%.  Humidified air given via face tent along w/3 L\\n   NP.  Avoided CPT due to pain from possible rib fx\\ns.  Turned q 1-3\\n   hrs.  Encouraged coughing & slow deep breathing.\\n   Response:\\n   Expectorated small amounts of thick yellow to white secretions.\\n   Plan:\\n   Continue pulmonary toilet.  Await team\\ns decision re: starting an\\n   inhaled steroid (daughter [**Name (NI) 1349**]\\nt say what inhaler(s )  patient used @\\n   home for her asthma).\\n   Pancreatitis, acute\\n   Assessment:\\n   T-tube drained: 15cc over the past 24 hours\\n   Action:\\n   Remains NPO after extubation.  C/o being hungry.\\n   Response:\\n   Decreased T-tube drainage from yesterday.\\n   Plan:\\n   Biliary team to possibly pull drain today.  ERCP planned for Mon for\\n   removal of pancreatic stent.\\n   Patient continues to have diarrhea several times/day.  3 specimens for\\n   C-diff sent, & so far, C-diff negative.  Colace held.  Soft abdomen.\\n   Patient continues to have musculoskeletal pain in L chest possibly from\\n   rib fx (has fx in R shoulder from CPR [**9-12**]). Cardiac enzymes negative\\n   X2.  EKG\\ns ([**9-21**]) negative also.  Dull intermittent pain, increases\\n   w/movement & touching painful area.  Given Tylenol & repositioned\\n   carefully.  Attempted CPT  for a few seconds but patient found it too\\n   painful.\\n   HR: 80\\ns SR\\n [**Street Address(2) 918**] w/ no to rare PVC.    Repleted w/20 mEq KCl to\\n   bring serum K up to 4.7.  Much less ectopy w/higher serum K.\\n   Patient is hungry & dramatically told her daughter that she was going\\n   to\\npass out because she was so hungry.\\n  FS 121 @ that time (0400).\\n   BP 152/sys   HR 100 O2 sat 93% RR 31.    Took po meds crushed & mixed\\n   w/bite of jello overnight.  No choking, swallowed well.  Plan: clear\\n   liqs today.\\n   Weighed 43.8kg-45.1kg (depending on how the bed was zeroed\\ninfo on this\\n   was erased).  This is still a big drop from 51.8 on [**9-19**].  Admission\\n   wgt was 54kg.   Her fluid balance on [**9-21**] was -1700cc.  So far today\\n   ([**9-22**] @ 0600) it was -350cc.\\n',\n",
              "  '58 yo male with  respiratory failure, intubated [**10-23**], trached [**10-24**].\\n   Has GVHD following BMT for CML.     PEJ placed in IR [**10-25**].\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   Patient is trached & vented on CPAP @ 40% w5/5.     Tmax 99.4po\\n   O2 sats: 95-98%             RR: [**11-6**]\\n   Action:\\n   Suctioned q 2-4 hrs for moderate amounts thick tan secretions.\\n   Response:\\n   RSBI 27.\\n   Plan:\\n   Transfer patient to [**Hospital 630**] Rehab in [**Location (un) 223**] today.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient c/o pain in abdomen & back: [**2125-2-19**], relieved w/dilaudid PCA\\n   down to 3/10.  Used PCA appropriately. See flow sheet for details.\\n   Action:\\n   Patient received 1800 dose of methadone 15mg @ [**2114**].  He received 2200\\n   dose of 20mg methadone @ 0230.  Doses of lyrica were similarly delayed\\n   due to hypotension.  Given 500cc NS bolus @ 0100 for hypotension & u/o\\n   only 20cc  for 1 hr.\\n   Response:\\n   Although hypotensive, patient was comfortable.\\n   Plan:\\n   Dilaudid PCA to be D/C\\ned [**10-27**].  Awaiting team\\ns evaluation of\\n   patient\\ns required dosage of pain med as ?morphine per PEJ.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Patient has multiple skin tears on all limbs.  Also continues to have\\n   pressure ulcer on back.\\n   Action:\\n   DSD\\ns w/adaptic applied to all skin tears.  Mepilex applied to pressure\\n   ulcer on back.\\n   Response:\\n   No infection noted @ any skin tears.  Very fragile skin.\\n   Plan:\\n   Continue to change dressings qd & prn.\\n   Alteration in Nutrition\\n   Assessment:\\n   Tube feed residual 0-3cc.  No bleeding noted.  Had very loose mostly\\n   liquid brown BM that was guiac negative.\\n   Action:\\n   Increased tube feeds of peptamen 1.5 from 30cc/hr to 55cc/hr\\n   Response:\\n   No c/o GI distress.  Soft distended abdomen w/positive bowel sounds.\\n   Plan:\\n   Hold colace & senna in am.\\n   Hct 22.7 Team will evaluate for possible\\n   transfusion.\\n',\n",
              "  'Pt. is a 50 yr old Spanish speaking man, who was admitted to 11R on [**10-12**]\\n   w/ urethral infection. Pt. went to the OR [**10-13**] for a cystoscopy . This\\n   was performed through the perineum. Large amts of pus removed and a\\n   packing was placed. Pt. transferred to [**Hospital Ward Name 51**] MICU for possible\\n   conscious sedation prior to removal of packing tomorrow.\\n   [**Last Name **] Problem\\n Perineal abcess\\n   Assessment:\\n   Patient had a large amount of not foul smelling serosanguinous drainage\\n   from his perineal dressing.   He has a  dilaudid  PCA (0.12/6/1.0)\\n   which he has only used 3x from [**10-13**] 1500-9/5 0400 ( 13 hours).  WBC\\n   12.6  Tmax 99.8 po overnight.\\n   Action:\\n   Changed pad under patient & reinforced dressing w/new ABD pad X2.\\n   Encouraged patient to use PCA.\\n   Response:\\n   Plan:\\n   To have packing removed under conscious sedation [**10-14**].\\n   ------ Protected Section ------\\n   Patient\\ns urine was hematuric, s/p cystoscopy.  Intern awre.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2129-10-14**] 07:22 ------\\n',\n",
              "  'This 34 yr old man w/frequent admissions to [**Hospital1 19**] for chronic\\n   pancreatitis & ETOH abuse is admitted through EW w/abdominal pain, N/V\\n   X10 hrs, from pancreatitis.  Says he has [**9-18**] pain in abdomen.  Appears\\n   in NAD.  Demanded to smoke, or he would sign himself out , he said &\\n   then smoke & then get readmitted.  Accepted patch alternative after\\n   talking to intern.  Then refused NGT w/out antianxiety med.\\n',\n",
              "  '66 yoM w/ a h/o DM and prostate cancer presents for prostatectomy. Pt\\n   is s/p suprapubic prostatectomy for prostate cancer with multiple bouts\\n   of urinary retention (partial prostatectomy with plans to have radition\\n   therapy in future), c/b 1.5 L EBL and difficult intubation- sent to\\n   [**Hospital Unit Name 1**] as is intubated and for hemodynamic monitoring.\\n   [**9-28**] pt found to have temp 103.5. CXR shows new pneumonia, pt with\\n   moderate amts thick tan secretions via ETT. BP dropped to 70\\ns at 0830\\n   and pt treated with 3.5 liters IVF boluses. Levophed drip started,left\\n   a-line and right IJ CVL inserted.  Family aware of turn of events. Pt\\n   started on triple antibiotics and vent settings advanced to let pt rest\\n   due to the new pneumonia. Pt cultured, 2 blood cultures and sputum sent\\n   before antibiotics started.\\n   [**9-29**]  able to wean the levophed drip off. Pt continued on AC\\n   ventiallation and was treated with broad spectrum antibiotics and his\\n   condition improved somewhat. Propofol drip was switched to versed/fent\\n   drips for sedation.  Switched back to propofol since CXR looked\\n   better.  Will try to wean off vent starting  tomorrow if he wakes up a\\n   little.\\n   Pneumonia, aspiration\\n   Assessment:\\n   Patient remains on A/C @40%/550/12/ 5 PEEP   RR 12-14  O2 sats\\n   99-100%.  Patient opened eyes & moved all extremities.  Sedated\\n   w/propofol 10-20 mcg/kg/min.  When propofol turned off for RSBI,\\n   patient responded to questions by nodding although he did not squeeze\\n   hand on command.\\n   Action:\\n   Sx\\ned q 1-3 hrs for moderate amount of thick yellow to tan secretions.\\n    Copious clear to blood tinged oral secretions.  Turned q 2 hrs.\\n   Response:\\n   RSBI 24     ABG\\ns:  7.47/41/130 showing metabolic alkalosis\\n   Plan:\\n   Continue pulmonary toilet.  Goal is to change to CPAP next as part of\\n   process to wean from vent.\\n   Sepsis without organ dysfunction\\n   Assessment:\\n   Tmax 100.2 po.  BP 80\\ns-120\\ns/sys w/MAP>60.  HR: 80\\ns SR-[**Street Address(2) 918**] no\\n   ectopy.   WBC 11.8 (8.6)\\n   Action:\\n   Received IV vancomycin, ceftazidime & cipro.\\n   Response:\\n   Maintained MAP>60.  No boluses given overnight.\\n   Plan:\\n   Treat low u/o & MAP<60 w/fluid bolus.\\n   This patient has a 12 point Hct drop since yesterday, from 33.4 to\\n   21.5.  Repeat Hct sent @ 0635.   Urine is blood tinged only , which is\\n   no change.  No c/o back pain when asked specifically about it.  HR 77\\n   SR-100 ST & MAP>60 (in assessing for retroperitoneal bleed).    Did nod\\n to abdominal pain.\\n   Labs that need to be repleted: Mg 1.7    K 3.4    Ca 7.7.\\n',\n",
              "  '59M with mm, s/p stem cell transplant, complicated by PTLD, and\\n   respiratory failure due to metabolic acidosis and fluid overload.\\n   Rec\\nd experimental doses of valcade, retuximab earlier in week.\\n   Patient has no gag, cough or muscle tone.    Family in to visit.\\n   Cancer (Malignant Neoplasm), Bone\\n   Assessment:\\n   After discussion w/Dr. [**First Name (STitle) **] & Dr. [**Last Name (STitle) 1070**] & [**Name (NI) **] (HCP), the\\n   decision was made to make patient CMO in the morning.  He will be\\n   placed on a morphine drip & will be extubated @ 1100.  This timing is\\n   so his mother can be present for extubation.\\n   Action:\\n   Maintained patient as full code overnight so that family can be\\n   w/patient tomorrow.  Nevertheless no blood draws overnight.  Patient\\n   received all his usual meds overnight.  TPN was held for extra fluid\\n   that would be given.    Patient\\ns comfort was promoted overnight.\\n   Given 1mg IV morphine to prevent pain w/turning @ 0420.\\n   Response:\\n   Vss overnight.\\n   Plan:\\n   As above.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Patient was on CPAP overnight  @ 40%//5 PS/ 5 PEEP.  Patient maintained\\n   RR 14-24.  O2 sats 95-98% .  Lungs: clear throughout except for\\n   diminished @ R base.  Sx\\ned q 8 hrs for small amount of  thick brown\\n   secretions (old blood).\\n   Action:\\n   Scopolamine patch in place to decrease secretions.\\n   Response:\\n   Patient maintained RR & sats on CPAP, even w/turning patient.\\n   Plan:\\n   Extubate patient @ 1100 in am [**6-27**].\\n   Liver function abnormalities\\n   Assessment:\\n   Appeared somnolent.  Unable to arouse patient w/turning, mouth care or\\n   sternal rub.    LDH 1895 on [**6-26**].\\n   Action:\\n   Patient has been off sedation since [**6-22**] 1600 for versed & [**6-24**] 1600 for\\n   fentanyl.\\n   Response:\\n   Encephalopathy from liver failure might be part of the reason patient\\n   does not arouse, as well as sedatives in blood stream still.\\n   Plan:\\n   Continue comfort measures.\\n   Foley was D/C\\ned @ 1900 [**6-26**].\\n',\n",
              "  '51 yo male with femur frx s/p ORIF, DVT/PE, C3-5 contusion with\\n   quadriplegia from MVC about a month ago. Initially pt of T/SICU and\\n   then transferred to [**Hospital3 1536**]. Back to [**Hospital1 5**] with a PNA  (VAP)\\n   with temp spikes up to 104.  [**11-20**] chest CT showed multifocal\\n   consolidations, since inproved by CXR.    Sputum from [**11-17**] grew out\\n   GPC (mostly mixed flora),  new specimen sent [**11-24**], still pending.\\n   Urine Cx negative.    BC pending.  Negative for influenza.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 76**])\\n   Assessment:\\n   Remains on CPAP @ 40% w/5 PEEP & 10 PS.         RR: [**10-16**]       O2\\n   sats: 98-100%\\n   Action:\\n   Suctioned rarely for small amounts thick white secretions.    Received\\n   IV cefepime & vanco for VAP.\\n   Response:\\n   Patient has small cuff leak.  Some vent alarms overnight from this.\\n   Plan:\\n   Stable on present vent settings.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient c/o constant back pain [**2139-6-4**].\\n   Action:\\n   Medicated w/oxycodone 10mg w/ultram 50mg X1.  Medicated w/dilaudid 1mg\\n   IV X1.  Medicated w/toredol 15mg IV X1.  Medicated w/lidocaine patch to\\n   upper back @ 0440.\\n   Response:\\n   Small pain relief from oxycodone & ultram.  Little pain relief from\\n   dilaudid.  Some relief from toredol.  Patient slept poorly, in part\\n   because of anxiety any time vent alarmed.\\n   Plan:\\n   Assess effectiveness of lidaocaine patch.  Continue to assess for pain.\\n   Fever, unknown origin (FUO, Hyperthermia, Pyrexia)\\n   Assessment:\\n   Tmax 98.7po             HR: 50\\ns SB  no ectopy           BP:\\n   89/38-104/58\\n   Action:\\n   Received 500cc NS bolus X2 w/no response in BP.  Received 1000cc NS in\\n   addition @ 0430 w/increase in BP to 92/45  & increase in u/o from\\n   15cc/hr to 30cc/hr+.\\n   Response:\\n   Fever possibly from spinal contusion.\\n   Plan:\\n   Continue to monitor  temp, HR & BP.\\n',\n",
              "  '54 yr old woman admitted from OSH w/gallstone pancreatitis, ?\\n   necrotizing pancreatitis.  Spanish speaking.   CXR [**12-25**] here confirmed\\n   large B pleural effusions involving R lower & middle lobes & L lower\\n   lobe.  PMH: GERD, depression & asthma.  Daughter stayed overnight in\\n   patient\\ns room to translate if needed.\\n   Pleural effusion, acute\\n   Assessment:\\n   Lungs sound clear w/diminished sounds @ bases.       RR: 18-22     O2\\n   sats 93-97% on 6L NP     Tmax 99.9po\\n   Action:\\n   Encouraged IS.  CPT.  Encouraged T,C,DB.\\n   Response:\\n   Coughing up scant white secretions.\\n   Plan:\\n   IS X10 q 1 hr while awake, CPT q 4 hrs, encourage T,C,DB.  Titrate O2\\n   down as tolerated.  Get up to chair during day.\\n   Pancreatitis, acute\\n   Assessment:\\n   Amylase & lipase trending down.  LFT\\ns WNL.    No c/o acute nausea.\\n   Burping w/turning but no flatus.\\n   Action:\\n   Hydrated w/IV LR @ 120cc/hr.  Medicated w/ipenum-cilastin IV.\\n   Response:\\n   Severe pancreatitis vs necrotizing pancreatitis\\n   Plan:\\n   NGT  placement planned under fluoro today for  post pyloric tube\\n   feeds.  EGD deferred @ this time (tonight) due to critical condition &\\n   lack of GI bleeding.  Possible KUB in future to r/o ileus w/distended\\n   abdomen (last BM [**12-21**]).  Goal:u/o>50cc/hr.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   C/o [**2139-5-19**]  abdominal pain  & back pain.\\n   Action:\\n   Medicated w/0.75 mg IV dilaudid q 4 hrs prn back & abdominal pain.\\n   Response:\\n   Pain relieved down to 0-3/10 w/0.75mg IV dilaudid.\\n   Plan:\\n   Continue to assess for pain.  Medicate w/IV dilaudid as needed.\\n   Tachycardia, Other\\n   Assessment:\\n   HR: 110-128 ST no ectopy\\n   Action:\\n   Receiving IVF @ 120cc/hr X2000cc.  (2^nd L infusing).   Medicated w/5mg\\n   IV lopressor q 6 hrs.  Medicated w/tylenol @ midnight.\\n   Response:\\n   HR down to  110 ST  while sleeping.\\n   Plan:\\n   Continue to monitor HR.\\n',\n",
              "  '43 yr old woman admitted from OSH to 11R w/prolonged vaginal bleed X4\\n   weeks. PMH: ? Hepatitis C, ? hepatitis B, bipolar disorder, substance\\n   abuse (cocaine).  ITP, possible TTP.  Transferred to F-MICU to have\\n   pheresis catheter placed & pheresis initiated.\\n   Thrombocytopenia, acute\\n   Assessment:\\n   PLT 37 after 2 units PLT\\ns [**7-7**] on 11R.\\n   Action:\\n   Received 1^st  pheresis Tx overnight.\\n   Response:\\n   No problems @ this time.   PLT CT drawn @ 0600.\\n   Plan:\\n   Next pheresis Tx most likely Sun am.  Transfer back to floor later this\\n   am.  Check results of am labs.\\n   Chronic back pain\\n   Assessment:\\n   Patient appeared comfortable, but responded that she had [**8-7**] back pain\\n   when asked.\\n   Action:\\n   Lidocaine patch placed to lower back, 50mg ultram po given, 5mg po\\n   oxycodone given.  Patient repositioned.\\n   Response:\\n   No relief of pain from above.    1mg IV dilaudid given  w/relief.\\n   Plan:\\n   Reposition patient as needed.  Assess for pain.  Medicate as needed.\\n',\n",
              "  'Pt admitted to 12R yesterday pre-op for cystectomy [**1-16**] bladder CA. Pt\\n   underwent radical cystectomy w/ iliocondiuit placement and pelvic lymph\\n   disection in OR on [**10-25**]. Pt received 2 units PRBC overnoc, pre-op hct\\n   34, interop hct 32. EBL 700ml, pt received 1 unit PRBC interop, and 3L\\n   IVF. Pt transferred to MICU post op for further management. Extubated\\n   in MICU @ 1900 on [**10-25**].\\n   .H/O chronic obstructive pulmonary disease (COPD, Bronchitis,\\n   Emphysema) without acute exacerbation\\n   Assessment:\\n   Lungs: clear throughout.\\n   Action:\\n   Titrated humidified O2 via face mask from 50% to 35% (the lowest\\n   setting).  Using IS X10 q 2 hrs w/assistance.  C&DB q 2 hrs.   Turned q\\n   2 hrs.  Attempted CPT but patient resisted because of discomfort.\\n   Given advair inhaler & atrovent inhaler overnight.\\n   Response:\\n   O2 sats remained 97-99%.  Nonproductive cough.  O2 sat 95% when O2 off\\n   for a while.\\n   Plan:\\n   Continue pulmonary toilet.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient using PCA : morphine (1.5mg/6 min/10mg lockout) w/ more\\n   attempts than necessary @ first\\n   Action:\\n   Given dose via PCA before turning.\\n   Response:\\n   Had 186 attempts w/8 delivered doses @ first, dropped to 8 attempts w/2\\n   delivered doses a few hours later.  Says he doesn\\nt have pain when\\n   lying still-still has pain w/turning.\\n   Plan:\\n   Continue to medicate patient w/PCA for turns.  Continue to monitor PCA\\n   use & effectiveness.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Ileal conduit has red stoma.  Appliance intact over it.  Draining dark\\n   pink urine w/occasional clots..  Abdominal DSD D&I.  JP draining\\n   45-65cc sanguinous drainage, emptied 4-6 hrs.  T 101 po @ 1900, down to\\n   98.9 po @ 0400.  No Tylenol given.\\n   Action:\\n   Emptied JP q 4-6 hrs.\\n   Response:\\n   Hct 25.2 (27.1)\\n   Plan:\\n   Continue to assess for bleeding & infection.\\n   Patient has hx PVD w/ bypass grafts to legs.  [**Name (NI) 2040**] PT\\n   bilaterally.  Only R DP dopplered, unable to Doppler L DP.  Dopplered L\\n   Anterior tibial pulse.  Feet cold & pale, not blue.  No ulcers.\\n     R IJ is bent @ insertion/exit site.  Positional.  Works best when\\n   patient\\ns head turned to R slightly.\\n   Received 50cc NS bolus @ [**2136**] for CVP 6 & BP 100\\ns/systolic.  CVP up to\\n   10 @ midnight, back down to 6 @ 0400.  BP improved though @\\n   120\\ns/systolic.  Received D5LR @ 150cc/hr throughout night.\\n   FS up to 262 on D5LR.  Covered w/regular sc insulin 1 6 hrs.\\n',\n",
              "  '82 y/o, M with severe gallstone pancreatitis and acute on chronic renal\\n   failure. ERCP with sphincterotomy on [**9-16**]. Remains Intubated post\\n   procedure for hypercarbic respiratory failure. Pt continues with\\n   profound metabolic acidosis and hypocalcemia. Pt also with a new RLL\\n   infiltrate, likely aspiration pneumonia.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Patient remained on A/C @ 40% w/400 Vt/ RR 18/ 8 PEEP overnight.  O2\\n   sats 92-98%    Patient has stable B pleural effusions by CXR ([**9-20**]) &\\n   atelectasis.\\n   Action:\\n   Suctioned patient q 4 hrs after instilling NS to loosen secretions, for\\n   small to moderate amounts tenacious clear to white secretions.\\n   Received  fentanyl IV @ 100mcg/hr & versed IV @ 4mg/hr to maintain\\n   sedation overnight.  Had CXR this am.\\n   Response:\\n   ABG\\ns: 7.31/41/92/-[**6-15**]  ( Metabolic acidosis)\\n   Plan:\\n   Start to wean sedation in am.  Continue to Sx q 4 hrs to prevent mucous\\n   plugs.\\n   Pancreatitis, acute\\n   Assessment:\\n   Patient had ERCP late afternoon [**9-20**].  Has had firm distended abdomen\\n   due presumably to air afterwards.  Hypoactive bowel sounds.  Had guiac+\\n   brown liquid BM X1 & positive flatus.\\n   Action:\\n   Had KUB @ [**2074**] [**9-20**] which could not r/o SBO especially in setting of\\n   pancreatitis.  NGT to low wall Sx, drained bilious fluid.  Tube feeding\\n   held.  Patient remains NPO, receiving TPN for nutrition.\\n   Response:\\n   Bladder pressures dropped from 13 @ [**2144**] to 6 @ 0500.     Lactate 1.4 @\\n   2100 [**9-20**].   Patient\\ns abdomen is a little softer @ 0500 than @ [**2144**].\\n   Plan:\\n   Continue to keep patient NPO w/low wall Sx until SBO r/o\\n   Renal failure, acute (Acute renal failure, ARF)/ Hypocalcemia\\n   Assessment:\\n   iCa @ 2100 ([**9-20**]): 1.10 (1.12-1.32 WNL)\\n   Action:\\n   Received 2Gm IV calcium gluconate @ 2300 [**9-20**]\\n   Response:\\n   iCa w/am labs: 1.08  Given 2Gm calcium gluconate @ 0645\\n   Plan:\\n   Continue to check calcium levels q 6-8 hrs & replete as needed.\\n',\n",
              "  'Mr. [**Known lastname 9611**] is an 83M with severe pancreatitis, respiratory failure, s/p\\n   tracheostomy, acute on chronic renal failure and septic shock.  Patient\\n   is a full code.\\n   Patient had abdominal CT [**10-21**], awaiting results.  Had A-line replaced\\n   over a wire [**10-22**].\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Remains on A/C @ 40%  w/ Vt500/ RR22/ PEEP 8.\\n   Action:\\n   Suctioned q 3-6 hrs for nothing to moderate amount thick white\\n   secretions.  Lungs are clear w/diminished breath sounds @ bases.\\n   RR22-28.  O2 sats: 96-100%mostly.  Desatted down to 90% while lying\\n   flat on R side (for linen change/back care)- only improved to 92% on\\n   FiO2 100% until patient repositioned.\\n   Response:\\n   Patient requires less suctioning.    ABG\\ns: 7.45/34/87\\n   Plan:\\n   Monitor ABG\\ns.   Continue VAP prevention.  Now on A/C @ 40% w/Vt 500/\\n   RR 18/ PEEP 8.\\n   Pancreatitis, acute\\n   Assessment:\\n   No c/o abdominal pain.  Abdomen remains firm &\\n   distended:unchanged.         Lactate: 2.7 (2.8)        NGT   drained\\n   100cc bilious fluid from 1900-midnight.    Had abdominal CT on\\n   [**10-21**]-results pending.  Flexiseal drained 200cc green liquid stool.\\n   Action:\\n   Continues to receive tube feedings w/postpyloric tube, now up to\\n   maximum of 40cc/hr.\\n   Response:\\n   No evidence of tube feeding in NGT output.\\n   Plan:\\n   Check NGT residual q 4 hrs-do not discard unless >200cc.  Continue to\\n   decompress stomach per NGT as needed for NGT output>200cc.\\n   Sepsis\\n   Assessment:\\n   Lactate 2.7 (2.8)           WBC 26.0 (28.5)                 Tmax 99.9\\n   po overnight.\\n   Action:\\n   Continues of IV phenylephrine @ 4-5mcg/kg/min.  Also continues on IV\\n   micafungin for yeast Cx\\ned [**10-15**] from dialysis catheter tip & IV vanco &\\n   cefepime (for klebsiella in sputum Cx  [**10-13**]).  Titrated phenylephrine\\n   IV down to 4mcg/kg/min.\\n   Response:\\n   BP ranges from 86/systolic to 130\\ns/ on phenylephrine 5mcg/kg/min.  NBP\\n   correlates w/A-line.\\n   Plan:\\n   Draw vanco level daily.  Dose vanco according to level.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   C/o generalized body aches & pains.\\n   Action:\\n   Repositioned frequently.  Received 10mg oxycodone w/650mg acetominophen\\n   per feeding tube @ midnight.\\n   Response:\\n   Pain relieved after midnight.& patient able to sleep for a few hours.\\n   Refused sleeping med.\\n   Plan:\\n   Continue to assess for pain.  Medicate w/oxycodone/acetominophen as\\n   needed for generalized body pain,  Monitor for bowel sounds & gastric\\n   motility w/use of oxycodone.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 36 (28)             Cr 1.9 (1.5)             K 3.4 (3.9)\\n   HCO3: 23 (22)       pH 7.45 (7.48)       Gained 0.1kg by bed scale\\n   since yesterday.  Gained 1L yesterday by I&O, & gained 100cc today.\\n   Action:\\n   Patient remains off CRRT since 1000 [**10-21**] when he became hypotensive&\\n   tachycardic to 120\\ns w/increased ventricular ectopy w/ attempted\\n   reinitiation of CVVHDF (Qb 100-150, PFR 0).\\n   Response:\\n   Patient had been clotting off filters (high TMP) w/little visible\\n   evidence of clotting perhaps secondary to cytokines & other byproducts\\n   of sepsis clogging filters.  Perhaps hemodynamic instability w/\\n   initiation from dialyzer reaction?  No c/o back pain.  No c/o SOB  but\\n   on vent.\\n   Plan:\\n    Await decision from renal  re:  CRRT.   Discuss w/renal &/or [**First Name4 (NamePattern1) **]\\n   [**Last Name (NamePattern1) 4288**]  re: if  another filter membrane is available for CRRT\\n   --perhaps Prisma  (was on prismaflex HF 1000)..\\n   Impaired Coping\\n   Assessment:\\n    Patient mouthed the following words to this nurse, night intern &\\n   resident:\\nStop everything.\\n   When asked by the resident if he wanted\\n   to continue all his present treatments, patient mouthed\\n   Action:\\n   Night resident told the patient to think about this overnight & the\\n   team would discuss it w/him in the morning.\\n   Response:\\n   Patient is communicating more every day by mouthing words.\\n   Plan:\\n   Give PMR to patient during day (tolerates this for 10min)  so he can\\n   discuss his feelings w/his family.\\n   ------ Protected Section ------\\n   CT of abdomen ([**10-21**]) showed unchanged severe pancreatitis, unchanged\\n   moderate ascites, moderate bilateral effusion w/ compression\\n   atelectasis.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 212**] [**Last Name (NamePattern1) 605**], RN\\n   on:[**2153-10-22**] 06:25 ------\\n',\n",
              "  'Mr. [**Known lastname 9611**] is an 83M with severe pancreatitis, respiratory failure, s/p\\n   tracheostomy on [**9-28**], PEG [**10-25**], acute on chronic renal failure and\\n   septic shock.  Patient is a full code.\\n   Sepsis, Severe (with organ dysfunction)\\n   Assessment:\\n   BP: 112-135/41-55                    HR: 59 SB- 71 SR w/rare\\n   PVC\\ns         WBC 11.2 (9.8)\\n   Action:\\n   Received vasopressin @ 2.4 units/hr overnight.     Continues on\\n   cefepime IV & tobramycin by inhalation.  Contact precautions maintained\\n   for resistant pseudomonas growing in sputum.  Vasopressin off 0300-0315\\n   until BP dropped to 102/43 w/MAP 57\\n   Response:\\n   MAP maintained>65 on vasopressin IV.  Tried to shut it off\\n   unsuccessfully @ 0300.\\n   Plan:\\n   Continue to attempt to titrate vasopressin down as tolerated.\\n   Respiratory failure, acute (not ARDS/[**Doctor Last Name 11**])\\n   Assessment:\\n   Remained on CPAP w/12 PS & 5 PEEP.  ABG\\ns were 7.36/52/66 on FiO2 40%\\n   (& O2 sat 96%).     O2 sats: 96-98%.   C/o SOB @ [**2144**] w/O2 sat 96% &\\n   RR17.\\n   Action:\\n   Suctioned q 1-4 hrs for moderate amount thick white secretions.  FiO2\\n   was increased to 60% @ 0500.\\n   Response:\\n   ABG\\ns on FiO2 60%:  7.34/55/101 w/O2 sat 100%.  FiO2 dropped to 50% @\\n   0540.\\n   Plan:\\n   ABG\\ns on FiO2 50% were:\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 68 (72)                     Cr 2.5 (2.5)                        K\\n   3.7 (3.9)                         HCO3: 32 (28)   Patient was 760cc\\n   fluid positive yesterday [**10-30**] & 200cc  positive so far today [**10-31**].\\n   Since admission, he gained 31.7 liters fluid.  Patient gained 2.2kg by\\n   bedscale since yesterday.  CVP 9-10\\n   Action:\\n   IV lasix drip stopped @ 1800 per team for hypotension earlier.\\n   Response:\\n   U/o remained 14-55cc/hr  overnight.\\n   Plan:\\n   Restart IV lasix drip later this morning.  If patient needs CRRT or\\n   hemodialysis, his L IJ  temporary dialysis catheter will need TPA or to\\n   be replaced.  No pull from either lumen.  Heparin replaced in each\\n   lumen.\\n   Chest pain\\n   Assessment:\\n   Patient had no c/o chest pain.  Did c/o abdominal tightness which was\\n   unchanged all day.  C/o SOB @ [**2144**] w/O2 sat 96%  & RR 17.     Hct 24.3\\n   (26.4)\\n   Action:\\n   EKG done @ [**2144**], no changes.  IV heparin D/C\\ned @ 2315.  Now on sc\\n   heparin tid.  Started on lopressor 12.5mg [**Hospital1 **] via PEG.\\n   Response:\\n   Troponin remains between 0.09-0.10 w/CK dropping.  ?If troponin leak\\n   w/renal failure.\\n   Plan:\\n   Continue to monitor for cardiac Sx.  Continue to follow cardiac\\n   enzymes.\\n',\n",
              "  '59 YO  s/p R Total Knee Replacement  (uncomplicated) admitted from [** 215**]\\n   for monitoring of resp status (hx OSA & angioedema following IgG\\n   administration a year ago).\\n   PMH/PSH: OA severe, chronic urticaria, steroid induced DM,\\n   fibromyalgia, allergic rhinitis, obesity s/p gastric bypass, long QT\\n   syndrome, OSA but refuses to use CPAP, hypothyroidism, cystocele,\\n   fld-filled paraspinal mass\\n   Allergies: Sulfa, methadone\\n   In [**Name (NI) 215**] pt put on ketamine gtt ( via PCA pump). Patient arrived on CPM\\n   @ 0-60 degrees to R knee.\\n   Note: Patient takes own meds which are in clear plastic box in room (\\n   not w/in patient\\ns reach).  Says she cannot take generic meds provided\\n   by hospital, that they may give her an adverse reaction.\\n   [**Last Name 19**] Problem\\n [**Name (NI) 217**] R total knee replacement [**7-6**]\\n   Assessment:\\n   Ace wrap to R knee & leg D&I.  B DP\\ns & PT\\ns easily palpable.  [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **]\\n   intact but no [**Male First Name (un) **] stocking on R due to ace wrap to R leg.  B pneumo\\n   boots in place.  Hemovac/JP kept @ half  compression & drained  170cc\\n   sanguinous drainage from 1900-0000.  Tmax 99.1 po.  Started dilaudid\\n   PCA (.25/10/1.5 mg) @ [**2153**] for c/o R knee pain unrelieved w/basal rate\\n   of 10mg/hr  ketamine.\\n   Action:\\n   Removed CPM for night @ 2300.  Kept pillow between knees.  Kept towel\\n   under R ankle to elevate R heel off bed.  No pillow under R knee.\\n   Patient used IS X10 q 1 hr while awake.\\n   Response:\\n   Patient c/o intolerable hip (&back) pain when turned side to side\\n   despite IV ketamine & dilaudid PCA\\n   Plan:\\n   Kept patient supine overnight.\\n   .H/O obstructive sleep apnea (OSA)\\n   Assessment:\\n   RR 12-21 overnight.  O2 sats: 95-98% on 2L NP[**MD Number(3) 218**]: clear to\\n   auscultation.    Refused  CPAP/bipap w/hx OSA.\\n   Action:\\n   Patient required continuous O2 sat monitoring in presence of ketamine &\\n   dilaudid for pain as well as OSA\\n   Response:\\n   O2 sats as above.\\n   Plan:\\n   Transfer patient to floor  in am [**7-7**]\\n   .H/O back pain\\n   Assessment:\\n   Patient  has chronic back pain, which she experienced when not supine.\\n   R leg [**Month/Year (2) **] pain more intense.  Refused bedpan for this reason.\\n   Action:\\n   Received neurontin 300mg X2 in eve & 20mg flexeril po which she\\n   chronically takes.  Not given lunesta (sleeper she usually takes) in\\n   presence of anesthesia earlier in day as well as IV ketamine &\\n   dilaudid.  Also not given darvocette.\\n   Response:\\n   Lights out by 2315.  Fell asleep in 15min.\\n   Plan:\\n   Continue to position patient as she tolerates & encourage IS, C& DB.\\n   .H/O [**Last Name **] Problem\\n Hx prolonged QT interval w/possible syncope\\n   Assessment:\\n   QTc =.38   HR: 60\\ns-70s SR no ectopy  BP: 90\\ns-130\\n   Action:\\n   Avoided all possible causes of prolonged QT interval such as low K, low\\n   Mg, dehydration, starvation, hypothyroidism ( received levothyroxin\\n   pre-op), and all meds that could lead to prolonged QT (meds listed @\\n   end of this note, & obtained from\\nUp to Date\\n   Response:\\n   QT interval remained WNL.  HR as above.\\n   Plan:\\n   Avoid all possible causes of prolonged QT interval as above\\nlist of\\n   meds to avoid in front of med book as well.\\n   Medications that could lead to Prolonged QT interval:\\n   Anti-arrythmics:  quinidine, procainamide, disopyramide, amiodarone,\\n   sotalol, dofetilide, ibutilide, azimilide, sematilide\\n   Anti-microbials: erythromycin, clarithromycin, telithromycin,\\n   azithromycin (minor), some fluoroquinolones (levofloxacin,\\n   moxifloxacin, sparfloxacin, gatifloxacin).\\n   Other antimicrobials: spiramycin, chloroquin, halofantrine, mefluquine\\n   Antihistamines: terfenadine, astemizole\\n   Psychotropics: thioridazine, phenothiazines, tricyclic or tetracyclic\\n   antidepressants, haloperidol & other batyrophenones, selective\\n   serotonin reuptake inhibitors, risperidone, methadone\\n   Other drugs: vasodilators:prenylamine, bepridil, mibefradil\\n                        Diuretics: via electrolyte changes ( hypokalemia,\\n   low Mg)                   Serotonin antagonist: ketanserin\\n                        Motility drugs: cisapride, domperidol\\n                                Droperidol, ranolazine\\n                        HIV protease inhibitors, organophosphate\\n   insecticides, probucol, cocaine, terodiline, papaverine, chloral\\n   hydrate,\\n   Arsenic trioxide (chemo), cesium chloride, levomethadyl.\\n',\n",
              "  'This 81 yr old Cantonese speaking woman was admitted to [**Hospital3 **]\\n   on [**9-21**] w/cholecystitis, ARF, pneumonia, & UTI.  Had cholecystotomy\\n   tube placed to decompress gallbladder.  On [**9-30**], abd CT  found tube no\\n   longer in place.  Transferred here for ERCP.  Started hemodialysis [**9-25**]\\n   for ARF from sepsis, dehydration & possible NSAID use.  Last HD [**10-1**],\\n   but Tx abbreviated.\\n   Had ERCP [**10-1**] here & stent placed.  Anesthesia placed ET to protect\\n   airway for procedure.  Will remain intubated overnight, to be extubated\\n   in am.  Patient is CO2 retainer.  Plan is to transfer her back to\\n   [**Hospital3 187**] today if OK w/GI team.\\n   Airway, Inability to Protect (Risk for Aspiration, Altered Gag, Airway\\n   Clearance, Cough)\\n   Assessment:\\n   On A/C @ 40%/400/16/ 5 PEEP overnight.  Lungs: upper exp wheezes, clear\\n   @ R base, crackles @ L base.\\n   Action:\\n   Sx\\ned for small amt bloody secretions (from intubation).  On propofol\\n   20-25 mcg/kg/hr until 0550 when it was stopped in order to arouse\\n   patient.  Had received 25mcg fentanyl IV in GI Unit during ERCP @\\n   2120.  Patient had received 50 mcg fentanyl @ 12 noon [**10-1**] & not\\n   awoken until 1900.\\n   Response:\\n   ABG\\ns: 7.38/50/117   (Previous ABG\\ns 7.39/50/421 on 100% FiO2)\\n   Plan:\\n   Will extubated patient  today if possible.  Awaiting patient to awaken\\n   more for RSBI.  Consider narcan if patient does not awaken in a timely\\n   fashion.\\n   [**Last Name 19**] Problem\\n S/p ERCP [**10-1**]\\n   Assessment:\\n   Had 2 small BM\\ns after ERCP.  + Bowel sounds.  Soft distended abdomen.\\n   No indications of pain.\\n   Action:\\n   Kept NPO.\\n   Response:\\n   Lipase 169 (179)        All LFT\\ns are down from last evening pre ERCP\\n   Plan:\\n   For abdominal ultrasound [**10-2**].\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   BUN 28 (24)          Cr 3.5 (3.2)            K 4.0 (4.2)   Serum\\n   albumin 2.6 (dropped from 3.2 but she may have received IV  albumin\\n   during dialysis.\\n   Action:\\n   Received shortened hemodialysis Tx [**10-1**] during which less than 1 kg\\n   was removed, in order to facilitate transfer to [**Hospital1 1**].\\n   Response:\\n   EDW may be 66 kg (post wgt on [**9-29**]).  Wgt on arrival was 67.3kg.\\n   Scale now not working\\nsays 64.3kg w/2.2 kg extra on the bed.\\n   Plan:\\n   MICU team to contact nephrology.\\n   Impaired Skin Integrity\\n   Assessment:\\n   Patient had femoral catheter @ [**Hospital3 **] which was removed @ some\\n   point.  Arrived w/ pressure drsg [**Name5 (PTitle) **] [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 2172**] & drsg [**Name5 (PTitle) **] [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 2172**].\\n   Overnight, had increased strikethrough on L [**Last Name (NamePattern4) 2172**] dressing which\\n   resolved.\\n   Action:\\n   Changed dressings to both groins: Folded 4X4 @ L [**Last Name (NamePattern4) 2172**] & 2 bandaids @ R\\n   [**Last Name (NamePattern4) 2172**].\\n   Response:\\n   No bleeding presently from either puncture site.   Small ecchymosis\\n   covered by drsg & even smaller hematoma (1X2cm) found under drsg @ L\\n   [**Last Name (NamePattern4) 2172**].  Nothing @ R [**Last Name (NamePattern4) 2172**].\\n   Plan:\\n   Continue to check B groins for bleeding.\\n',\n",
              "  'vv87M with history of prostate CA, bladder rupture, indwelling foley\\n   and multiple UTIs presents to ED [**6-3**] 09  from NH with weeks of lower\\n   abdominal pain, groin pain. Bright red hematuria at NH. Foley changed 1\\n   week ago with sm amount of blood that cleared at the time. In [**Name (NI) **] pt had\\n   n/v and one episode of abd pain,tachycardia with HR 130s while\\n   vomiting. Abd soft He had gross hematuria noted and urology consulted,\\n   per their recs CT with IV contrast which showed the foley catheter\\n   balloon dilated in urethra, urology came and replaced the foley.  Pt\\n   started to become hypotensive, lowest BP to 65/30, had received\\n   approximately 2-3L liters IVF with minimal response.  Had RIJ line\\n   placed, was started on on norepinephrine, labs notable for lactate 2.4,\\n   WBC 7.7 with 15% bands.  UA positive.  Got CTX/gent/vanc.\\n   Overnight pt\\ns abdominal pain worsened. A-line was placed and pt\\n   received 2.5 liters IVF boluses for hypotension/tachycardia. Given\\n   morphine PRN for pain. Lactate was rising throughout the night and AM.\\n   Decision was made to take pt to OR.\\n   Pt went to OR at 9AM on [**2176-6-4**]. He had exploratory lap with repair of\\n   bladder rupture and release of some bowel adhesions. Supra-pubic tube\\n   was placed in bladder and foley remained in place. JP was inserted in\\n   his peritoneum which will drain the peritoneal fluid as well as left\\n   over urine in peritoneum. He had general anesthesia, required sone neo\\n   intra-operatively but returned off pressors. He did receive 3.8 liters\\n   crystaloids in OR.\\n   Pt returned to ICU at 12:30 [**6-4**] with stable vital signs, sleepy but\\n   extubated with stable O2 sat on 4L simple face mask.. His blood gas is\\n   acidotic and the lactate continues to rise somewhat. He continues on\\n   triple antibioitics and all drains seem to be functioning well. He has\\n   a midline abdominal incision covered with gauze which is stained with\\n   serous fluid. Will need to be followed closely post-operatively. [**Month (only) 60**]\\n   change midline abdominal wound dressing PRN.   Vigileo D/C\\ned on [**6-5**].\\n   Peritonitis (non-SBP)\\n   Assessment:\\n   Midline abdominal incision stapled & intact.  No redness.  Patient is\\n   leaking serous drainage from abdominal incision, JP exit site &\\n   suprapubic tube exit site especially.    WBC 11 (12.6)\\n   Action:\\n   Abdominal dressing changed @ midnight & prn.  JP drainage sent for Cr\\n   level.\\n   Response:\\n   Afebrile overnight, after receiving 650mg Tylenol per NGT @ [**2197**].\\n   Plan:\\n   Continue to monitor temp.  Continue to change abdominal dressing [**Hospital1 **] &\\n   prn.\\n   Hypoglycemia\\n   Assessment:\\n   FS was 64 @ [**2167**].        FS was 74 @ 0230.  Patient became agitated\\n   w/each episode FS<80.\\n   Action:\\n   Given 1 amp D50 @ [**2180**].   Given\\n amp D50 @ 0230.\\n   Response:\\n   FS 116 @ 2200 & FS 92 @ midnight.  Started tube feed w/fibersource HN @\\n   10cc/hr @ 2300. FS @ 0530:101\\n   Plan:\\n   As patient ran hypoglycemic all afternoon [**6-5**] after\\n dose NPH,\\n   consider cutting dose NPH again on [**6-6**].\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient had abdominal pain [**6-9**] w/coughing & dressing change & [**9-9**]\\n   w/turning.\\n   Action:\\n   Medicated w/0.25-0.5mg IV dilaudid IV  q 2 hrs prn for abdominal pain.\\n   Response:\\n   Patient\\ns pain dropped to 2/10 after IV dilaudid.   BP dropped\\n   transiently after 0.5mg IV dilaudid.  MAP remained >65.\\n   Plan:\\n   Continue to medicate w/0.25mg IV dilaudid q 2 hrs prn abdominal pain\\n   [**Last Name **] Problem\\n mental status changes\\n   Assessment:\\n     Patient became progressively more disoriented overnight.  He did not\\n   sleep, but lay in bed w/his eyes open.  At 0200, he became paranoid &\\n   afraid, saying that he was going to die, that there was a fire & anyone\\n   in his room was going to die.  Then he said things were falling down &\\n   he was going to die.\\n   Action:\\n   Medicated for pain w/0.25mg dilaudid(@ 0215) & given\\n amp D50 @ 0230\\n   for low FS. Patient remained agitated & fearful.   Given zyprexa 2.5mg\\n   per NGT @ 0300.\\n   Response:\\n   Patient calmed down by 0330.\\n   Plan:\\n   Continue to orient patient.   Continue to provide adequate pain\\n   management.  Continue to maintain adequate serum glucose level.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 90\\ns-110\\ns AF no ectopy.  A-line positional as patient moves hand\\n   so much.\\n   Action:\\n   Held lopressor @ midnight for BP<100/systolic\\n   Response:\\n   BP : 100\\ns-150\\ns/ while awake, down to 80\\ns-90\\ns/systolic while asleep\\n   after zyprexa\\n   Plan:\\n   Continue to monitor HR & BP\\n   Repleted w/2 packets neutraphos @ 0300 [**6-6**] for serum PO4 1.6 @ 2300\\n   [**6-5**].  PO4 @ 0400: 1.8.\\n   ------ Protected Section ------\\n   Gentamycin held overnight awaiting genta level to be drawn @ 0400.\\n   Came back @ 2.5.  Team wants level of 2.0 or <.  Will continue to hold\\n   gentamycin per intern.\\n   Tube feeding held @ 0500 for TF residual of 180cc. (>150cc).  Will\\n   check next residual @ 0800.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2176-6-6**] 06:00 ------\\n   Problem : Mental status changes (addendum)\\n   Assessment: Patient required bilateral soft limb arm restraints as he\\n   picked @ lines ( A-line especially, CVL)  unknowingly starting to pull\\n   line out.  All 4 siderails up as well.  Patient is oriented only to\\n   himself.  Is not aware of where he is (denies repeatedly that he is in\\n   the hospital after being oriented), nor when it is\\n   (time).\\n                                                    Action: Removed limb\\n   restraints while @ patient\\ns bedside ,doing his care.  Turned patient\\n   light on when he thought his empty room was full of people.  Turned\\n   light off when light was too much stimulation.  Sat by patient\\n   bedside for 1.5 hrs when he was paranoid & afraid, to reassure him of\\n   his safety.  Held his hand. Explained procedures before doing\\n   them.\\n                 Response: He soon started to pull @ his lines.  He tugged\\n   @ his JP tube, his foley & removed his O2 sat.  He then started to pull\\n   @ his A-line.  His arms were then restrained again.\\n   Plan: Continue bilateral limb restraints until patient no longer\\n   requires them.   Continue to assess need for restraints.\\n   ------ Protected Section Addendum Entered By:[**Name (NI) 1095**] [**Last Name (NamePattern1) 1349**], RN\\n   on:[**2176-6-6**] 07:39 ------\\n',\n",
              "  '68F ventilator-dependent secondary to [**Last Name (un) 9456**]-[**Location (un) **] vs CIPD,\\n   insulin-dependent diabetes mellitus, recurrent urinary tract infections\\n   with chronic indwelling Foley catheter, recent C difficile infection on\\n   vancomycin PO admitted from [**Hospital 328**] Rehab for fever x1 week, diarrhea,\\n   and lethargy x1 days.  On [**7-13**], dropped BP to 80\\ns/50 w/poor u/o.\\n   T101po.   Lactate 1.1, down to 0.7.  Received 6L NS.  BCX2 & urine Cx\\n   sent.   Started on ARDs net protocol.     A-line placed but patient\\n   refused CVL.  Has R AC midline & #18G PIV @ L AC.\\n   .H/O respiratory failure, chronic\\n   Assessment:\\n   Patient remains on A/C @ 40% w/400cc Vt/ 20 RR/ 5 PEEP.  Patient\\n   overbreathing vent by 5-10 breaths/min.  Patient continues to clench\\n   teeth w/mouth care & nystantin.  Afebrile.  Sputum from [**7-11**] grew\\n   sparse to moderate gram negative rods (3 kinds).\\n   Action:\\n   Suctioned q 4 hrs for thick yellow secretions. Turned q 2 hrs.  Po\\n   cipro D/C\\ned.  Continues on IV meropenum & IV vanco.\\n   Response:\\n   ABG\\ns: ([**7-13**]@  2200) 7.32/51/84\\n   Plan:\\n   Continue to suction as needed.  Continue to check ABG\\ns w/any vent\\n   change.\\n   Diarrhea\\n   Assessment:\\n   Patient continues to have liquid brown stool.  Stool specimen from [**7-12**]\\n   was negative for C-diff.  Skin reddened @ peri-anal area & upper thighs\\n   between legs.\\n   Action:\\n   Flexiseal placed [**7-13**].  Continues on po vanco for C-diff.  Applied\\n   nystantin cream to upper thighs.  Used barrier cream mixed w/nystantin\\n   cream to peri-anal area.\\n   Response:\\n   Flexiseal collecting stool & flatus.\\n   Plan:\\n   Send another stool specimen for C-diff.\\n   Fever, unknown origin (FUO, Hyperthermia, Pyrexia)\\n   Assessment:\\n   BC & urine Cx from [**7-13**] are pending. Urine from [**7-11**] grew yeast.    WBC\\n   6.6 on [**7-13**], down from 10.2.  Patient had general edema before 6L IVF.\\n   Action:\\n   Received  IV abx as above.\\n   Response:\\n   Tmax 100.1 po    WBC on [**7-14**]:   7.5\\n   Plan:\\n   Hydrate w/LR instead of NS if patient needs more IV fluid.\\n   Hct  22.7, down from 25.3 earlier on [**7-13**].    Received 1 unit PRBC\\n   2200.  Post Hct was:  26.3 @ 0330 [**7-14**].\\n',\n",
              "  '48 yr old HIV+ man transferred  w/PCP pneumonia from 11R.  Here for\\n   bactrim desensitization.  Had pancreatitis in past from bactrim.\\n   PMH: asthma & parotitis.\\n   Pneumonia, pneumocystis jiroveci (PCP, [**Name10 (NameIs) **] [**Name11 (NameIs) **] Pneumonia)\\n   Assessment:\\n   RR 20-27  O2 sats 94-96% on room air.  Lungs: clear w/diminished breath\\n   sounds @ bases. Tmax 98.9po\\n   Action:\\n   Given clindamycin IV q 8 hrs.\\n   Response:\\n   Patient is breathing comfortably.\\n   Plan:\\n   Bactrim desensitization  not done overnight as patient\\ns adverse\\n   reaction to bactrim was pancreatitis.  This was thought not to be a\\n   histamine mediated response by the resident.   Await ID\\ns final\\n   recommendation.\\n',\n",
              "  'Pt w/ type 1 diabetes known to be brittle ,now with fetal demise\\n   .Arrived from OSH after 3 day hx of N/V. Pt w/ large morphine\\n   requirements from chronic pain r/t multiple surgeries for ovarian cysts\\n   and endometriosis. Pt was found to be in DKA and was started on insulin\\n   gtt and transferred to the ICU for further management. Once her gap is\\n   closed she will go to L&D and will have induction of labor. [**8-3**] CT\\n   abdomen done.\\n   Diabetic Ketoacidosis (DKA)\\n   Assessment:\\n   Patient admitted with DKA from outside hospital, She currently on an\\n   insulin infusion being managed per ICU protocol with the inclusion for\\n   [**Month/Day (4) **] sugars less than 200mg/dl, [**Name8 (MD) **] MD DO NOT TURN OFF DRIP.\\n   FS231-91 since 2200.  Anion gap 14 @ 2200, down from 19 earlier.\\n   Action:\\n   Patient For IVF maintenance she is currently on D5W at 100-150ml/hr.\\n   This is to be continued for 5l as ordered.\\n   Response:\\n    Both the insulin and the D5W are infusing via her power PICC to the\\n   upper left arm.  0035 FS 91.  Insulin now infusing @ 2 units/hr\\n   Plan:\\n   Continue with close monitoring of [**Name8 (MD) **] glucose levels.  Continue\\n   insulin gtt and inform MD [**First Name (Titles) **] [**Last Name (Titles) **] glucose is less than 200.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   Patient with chronic abdominal pain [**1-30**] endometriosis, ovarian cysts\\n   and multiple surgeries. Noted that patient does have elevated liver\\n   enzymes and pain.\\n   Action:\\n   For pain medication intervention she is on morphine 2-8mg IV q4hr/prn.\\n   She prefers that her medication be given in divided doses of 4mgIV\\n   q2hr. Last dose morhine 4mg @ 2130.  Received 1mg IV ativan @ 2200 for\\n   anxiety.\\n   Response:\\n   Patient is rarely pain free but does admit to feeling some relief with\\n   the administration of morphine. No official results from the CT are\\n   back yet.  Fell asleep after ativan.\\n   Plan:\\n   Continue with pain interventions as needed. Monitor for any signs of\\n   respiratory compromise.\\n   [**Last Name **] Problem\\n Fetal demise\\n   Assessment:\\n   Patient with undelivered demised fetus. Lactate 1.5.\\n   Action:\\n   She is to be transferred to L&D some time during the course of the\\n   evening.\\n   Response:\\n   Plan:\\n   Sent to L&D overnight.\\n',\n",
              "  'This is a 36 yr male w/ ulcerative colitis. Sigmoid cancer dx [**4-9**] for\\n   which pt is receiving XRT and chemo (5FU). Pt  3 days into radiation\\n   tx. 5 days into 24/7  6 week  5fu tx awoke [**7-3**] w/ severe abd pain w/\\n   BM . Pt reports feeling light-headed, dizzy and weak on toilet, and\\n   reports that he had to lower himself to floor before he passed out. Pt\\n   reports large amount BRB in toilet\\n mother called 911 and pt brought\\n   to [**Hospital1 54**] by EMS. On arrival to EW pt reports pain [**8-11**], and continued\\n   frequent large BM\\ns (BRB per report). Hct on arrival 41. Pt was given 2\\n   L NS  and 1 unit PRBC in EW. [**7-5**] pt went to or for colectomy and\\n   illeostomy. At that time found sm  perforation of upper rectum.\\n   Transferred back to icu for further monitoring.  Called out to floor\\n   [**7-6**].  Still awaiting bed.\\n   Pain control (acute pain, chronic pain)\\n   Assessment:\\n   C/o incisional pain.  Says pain med (15mg morphine IR) is too strong,\\n   ie makes him sleep, & too weak, ie has pain all the time.  Stood up &\\n   ambulated in room a few steps w/[**2-2**] assist.\\n   Action:\\n   Patient receiving 7.5mg ([**2-2**] pill)  morphine IR po q 2 hrs as needed\\n   for incisional pain.  Tried\\n pill per patient\\ns request.  Patient\\n   started on MS Contin 15 mg po q 12 hrs @ 2200.  Receives 1mg IV zofran\\n   w/each dose morphine per patient\\ns request.  Refuses 4-8mg given @ one\\n   time q 8 hrs as ordered.\\n   Response:\\n   Reduced pain from\\n to\\n on [**2-10**] scale.\\n   Plan:\\n   Continue to assess for pain, offer pain meds.  Get patient up to chair\\n   & ambulate as much as he tolerates.\\n   .H/O ulcerative colitis\\n   Assessment:\\n   Pod#2 s/p colectomy & ileostomy.  Abdominal incision stapled & OTA:\\n   clean & healing.  Ileostomy pink & putting out scant amounts bilious\\n   fluid.  Patient burping but no gas via stoma.  + Bowel sounds.  Hct\\n   26.5 (27.9)  Resident & surgery aware.  No transfusion planned. K3.4\\n   Action:\\n   Patient used IS q1 hr while awake.  NPO except ice chips & meds.  [**First Name8 (NamePattern2) 1270**]\\n   [**Last Name (NamePattern1) 2571**] following, last bag change [**7-6**].  Given zofran q 8 hrs in divided\\n   doses per patient\\ns request.  Repleted w/20 mEq KCl out of 60 mEq total\\n   to be given.\\n   Response:\\n   Lungs clear.  O2 sats 97-100%  on room air.  Ileostomy bag intact.\\n   Ileostomy output =18cc clear bilious guiac neg .\\n   Plan:\\n   Cont to check ileostomy output.  Cont to assess for N/V.\\n   Tmax 101.6po on [**7-7**].  Intern & resident aware.  BC X2 sent  & urine Cx\\n   sent.  Medicated w/Tylenol X2.  All cultures negative to date.\\n',\n",
              "  'New #16 Fr foley placed w/small amount u/o (10cc) immediately out.\\n   Urojet applied to urinary meatus for pain.  1L NS bolus started for\\n   dehydration as shown by low u/o.  Fluid seen on bladder scan most\\n   likely ascites, per intern, Dr [**First Name8 (NamePattern2) 3081**] [**Last Name (NamePattern1) 9286**].  Patient comfortable & in\\n   no  distress, sent to 7 South in own bed, no monitor.\\n',\n",
              "  '88 yo M with bladder cancer s/p recent intravesicular BCG infusion\\n   presents with cardiopulmonary collapse, respiratory failure, ards,\\n   bandemia  after BCG infusion--?  septic shock vs cytokine\\n   storm/inflammatory rx/hypersensitivity rx/ disseminated M Bovis from\\n   BCG.\\n   Renal failure, acute (Acute renal failure, ARF)\\n   Assessment:\\n   Remained on CRRT for 2 hrs from 10-MN.  Filter did not clot off but was\\n   not able to be used further.  Restarted @ 0330 w/new filter w/out\\n   problems.\\n   Action:\\n   Started citrate to prolong duration of filter use (>24 hrs considered\\n   minimum).\\n   Response:\\n   Unable to remove fluid overnight as had so much fluid to account for.\\n   Plan:\\n   Remove 50-100cc/hr as patient tolerates.\\n   .H/O acute Respiratory Distress Syndrome (ARDS, Acute Lung Injury, [**Doctor Last Name 2**])\\n   Assessment:\\n   Remained on A/C @ 40% w/500Vt/RR12 & 8 PEEP.  RR 12-17     O2 sats:\\n   98-100%\\n   Action:\\n   Received 100mcg/hr fentanyl IV & 3mg/hr versed IV overnight.  Suctioned\\n   twice for scant amount thick yellow secretions.\\n   Response:\\n   ABG\\ns: 7.52/ 33/ 85     & later, 7.50/33/102\\n   Plan:\\n   Assess patient for readiness for CPAP.\\n   Shock, septic\\n   Assessment:\\n   BP @ a low of 85/ on 0.6mcg/kg/min levophed  [**6-11**] evening, increased to\\n   160\\ns/ off pressors overnight.  T 97.4ax- 97.9 po overnight.\\n   Action:\\n   Levophed IV weaned off by midnight.  Continues on hydrocortisone IV.\\n   Response:\\n   Remained off pressors since midnight.\\n   Plan:\\n   Place back on levophed in order to remove fluid w/CRRT.\\n   Received cryoprecipitate for fibrinogen level 93 (<100).  Hct down to\\n   22.3 from 24.7.  Intern aware.  Awaiting decision on transfusion.\\n',\n",
              "  'Respiratory failure, acute (not ARDS/[**Doctor Last Name **])\\n   Assessment:\\n   OnCMV  @ 50%/Vt 490/RR 32/PEEP 10.  Last ABG\\ns @0200: 7.26/44/79.  O2\\n   sats 96-98%.  Lungs sounds are clear to diminished throughout.  Small\\n   amount clear oral secretions. Rarely Sx\\ned  inline  for scant\\n   secretions.  Hx emphysema.\\n   Action:\\n   CXR done overnight.\\n   Response:\\n   ABG\\ns @ 0600 improved @ 7.28/44/85.\\n   Plan:\\n   Patient is DNR now.\\n   .H/O liver function abnormalities\\n   Assessment:\\n   Oral gastric tube to low intermittent Sx.  Absent bowel sounds.\\n   Abdomen more firm & didtended than last night.   Ileostomy output\\n   small  , about 40cc for 12 hours of liquid melenotic stool, grossly\\n   guiac +.   INR 5.5  Bladder pressure unchanged @ 10.  Total bili:2.8.\\n   Albumin 3.5.  CTA of abdomen [**4-7**] showed no abcess.  Did show small\\n   amount ascites ( not seen on US).\\n   Action:\\n   Ranitidine per NG changed to protonix  IV.  Received 10mg sc vit K  & 2\\n   units FFP.  X-ray of abdomen done overnight.\\n   Response:\\n   INR dropped to 4.1 after vit K & FFP.\\n   Plan:\\n   Check bladder pressure once a shift.  Guiac stool.  Hold ASA per OGT.\\n   .H/O renal failure, End stage (End stage renal disease, ESRD)\\n   Assessment:\\n     K 5.4 (Mn) BUN 44 & Cr 4.8 @ 2100.  On CVVHDF.  Refer to dialysis\\n   section of metavision for details.\\n   Action:\\n   Attempted to remove 75cc/hr.\\n   Response:\\n   Patient\\ns BP  tolerated it well.  Although he requires triple pressors,\\n   his BP was improved on CVVHDF, perhaps because it treats metabolic\\n   acidosis (lactic acidosis as well as acidosis from ESRD), allowing\\n   pressors to work in more ideal environment . K down to 4.9 @ 0600.\\n   Plan:\\n   Continue CVVHDF.  Too unstable hemodynamically for hemodialysis.\\n   .H/O atrial fibrillation (Afib)\\n   Assessment:\\n   HR: 80\\ns-110\\ns A-fib\\n   Action:\\n   Started back on amiodarone 0.5mg/min IV as his bowel sounds are absent.\\n   Response:\\n   HR maintained as above.  Cardiac echo [**4-7**] showed enlarged R atrium & R\\n   ventricle.  R/o\\ned for PE by CTA on [**4-7**]. Hx COPD.  On  Vigileo monitor\\n   for CCO.  CO 5.4-6.7.  AF disrupts monitors ability to determine CO\\n   however.\\n   Plan:\\n   Attempt to remove up to 75cc/hr w/CVVHDF  to decrease preload.\\n   Shock, septic\\n   Assessment:\\n   Lactate down to 3.3 (from a high of 5) from 3.8.  WBC down to 13 from\\n   18.4 yesterday.\\n   Action:\\n   Remains on 4mcg/kg/min neo & 2.4 units/hr vasopressin.  Levophed ranges\\n   from off to 0.02mcg/kg/min.\\n   Response:\\n   MAP remains >65 on triple pressors.  After levophed off for 30-60min,\\n   MAP drifts down to low 60\\n   Plan:\\n   Continue to run levophed @ low rate until patient tolerates it off.\\n']}"
            ]
          },
          "metadata": {},
          "execution_count": 65
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from scipy.spatial.distance import cdist\n",
        "\n",
        "distortions = []\n",
        "inertias = []\n",
        "mapping1 = {}\n",
        "mapping2 = {}\n",
        "K = range(1, 15)\n",
        "X = sentence_embeddings_np \n",
        "for k in K:\n",
        "    # Building and fitting the model\n",
        "    kmeanModel = KMeans(n_clusters=k).fit(X)\n",
        "    kmeanModel.fit(X)\n",
        "  \n",
        "    distortions.append(sum(np.min(cdist(X, kmeanModel.cluster_centers_,\n",
        "                                        'cosine'), axis=1)) / X.shape[0])\n",
        "    inertias.append(kmeanModel.inertia_)\n",
        "  \n",
        "    mapping1[k] = sum(np.min(cdist(X, kmeanModel.cluster_centers_,\n",
        "                                   'euclidean'), axis=1)) / X.shape[0]\n",
        "    mapping2[k] = kmeanModel.inertia_"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "91vBRnW5tRAN",
        "outputId": "3a21b3b4-7c3d-4dc0-cc21-3b6166d0445d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.9/dist-packages/sklearn/cluster/_kmeans.py:870: FutureWarning: The default value of `n_init` will change from 10 to 'auto' in 1.4. Set the value of `n_init` explicitly to suppress the warning\n",
            "  warnings.warn(\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import matplotlib.pyplot as plt\n",
        "plt.plot(K, distortions, 'bx-')\n",
        "plt.xlabel('Values of K')\n",
        "plt.ylabel('Distortion')\n",
        "plt.title('The Elbow Method using Distortion')\n",
        "plt.show()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 480
        },
        "id": "igGVOyMJtlD_",
        "outputId": "16b8dbd3-b14d-41db-b4bf-bd8e73c37361"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    }
  ]
}